
-- phpMyAdmin SQL Dump
-- version 2.11.11.3
-- http://www.phpmyadmin.net
--
-- Host: 50.63.228.172
-- Generation Time: Dec 20, 2013 at 06:17 AM
-- Server version: 5.0.96
-- PHP Version: 5.1.6

SET SQL_MODE="NO_AUTO_VALUE_ON_ZERO";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;

--
-- Database: `aavishkarllc`
--

-- --------------------------------------------------------

--
-- Table structure for table `inventions`
--

CREATE TABLE `inventions` (
  `id` int(11) NOT NULL auto_increment,
  `submission_date` datetime NOT NULL default '0000-00-00 00:00:00',
  `user_id` int(11) NOT NULL,
  `title` varchar(255) NOT NULL,
  `invention_type` varchar(255) NOT NULL,
  `gansh4_other` varchar(255) NOT NULL,
  `invention_type_other` varchar(255) NOT NULL,
  `category_invention` varchar(255) NOT NULL,
  `cat_invention_1` varchar(255) NOT NULL,
  `cat_invention_2` varchar(255) NOT NULL,
  `name_drug` varchar(255) NOT NULL,
  `cat_invention_3` varchar(255) NOT NULL,
  `impect_areas` text NOT NULL,
  `stage_of_devolpment` varchar(255) NOT NULL,
  `stage_of_devolpment_1` varchar(255) NOT NULL,
  `abstract_invantion` text NOT NULL,
  `institutional_title` varchar(255) NOT NULL,
  `type` varchar(255) NOT NULL,
  `abstract_of_invention` varchar(255) NOT NULL,
  `funding_source` varchar(255) NOT NULL,
  `funding_source_other` varchar(255) NOT NULL,
  `principal_investigator` text NOT NULL,
  `entitiy_name` text NOT NULL,
  `agrement_number` text NOT NULL,
  `amount_of_funding` text NOT NULL,
  `grant_documents` varchar(255) NOT NULL,
  `invention_attachments` varchar(255) NOT NULL,
  `status` enum('open','field','process') NOT NULL default 'process',
  `final_score` varchar(255) NOT NULL,
  `already_invention` varchar(255) NOT NULL,
  `already_invention_date` datetime NOT NULL default '0000-00-00 00:00:00',
  `already_invention_doc` varchar(255) NOT NULL,
  `journal_invention_date` datetime NOT NULL default '0000-00-00 00:00:00',
  `journal_invention_doc` varchar(255) NOT NULL,
  `upcoming_invention` varchar(255) NOT NULL,
  `upcoming_invention_date` datetime NOT NULL default '0000-00-00 00:00:00',
  `upcoming_invention_doc` varchar(255) NOT NULL,
  `submitted_invention` varchar(255) NOT NULL,
  `submitted_invention_date` datetime NOT NULL default '0000-00-00 00:00:00',
  `submitted_invention_doc` varchar(255) NOT NULL,
  `plan_invention` varchar(255) NOT NULL,
  `plan_invention_date` datetime NOT NULL default '0000-00-00 00:00:00',
  `input_key_invention` varchar(255) NOT NULL,
  `prior_inventions` text NOT NULL,
  `other_inventions` text NOT NULL,
  `module3_score` int(11) NOT NULL,
  `have_worked` varchar(100) NOT NULL,
  `estimated_size` varchar(100) NOT NULL,
  `products_exist` varchar(100) NOT NULL,
  `product_count` varchar(100) NOT NULL,
  `products_count` int(11) NOT NULL,
  `products_name` text NOT NULL,
  `limitations` varchar(100) NOT NULL,
  `module4_score` float NOT NULL,
  `result_11b` text NOT NULL,
  `result_11b2` text NOT NULL,
  `distinct_aspects1` text NOT NULL,
  `distinct_aspects2` text NOT NULL,
  `distinct_aspects3` text NOT NULL,
  `result_15b` text NOT NULL,
  `result_15` text NOT NULL,
  `search_15` varchar(255) NOT NULL,
  `text_pdfsearch` text NOT NULL,
  `pdfresult` text NOT NULL,
  `big_company_count` varchar(255) NOT NULL,
  `small_company_count` varchar(255) NOT NULL,
  `signature` text NOT NULL,
  `progress` int(11) NOT NULL default '0',
  PRIMARY KEY  (`id`)
) ENGINE=InnoDB  DEFAULT CHARSET=latin1 AUTO_INCREMENT=249 ;

--
-- Dumping data for table `inventions`
--

INSERT INTO `inventions` VALUES(44, '2013-10-09 12:31:37', 2, 'Science processes and methods', 'patent', '', '', 'gansh3', 'gansh11', 'gansh14_3', '', '', 'Process for catalyst manufacture', 'b', '', 'Process for catalyst manufacture.', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '50', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'process for catalyst manufacture', '{"1":{"radio_11a1":"May be","title":"Olefin catalyst for polymerization","id":"105","status":"field"}}', '{"1":{"radio_11a2":"May be","title":"Olefin catalyst for polymerization","id":"105","status":"Disclosure Done & Under Review"}}', 16, '', '100k-1m', 'No', '', 0, '', 'Maybe', 22, '[{"title":"CATALYST MANUFACTURING PROCESS","link":"http:\\/\\/www.google.com\\/patents\\/about?id=w7R8AAAAEBAJ&dq=process+for+catalyst+manufacture&num=8&client=internal-uds&source=uds;","filedate":"Mon, 28 Jun 1971 00:00:00 -0700","applicant":"","desc":"United States Patent 3,746,657 <b>CATALYST MANUFACTURING PROCESS<\\/b>  Arthur F. Miller and Wilfrid G. Shaw, Lyndhurst, and Hugh M. Blythe, Lima, Ohio,\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Catalyst, process for catalyst manufacture and process for catalytic ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2606963A1?cl=en&dq=process+for+catalyst+manufacture&source=uds;","filedate":"Tue, 20 Dec 2011 00:00:00 -0800","applicant":"Solvay Sa, Technische Universit\\u00e4t M\\u00fcnchen","desc":"The present invention relates to a <b>catalyst<\\/b>, a <b>process<\\/b> for the <b>manufacture<\\/b> of said  <b>catalyst<\\/b> and a <b>process for catalytic<\\/b> oxidative dehydrogenation\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Process for manufacturing ethanol using a tin catalyst supported on titania","link":"http:\\/\\/www.google.com\\/patents\\/WO2013112228A1?cl=en&dq=process+for+catalyst+manufacture&source=uds;","filedate":"Tue, 27 Nov 2012 00:00:00 -0800","applicant":"Celanese International Corporation","desc":"4,804,791 describes another <b>process<\\/b> for the <b>production<\\/b> of alcohols by the  hydrogenation of carboxylic acids in the presence of a <b>catalyst<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Ethanol Manufacturing Process Over Catalyst Having Improved Radial Crush ...","link":"http:\\/\\/www.google.com\\/patents\\/US20130245333?dq=process+for+catalyst+manufacture&source=uds;","filedate":"Tue, 13 Mar 2012 00:00:00 -0700","applicant":"Celanese International Corporation","desc":"Acetic acid is hydrogenation in the presence of a <b>catalyst<\\/b> comprising one or more  active metals on a silica support, wherein the <b>catalyst<\\/b> has a\\u00a0<b>...<\\/b>","radio_11b":"duplicate"}]', '[{"title":"Strategies for Designing Supported Gold-Palladium Bimetallic Catalysts for the Direct Synthesis of Hydrogen Peroxide.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24175914","desc":"Edwards JK, Freakley SJ, Carley AF, Kiely CJ, Hutchings GJ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Accounts of chemical research&quot;&gt;Acc Chem Res&lt;\\/span&gt;. 2013 Oct 31. [Epub ahead of print]","radio_11b2":"duplicate"},{"title":"Life cycle analysis of solvent reduction in pharmaceutical synthesis using continuous adsorption for palladium removal.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23947697","desc":"Slater CS, Savelski MJ, Ruiz-Felix MN.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of environmental science and health. Part A, Toxic\\/hazardous substances &amp; environmental engineering&quot;&gt;J Environ Sci Health A Tox Hazard Subst Environ Eng&lt;\\/span&gt;. 2013;48(13):1602-8. doi: 10.1080\\/10934529.2013.815080.","radio_11b2":"duplicate"},{"title":"In situ reduction study of cobalt model Fischer-Tropsch synthesis catalysts.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23752408","desc":"du Plessis HE, Forbes RP, Barnard W, Erasmus WJ, Steuwer A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Physical chemistry chemical physics : PCCP&quot;&gt;Phys Chem Chem Phys&lt;\\/span&gt;. 2013 Jul 28;15(28):11640-5. doi: 10.1039\\/c3cp50274k.","radio_11b2":"duplicate"},{"title":"From powder to technical body: the undervalued science of &lt;b&gt;catalyst&lt;\\/b&gt; scale up.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23648466","desc":"Mitchell S, Michels NL, P&Atilde;&copy;rez-Ram&Atilde;&shy;rez J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Chemical Society reviews&quot;&gt;Chem Soc Rev&lt;\\/span&gt;. 2013 Jul 21;42(14):6094-112. doi: 10.1039\\/c3cs60076a.","radio_11b2":"duplicate"},{"title":"Gas-liquid countercurrent integration &lt;b&gt;process&lt;\\/b&gt; for continuous biodiesel production using a microporous solid base KF\\/CaO as &lt;b&gt;catalyst&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22940350","desc":"Hu S, Wen L, Wang Y, Zheng X, Han H.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Bioresource technology&quot;&gt;Bioresour Technol&lt;\\/span&gt;. 2012 Nov;123:413-8. doi: 10.1016\\/j.biortech.2012.05.143. Epub 2012 Jul 9.","radio_11b2":"duplicate"}]', 'test test test test', 'test test test test test', 'test test test test test test', '[{"title":"Top 10 <b>Catalysts Companies<\\/b> - Arabian Oil And Gas","link":"http:\\/\\/www.arabianoilandgas.com\\/article-9496-top-10-catalysts-companies\\/1\\/print\\/","desc":"Sep 27, 2011 <b>...<\\/b> Axens is organised along three <b>business<\\/b> units comprising <b>process<\\/b> licensing, \\nperformance and <b>catalysts<\\/b> which commercialise and <b>manufacture<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"W. R. Grace & <b>Co<\\/b>. Enriching Lives, Everywhere.\\u00ae - Specialty <b>Catalysts<\\/b>","link":"http:\\/\\/www.grace.com\\/SpecialtyCatalysts\\/","desc":"<b>...<\\/b> the polyolefins industry for a variety of polyethylene and polypropylene <b>process<\\/b> \\ntechnologies. Our specialty <b>catalysts<\\/b> are used in the <b>manufacture<\\/b> of polyethylene \\nand <b>...<\\/b> Our <b>business<\\/b> is built on the foundation of a global infrastructure, which\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Advanced <b>Catalytic<\\/b> Olefins (ACO\\u2122) | <b>Process<\\/b> Technologies <b>...<\\/b> - KBR","link":"http:\\/\\/www.kbr.com\\/Technologies\\/Process-Technologies\\/Advanced-Catalytic-Olefins\\/","desc":"The ACO <b>catalytic<\\/b> cracking <b>process<\\/b> makes about 15-25% more ethylene plus <b>...<\\/b> \\nComparing the Cost of <b>Production<\\/b> (COP) of ethylene from the ACO <b>catalytic<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Affiliated <b>Companies<\\/b> - Criterion <b>Catalysts<\\/b> & Technologies","link":"http:\\/\\/www.criterioncatalysts.com\\/en\\/about-criterion\\/affiliate-companies.html","desc":"CRI \\/Criterion, <b>Inc<\\/b>. (<b>catalyst manufacturer<\\/b>), Zeolyst (our zeolite-based <b>catalyst<\\/b> \\njoint <b>...<\\/b> styrene <b>production<\\/b>, hydrogenation <b>processes<\\/b>, hydrogen <b>production<\\/b> and\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Petrochemical <b>Manufacturers<\\/b>, <b>Catalyst<\\/b> Reclamation, Hydrogen <b>...<\\/b>","link":"http:\\/\\/www.globalcatalyst.com\\/","desc":"Global <b>Catalyst<\\/b> & Technology Management, PLLC, is a provider of <b>business<\\/b> <b>...<\\/b> \\n<b>catalyst<\\/b> Global <b>Catalyst<\\/b> & <b>Process<\\/b> Technology Management, PLLC assists\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"<b>Catalysts<\\/b>: Petroleum and Chemical <b>Process<\\/b> | IHS Chemical","link":"http:\\/\\/www.ihs.com\\/products\\/chemical\\/planning\\/scup\\/catalysts-petroleum-and-chemical.aspx","desc":"<b>Process catalysts<\\/b>, a $13 billion-per-year <b>business<\\/b> worldwide, play a vital role in \\nthe <b>...<\\/b> About 90% of chemical <b>manufacturing processes<\\/b> and more than 20% of all\\n\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Chemical Engineering, January 2010, Boosting <b>Catalyst<\\/b> Productivity","link":"http:\\/\\/www.qsinano.com\\/pdf\\/jan_10_chem_eng_catalysts.pdf","desc":"chemical <b>process<\\/b> industries (CPI) have depended on <b>...<\\/b> Industrial <b>catalyst<\\/b> \\n<b>manufacturers<\\/b> are partners in <b>...<\\/b> <b>Companies<\\/b> are looking to downsize their \\nequipment\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Locations - BASF <b>Catalysts<\\/b> - The Global Leader in <b>Catalysis<\\/b>","link":"http:\\/\\/www.catalysts.basf.com\\/p02\\/USWeb-Internet\\/catalysts\\/en\\/content\\/microsites\\/catalysts\\/aboutus\\/locations","desc":"<b>Catalysts<\\/b> BASF <b>Corporation<\\/b> 1800 E. President Street Savannah, GA 31404. Tel: (\\n912) 644-3800. Fax: (912) 644-3902, Office <b>Manufacturing<\\/b>, <b>Process Catalysts<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"duplicate"}]', '[{"title":"LyondellBasell Opens Chemical Research Center in Houston <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/news-article\\/7713352-lyondellbasell-opens-chemical-research-center-in-houston","desc":"Sep 30, 2013 <b>...<\\/b> Research and development activities at the facility will focus on improving \\n<b>catalyst<\\/b> and <b>process<\\/b> technologies to reduce <b>manufacturing<\\/b> costs,\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"Honeywell To <b>Build<\\/b> New <b>Production<\\/b> Facility In China To Support <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/news-article\\/7991302-honeywell-to-build-new-production-facility-in-china-to-support-growth-of-performance-materials-and-technologies-business","desc":"Oct 29, 2013 <b>...<\\/b> The initial phase of the project will include a <b>production<\\/b> facility for advanced \\n<b>catalysts<\\/b> for Honeywell UOP''s OleflexTM <b>process<\\/b> technology,\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"Xilinx, Inc. (XLNX): Xilinx Needs New <b>Catalyst<\\/b> To Move Significantly <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1571692-xilinx-needs-new-catalyst-to-move-significantly-higher","desc":"Jul 25, 2013 <b>...<\\/b> Xilinx Needs New <b>Catalyst<\\/b> To Move Significantly Higher <b>...<\\/b> but every time you \\nmake a change you have to redo the <b>manufacturing process<\\/b>.","radio_15":"duplicate"},{"title":"Kadant Is Undervalued With Multiple Value <b>Catalysts<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1599112-kadant-is-undervalued-with-multiple-value-catalysts","desc":"Aug 2, 2013 <b>...<\\/b> KAI <b>manufactures<\\/b> stock-preparation (recovers recycled fibers and <b>processes<\\/b> \\nvirgin fibers), fluid-handling (transfers fluids, steam or air between\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"Honeywell''s UOP Selected To Provide Technology For <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/news-article\\/7614992-honeywells-uop-selected-to-provide-technology-for-petrochemical-production-in-china","desc":"Sep 18, 2013 <b>...<\\/b> ","radio_15":"duplicate"},{"title":"Touch Sensor Wars: Uni-Pixel Vs. CIT - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1100041-touch-sensor-wars-uni-pixel-vs-cit","desc":"Jan 8, 2013 <b>...<\\/b> The <b>manufacturing process<\\/b> to fabricate metal mesh touch sensors consists of \\ndrawing the touch sensing circuit with a special <b>catalytic<\\/b> ink on\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"Intel Treads Water: Bland Benchmarks, No <b>Catalysts<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1752632-intel-treads-water-bland-benchmarks-no-catalysts","desc":"Oct 17, 2013 <b>...<\\/b> Bland business metrics and no ready <b>catalysts<\\/b> signify nothing better than <b>...<\\/b> \\nwhich Intel is managing physical facilities, <b>manufacturing processes<\\/b>\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"Albemarle focuses on growth and innovation with realignment of <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/news-article\\/7656562-albemarle-focuses-on-growth-and-innovation-with-realignment-of-global-business-units","desc":"Sep 23, 2013 <b>...<\\/b> The <b>Catalyst<\\/b> Solutions GBU will include Refinery <b>Catalyst<\\/b> Solutions, <b>...<\\/b> team of \\nsales, R&D, <b>process<\\/b> engineering, <b>manufacturing<\\/b> and sourcing,\\u00a0<b>...<\\/b>","radio_15":"duplicate"}]', 'process for catalyst manufacture', 'process for catalyst manufacture', '[{"title":"THE ADVANCED <b>CATALYTIC<\\/b> OLEFINS (ACO) <b>PROCESS<\\/b> - KBR","link":"http:\\/\\/www.kbr.com\\/Newsroom\\/Publications\\/technical-papers\\/A-Catalytic-Cracking-Process-for-Ethylene-and-Propylene-from-Paraffin-Streams.pdf"},{"title":"syngas <b>production<\\/b> and conversion to products - The <b>Catalyst<\\/b> Group","link":"http:\\/\\/www.catalystgrp.com\\/cmsAdmin\\/uploads\\/PRES-Syngas-Production-and-Conversion-to-Products-Volume1and2.pdf"},{"title":"A <b>catalyst<\\/b> for growth article - LyondellBasell","link":"http:\\/\\/www.lyondellbasell.com\\/NR\\/rdonlyres\\/EF92F59A-27F0-4776-8B73-6E77480A9950\\/0\\/Catalyst_for_Growth.pdf"},{"title":"Refinery <b>catalysts<\\/b> - BASF.com","link":"http:\\/\\/www.basf.com\\/group\\/corporate\\/...\\/function\\/conversions:\\/publish\\/content\\/investor-relations\\/calendar\\/images\\/070625\\/BASF_IR-Day_Smith_Catalysts.pdf"}]', '1', '4', '', 100);
INSERT INTO `inventions` VALUES(58, '2013-10-10 08:17:55', 1, 'CDx without drug on market', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_4', '', 'no', 'CDx for kras mutant colon cancer therapy', 'b', '', 'CDx for kras mutant colon cancer\n', '', '', '', 'a', '', 'Michael Scott', '', '', '', '', '', 'field', '59', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-10-08 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'companion diagnostic for kras mutant colon cancer therapy', '{"1":{"radio_11a1":"No","title":"method for detecting cancer","id":"87","status":"field"},"2":{"radio_11a1":"No","title":"pancreatic cancer drug","id":"92","status":"field"},"3":{"radio_11a1":"No","title":"Biomarker Dx for cancer","id":"100","status":"field"},"4":{"radio_11a1":"No","title":"pancreatic cancer","id":"108","status":"field"},"5":{"radio_11a1":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"6":{"radio_11a1":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"}}', '{"1":{"radio_11a2":"No","title":"testing questionnaire 10-9","id":"44","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"No","title":"Cancer Target screening tools","id":"61","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"No","title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"May be","title":"method for detecting cancer","id":"87","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"No","title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"No","title":"Biomarker Dx for cancer","id":"100","status":"Disclosure Done & Under Review"},"7":{"radio_11a2":"No","title":"pancreatic cancer","id":"108","status":"Disclosure Done & Under Review"},"8":{"radio_11a2":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"},"9":{"radio_11a2":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"Disclosure Done & Under Review"}}', 54, 'In-disk', '100k-1m', 'Yes', 'Yes', 1, 'sdfsdf', 'Yes', 19, '[{"title":"Use of microvesicles in analyzing kras mutations","link":"http:\\/\\/www.google.com\\/patents\\/EP2475989A1?cl=en&dq=companion+diagnostic+for+kras+mutant+colon+cancer&source=uds;","filedate":"Thu, 09 Sep 2010 00:00:00 -0700","applicant":"The General Hospital Corporation","desc":"The method of claim 7, wherein the <b>cancer<\\/b> is <b>colorectal<\\/b>, pancreatic, <b>...<\\/b> One family  of oncogenes that is commonly <b>mutated<\\/b> in <b>cancers<\\/b> is the <b>RAS<\\/b> family. <b>.....<\\/b> a  <b>companion diagnostic<\\/b> test kit may be developed to test for one or\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Multiplex genotyping assay for detecting mutations in k-ras","link":"http:\\/\\/www.google.com\\/patents\\/WO2010048691A1?cl=en&dq=companion+diagnostic+for+kras+mutant+colon+cancer&source=uds;","filedate":"Wed, 09 Sep 2009 00:00:00 -0700","applicant":"British Columbia Cancer Agency Branch","desc":"A method for detecting <b>k-ras mutations<\\/b> in a sample from a subject comprising: a)  <b>...<\\/b> The method of claim 21 , wherein the subject has <b>colon cancer<\\/b> <b>.....<\\/b> or  <b>companion diagnostic<\\/b> assay\\/tool applicable to multiple cancer types and\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Compositions, process of preparation of said compositions and method of ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013086002A1?cl=en&dq=companion+diagnostic+for+kras+mutant+colon+cancer&source=uds;","filedate":"Wed, 05 Dec 2012 00:00:00 -0800","applicant":"Cellworks Research India Private Limited, Cellworks Group, Inc.","desc":"The method of claim 51 , wherein the cancer is a <b>colorectal cancer<\\/b>. <b>.....<\\/b> <b>KRAS<\\/b> and \\/or BRAF <b>mutations<\\/b> in tumor cells associated with <b>KRAS<\\/b> and\\/or <b>......<\\/b> <b>companion<\\/b>  <b>diagnostic<\\/b> tests to discover a subject''s predisposition to certain\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"A method of analysing a blood sample of a subject for the presence of a ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2593787A2?cl=en&dq=companion+diagnostic+for+kras+mutant+colon+cancer&source=uds;","filedate":"Fri, 15 Jul 2011 00:00:00 -0700","applicant":"Stichting VU-VUmc","desc":"The invention is in the field of medical diagnostics, in particular in the <b>.....<\\/b> In the  case of <b>colorectal cancer KRAS mutations<\\/b> are suitable cancer markers. <b>.....<\\/b> on  disease profiling and the development of <b>companion diagnostics<\\/b>.","radio_11b":"least_relevant"},{"title":"Predictors of patient response to treatment with egf receptor inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2009140409A1?cl=en&dq=companion+diagnostic+for+kras+mutant+colon+cancer&source=uds;","filedate":"Wed, 13 May 2009 00:00:00 -0700","applicant":"Genomic Health Inc., Bristol-Myers Squibb Company","desc":"The method of claim 1, wherein said cancer is <b>colorectal cancer<\\/b>, <b>colon cancer<\\/b> <b>...<\\/b>  conditions to a nucleic acid comprising an activating <b>KRAS mutation<\\/b>. <b>...<\\/b> been a  push to develop drugs in concert with <b>companion diagnostic<\\/b> tests\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"}]', '', 'better in sensitivity and accuracy', 'happier and blah blah blah blah', 'new and wild nd sensitivity and closeness', '', '[{"title":"Mercator raises $6.5M for micro-infusion tech","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/mercator-raises-65m-micro-infusion-tech\\/2013-05-31","desc":" hypertension and cancer."},{"title":"Mercator micro-infusion drug delivery catheter snags CE mark","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/mercator-micro-infusion-drug-delivery-catheter-snags-ce-mark\\/2013-03-05","desc":" and <strong>Cricket<\\/strong> micro-infusion catheters, for peripheral and coronary arteries respectively, have already netted ..."},{"title":"Pharma-funded CME falls off again; Bayer may boost dividend, CFO says;","link":"http:\\/\\/www.fiercepharma.com\\/story\\/pharma-funded-cme-falls-again-bayer-may-boost-dividend-cfo-says\\/2012-08-06","desc":" for patients. Story And Finally... Jiminy <strong>Cricket<\\/strong> knew what he was talking about: Telling the truth is healthier ..."},{"title":"Mercator wins CE mark for micro-infusion catheters; MIT reveals solar-powered med equipment sterilization tool;","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/mercator-wins-ce-mark-micro-infusion-catheters-mit-reveals-solar-powered-me\\/2013-03-04","desc":" <strong>Cricket<\\/strong> and Bullfrog micro-infusion catheters, which are designed to deliver drug treatments across any ..."}]', 'cricket', 'hoemo', '[{"title":"Attachment B - California Earthquake Authority","link":"http:\\/\\/www.earthquakeauthority.com\\/%5CUserFiles%5CFile%5C02-28-2013_GB_Attachments%5CAI10_B.pdf"},{"title":"Safety issues in the preparation of homeopathic medicines","link":"http:\\/\\/www.who.int\\/medicines\\/areas\\/traditional\\/Homeopathy.pdf"},{"title":"(09\\/13) - document updated as needed - State of Oklahoma Web Site","link":"http:\\/\\/www.ok.gov\\/oid\\/documents\\/090313-Home_Owners_Web.pdf"},{"title":"Co-Opetition - U.S. Department of Energy","link":"http:\\/\\/apps1.eere.energy.gov\\/buildings\\/publications\\/pdfs\\/building_america\\/issue8_co_opetition.pdf"}]', '3', '3', '', 100);
INSERT INTO `inventions` VALUES(61, '2013-10-10 08:38:02', 2, 'Cancer Target screening tools', 'patent', '', '', 'gansh1', 'gansh11', 'gansh11_2', '', '', 'Non small cell lung cancer therapeutic', 'b', '', 'cancer target', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '62', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'screening tools for NSCLC targets', '{"1":{"radio_11a1":"No","title":"test 10-29-13 ","id":"109","status":"field"}}', '{"1":{"radio_11a2":"May be","title":"test 10-29-13 ","id":"109","status":"Disclosure Done & Under Review"}}', 11, 'No', '>1m', 'Yes', 'No', 2, '', 'Maybe', 29.5, '[{"title":"Lung cancer diagnostic assay","link":"http:\\/\\/www.google.com\\/patents\\/WO2007079284A2?cl=en&dq=screening+tools+for+NSCLC+targets&source=uds;","filedate":"Fri, 10 Nov 2006 00:00:00 -0800","applicant":"Edward A Hirschowitz, Nada H Khattar, Arnold J Stromberg, Univ Kentucky, Li Zhong","desc":"A diagnostic assay for determining presence of <b>lung cancer<\\/b> in a patient depends,  <b>...<\\/b> The instant assay can be used as a <b>screening test<\\/b> for asymptomatic patients,  <b>....<\\/b> Molecules from individuals in the <b>target<\\/b> population can be\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Lung cancer tests","link":"http:\\/\\/www.google.com\\/patents\\/WO2012054732A2?cl=en&dq=screening+tools+for+NSCLC+targets&source=uds;","filedate":"Thu, 20 Oct 2011 00:00:00 -0700","applicant":"Rush University Medical Center","desc":"Methods for the diagnosis of <b>lung cancer<\\/b> and more specifically, non-small <b>...<\\/b> A  <b>screening tool<\\/b> capable of early stage detection will allow for decreased <b>......<\\/b>  Commercial antibodies (as used above for <b>target<\\/b> confirmation) were\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Lung cancer biomarkers","link":"http:\\/\\/www.google.com\\/patents\\/EP2462164A2?cl=en&dq=screening+tools+for+NSCLC+targets&source=uds;","filedate":"Wed, 04 Aug 2010 00:00:00 -0700","applicant":"Biosystems International SAS","desc":"The current tests using CT-scan as <b>screening tool<\\/b> have to cope with the high <b>...<\\/b>  thus represent novel valuable <b>targets<\\/b> for <b>lung cancer<\\/b> detection,\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"Cybp as a marker of lung cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2430450A1?cl=en&dq=screening+tools+for+NSCLC+targets&source=uds;","filedate":"Mon, 17 May 2010 00:00:00 -0700","applicant":"F.Hoffmann-La Roche Ag, Roche Diagnostics GmbH","desc":"The present invention relates to the <b>assessment<\\/b> of <b>lung cancer<\\/b>. <b>...<\\/b> to a molecule  to be used as a <b>target<\\/b> for analyzing a patient''s <b>test<\\/b> sample.","radio_11b":"No"}]', '[{"title":"&lt;b&gt;Lung&lt;\\/b&gt; &lt;b&gt;cancer&lt;\\/b&gt; epigenetics and genetics.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/18425819","desc":"Risch A, Plass C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of cancer. Journal international du cancer&quot;&gt;Int J &lt;b&gt;Cancer&lt;\\/b&gt;&lt;\\/span&gt;. 2008 Jul 1;123(1):1-7. doi: 10.1002\\/ijc.23605. Review.","radio_11b2":"Already Assigned"},{"title":"Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III &lt;b&gt;NSCLC&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/16168828","desc":"van S&Atilde;&para;rnsen de Koste JR, Senan S, Underberg RW, Oei SS, Elshove D, Slotman BJ, Lagerwaard FJ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of radiation oncology, biology, physics&quot;&gt;Int J Radiat Oncol Biol Phys&lt;\\/span&gt;. 2005 Oct 1;63(2):334-9.","radio_11b2":"Yes"},{"title":"Molecular genetics of small cell &lt;b&gt;lung&lt;\\/b&gt; &lt;b&gt;carcinoma&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/11479891","desc":"Wistuba II, Gazdar AF, Minna JD.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Seminars in oncology&quot;&gt;Semin Oncol&lt;\\/span&gt;. 2001 Apr;28(2 Suppl 4):3-13. Review.","radio_11b2":"Yes"}]', 'test test test test test', 'a', 'a', '[{"title":"<b>Treatment<\\/b> paradigms for patients with metastatic <b>non<\\/b>-<b>small<\\/b>-<b>cell lung<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.current-oncology.com\\/index.php\\/oncology\\/article\\/view\\/1114","radio_15b":"No","desc":"<b>Treatment<\\/b> paradigms for patients with metastatic <b>non<\\/b>-<b>small<\\/b>-<b>cell lung cancer<\\/b>: first-\\n, second-, and third-line. <b>...<\\/b> Although <b>treatment<\\/b> outcomes in advanced disease \\nremain modest, with paradigm shifts in <b>...<\\/b> DOI: http:\\/\\/dx.doi.org\\/10.3747\\/<b>co<\\/b>.\\n19.1114."},{"title":"BIND Doses First Patient in a Phase 2 Clinical Study of BIND-014 in <b>...<\\/b>","link":"http:\\/\\/bindtherapeutics.com\\/newsevents\\/releases\\/2013%200729%20BIND014%20NSCLC%20Dosing.html","radio_15b":"No","desc":"<b>...<\\/b> 2013\\u2014BIND <b>Therapeutics<\\/b>, a clinical-stage nanomedicine platform <b>company<\\/b> <b>...<\\/b> \\ndocetaxel, as second-line <b>therapy<\\/b> in patients with <b>non<\\/b>-<b>small cell lung cancer<\\/b>."},{"title":"<b>Lung Cancer<\\/b> Trials | OncoGenex Pharmaceuticals <b>Inc<\\/b>","link":"http:\\/\\/www.oncogenex.com\\/patients\\/lung-cancer-trials-","radio_15b":"Yes","desc":"Phase 2 Clinical Trial in Advanced <b>Non<\\/b>-<b>Small Cell Lung Cancer<\\/b> (<b>NSCLC<\\/b>) <b>...<\\/b> the \\npotential benefit of adding apatorsen to carboplatin and pemetrexed <b>therapy<\\/b> by\\u00a0<b>...<\\/b>"},{"title":"Spotlight on... <b>Non<\\/b>-<b>small<\\/b>-<b>cell lung cancer<\\/b>: A new <b>...<\\/b> - Thomson Reuters","link":"http:\\/\\/thomsonreuters.com\\/business-unit\\/science\\/pdf\\/ls\\/pharma-matters\\/SpotlightOn-cwp-en_issue11.pdf","radio_15b":"No","desc":"MOLECULARLY TARGETED <b>THERAPIES<\\/b> IN <b>NSCLC<\\/b> . <b>....<\\/b> of licensing deals \\nbetween pharmaceutical and diagnostic <b>companies<\\/b> since 2009 to give \\n<b>companies<\\/b>."},{"title":"Novocure - <b>Non<\\/b>-<b>Small Cell Lung Cancer<\\/b>","link":"http:\\/\\/www.novocure.com\\/product.php?ID=23","radio_15b":"No","desc":"Novocure is an oncology <b>company<\\/b> pioneering a novel <b>therapy<\\/b> for solid tumors. <b>...<\\/b> \\n<b>Non<\\/b>-<b>small cell lung cancer<\\/b> (<b>NSCLC<\\/b>) accounts for 85% of all <b>lung cancers<\\/b>."},{"title":"Biothera''s Phase 2b Study in <b>Non<\\/b>-<b>Small Cell Lung Cancer<\\/b> Meets <b>...<\\/b>","link":"http:\\/\\/www.businesswire.com\\/news\\/sdbio\\/20131104005822\\/en","radio_15b":"Yes","desc":"3 days ago <b>...<\\/b> Biothera''s Phase 2b Study in <b>Non<\\/b>-<b>Small Cell Lung Cancer<\\/b> Meets Primary <b>...<\\/b> cell \\n<b>lung cancer<\\/b> (<b>NSCLC<\\/b>) that evaluated its <b>immunotherapeutic<\\/b> <b>...<\\/b> Biothera is a U.S. \\nbiotechnology <b>company<\\/b> dedicated to improving immune health."},{"title":"Tarceva\\u00ae (erlotinib) Tablets Advanced <b>Non<\\/b>-<b>Small Cell Lung Cancer<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.tarceva.com\\/professional\\/data\\/trial.jsp","radio_15b":"Yes","desc":"The <b>treatment<\\/b> of patients with locally advanced or metastatic <b>NSCLC<\\/b> after failure \\n<b>...<\\/b> <b>Inc<\\/b>. NCCN Clinical Practice Guidelines in Oncology\\u00ae: <b>Non<\\/b>-<b>Small Cell<\\/b> Lung\\u00a0<b>...<\\/b>"},{"title":"<b>Non<\\/b>-<b>small<\\/b>-<b>cell lung cancer<\\/b>: molecular targeted <b>therapy<\\/b> and <b>...<\\/b>","link":"http:\\/\\/www.dovepress.com\\/non-small-cell-lung-cancer-molecular-targeted-therapy-and-personalized-peer-reviewed-article-PGPM","radio_15b":"Yes","desc":"Apr 4, 2013 <b>...<\\/b> <b>Non<\\/b>-<b>small<\\/b>-<b>cell lung cancer<\\/b>: molecular targeted <b>therapy<\\/b> and <b>...<\\/b> Care, 2Program in \\nCancer Biology, University of Colorado, Aurora, <b>CO<\\/b>, USA;\\u00a0<b>...<\\/b>"}]', '[{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" cash for next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong> Florida Keys home to potential colon <strong>cancer<\\/strong> fighter Bracing for FDA ...","radio_15":"Yes"},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ...","radio_15":"Yes"},{"title":"Enzyme inhibitor spurs breakthrough on pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/enzyme-inhibitor-spurs-breakthrough-pancreatic-cancer\\/2009-09-25","desc":" was useless in stopping <strong>pancreatic<\\/strong> <strong>cancer<\\/strong>, but the researchers said that in combination with the TAK-1 ...","radio_15":"Yes"},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ...","radio_15":"Yes"},{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ...","radio_15":"Yes"},{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" cash for next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong> Florida Keys home to potential colon <strong>cancer<\\/strong> fighter Bracing for FDA ...","radio_15":"No"},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ...","radio_15":"No"},{"title":"Enzyme inhibitor spurs breakthrough on pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/enzyme-inhibitor-spurs-breakthrough-pancreatic-cancer\\/2009-09-25","desc":" was useless in stopping <strong>pancreatic<\\/strong> <strong>cancer<\\/strong>, but the researchers said that in combination with the TAK-1 ...","radio_15":"Yes"},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ...","radio_15":"No"},{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ...","radio_15":"Yes"}]', 'non small cell lung cancer therapeutic', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(62, '2013-10-10 08:51:57', 2, 'Kras mutant pancreatic cancer drug', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_4', '', '', 'kras mutant pancreatic cancer drug', 'd', '', 'drug to prevent resistance to kras mutant pancreatic cancer drug treatment', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '87', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-10-24 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'testing', '{"1":{"radio_11a1":"May be","title":"testing happy head","id":"63","status":"field"},"2":{"radio_11a1":"May be","title":"testing 12-3","id":"194","status":"field"}}', '{"2":{"radio_11a2":"May be","title":"testing happy head","id":"63","status":"field"},"3":{"radio_11a2":"May be","title":"Oct 16 hemophilia testing","id":"77","status":"field"},"4":{"radio_11a2":"May be","title":"Oct 25 Dx testing","id":"104","status":"field"},"5":{"radio_11a2":"May be","title":"Better plastics","id":"141","status":"field"},"6":{"radio_11a2":"May be","title":"testing 11-19-13","id":"160","status":"field"},"7":{"radio_11a2":"May be","title":"testing 15a, 15b and analytics","id":"168","status":"field"},"8":{"radio_11a2":"May be","title":"testing 12-3","id":"194","status":"field"}}', 63, 'Yes', '100k-1m', 'Yes', 'No', 2, '', 'Maybe', 18, '[{"title":"Automatic synthesis of unit tests for security testing","link":"http:\\/\\/www.google.com\\/patents\\/US20130205399?dq=testing&source=uds;","desc":"Performing security analysis on a computer program under <b>test<\\/b> (CPUT). The  CPUT can be analyzed to identify data pertinent to potential\\u00a0<b>...<\\/b>","filedate":"Tue, 31 Jul 2012 00:00:00 -0700","applicant":"International Business Machines Corporation","radio_11b":"duplicate"},{"title":"System and method for performing bulge testing of films, coatings and\\/or layers","link":"http:\\/\\/www.google.com\\/patents\\/WO1999021057A3?cl=en&dq=testing&source=uds;","desc":"A system and corresponding method for bulge <b>testing<\\/b> films (e.g. thin films (57), <b>...<\\/b>  is provided, as well as membrane structures (47) for use in bulge <b>testing<\\/b> and\\u00a0<b>...<\\/b>","filedate":"Tue, 20 Oct 1998 00:00:00 -0700","applicant":"Exponent Inc","radio_11b":"duplicate"},{"title":"Method for testing multilayer tablets in a multiple rotary press, the tested ...","link":"http:\\/\\/www.google.com\\/patents\\/US8525050?dq=testing&source=uds;","desc":"The invention is related to a method for <b>testing<\\/b> multilayer tablets in a multiple  rotary press, in which die holes of a circulating die plate are\\u00a0<b>...<\\/b>","filedate":"Wed, 09 Sep 2009 00:00:00 -0700","applicant":"Fette Gmbh","radio_11b":"duplicate"},{"title":"Systems and methods for testing over a distributed network","link":"http:\\/\\/www.google.com\\/patents\\/US8554129?dq=testing&source=uds;","desc":"A computer-based <b>testing<\\/b> system includes <b>testing<\\/b> stations connected to a <b>testing<\\/b>  service center and backend via the Internet for providing\\u00a0<b>...<\\/b>","filedate":"Thu, 13 Nov 2003 00:00:00 -0800","applicant":"Educational Testing Service","radio_11b":"duplicate"},{"title":"Fatigue testing device for wind turbine blade testing, a method of testing ...","link":"http:\\/\\/www.google.com\\/patents\\/US8393216?dq=testing&source=uds;","desc":"The invention provides a fatigue exciter for wind turbine blades. Wind turbine  blades require excitation at or near their natural frequency to\\u00a0<b>...<\\/b>","filedate":"Fri, 30 May 2008 00:00:00 -0700","applicant":"Vestas Wind Systems A\\/S","radio_11b":"duplicate"},{"title":"Testing and operating a multiprocessor chip with processor redundancy","link":"http:\\/\\/www.google.com\\/patents\\/US20130031418?dq=testing&source=uds;","desc":"A system and method for improving the yield rate of a multiprocessor  semiconductor chip that includes primary processor cores and one or\\u00a0<b>...<\\/b>","filedate":"Tue, 02 Aug 2011 00:00:00 -0700","applicant":"International Business Machines Corporation","radio_11b":"duplicate"},{"title":"Chip testing apparatus and testing method thereof","link":"http:\\/\\/www.google.com\\/patents\\/US8552756?dq=testing&source=uds;","desc":"A chip <b>testing<\\/b> apparatus and a chip <b>testing<\\/b> method are provided. The chip <b>testing<\\/b>  apparatus includes a command generating module,\\u00a0<b>...<\\/b>","filedate":"Wed, 26 Aug 2009 00:00:00 -0700","applicant":"Mstar Semiconductor, Inc.","radio_11b":"duplicate"},{"title":"System for tree sequence testing of a device and method for tree sequence ...","link":"http:\\/\\/www.google.com\\/patents\\/US8533544?dq=testing&source=uds;","desc":"A system comprises a <b>test<\\/b> framework architecture for tree sequence <b>testing<\\/b> of a  device, comprising a plurality of hierarchical layers at least\\u00a0<b>...<\\/b>","filedate":"Tue, 31 Mar 2009 00:00:00 -0700","applicant":"Freescale Semiconductor, Inc.","radio_11b":"duplicate"}]', '[{"title":"Staff views of an opportunistic chlamydia &lt;b&gt;testing&lt;\\/b&gt; pilot in a primary health organisation.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294616","desc":"McKernon S, Azariah S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of primary health care&quot;&gt;J Prim Health Care&lt;\\/span&gt;. 2013 Dec 1;5(4):283-9.","radio_11b2":"duplicate"},{"title":"Computer Modeled Multiportal Approaches to the Skull Base.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294560","desc":"Bly RA, Su D, Hannaford B, Ferreira M Jr, Moe KS.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of neurological surgery. Part B, Skull base&quot;&gt;J Neurol Surg B Skull Base&lt;\\/span&gt;. 2012 Dec;73(6):415-423. Epub 2012 Nov 16.","radio_11b2":"duplicate"},{"title":"Characteristics and Management of Superior Semicircular Canal Dehiscence.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294552","desc":"Yew A, Zarinkhou G, Spasic M, Trang A, Gopen Q, Yang I.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of neurological surgery. Part B, Skull base&quot;&gt;J Neurol Surg B Skull Base&lt;\\/span&gt;. 2012 Dec;73(6):365-370. Epub 2012 Aug 8. Review.","radio_11b2":"duplicate"},{"title":"Evaluation of &lt;i&gt;Mycobacterium tuberculosis&lt;\\/i&gt; drug susceptibility in clinical specimens from Nigeria using genotype MTBDRplus and MTBDRsl assays.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294494","desc":"Felkel M, Exner R, Schleucher R, Lay H, Autenrieth IB, Kempf VA, Frick JS.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;European journal of microbiology &amp; immunology&quot;&gt;Eur J Microbiol Immunol (Bp)&lt;\\/span&gt;. 2013 Dec;3(4):252-257. Epub 2013 Nov 21.","radio_11b2":"duplicate"},{"title":"&lt;b&gt;Testing&lt;\\/b&gt; and Validating Machine Learning Classifiers by Metamorphic &lt;b&gt;Testing&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3082144\\/","desc":"Xiaoyuan Xie, Joshua W. K. Ho, Christian Murphy, Gail Kaiser, Baowen Xu, Tsong Yueh Chen","details":null,"radio_11b2":"duplicate"},{"title":"Factors Associated With Intention to Use Internet-Based &lt;b&gt;Testing&lt;\\/b&gt; for Sexually Transmitted Infections Among Men Who Have Sex With Men","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3841365\\/","desc":"Mark Gilbert, Travis Salway Hottes, Thomas Kerr, Darlene Taylor, Christopher K Fairley, Richard Lester, Tom Wong, Terry Trussler, Rick Marchand, Jean Shoveller, Gina Ogilvie","details":"J Med Internet Res. &lt;span class=&quot;citation-publication-date&quot;&gt;2013 November; &lt;\\/span&gt;15(11): e254.  &lt;span class=&quot;&quot;&gt;Published online 2013 November 14. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.2196\\/jmir.2888&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"A Review of Self-&lt;b&gt;Testing&lt;\\/b&gt; for HIV: Research and Policy Priorities in a New Era of HIV Prevention","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3669524\\/","desc":"Sue Napierala Mavedzenge, Rachel Baggaley, Elizabeth L. Corbett","details":null,"radio_11b2":"duplicate"},{"title":"POINT-OF-CARE HEMATOLOGY AND COAGULATION &lt;b&gt;TESTING&lt;\\/b&gt; IN PRIMARY, RURAL EMERGENCY, AND DISASTER CARE SCENARIOS","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3703674\\/","desc":"Corbin M. Curtis, Gerald J. Kost, Richard F. Louie, Rebecca J. Sonu, Erika B. Ammirati, Stephanie Sumner","details":null,"radio_11b2":"duplicate"},{"title":"Basic biostatistics : statistics for public health practice","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101615632","desc":"Gerstman, B Burt.","details":"&lt;span class=&quot;src&quot;&gt;Second edition. &lt;br&gt;Burlington, Massachusetts : Jones &amp; Bartlett Learning, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"Essentials of public health ethics","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101617718","desc":"Bernheim, Ruth Gaare; Childress, James F; Bonnie, Richard J; Melnick, Alan L.","details":"&lt;span class=&quot;src&quot;&gt;Burlington, Massachusetts : Jones &amp; Bartlett Learning, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"}]', 'test test ', 'test test test', 'test test test test test', '[{"title":"TrovaGene <b>Inc<\\/b> (TROV): TrovaGene: A Stock Filled With Freebies <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1572552-trovagene-a-stock-filled-with-freebies","desc":"Jul 25, 2013 <b>...<\\/b> However, these drugs have shown lower efficacy when treating colorectal and   <b>pancreatic cancer<\\/b> patients who have the <b>KRAS mutation<\\/b>.","radio_15b":"No"},{"title":"Trovagene to Study Trans-Renal <b>KRAS Mutation<\\/b> Detection in <b>...<\\/b>","link":"http:\\/\\/www.prnewswire.com\\/news-releases\\/trovagene-to-study-trans-renal-kras-mutation-detection-in-pancreatic-cancer-161186565.html","desc":"Jul 3, 2012 <b>...<\\/b> Study will compare detection of <b>KRAS mutations<\\/b> in urine to their detection in <b>...<\\/b> A   molecular diagnostics <b>company<\\/b> with unique intellectual property around the <b>...<\\/b>   <b>KRAS mutations<\\/b> in the urine of patients with <b>pancreatic cancer<\\/b>.","radio_15b":"Already Assigned"},{"title":"<b>KRAS Mutation<\\/b> Analysis - Quest Diagnostics","link":"http:\\/\\/www.questdiagnostics.com\\/testcenter\\/testguide.action?dc=TS_KRAS","desc":"Table 1. <b>RAS Mutation<\\/b> Frequency1. Cancer, Frequency, %. Adenocarcinoma.   Lung. Colon. <b>Pancreas<\\/b>. 30. 43. 80. Thyroid cancer. Follicular. Undifferentiated.   53.","radio_15b":"No"},{"title":"<b>KRAS Mutation<\\/b> Test - Lab21","link":"http:\\/\\/www.lab21.com\\/ClinicalLab\\/Services\\/HealthcareProfessionals\\/ONCOLOGY\\/KRASMutationTest.aspx","desc":"Such <b>KRAS<\\/b> gene <b>mutations<\\/b> are often found in e.g. colorectal, <b>pancreatic<\\/b> and <b>...<\\/b>   for colorectal <b>cancer<\\/b> is funded by pharmaceutical <b>companies<\\/b> for certain patients.","radio_15b":"Yes"},{"title":"<b>KRAS Mutation<\\/b> Analysis - Pathology, <b>Inc<\\/b>.","link":"http:\\/\\/www.pathologyinc.com\\/assets\\/pdfs\\/kras_technote.pdf","desc":"prognosis.4. <b>KRAS mutations<\\/b> are found in the following percentages of cancers:   59% <b>pancreas<\\/b>, 32% biliary tract, 32% large intestine, 20% small intestine, 19%\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Ras<\\/b> in <b>Cancer<\\/b> and Developmental Diseases - Genes & <b>Cancer<\\/b>","link":"http:\\/\\/gan.sagepub.com\\/content\\/2\\/3\\/344.full","desc":"In summary, although the specificity between tumor type and mutated Ras <b>...<\\/b>   prognosis of nonresectable <b>pancreatic cancers<\\/b> harboring <b>K-ras mutations<\\/b>42 and   <b>......<\\/b> in pyramidal neurons in Alzheimer''s disease is highly <b>co<\\/b>-localized with   p21ras\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Targeting glucose metabolism in <b>K-Ras<\\/b>-driven <b>pancreatic cancer<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/scibx\\/journal\\/v5\\/n20\\/full\\/scibx.2012.513.html","desc":"May 17, 2012 <b>...<\\/b> Prior work had shown that <b>mutant K-Ras<\\/b> drives <b>tumor<\\/b> growth in part by hijacking   <b>...<\\/b> The <b>company<\\/b> has multiple preclinical programs focused on\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"Targeting <b>K-Ras<\\/b>\\u2013activated glutamine metabolism in <b>pancreatic<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/scibx\\/journal\\/v6\\/n13\\/full\\/scibx.2013.302.html","desc":"Apr 4, 2013 <b>...<\\/b> Cornerstone Pharmaceuticals <b>Inc<\\/b>. <b>...<\\/b> The <b>K-Ras<\\/b> oncogene is expressed in   various cancer types, including about 90% of <b>pancreatic cancers<\\/b>. <b>...<\\/b> due to the   complex biology and interactions of the enzyme''s <b>mutant<\\/b> form. Building\\u00a0<b>...<\\/b>","radio_15b":"No"}]', '[{"title":"AstraZeneca inks cancer deals with Bind Therapeutics, Horizon Discovery","link":"http:\\/\\/www.fiercepharma.com\\/story\\/astrazeneca-inks-cancer-deals-bind-therapeutics-horizon-discovery\\/2013-04-22","desc":" AstraZeneca ($AZN) forged two oncology development deals on either side of the Atlantic. It teamed up with the U.K.''s Horizon Discovery on a program to target <strong>K-Ras<\\/strong> <strong>mutant<\\/strong> tumors, and tapped Bind Therapeutics for its nanotech <strong>cancer<\\/strong> treatment.\\u00a0 Report | Report  ...","radio_15":"Yes"},{"title":"New therapeutic target for pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/new-therapeutic-target-pancreatic-cancer\\/2008-12-16","desc":" <strong>Pancreatic<\\/strong> enzyme medically necessary <strong>KRAS<\\/strong> gene star at ASCO  ...","radio_15":"Yes"},{"title":"Erbitux, KRAS gene star at ASCO","link":"http:\\/\\/www.fiercepharma.com\\/story\\/erbitux-kras-gene-star-asco\\/2008-06-02","desc":" as a first-line colon <strong>cancer<\\/strong> treatment--but only for those with the non-mutated <strong>KRAS<\\/strong> gene.) The Novartis bone drug ...","radio_15":"Yes"},{"title":"FDA lets KRAS gene narrow drug use","link":"http:\\/\\/www.fiercepharma.com\\/story\\/fda-lets-kras-gene-narrow-drug-use\\/2009-07-20","desc":" Personalized <strong>cancer<\\/strong> treatment took a giant step forward today. FDA has OK''d a label change for Erbitux and Vectibix, narrowing the indication for advanced colon <strong>cancer<\\/strong>. The label now recommends ...","radio_15":"Yes"},{"title":"Amgen touts KRAS results for Vectibix","link":"http:\\/\\/www.fiercepharma.com\\/story\\/amgen-touts-kras-results-vectibix\\/2009-08-07-0","desc":" with <strong>KRAS<\\/strong> <strong>mutant<\\/strong> tumors were negatively affected when Vectibix was added to a standard chemotherapy ...","radio_15":"No"},{"title":"Study validates gene variant in ovarian cancer","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/study-validates-gene-variant-ovarian-cancer\\/2012-05-29","desc":" the abstract Related Articles: <strong>KRAS<\\/strong> marks poor survival and response in ovarian <strong>cancer<\\/strong> MicroRNA marks ovarian ...","radio_15":"Yes"},{"title":"Takeda, Hopkins developing new pancreatic cancer drugs","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/takeda-hopkins-developing-new-pancreatic-cancer-drugs\\/2013-10-22","desc":" to the proliferation of <strong>cancerous<\\/strong> cells in most <strong>pancreatic<\\/strong> <strong>cancers<\\/strong>. One of the drug combinations, dinaciclib plus MK2206, was so successful in a preclinical model of <strong>pancreatic<\\/strong> <strong>cancer<\\/strong> that the researchers are launching ...","radio_15":"No"},{"title":"Developing proteomic signatures focus pancreatic cancer therapy","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/developing-proteomic-signatures-focus-pancreatic-cancer-therapy\\/2012-07-02","desc":" at the European Society of Medical Oncology''s 14th World Congress on Gastrointestinal <strong>Cancer<\\/strong>, patients with Ras <strong>mutant<\\/strong> positive adenocarcinoma of the pancreas received gemcitabine alone or in combination ...","radio_15":"Yes"},{"title":"Amgen asks FDA to narrow Vectibix use","link":"http:\\/\\/www.fiercepharma.com\\/story\\/amgen-asks-fda-narrow-ital-vectibix-use\\/2008-12-16","desc":" <strong>cancer<\\/strong> patients who failed other treatments, but this year researchers discovered that the drugs ...","radio_15":"Yes"},{"title":"AstraZeneca works both sides of the Atlantic in forging new cancer drug deals","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/astrazeneca-works-both-sides-atlantic-forging-new-cancer-drug-deals\\/2013-04-22","desc":" oncology deal with Horizon Discovery, which underscores its intense interest in the <strong>cancer<\\/strong> field while ...","radio_15":"No"}]', 'kras mutant pancreatic cancer', 'kras mutant pancreatic cancer', '[{"title":"<b>Pancreatic cancer<\\/b>","link":"http:\\/\\/www.ptc.dcs.edu\\/schools\\/elem\\/wd\\/talent%20show\\/talent\\/12647613.pdf"},{"title":"<b>K-ras Mutations<\\/b> in DNA Extracted From the Plasma of Patients With <b>...<\\/b>","link":"http:\\/\\/jco.ascopubs.org\\/content\\/17\\/2\\/578.full.pdf"},{"title":"Association of matrilysin mRNA expression with <b>K-ras mutations<\\/b> and <b>...<\\/b>","link":"http:\\/\\/carcin.oxfordjournals.org\\/content\\/22\\/7\\/1049.full.pdf"},{"title":"High proportion of <b>mutant K-ras<\\/b> gene in <b>pancreatic<\\/b> juice of <b>...<\\/b> - Gut","link":"http:\\/\\/gut.bmj.com\\/content\\/45\\/5\\/737.full.pdf"}]', '4', '2', '', 100);
INSERT INTO `inventions` VALUES(63, '2013-10-10 09:02:04', 2, 'testing happy head', 'patent', '', '', 'gansh1', 'gansh11', 'gansh11_3', '', '', 'renal cell carcinoma for VHL positive cases', 'e', '', 'small molecule', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '86', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-10-18 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '1969-12-31 17:00:00', 'happy', '{"62":"Yes"}', '{"58":"No","62":"Yes"}', 66, 'Yes', '>1m', 'Dont know', '', 0, '', 'Maybe', 30, '{"a_1":"Yes","a_2":"Yes","a_3":"No","a_4":"No","a_5":"May Be","a_6":"May Be","a_7":"May Be","a_8":"May Be","a_9":"May Be","a_10":"May Be"}', '', 'test test happy happy happy', 'test test happy happy happy', 'test', '[{"title":"Homeopathy: The Ultimate Fake - Quackwatch","link":"http:\\/\\/www.quackwatch.com\\/01QuackeryRelatedTopics\\/homeo.html","desc":"In 1984, the FDA warned Botanical Laboratories, <b>Inc<\\/b>., of Bellingham, Washington\\n, that none of its homeopathic products could be legally marketed with drug\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>HOEMO<\\/b> ABD | <b>Company<\\/b> Profile from Hoover''s","link":"http:\\/\\/www.hoovers.com\\/company-information\\/cs\\/company-profile.HOEMO_ABD.c6699bf701a32b71.html","desc":"Up-to-the moment intelligence helps you set strategy, prepare for sales calls, and \\nclose <b>business<\\/b>. Easy-to-read reports on over 85 million <b>companies<\\/b> and 900\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Homeo<\\/b>- | Define <b>Homeo<\\/b>- at Dictionary.com","link":"http:\\/\\/dictionary.reference.com\\/browse\\/homeo-","desc":"<b>Homeo<\\/b>- definition, a combining form meaning \\u201csimilar,\\u201d used in the formation of \\ncompound words: homeostatic. <b>...<\\/b> Published by Houghton Mifflin <b>Company<\\/b>.","radio_15b":"Yes"},{"title":"Span <b>Homeo Company<\\/b> | Facebook","link":"https:\\/\\/www.facebook.com\\/pages\\/Span-Homeo-Company\\/107206229389569","desc":"Span <b>Homeo Company<\\/b>. 8 likes \\u00b7 0 talking about this. TO SPREAD ONE SIDE TO \\nOTHER SIDE TO EXTEND IN ALL DIRECTIONS TO EXPANSION OF EVRYING\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>HOMEO<\\/b> GREEN, <b>INC<\\/b>. - HONOLULU, HI - ZapConnect.com","link":"http:\\/\\/www.zapconnect.com\\/companies\\/index.cfm\\/fuseaction\\/companies_detail\\/eregnum\\/2953722.html","desc":"Records 1 - 11 of 1872 <b>...<\\/b> FDA-Registered <b>Company<\\/b> Profile for <b>HOMEO<\\/b> GREEN, <b>INC<\\/b>. FDA-Supplied \\nEstablishment Information: Establishment Registration\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Bawa <b>Homeo<\\/b> Pathic - Jamaica, New York (NY) | <b>Company<\\/b> Profile","link":"http:\\/\\/www.manta.com\\/c\\/mmlpjn6\\/bawa-homeo-pathic","desc":"Bawa <b>Homeo<\\/b> Pathic <b>company<\\/b> profile in Jamaica, NY. Our free <b>company<\\/b> profile \\nreport for Bawa <b>Homeo<\\/b> Pathic includes <b>business<\\/b> information such as contact,\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Homeo<\\/b> Treatments | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/company\\/homeo-treatments","desc":"Welcome to the <b>company<\\/b> profile of <b>Homeo<\\/b> Treatments on LinkedIn. People \\nlooking for Homeopahic Doctor, clinic and consultation in any part of the world for\\n\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"","link":"http:\\/\\/www.imdb.com\\/title\\/tt0642687\\/","desc":"<b>Homeo<\\/b> & Juliet (1996) Poster \\u00b7 More at IMDbPro \\u00bb <b>...<\\/b> <b>Homeo<\\/b> & Juliet (28 Feb. \\n1996). TV Episode <b>.....<\\/b> Show detailed <b>company<\\/b> contact information on IMDbPro \\u00bb\\n\\u00a0<b>...<\\/b>","radio_15b":"Yes"}]', '', 'hoemo', '', '', '5', '5', '', 100);
INSERT INTO `inventions` VALUES(77, '2013-10-16 09:33:55', 1, 'Oct 16 hemophilia testing', 'patent', '', '', 'gansh1', 'gansh9', 'gansh16_4', '', '', 'Hemocoagulase enzyme with applications in wound healing, hemophilia, plastic surgery etc', 'c', '', 'Snake venom extract that is a powerful clotting agent with profound effects to treat hemophilia.', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '62', 'Yes', '2012-08-01 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'TEST', '{"1":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"2":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"3":{"title":"test","id":"117","status":"process"},"4":{"title":"aavishkar","id":"132","status":"field"},"5":{"title":"test14nov","id":"149","status":"field"},"6":{"title":"test","id":"152","status":"field"},"7":{"title":"Gut Microbiome","id":"165","status":"field"},"8":{"title":"test","id":"166","status":"field"},"9":{"title":"Test by Karthik Team","id":"171","status":"field"},"10":{"title":"test","id":"172","status":"field"}}', '{"2":{"title":"testing happy head","id":"63","status":"field"},"3":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"4":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"5":{"title":"laser excitation fluorescence","id":"107","status":"field"},"6":{"title":"test 10-29-13 ","id":"109","status":"field"},"7":{"title":"test","id":"117","status":"process"},"8":{"title":"aavishkar","id":"132","status":"field"},"9":{"title":"Better plastics","id":"141","status":"field"},"10":{"title":"test14nov","id":"149","status":"field"},"11":{"title":"test","id":"150","status":"field"}}', -39, '', '>1m', 'Yes', 'No', 3, '', 'Yes', 41, '[{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"most_relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"most_relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"most_relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"most_relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"most_relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"most_relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"relevant"},{"title":"","link":"","filedate":"","applicant":"","desc":"","radio_11b":"relevant"}]', '[{"title":"Deep Vein Thrombosis After Total Hip Arthroplasty and Total Knee Arthroplasty in Patients With Previous Ischemic Stroke.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24043672","desc":"","details":"","radio_11b2":"relevant"},{"title":"[Multi-center study on the treatment of sudden total deafness].","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24016561","desc":"","details":"","radio_11b2":"relevant"},{"title":"[Multi-center clinical study on the treatment of the low-middle frequency sudden hearing loss].","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24016558","desc":"","details":"","radio_11b2":"relevant"},{"title":"Protective effects of &lt;b&gt;Batroxobin&lt;\\/b&gt; on spinal cord injury in rats.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23852558","desc":"","details":"","radio_11b2":"relevant"},{"title":"The effects of &lt;b&gt;Batroxobin&lt;\\/b&gt; on the intimal hyperplasia of graft veins.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23806822","desc":"","details":"","radio_11b2":"relevant"}]', 'very safe and effective in humans', 'has multitude of applications in medicine', 'proven use in humans over a long time', '', '', 'TEST', '', '', '2', '2', '', 100);
INSERT INTO `inventions` VALUES(85, '2013-10-20 05:43:48', 1, 'HDAC inhibitor for alzheimers', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'treatment of alzheimers patients', 'e', '', 'HDAC are important class of enzymes involved in normal cell cycle an maturation. these inhibitors have been shown to have great effect on neurodegeneration.  we have found a novel class of small molecule scaffolds that are potent inhibitors of HDAC2.   ', '', '', '', 'a', '', 'John Smith', '', '15', '3 million 8/12-7/15', '', '', 'field', '85', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-11-20 00:00:00', '', 'Yes', '2013-10-16 00:00:00', '', '', '0000-00-00 00:00:00', 'HDAC inhibitor for pancreatic cancer', '{"1":{"radio_11a1":"No","title":"Oct 16 hemophilia testing","id":"77","status":"field"},"2":{"radio_11a1":"No","title":"Bhasma nanoparticles","id":"87","status":"field"},"3":{"radio_11a1":"No","title":"cell line for better expression","id":"88","status":"field"},"4":{"radio_11a1":"No","title":"Olefin catalyst for polymerization","id":"105","status":"field"},"5":{"radio_11a1":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"6":{"radio_11a1":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"7":{"radio_11a1":"No","title":"aavishkar","id":"132","status":"field"},"8":{"radio_11a1":"No","title":"Hemophilia drug","id":"133","status":"field"},"9":{"radio_11a1":"No","title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"10":{"radio_11a1":"No","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"}}', '{"2":{"title":"Science processes and methods","id":"44","status":"field"},"3":{"title":"CDx without drug on market","id":"58","status":"field"},"4":{"title":"testing happy head","id":"63","status":"field"},"5":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"6":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"7":{"title":"cell line for better expression","id":"88","status":"field"},"8":{"title":"Health Drink","id":"89","status":"field"},"9":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"10":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"11":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"}}', 82, '', '100k-1m', 'Yes', 'No', 2, '', 'Yes', 20, '{"1":{"radio_11b":"least_relevant"},"2":{"radio_11b":"least_relevant"},"3":{"radio_11b":"least_relevant"},"4":{"radio_11b":"least_relevant"},"5":{"radio_11b":"least_relevant"},"6":{"radio_11b":"least_relevant"},"7":{"radio_11b":"least_relevant"},"8":{"radio_11b":"least_relevant"},"9":{"radio_11b":"least_relevant"},"10":{"radio_11b":"least_relevant"},"11":{"radio_11b":"least_relevant"}}', '[{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Oct 14. doi:pii: S0006-291X(13)01670-7.  10.1016\\/j.bbrc.2013.10.010. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17.","radio_11b2":"least_relevant"},{"title":"The novel &lt;b&gt;HDAC inhibitor&lt;\\/b&gt; NDACI054 sensitizes human &lt;b&gt;cancer&lt;\\/b&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/span&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4.  10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"The anti-tumor effect of &lt;b&gt;HDAC&lt;\\/b&gt; inhibition in a human pancreas &lt;b&gt;cancer&lt;\\/b&gt; model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"least_relevant"},{"title":"Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23994577","desc":"Farrelly LA, Savage NT, O''Callaghan C, Toulouse A, Yilmazer-Hanke DM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Regulatory peptides&quot;&gt;Regul Pept&lt;\\/span&gt;. 2013 Sep 10;186:123-30. doi: 10.1016\\/j.regpep.2013.08.005. Epub 2013 Aug 28.","radio_11b2":"relevant"}]', 'the scaffolds we have are completely novel', 'our inhibitors are more specific (100 fold) and higher affinity', 'they are safe and non toxic due to less cross reactivity', '', '', 'TEST', '', '', '455', '77', '', 100);
INSERT INTO `inventions` VALUES(87, '2013-10-20 06:31:27', 1, 'Bhasma nanoparticles', 'patent', '', '', 'gansh1', 'gansh9', 'gansh10_3', '', '', 'immunology and', 'f', '', 'using serum from cancer patients as well as from normals, we have developed a method to detect circulating tumor cells.  This is based on selective tagging of the tuore cells using a contrast agent and subsequent spectroscopy.  Tagging can be flourescent, radioactive or amenable to any classical spectroscopic techniques. ', '', '', '', 'a,b', '', 'John Smith', 'NIH,Pfizer', '213', '', '', '', 'field', '110', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-10-30 00:00:00', '', 'Yes', '2013-10-09 00:00:00', '', '', '0000-00-00 00:00:00', 'biotech g', '{"1":{"radio_11a1":"Yes","title":"Oct 16 hemophilia testing","id":"77","status":"field"},"2":{"radio_11a1":"Yes","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"3":{"radio_11a1":"Yes","title":"cell line for better expression","id":"88","status":"field"},"4":{"radio_11a1":"Yes","title":"pancreatic cancer drug","id":"92","status":"field"},"5":{"radio_11a1":"Yes","title":"Oct 25 Dx testing","id":"104","status":"field"},"6":{"radio_11a1":"Yes","title":"Hemophilia drug","id":"133","status":"field"},"7":{"radio_11a1":"Yes","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"},"8":{"radio_11a1":"Yes","title":"Cancer drug","id":"146","status":"field"},"9":{"radio_11a1":"Yes","title":"Gut Microbiome","id":"165","status":"field"}}', '{"1":{"title":"CDx without drug on market","id":"58","status":"Disclosure Done & Under Review"},"2":{"title":"Cancer Target screening tools","id":"61","status":"Disclosure Done & Under Review"},"3":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"4":{"title":"testing happy head","id":"63","status":"Disclosure Done & Under Review"},"5":{"title":"Oct 16 hemophilia testing","id":"77","status":"Disclosure Done & Under Review"},"6":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"7":{"title":"cell line for better expression","id":"88","status":"Disclosure Done & Under Review"},"8":{"title":"Health Drink","id":"89","status":"Disclosure Done & Under Review"},"9":{"title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"10":{"title":"Oct 25 Dx testing","id":"104","status":"Disclosure Done & Under Review"}}', 144, '', '>1m', 'Yes', 'No', 5, '', 'Yes', 20, '', '[{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"}]', 'more sensitive than any of the other methods (100 fold)', 'novel contrast agent chemistry - this ligand has not been identified before', 'can pick out even transformed cells that are pre-cancerous.', '', '', 'cri', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(88, '2013-10-20 06:43:29', 1, 'cell line for better expression', 'patent', '', '', 'gansh1', 'gansh11', 'gansh11_1', '', '', 'can produce proteins and antibodies at very high titers (100 g per liter) can significantly change the cost of manufacture for these products', 'c', '', 'novel cell line that can produce significnat amounts of recombinant proetinas and antibodies\n', '', '', '', 'a', '', 'John Smith', 'NIH', '11', '', '', '', 'field', '80', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'cell line for high productivity', '', '', 30, '', '100k-1m', 'Yes', 'No', 2, '', 'Yes', 25, '[{"title":"Vector and mammalian cell line having improved productivity","link":"http:\\/\\/www.google.com\\/patents\\/EP0629700A2?cl=en&dq=cell+line+for+high+productivit&source=uds;","filedate":"Mon, 30 May 1994 00:00:00 -0700","applicant":"Bayer Corporation","desc":"In an illustrative example, the sequence codes for Factor VIII and <b>high<\\/b>  <b>productivity<\\/b> of a transfected <b>cell line<\\/b> is assured by establishing a minimum  amplifiability\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"Vector and mammalian cell line having improved productivity","link":"http:\\/\\/www.google.com\\/patents\\/EP0874057B1?cl=en&dq=cell+line+for+high+productivit&source=uds;","filedate":"Mon, 30 May 1994 00:00:00 -0700","applicant":"Bayer Corporation","desc":"The <b>productivity<\\/b> of a transfected mammalian <b>cell line<\\/b> can be enhanced by  establishing <b>...<\\/b> Derivation of stable cell clones with <b>high productivity<\\/b>.","radio_11b":"Yes"},{"title":"Vector and mammalian cell line having improved productivity","link":"http:\\/\\/www.google.com\\/patents\\/CA2125449C?cl=en&dq=cell+line+for+high+productivit&source=uds;","filedate":"Wed, 08 Jun 1994 00:00:00 -0700","applicant":"Bayer Corporation, Sham-Yuen Chan, Miles Inc.","desc":"In an illustrative example, the sequence codes for Factor VIII and <b>high<\\/b>  <b>productivity<\\/b> of a transfected <b>cell line<\\/b> is assured by establishing a\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"Methods for high-throughput screening of cell lines","link":"http:\\/\\/www.google.com\\/patents\\/WO2007124143A2?cl=en&dq=cell+line+for+high+productivit&source=uds;","filedate":"Fri, 20 Apr 2007 00:00:00 -0700","applicant":"Nadine Barron, Judy H Chou, Peter Franchi, Sarah Koob, Wyeth Corp","desc":"Disclosed are methods for <b>high<\\/b>-throughput screening of <b>cell lines<\\/b> for use in  protein <b>...<\\/b> and biotechnological processes such that <b>high productivity cell lines<\\/b>  are\\u00a0<b>...<\\/b>","radio_11b":"Yes"}]', '[{"title":"Gut neuroendocrine tumor blood qPCR fingerprint assay: characteristics and reproducibility.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24127543","desc":"Modlin IM, Drozdov I, Kidd M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Clinical chemistry and laboratory medicine : CCLM \\/ FESCC&quot;&gt;Clin Chem Lab Med&lt;\\/span&gt;. 2013 Oct 14:1-11. doi: 10.1515\\/cclm-2013-0496. [Epub ahead of print]","radio_11b2":"No"},{"title":"Transcriptome dynamics of transgene amplification in Chinese Hamster Ovary cells.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24108600","desc":"Vishwanathan N, Le H, Jacob NM, Tsao YS, Ng SW, Loo B, Liu Z, Kantardjieff A, Hu WS.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biotechnology and bioengineering&quot;&gt;Biotechnol Bioeng&lt;\\/span&gt;. 2013 Sep 21. doi: 10.1002\\/bit.25117. [Epub ahead of print]","radio_11b2":"No"},{"title":"[First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer].","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24107823","desc":"Mar&Atilde;&iexcl;z A, Bodrogi I, Csejtei A, Dank M, G&Atilde;&copy;czi L, K&Atilde;&frac14;ronya Z, Mangel L, Petr&Atilde;&iexcl;nyi A, Sz&Atilde;&raquo;cs M, Bodoky G.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Magyar onkologia&quot;&gt;Magy Onkol&lt;\\/span&gt;. 2013 Oct;57(3):173-6. doi: MagyOnkol.2013.57.3.173. Epub 2013 Aug 9. Hungarian. ","radio_11b2":"Yes"},{"title":"Polymyxin B Treatment Improves Bactofection Efficacy and Reduces Cytotoxicity.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24093973","desc":"Jones CH, Rane S, Patt E, Ravikrishnan A, Chen CK, Cheng C, Pfeifer BA.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Molecular pharmaceutics&quot;&gt;Mol Pharm&lt;\\/span&gt;. 2013 Oct 4. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"Identification of palmitoyl protein thioesterase 1 in human THP-1 monocytes\\/macrophages and characterization of unique biochemical activities for this enzyme.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24083319","desc":"Wang R, Borazjani A, Matthews AT, Mangum LC, Edelmann MJ, Ross MK.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemistry&quot;&gt;Biochemistry&lt;\\/span&gt;. 2013 Oct 1. [Epub ahead of print]","radio_11b2":"Yes"}]', 'this is better that previous cell lines', 'higher productivity without loss of cell viability', 'novel vector for stability and no loss of copy number', '[{"title":"Addgene - Vector Database","link":"http:\\/\\/www.addgene.org\\/vector-database\\/query\\/?q_vdb=RIS;","desc":"Strep 2, Unspecified, Ampicillin, <b>Qiagen<\\/b>. pQE-TriSystem-7. pUFR034,   Unspecified, <b>ATCC<\\/b>. pWZL-Neo-Myr-Flag-DEST, Mammalian Expression,   Retroviral\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Whole genome amplification & labeling for arrayCGH <b>...<\\/b> - <b>Qiagen<\\/b>","link":"http:\\/\\/www.qiagen.com\\/resources\\/download.aspx?id=96310e3d-e9c6-494a-815b-b92a2a0ee93a&lang=EN&ver=2;","desc":"Reference DNA was purchased from Promega and tumor DNA from <b>ATCC<\\/b>. The   DNA was amplified according to the standard REPLI-g Mini Kit protocol of the\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Preparation of Standard Plasmids for Real-Time PCR - <b>ATCC<\\/b>","link":"http:\\/\\/www.atcc.org\\/~\\/media\\/AAV8_Information\\/AAV2_Information\\/Preparation_of_Reference%20Material_for_qPCR.ashx;","desc":"Biosafety cabinet with UV capabilities. \\u2022 QIAquick PCR Purification Kit (<b>Qiagen<\\/b>,   Cat# 28104). \\u2022 QIAmp DNA Mini Kit (<b>Qiagen<\\/b>, Cat# 51304). \\u2022 Spectrophotometer.","radio_15b":"No"},{"title":"The Rumor Mill | Biofind","link":"http:\\/\\/www.biofind.com\\/rumor\\/;","desc":"Topic \\u00b7 Rating \\u00b7 Replies \\u00b7 Created \\u00b7 Last reply sort icon \\u00b7 Affymetrix Layoffs!!!   Company burning to death!!! 0.0, 38, 40 weeks 3 days ago by Anonymous, 1 hour   6\\u00a0<b>...<\\/b>","radio_15b":"Yes"}]', '[{"title":"Exosome, Mount Sinai forge Dx development partnership","link":"http:\\/\\/www.fiercediagnostics.com\\/story\\/exosome-mount-sinai-forge-dx-development-partnership\\/2013-08-27","desc":" forging ties with other related companies. Exosome recently partnered with <strong>Qiagen<\\/strong> ($QGEN) to develop ...","radio_15":"No"},{"title":"Bacterin picks new CEO; Medtronic launches MRI-safe pain tech;","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/bacterin-picks-new-ceo-medtronic-launches-mri-safe-pain-tech\\/2013-08-07","desc":" the patent to a multipurpose diagnostic technology from <strong>Qiagen<\\/strong> ($QGEN). News > Medtronic ($MDT) has ...","radio_15":"Yes"},{"title":"Qiagen unveils $100M share repurchase plan as income improves ","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/qiagen-unveils-100m-share-repurchase-plan-income-improves\\/2013-07-31","desc":" project.","radio_15":"Yes"},{"title":"Aeterna Zentaris completes $7.8M offering; High-flying startup Moderna gets former Millennium CSO as president of R&D; ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/aeterna-zentaris-completes-78m-offering-high-flying-startup-moderna-gets-fo\\/2013-07-31","desc":" <strong>Qiagen<\\/strong> unveils $100M share repurchase plan as income improves.\\u00a0 Report > Trovagene hauls in $15M ...","radio_15":"Yes"},{"title":"Amgen beats estimates as standby drugs pump out growth; Strides Arcolab responds to FDA on plant lapses;","link":"http:\\/\\/www.fiercepharma.com\\/story\\/amgen-beats-estimates-standby-drugs-pump-out-growth-strides-arcolab-respond\\/2013-07-31","desc":" quality in China and India.\\u00a0 Item > <strong>Qiagen<\\/strong> unveils $100M share repurchase plan as income improves.\\u00a0 ...","radio_15":"No"},{"title":"J&J warns over pump safety; Researchers say their bot beats Intuitive''s;","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/jj-warns-over-pump-safety-researchers-say-their-bot-beats-intuitives\\/2013-07-24","desc":" label to the problem. Note > <strong>Qiagen<\\/strong> ($QGEN) and Exosome Diagnostics have teamed up to develop ...","radio_15":"Yes"},{"title":"ResearchDx expands to meet contract diagnostics demand","link":"http:\\/\\/www.fiercecro.com\\/story\\/researchdx-expands-meet-contract-diagnostics-demand\\/2013-07-22","desc":" ($RHHBY) and Abbott Laboratories ($ABT), and pure-play diagnostics outfits like <strong>Qiagen<\\/strong> ($QGEN) ...","radio_15":"No"},{"title":"Qiagen scores FDA nod for lung cancer companion Dx","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/qiagen-scores-fda-nod-lung-cancer-companion-dx\\/2013-07-12","desc":" FDA-approved test based on <strong>Qiagen<\\/strong>''s Rotor-Gene Q MDx platform, and the company estimates the market ...","radio_15":"Yes"},{"title":"Boehringer celebrates FDA OK for lung cancer drug afatinib ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/boehringer-celebrates-fda-ok-lung-cancer-drug-afatinib\\/2013-07-12","desc":" FierceMedicalDevices '' take on <strong>Qiagen<\\/strong>''s test Related Articles: \\u00a0 Boehringer sights AZ and Roche drugs ...","radio_15":"Yes"},{"title":"FDA approval for Boehringer means fast competition to Roche''s targeted Tarceva ","link":"http:\\/\\/www.fiercepharma.com\\/story\\/fda-approval-boehringer-means-fast-competition-roches-targeted-tarceva\\/2013-07-12","desc":" story- here''s\\u00a0 FierceMedicalDevices '' take on <strong>Qiagen<\\/strong>''s\\u00a0 test Related Articles Roche wins ...","radio_15":"Yes"}]', 'atcc, qiagen, ', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(89, '2013-10-20 12:01:14', 2, 'Health Drink', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_4', '', '', 'rehydration drink with orange juice', 'f', '', 'Salts, sugars and orange juice mixture', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '125', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '0000-00-00 00:00:00', 'rehydration drink', '', '', 20, '', '>1m', 'Yes', 'No', 2, '', 'Maybe', 17.5, '[{"title":"Rehydration drink","link":"http:\\/\\/www.google.com\\/patents\\/WO1994015488A3?cl=en&dq=rehydration+drink&source=uds;","filedate":"Sun, 09 Jan 1994 00:00:00 -0800","applicant":"Buechel Jutta, Technolizenz Ets","desc":"A liquid composition to be used as a <b>rehydration drink<\\/b>, particularly suited for the  admistration to people who do heavy work under severe\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Rehydration drink","link":"http:\\/\\/www.google.com\\/patents\\/EP0681434B1?cl=en&dq=rehydration+drink&source=uds;","filedate":"Sun, 09 Jan 1994 00:00:00 -0800","applicant":"Charles B. Simone","desc":"A liquid composition to be used as a <b>rehydration drink<\\/b>, particularly suited for the  admistration to people who do heavy work under severe\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Rice-based oral rehydration solution","link":"http:\\/\\/www.google.com\\/patents\\/WO1998009669A1?cl=en&dq=rehydration+drink&source=uds;","filedate":"Wed, 03 Sep 1997 00:00:00 -0700","applicant":"Cleghorn Geoffrey, Royal Children S Hospital Foun, Shepherd Ross, Wall Clare","desc":"This invention relates to cereal-based oral <b>rehydration<\\/b> solutions (''ORS'') which  are particularly useful in treating dehydrated humans.","radio_11b":"duplicate"},{"title":"Rehydration drink","link":"http:\\/\\/www.google.com\\/patents\\/CA2152784C?cl=en&dq=rehydration+drink&source=uds;","filedate":"Sun, 09 Jan 1994 00:00:00 -0800","applicant":"Charles B. Simone","desc":"A liquid composition to be used as a <b>rehydration drink<\\/b>, particularly suited for the  administration to people who do heavy work under severe\\u00a0<b>...<\\/b>","radio_11b":"duplicate"}]', '[{"title":"The effect of water temperature and voluntary drinking on the post &lt;b&gt;rehydration&lt;\\/b&gt; sweating.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040477","desc":"Hosseinlou A, Khamnei S, Zamanlu M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of clinical and experimental medicine&quot;&gt;Int J Clin Exp Med&lt;\\/span&gt;. 2013 Sep 1;6(8):683-7.","radio_11b2":"duplicate"},{"title":"Effect of &lt;b&gt;Drink&lt;\\/b&gt; Carbohydrate Content on Post-Exercise Gastric Emptying, &lt;b&gt;Rehydration&lt;\\/b&gt; and the Calculation of Net &lt;b&gt;Fluid&lt;\\/b&gt; Balance.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23980237","desc":"Clayton DJ, Evans GH, James LJ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of sport nutrition and exercise metabolism&quot;&gt;Int J Sport Nutr Exerc Metab&lt;\\/span&gt;. 2013 Aug 26. [Epub ahead of print]","radio_11b2":"duplicate"},{"title":"Ad Libitum &lt;b&gt;Fluid&lt;\\/b&gt; Intake and Plasma Responses After Pickle Juice, Hypertonic Saline, or Deionized Water Ingestion.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23952039","desc":"Allen S, Miller K, Albrecht J, Garden-Robinson J, Salafia EB.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of athletic training&quot;&gt;J Athl Train&lt;\\/span&gt;. 2013 Aug 16. [Epub ahead of print]","radio_11b2":"duplicate"},{"title":"Preoperative oral &lt;b&gt;rehydration&lt;\\/b&gt; &lt;b&gt;therapy&lt;\\/b&gt; with 2.5&Acirc;&nbsp;% carbohydrate beverage alleviates insulin action in volunteers.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23917335","desc":"Yatabe T, Tamura T, Kitagawa H, Namikawa T, Yamashita K, Hanazaki K, Yokoyama M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs&quot;&gt;J Artif Organs&lt;\\/span&gt;. 2013 Aug 6. [Epub ahead of print]","radio_11b2":"duplicate"},{"title":"Physiological and behavioral responses to different watering intervals in lactating camels (Camelus dromedarius).","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23842680","desc":"Bekele T, Olsson K, Olsson U, Dahlborn K.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;American journal of physiology. Regulatory, integrative and comparative physiology&quot;&gt;Am J Physiol Regul Integr Comp Physiol&lt;\\/span&gt;. 2013 Sep;305(6):R639-46. doi: 10.1152\\/ajpregu.00015.2013. Epub 2013 Jul 10.","radio_11b2":"duplicate"}]', 'a', 'a', 'a', '[{"title":"Local <b>company<\\/b> makes <b>drink<\\/b> that drives off <b>dehydration<\\/b> - Santa <b>...<\\/b>","link":"http:\\/\\/smdp.com\\/local-company-makes-drink-that-drives-off-dehydration\\/127197","desc":"Sep 21, 2013 <b>...<\\/b> Liquid I.V. bills itself as an all-natural <b>rehydration<\\/b> therapy product. <b>...<\\/b> One of the   keys to sports <b>drink<\\/b> marketing is that, unlike the <b>health<\\/b> claims of\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Got a hangover? Trinity alumni claim new <b>rehydration drink<\\/b> is <b>...<\\/b>","link":"http:\\/\\/www.khou.com\\/news\\/health\\/Got-a-hangover-Trinity-alumni-claim-new-rehydration-drink-is-ultimate-cure-230346791.html","desc":"4 days ago <b>...<\\/b> The <b>beverage<\\/b> alleges to be a premium all-natural <b>rehydration drink<\\/b>. <b>...<\\/b> The   <b>company<\\/b> is based in Los Angeles but pours its so-called cure all across the   country. In fact, their <b>...<\\/b> By CBS News; Super seeds: <b>Health<\\/b> or Hype?","radio_15b":"duplicate"},{"title":"5 Best <b>Drink<\\/b> for <b>Hydration<\\/b> - Eat This, Not That - Men''s <b>Health<\\/b>","link":"http:\\/\\/eatthis.menshealth.com\\/node\\/186950","desc":"#5 Best <b>Drink<\\/b> for <b>Hydration<\\/b>: Coconut Water <b>...<\\/b> Chang''s Broccoli Beef or Panda   Express Broccoli Beef? http:\\/\\/t.<b>co<\\/b>\\/9ANL5nRS Choose right to save 705 calories!","radio_15b":"duplicate"},{"title":"<b>Healthy Hydration<\\/b>, <b>Health<\\/b> and water - Nestle Waters","link":"http:\\/\\/www.nestle-waters.com\\/healthy-hydration","desc":"Nestle Waters reminds that <b>healthy hydration<\\/b> goes beyond a question of <b>...<\\/b> At   Nestl\\u00e9 Waters, we believe what you <b>drink<\\/b> is as important as what you eat. <b>...<\\/b>   public <b>health<\\/b> challenges, we firmly believe our products constitute the <b>company''s<\\/b>   very\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"<b>Hydration<\\/b> Tips from - The Coca-Cola <b>Company<\\/b>","link":"http:\\/\\/www.coca-colacompany.com\\/our-company\\/hydration-tips","desc":"pays to get the facts on sweat, <b>hydration<\\/b>, and keeping your <b>energy<\\/b> level high. <b>...<\\/b>   it''s okay to reach for something else you enjoy like a sports <b>drink<\\/b>, tea or a soft\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"What Causes <b>Dehydration<\\/b>? | Golden Rule Insurance <b>Company<\\/b>","link":"http:\\/\\/www.goldenrule.com\\/health-wellness\\/what-causes-dehydration\\/","desc":"Several underlying <b>health<\\/b> problems can also increase your body''s need for water   or <b>...<\\/b> This means <b>dehydration<\\/b> can happen even when you think you''re <b>drinking<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"The truth about sports <b>drinks<\\/b> | BMJ","link":"http:\\/\\/www.bmj.com\\/content\\/345\\/bmj.e4737","desc":"10 Indeed, just as drug <b>companies<\\/b> have appointed key opinion leaders to   influence doctors'' prescribing patterns, <b>...<\\/b> And they have spread fear about the   dangers of <b>dehydration<\\/b>. <b>...<\\/b> \\u201cThe buzz around sports and <b>energy drinks<\\/b> is here to   stay.","radio_15b":"duplicate"},{"title":"Sports <b>Drinks<\\/b> vs. Water - Men''s Fitness","link":"http:\\/\\/www.mensfitness.com\\/nutrition\\/what-to-drink\\/sports-drinks-vs-water","desc":"<b>...<\\/b> when the <b>company<\\/b> instructed America to \\"Be Like Mike\\" that sports <b>drinks<\\/b>   really <b>...<\\/b> The formula is designed so that you''ll absorb the fluid and <b>energy<\\/b> quickly  , and <b>...<\\/b> \\"This is another well designed <b>hydration beverage<\\/b> with adequate sodium,  \\"\\u00a0<b>...<\\/b>","radio_15b":"duplicate"}]', '[{"title":"Sanofi, Coca-Cola team up on ''Beautific'' drinks","link":"http:\\/\\/www.fiercepharma.com\\/story\\/sanofi-coca-cola-team-beautific-drinks\\/2012-10-17","desc":" are engaging in a pilot project to find out. They''re collaborating on a line of <strong>drinks<\\/strong>, called Beautific ...","radio_15":"duplicate"},{"title":"Drink from the hose of DIA product news; Accelrys releases modeling software;","link":"http:\\/\\/www.fiercebiotechit.com\\/story\\/drink-hose-dia-product-news-accelrys-releases-modeling-software\\/2012-06-25","desc":" Announcement > IMS <strong>Health<\\/strong> revealed the launch of a web-based software product called SiteOptimizer, which ...","radio_15":"duplicate"},{"title":"GSK unloading drinks brands to Japan''s Suntory for $2.1B","link":"http:\\/\\/www.fiercepharma.com\\/story\\/gsk-unloading-drinks-brands-japans-suntory-21b\\/2013-09-09","desc":" GlaxoSmithKline-\\u00a0Top 10 Pharma Companies by Employees Related Articles: GlaxoSmithKline near $1.6B <strong>drinks<\\/strong>-brands sale ...","radio_15":"duplicate"},{"title":"Nevada lawmaker urges Purdue to unveil prescribers list; GSK splits U.K., Ireland business ahead of drink brands sale;","link":"http:\\/\\/www.fiercepharma.com\\/story\\/nevada-lawmaker-urges-purdue-unveil-prescribers-list-gsk-splits-uk-ireland\\/2013-08-19","desc":" for its planned divestment of the <strong>drink<\\/strong> brands Lucozade and Ribena.\\u00a0 Report > <strong>Health<\\/strong> Canada has ...","radio_15":"duplicate"},{"title":"Vaccine process shuns the cold","link":"http:\\/\\/www.fiercepharmamanufacturing.com\\/story\\/vaccine-process-shuns-cold\\/2010-02-22","desc":" The Hypodermic <strong>Rehydration<\\/strong> Injection System (HydRIS)\\u00a0yields vaccines that can be stored in tropical heat, say collaborators Nova Labs and Oxford University. The process involves mixing live vaccine with common sugars, dripping the substance onto a glass fiber membrane, and then drying it in low-humidity ...","radio_15":"duplicate"},{"title":"Epilepsy drug proves positive in alcoholism trial","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/epilepsy-drug-proves-positive-alcoholism-trial\\/2008-06-10","desc":" to <strong>drinking<\\/strong> following animal \\u2018rehab.''- read the BBC article Related Articles: Compound found for reducing ...","radio_15":"duplicate"},{"title":"Musicians rock on with energy drinks, pharma misuse","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/musicians-rock-energy-drinks-pharma-misuse\\/2011-06-20","desc":" Ninety-four percent were caffeine users and 57 percent reported use of energy <strong>drinks<\\/strong> specifically, according ...","radio_15":"duplicate"},{"title":"Alkermes drug helped cut heavy drinking","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/alkermes-drug-helped-cut-heavy-drinking\\/2005-05-24","desc":" that they had a median 1.6 days of heavy <strong>drinking<\\/strong> per month. Heavy <strong>drinking<\\/strong> was defined as five or more <strong>drinks<\\/strong> ...","radio_15":"duplicate"},{"title":"Private equity buyers eye offer for GlaxoSmithKline''s drinks brands ","link":"http:\\/\\/www.fiercepharma.com\\/story\\/private-equity-buyers-eye-offer-glaxosmithklines-drinks-brands\\/2013-07-01","desc":" Private equity firms Blackstone and Lion Capital are together eyeing an offer for GlaxoSmithKline''s ($GSK) <strong>drinks<\\/strong> brands Lucozade and Ribena. Up for sale as the U.K.-based drugmaker sheds lower-performing and non-core assets, the brands could fetch a bid worth more than \\u00a31 billion. Report  ...","radio_15":"duplicate"},{"title":"PhIII placebo response complicates Lundbeck''s case for anti-drinking drug ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/high-ph3-placebo-response-complicates-lundbeck-s-case-anti-drinking-drug\\/2012-03-05","desc":" was linked with a drop in the number of heavy <strong>drinking<\\/strong> days from 19 to 7, with total alcohol consumption ...","radio_15":"duplicate"}]', 'rehydration health drink', 'rehydration health drink', '[{"title":"Consumption of Sports <b>Drinks<\\/b> by Children and Adolescents","link":"http:\\/\\/www.healthyeatingresearch.org\\/images\\/stories\\/her_research_briefs\\/RRSportsDrinkFINAL6-2012.pdf"},{"title":"Assessing the Effects of <b>Energy Drinks<\\/b> upon Firefighter <b>Health<\\/b> and <b>...<\\/b>","link":"http:\\/\\/www.usfa.fema.gov\\/pdf\\/efop\\/efo45842.pdf"},{"title":"<b>Energy Drinks<\\/b> \\u2013 What You Don''t Know","link":"https:\\/\\/www1.villanova.edu\\/content\\/dam\\/villanova\\/studentlife\\/documents\\/healthpromotion\\/EnergyDrinks.pdf"},{"title":"<b>Energy<\\/b> & Sports <b>Drinks<\\/b>: <b>Hydration<\\/b> and <b>health<\\/b> <b>...<\\/b> - Drug Free Wilco","link":"http:\\/\\/www.drugfreewilco.org\\/docs\\/energy-and-sports-drinks.pdf"}]', '2', '3', '', 100);
INSERT INTO `inventions` VALUES(92, '2013-10-21 06:20:40', 1, 'pancreatic cancer drug', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'pancreatic diseases', 'e', 'b', 'pancreatic diseases', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '115', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '0000-00-00 00:00:00', 'HDAC inhibitors pancreatic cancer', '', '', 27, '', '100k-1m', 'Yes', 'No', 2, '', 'Yes', 33, '[{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=HDAC+inhibitors+pancreatic+cancer&source=uds;","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the preparation  of <b>...<\\/b> cancer is hepatocellular carcinoma or <b>pancreatic cancer<\\/b>.","radio_11b":"Already Assigned"},{"title":"Cancer therapy with a parvovirus combined with an HDAC inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2366398A1?cl=en&dq=HDAC+inhibitors+pancreatic+cancer&source=uds;","filedate":"Wed, 17 Mar 2010 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>HDAC inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2547349A1?cl=en&dq=HDAC+inhibitors+pancreatic+cancer&source=uds;","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/EP2142190A1?cl=en&dq=HDAC+inhibitors+pancreatic+cancer&source=uds;","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Novartis Ag","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the preparation  of <b>...<\\/b> cancer is hepatocellular carcinoma or <b>pancreatic cancer<\\/b>.","radio_11b":"Yes"}]', '[{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17.","radio_11b2":"Yes"},{"title":"The Anti-Tumor Effect of &lt;b&gt;HDAC&lt;\\/b&gt; Inhibition in a Human Pancreas &lt;b&gt;Cancer&lt;\\/b&gt; Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"Yes"},{"title":"Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize &lt;b&gt;pancreatic cancer&lt;\\/b&gt; to &lt;b&gt;histone deacetylase inhibitors&lt;\\/b&gt; (HDACi).","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23922886","desc":"Zou Y, Howell GM, Humphrey LE, Wang J, Brattain MG.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Jul 29;8(7):e69992. doi: 10.1371\\/journal.pone.0069992. Print 2013.","radio_11b2":"Yes"},{"title":"Identification of novel &lt;b&gt;HDAC inhibitors&lt;\\/b&gt; through cell based screening and their evaluation as potential anticancer agents.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23906422","desc":"Wang T, Sepulveda M, Gonzales P, Gately S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Bioorganic &amp; medicinal chemistry letters&quot;&gt;Bioorg Med Chem Lett&lt;\\/span&gt;. 2013 Sep 1;23(17):4790-3. doi: 10.1016\\/j.bmcl.2013.07.001. Epub 2013 Jul 10.","radio_11b2":"May Be"},{"title":"Belinostat-induced apoptosis and growth inhibition in &lt;b&gt;pancreatic cancer&lt;\\/b&gt; cells involve activation of TAK1-AMPK signaling axis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23743198","desc":"Wang B, Wang XB, Chen LY, Huang L, Dong RZ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Jul 19;437(1):1-6. doi: 10.1016\\/j.bbrc.2013.05.090. Epub 2013 Jun 4.","radio_11b2":"Yes"}]', 'Test test test test test', '', '', '[{"title":"<b>HDAC Inhibitors<\\/b> - Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/hdac_inhibitors.html;","desc":"Description of Pan <b>HDAC Inhibitors<\\/b> within Pharmacyclics'' therapeutic programs."},{"title":"Pharmaceutical <b>companies<\\/b> to invest in <b>HDAC inhibitor<\\/b> research <b>...<\\/b>","link":"http:\\/\\/www.hdlf.org\\/node\\/47;","desc":"Pharmaceutical <b>companies<\\/b> to invest in <b>HDAC inhibitor<\\/b> research. MethylGene, <b>Inc<\\/b>   Press Release, Sun, 07\\/18\\/2004. Histone deacetylase (<b>HDAC<\\/b>) <b>inhibitors<\\/b> are a\\u00a0<b>...<\\/b>"},{"title":"<b>Histone deacetylase inhibitor<\\/b> - Wikipedia, the free encyclopedia","link":"http:\\/\\/en.wikipedia.org\\/wiki\\/Histone_deacetylase_inhibitor;","desc":"HDIs should not be considered to act solely as enzyme <b>inhibitors<\\/b> of <b>HDACs<\\/b>. A   large variety of nonhistone transcription factors and transcriptional <b>co<\\/b>-regulators  \\u00a0<b>...<\\/b>"},{"title":"Closer to class IIa <b>HDAC inhibitors<\\/b> - Nature","link":"http:\\/\\/www.nature.com\\/scibx\\/journal\\/v6\\/n13\\/full\\/scibx.2013.301.html;","desc":"Apr 4, 2013 <b>...<\\/b> At least 23 <b>companies<\\/b> have <b>HDAC inhibitors<\\/b> in clinical trials, mostly for cancer, <b>...<\\/b>   For example, the two marketed <b>HDAC inhibitors<\\/b>, Merck & <b>Co<\\/b>."}]', '[{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" working on <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> include MEI Pharma ($MEIP) and 4SC, and gene therapy can flip the switch ..."},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" azacitidine. Role of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> in cancer Genes that regulate cell growth are frequently silenced ..."},{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" of Gothenburg in Sweden believe that <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong>\\u00a0can also help prevent blood clots through stimulating ..."},{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ..."},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" working on <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> include MEI Pharma ($MEIP) and 4SC, and gene therapy can flip the switch ..."},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" azacitidine. Role of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> in cancer Genes that regulate cell growth are frequently silenced ..."},{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" of Gothenburg in Sweden believe that <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong>\\u00a0can also help prevent blood clots through stimulating ..."},{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ..."}]', 'HDAC inhibitors Companies', '', '', '', '', '', 93);
INSERT INTO `inventions` VALUES(94, '2013-10-21 08:13:37', 1, 'pancreatic diseases', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_4', '', '', 'pancreatic diseases', 'b', '', 'pancreatic diseases', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '95', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'HDAC inhibitor for pancreatic cancer', '{"1":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"3":{"title":"pancreatic cancer drug","id":"92","status":"field"},"4":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"5":{"title":"pancreatic cancer","id":"108","status":"field"},"6":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"7":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"8":{"title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"9":{"title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"},"10":{"title":"Cancer drug","id":"146","status":"field"}}', '{"2":{"title":"CDx without drug on market","id":"58","status":"field"},"3":{"title":"Cancer Target screening tools","id":"61","status":"field"},"4":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"5":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"6":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"7":{"title":"pancreatic cancer drug","id":"92","status":"field"},"8":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"9":{"title":"pancreatic cancer","id":"108","status":"field"},"10":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"11":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"}}', 0, '', '', '', '', 0, '', '', 0, '[{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=hdac+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the <b>...<\\/b> Use of  <b>hdac inhibitors for<\\/b> the treatment of gastrointestinal <b>cancers<\\/b>"},{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2547349A1?cl=en&dq=hdac+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>"},{"title":"Metabolite derivatives of the hdac inhibitor fk228","link":"http:\\/\\/www.google.com\\/patents\\/CA2630216A1?cl=en&dq=hdac+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 17 Nov 2006 00:00:00 -0800","applicant":"Gloucester Pharmaceuticals, Inc., Mitchell Keegan, Yat Sun Or, Gregory L. Verdine","desc":"The present invention relates to <b>HDAC inhibitor<\\/b> derivatives, particularly <b>...<\\/b> cancer,  prostate cancer, colorectal and non-small cell lung cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>"},{"title":"Cancer therapy with a parvovirus combined with an HDAC inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2366398A1?cl=en&dq=hdac+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Wed, 17 Mar 2010 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>HDAC inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>"}]', '[{"title":"Suppressed Expression of NDRG2 Correlates with Poor Prognosis in &lt;b&gt;Pancreatic Cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Oct 14. doi:pii: S0006-291X(13)01670-7.  10.1016\\/j.bbrc.2013.10.010. [Epub ahead of print]"},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17."},{"title":"The novel &lt;b&gt;HDAC inhibitor&lt;\\/b&gt; NDACI054 sensitizes human &lt;b&gt;cancer&lt;\\/b&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/span&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4.  10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]"},{"title":"The Anti-Tumor Effect of &lt;b&gt;HDAC&lt;\\/b&gt; Inhibition in a Human Pancreas &lt;b&gt;Cancer&lt;\\/b&gt; Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102."},{"title":"Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23994577","desc":"Farrelly LA, Savage NT, O''Callaghan C, Toulouse A, Yilmazer-Hanke DM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Regulatory peptides&quot;&gt;Regul Pept&lt;\\/span&gt;. 2013 Sep 10;186:123-30. doi: 10.1016\\/j.regpep.2013.08.005. Epub 2013 Aug 28."}]', 'a', 'a', 'a', '[{"title":"The Anti-<b>Tumor<\\/b> Effect of <b>HDAC Inhibition<\\/b> in a Human <b>Pancreas<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.plosone.org\\/article\\/info%3Adoi%2F10.1371%2Fjournal.pone.0075102;","desc":"Sep 11, 2013 <b>...<\\/b> The lack of efficacy of <b>HDAC inhibitors<\\/b> in <b>pancreatic cancer<\\/b> could be <b>.....<\\/b> of pRb   appeared with the <b>co<\\/b>-inhibition of class I HDAC and COX-2."},{"title":"<b>Histone deacetylase inhibitors<\\/b> in the treatment of <b>cancer<\\/b>: overview <b>...<\\/b>","link":"http:\\/\\/www.reactionbiology.com\\/webapps\\/main\\/press\\/20130128.pdf;","desc":"Jan 28, 2013 <b>...<\\/b> perspectives. <b>Histone deacetylase inhibitors<\\/b> (HDACis) are one of the last   frontiers in pharmaceutical research. <b>...<\\/b> developed by Merck 56 <b>Co<\\/b>., <b>Inc<\\/b>. and, in.   November <b>......<\\/b> Gemcitabine <b>Pancreatic cancer<\\/b> or non-small-cell lung."},{"title":"<b>Histone deacetylase inhibitors<\\/b> and <b>pancreatic cancer<\\/b>: Are there any <b>...<\\/b>","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/pmc\\/articles\\/PMC3587473\\/;","desc":"Feb 28, 2013 <b>...<\\/b> <b>Histone deacetylase inhibitors<\\/b> and <b>pancreatic cancer<\\/b>: Are there any <b>......<\\/b> provided   here courtesy of Baishideng Publishing Group <b>Co<\\/b>., Limited\\u00a0<b>...<\\/b>"},{"title":"fVIIa <b>Inhibitor<\\/b> Phase II Trial in <b>Pancreatic Cancer<\\/b> - Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/clinical_trial_fVIIai_pcyc1001.html;","desc":"PCYC-1001: Factor VIIa Inhibitor Phase II Trial in <b>Pancreatic Cancer<\\/b> <b>...<\\/b> PCYC   1001 Factor VIIa Inhibitor <b>Pancreatic Cancer<\\/b> \\u00b7 PCYC 0403 <b>HDAC Inhibitor<\\/b> <b>...<\\/b>   Phase II Study of Coagulation Factor VIIa Inhibitor PCI-27483 in <b>Pancreatic<\\/b>   <b>Cancer<\\/b>\\u00a0<b>...<\\/b>"}]', '{"1":{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" cash for next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong> Florida Keys home to potential colon <strong>cancer<\\/strong> fighter Bracing for FDA ..."},"2":{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},"3":{"title":"Enzyme inhibitor spurs breakthrough on pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/enzyme-inhibitor-spurs-breakthrough-pancreatic-cancer\\/2009-09-25","desc":" was useless in stopping <strong>pancreatic<\\/strong> <strong>cancer<\\/strong>, but the researchers said that in combination with the TAK-1 ..."},"4":{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ..."},"5":{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ..."},"6":{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" cash for next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong> Florida Keys home to potential colon <strong>cancer<\\/strong> fighter Bracing for FDA ..."},"7":{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},"8":{"title":"Enzyme inhibitor spurs breakthrough on pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/enzyme-inhibitor-spurs-breakthrough-pancreatic-cancer\\/2009-09-25","desc":" was useless in stopping <strong>pancreatic<\\/strong> <strong>cancer<\\/strong>, but the researchers said that in combination with the TAK-1 ..."},"9":{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ..."},"10":{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ..."}}', 'hdac inhibitor for pancreatic cancer', '', '', '', '', '', 86);
INSERT INTO `inventions` VALUES(100, '2013-10-24 08:44:46', 1, 'Biomarker Dx for cancer', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_3', '', '', 'Satellite expression as biomarker for cancer', 'd', '', 'LINE-1 expression as biomarker for early detection of cancer', '', '', '', 'a', '', 'John Smith', 'NIH', '1211212121', '1 million over 3 years', '', '', 'field', '95', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-09 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'LINE-1 expression as biomarker for cancer', '{"1":{"title":"Testing for happy face","id":"58","status":"field"},"2":{"title":"method for detecting cancer","id":"87","status":"field"},"3":{"title":"pancreatic cancer drug","id":"92","status":"field"},"4":{"title":"Pancreatic cancer drug","id":"98","status":"field"}}', '{"2":{"title":"Testing for happy face","id":"58","status":"field"},"3":{"title":"testing happy face","id":"62","status":"process"},"4":{"title":"method for detecting cancer","id":"87","status":"field"},"5":{"title":"pancreatic cancer drug","id":"92","status":"field"},"6":{"title":"Pancreatic cancer drug","id":"98","status":"field"}}', 50, '', '>1m', 'Not Sure', '', 0, '', 'Not Sure', 20, '{"0":{"title":"Line-1 hypomethylation as a biomarker for early-onset colorectal cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2012129008A1?cl=en&dq=LINE-1+expression+as+biomarker+for+cancer&source=uds;","desc":"A method for detecting an early-onset of colorectal <b>cancer<\\/b> in a human <b>...<\\/b> a  <b>biomarker<\\/b> to determine a methylation level of <b>LINE<\\/b>-<b>1<\\/b>, wherein a lower <b>.....<\\/b> <b>Tumor<\\/b>  mismatch repair protein <b>expression<\\/b>, microsatellite instability status,\\u00a0<b>...<\\/b>","filedate":"Tue, 13 Mar 2012 00:00:00 -0700","applicant":"Baylor Research Institute"},"1":{"title":"Biomarkers and methods of treatment","link":"http:\\/\\/www.google.com\\/patents\\/WO2012031027A1?cl=en&dq=LINE-1+expression+as+biomarker+for+cancer&source=uds;","desc":"The present invention concerns <b>cancer biomarkers<\\/b>. <b>...<\\/b> The method of claim 7,  wherein cell <b>line<\\/b> A549 has moderate c-met staining intensity. 9. <b>...<\\/b> The method of  claim <b>1<\\/b> or 2, wherein c-met <b>biomarker expression<\\/b> is nucleic acid\\u00a0<b>...<\\/b>","filedate":"Wed, 31 Aug 2011 00:00:00 -0700","applicant":"Genentech, Inc."},"3":{"title":"A ctc biomarker assay to combat breast cancer brain metastasis","link":"http:\\/\\/www.google.com\\/patents\\/WO2013082163A1?cl=en&dq=LINE-1+expression+as+biomarker+for+cancer&source=uds;","desc":"The method of claim <b>1<\\/b> , wherein the cells are circulating <b>tumor<\\/b> cells (CTCs). <b>...<\\/b>  and that comprise <b>expression<\\/b> of heparanase (HPSE) and\\/or Notch <b>1<\\/b> in a <b>...<\\/b> from  <b>cancer<\\/b> patients - establishing CTC <b>lines<\\/b> has been reported in the\\u00a0<b>...<\\/b>","filedate":"Wed, 28 Nov 2012 00:00:00 -0800","applicant":"Baylor College Of Medicine"},"4":{"title":"Method for selectively inducing biomarker expression in urologic tumor ...","link":"http:\\/\\/www.google.com\\/patents\\/WO1995034637A1?cl=en&dq=LINE-1+expression+as+biomarker+for+cancer&source=uds;","desc":"The method of Claim 5, wherein said urological <b>cancer marker<\\/b> is a prostate  <b>cancer marker<\\/b>. <b>...<\\/b> (b) culturing said biopsy or a cell <b>line<\\/b> derived therefrom in a <b>.....<\\/b>  <b>1<\\/b> is a graphical depiction of <b>biomarker expression<\\/b> rates in PC3-MF\\u00a0<b>...<\\/b>","filedate":"Fri, 16 Jun 1995 00:00:00 -0700","applicant":"Urocor Inc"},"5":{"title":"Biomarkers for cancers responsive to modulators of hec1 activity","link":"http:\\/\\/www.google.com\\/patents\\/WO2013078145A1?cl=en&dq=LINE-1+expression+as+biomarker+for+cancer&source=uds;","desc":"In addition, Hec <b>1<\\/b> inhibitors may show synergistic effects when used in <b>...<\\/b> 2  shows Heel <b>expression<\\/b> in different <b>cancer<\\/b> cell <b>lines<\\/b> and in subtypes\\u00a0<b>...<\\/b>","filedate":"Mon, 19 Nov 2012 00:00:00 -0800","applicant":"Taivex Therapeutics Corporation"},"6":{"title":"LINE-1 Hypomethylation as a Biomarker for Early-Onset Colorectal Cancer","link":"http:\\/\\/www.google.com\\/patents\\/US20120238463?dq=LINE-1+expression+as+biomarker+for+cancer&source=uds;","desc":"a <b>biomarker<\\/b> to determine a methylation level of <b>LINE<\\/b>-<b>1<\\/b>, wherein a lower <b>.....<\\/b>  <b>Tumor<\\/b> mismatch repair protein <b>expression<\\/b>, microsatellite instability\\u00a0<b>...<\\/b>","filedate":"Wed, 14 Mar 2012 00:00:00 -0700","applicant":"Baylor Research Institute"},"7":{"title":"Biomarkers of cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2013063035A1?cl=en&dq=LINE-1+expression+as+biomarker+for+cancer&source=uds;","desc":"determining an <b>expression<\\/b> level of <b>one<\\/b> or more Satellite Correlated <b>.....<\\/b> tumors ( Tumors <b>1<\\/b>-3) and a stable cell <b>line<\\/b> (CL3) derived from <b>Tumor<\\/b> 3.","filedate":"Wed, 24 Oct 2012 00:00:00 -0700","applicant":"The General Hospital Corporation"}}', '[{"title":"Clinical implications of the &lt;b&gt;LINE-1&lt;\\/b&gt; methylation levels in patients with gastrointestinal &lt;b&gt;cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24150097","desc":"Baba Y, Murata A, Watanabe M, Baba H.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Surgery today&quot;&gt;Surg Today&lt;\\/span&gt;. 2013 Oct 23. [Epub ahead of print]"},{"title":"Mast cell-deficient Kit(W-sh) ","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23636054","desc":"Michel A, Sch&Atilde;&frac14;ler A, Friedrich P, D&Atilde;&para;ner F, Bopp T, Radsak M, Hoffmann M, Relle M, Distler U, Kuharev J, Tenzer S, Feyerabend TB, Rodewald HR, Schild H, Schmitt E, Becker M, Stassen M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of immunology (Baltimore, Md. : 1950)&quot;&gt;J Immunol&lt;\\/span&gt;. 2013 Jun 1;190(11):5534-44. doi: 10.4049\\/jimmunol.1203355. Epub 2013 May 1."},{"title":"&lt;b&gt;LINE-1&lt;\\/b&gt; ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23153584","desc":"Lu Y, Feng F, Yang Y, Gao X, Cui J, Zhang C, Zhang F, Xu Z, Qv J, Wang C, Zeng Z, Zhu Y, Yang Y.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cellular signalling&quot;&gt;Cell Signal&lt;\\/span&gt;. 2013 Feb;25(2):479-89. doi: 10.1016\\/j.cellsig.2012.11.004. Epub 2012 Nov 12."},{"title":"Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23152053","desc":"Westerberg CM, H&Atilde;&curren;gglund H, Nilsson G.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cell death &amp; disease&quot;&gt;Cell Death Dis&lt;\\/span&gt;. 2012 Nov 15;3:e417. doi: 10.1038\\/cddis.2012.157."},{"title":"A high degree of &lt;b&gt;LINE-1&lt;\\/b&gt; hypomethylation is a unique feature of early-onset colorectal &lt;b&gt;cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23049789","desc":"Antelo M, Balaguer F, Shia J, Shen Y, Hur K, Moreira L, Cuatrecasas M, Bujanda L, Giraldez MD, Takahashi M, Cabanne A, Barugel ME, Arnold M, Roca EL, Andreu M, Castellvi-Bel S, Llor X, Jover R, Castells A, Boland CR, Goel A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2012;7(9):e45357. doi: 10.1371\\/journal.pone.0045357. Epub 2012 Sep 25."}]', '', '', '', '', '', '', '', '', '', '', '', 86);
INSERT INTO `inventions` VALUES(103, '2013-10-24 09:10:48', 1, 'Plastics 10-29-13', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'Plastics', 'b', '', 'ttt', '', '', '', 'a', '', 'ttt', '', '', '', '', '', 'field', '85', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '0000-00-00 00:00:00', 'Polymerization catalyst ', '', '', 68, '', '100k-1m', 'Yes', 'No', 2, '', 'Yes', 16, '[{"title":"Ethylene polymerization catalyst","link":"http:\\/\\/www.google.com\\/patents\\/CA1249574A1?cl=en&dq=Polymerization+catalyst&source=uds;","filedate":"Wed, 31 Jul 1985 00:00:00 -0700","applicant":"Exxon Research And Engineering Company, Victoria Graves","desc":"ABSTRACT OF THE DISCLOSURE An olefin <b>polymerization catalyst<\\/b> system  comprising (I) a <b>polymerization catalyst<\\/b> produced by treating an inert support\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Olefin polymerization catalyst component, olefin polymerization catalyst and ...","link":"http:\\/\\/www.google.com\\/patents\\/EP0363029A3?cl=en&dq=Polymerization+catalyst&source=uds;","filedate":"Wed, 13 Sep 1989 00:00:00 -0700","applicant":"Mitsui Petrochemical Industries, Ltd.","desc":"In accordance with the present invention, there are provided olefin  <b>polymerization catalyst<\\/b> components comprising an organoaluminum oxy- compound having\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Polymerization catalyst systems, their production and use","link":"http:\\/\\/www.google.com\\/patents\\/WO1995007939A1?cl=en&dq=Polymerization+catalyst&source=uds;","filedate":"Mon, 29 Aug 1994 00:00:00 -0700","applicant":"Exxon Chemical Patents Inc","desc":"This invention is generally directed toward a supported <b>catalyst<\\/b> system useful for  polymerizing olefins. The method for supporting the <b>catalyst<\\/b> of the invention\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Modified particle, support, catalyst component for addition polymerization ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2002051878A1?cl=en&dq=Polymerization+catalyst&source=uds;","filedate":"Fri, 21 Dec 2001 00:00:00 -0800","applicant":"Yasuki Fujiwara, Takuya Ogane, Hideki Oshima, Sumitomo Chemical Co, Kazuo Takaoki, Masatada Tasaka, Kenichiro Yada","desc":"Modified particle, support, catalyst component for addition <b>polymerization<\\/b>,  <b>catalyst<\\/b> for addition polymerization, and process for producing addition polymer","radio_11b":"least_relevant"},{"title":"Polymerization catalysts, their production and use","link":"http:\\/\\/www.google.com\\/patents\\/WO1995004761A1?cl=en&dq=Polymerization+catalyst&source=uds;","filedate":"Wed, 03 Aug 1994 00:00:00 -0700","applicant":"Exxon Chemical Patents Inc","desc":"This invention is directed toward the <b>polymerization<\\/b> of olefins, optionally with a  comonomer in the presence of metallocene <b>catalyst<\\/b> to produce a <b>polymer<\\/b>  product\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"CATALYST FOR \\u03b1-OLEFIN POLYMERIZATION AND METHOD OF POLYMERIZATION WITH THIS ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2002062855A1?cl=en&dq=Polymerization+catalyst&source=uds;","filedate":"Thu, 07 Feb 2002 00:00:00 -0800","applicant":"Hiroyuki Ikeuchi, Katsunori Masaki, Yoshiyuki Sakuda, Ube Industries","desc":"A <b>polymerization catalyst<\\/b> effective in producing a flexible polymer through \\u03b1- olefin polymerization, which comprises the following ingredients: (A) a solid  catalyst\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Non-supported heterogeneous polyolefin polymerization catalyst composition ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013066109A1?cl=en&dq=Polymerization+catalyst&source=uds;","filedate":"Fri, 02 Nov 2012 00:00:00 -0700","applicant":"Lg Chem, Ltd., \\uc8fc\\uc2dd\\ud68c\\uc0ac \\uc5d8\\uc9c0\\ud654\\ud559","desc":"<b>...<\\/b> invention relates to a polyolefin polymerization metallocene catalyst <b>...<\\/b> to a non -supported heterogeneous polyolefin <b>polymerization catalyst<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Method for transitioning between incompatible olefin polymerization catalyst ...","link":"http:\\/\\/www.google.com\\/patents\\/US8481658?dq=Polymerization+catalyst&source=uds;","filedate":"Thu, 17 Dec 2009 00:00:00 -0800","applicant":"Basell Polyolefine Gmbh","desc":"A method for transitioning from a Ziegler-Natta to a Phillips <b>catalyst<\\/b> system for the  olefin <b>polymerization<\\/b> reaction in one reactor, preferably a gas\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"}]', '[{"title":"Control the Wettability of Poly(N-isopropylacrylamide-co-1-adamantan-1-ylmethyl acrylate) Modified Surfaces: the More Ada, the Bigger Impact?","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24152189","desc":"Shi X, Chen G, Wang Y, Yuan L, Zhang Q, Haddleton DM, Chen H.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Langmuir : the ACS journal of surfaces and colloids&quot;&gt;Langmuir&lt;\\/span&gt;. 2013 Oct 24. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Exploring Quality in Gradient Copolymers.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24150838","desc":"Elsen AM, Li Y, Li Q, Sheiko SS, Matyjaszewski K.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Macromolecular rapid communications&quot;&gt;Macromol Rapid Commun&lt;\\/span&gt;. 2013 Oct 22. doi: 10.1002\\/marc.201300654. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Facile Iron-Mediated Dispersant-Free Suspension &lt;b&gt;Polymerization&lt;\\/b&gt; of Methyl Methacrylate via Reverse ATRP in Water.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24127349","desc":"Cao J, Zhang L, Jiang X, Tian C, Zhao X, Ke Q, Pan X, Cheng Z, Zhu X.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Macromolecular rapid communications&quot;&gt;Macromol Rapid Commun&lt;\\/span&gt;. 2013 Oct 11. doi: 10.1002\\/marc.201300513. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Extension of Polyphenolics by CWPO-C Peroxidase Mutant Containing Radical-Robust Surface Active Site.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24122664","desc":"Pham LT, Kim SJ, Ahn US, Choi JW, Song BK, Kim YH.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Applied biochemistry and biotechnology&quot;&gt;Appl Biochem Biotechnol&lt;\\/span&gt;. 2013 Oct 13. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Influence of Activation Mode of Resin Cement on the Shade of Porcelain Veneers.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24118675","desc":"Magalh&Atilde;&pound;es AP, Cardoso PD, de Souza JB, Fonseca RB, Pires-de-Souza FD, Lopez LG.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of prosthodontics : official journal of the American College of Prosthodontists&quot;&gt;J Prosthodont&lt;\\/span&gt;. 2013 Oct 7. doi: 10.1111\\/jopr.12098. [Epub ahead of print]","radio_11b2":"least_relevant"}]', 'the by products are not toxic', 'the time is accelerated by a lot', 'the product works much better', '', '[{"title":"Graphene Will Change The World And Fortunes Will Be Made <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/instablog\\/524943-retirefund\\/2032402-graphene-will-change-the-world-and-fortunes-will-be-made","desc":"Jul 15, 2013<b>...<\\/b> engines; Diesel oxidation <b>catalysts<\\/b>; <b>Polymer<\\/b> production from waste CO2 <b>...<\\/b>   Head (tennis rackets), Kia and Hyundai (<b>fuel<\\/b> cells), Saab (de-icing\\u00a0<b>...<\\/b>"},{"title":"Phillips 66 <b>Catalysts<\\/b> Include Dividend Growth And MLP Spin-Off <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1260891-phillips-66-catalysts-include-dividend-growth-and-mlp-spin-off","desc":"Mar 10, 2013 <b>...<\\/b> The company''s marketing operations include 10,000 retail <b>fuel<\\/b> sites across <b>...<\\/b>   <b>plastic<\\/b> piping, <b>polymer<\\/b> resins, styrenics and specialty chemicals,\\u00a0<b>...<\\/b>"},{"title":"Ballard Power: Great Karma But Poor Investment - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/291474-ballard-power-great-karma-but-poor-investment","desc":"Sep 2, 2011 <b>...<\\/b> PEM <b>fuel<\\/b> cells use a solid <b>polymer<\\/b> as an electrolyte and porous carbon   electrodes containing a platinum <b>catalyst<\\/b>. They need only hydrogen,\\u00a0<b>...<\\/b>"},{"title":"Albemarle to increase the price of ETHANOX 330 antioxidant <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/news-article\\/7635062-albemarle-to-increase-the-price-of-ethanox-330-antioxidant","desc":"Sep 19, 2013<b>...<\\/b> antioxidants for the <b>polymers<\\/b>, <b>fuel<\\/b> and lube industries, announced today that <b>...<\\/b>   Albemarle''s antioxidants are part of the company''s <b>polymer<\\/b> <b>...<\\/b> in its three   business segments, <b>Polymer<\\/b> Solutions, <b>Catalysts<\\/b> and Fine Chemistry."},{"title":"Albemarle Corporation CFO Speaks About His Company - Seeking <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/38606-albemarle-corporation-cfo-speaks-about-his-company","desc":"Jun 18, 2007 <b>...<\\/b> The three segments are <b>Polymer<\\/b> Additives, <b>Catalysts<\\/b> and Fine <b>...<\\/b> new,   environmentally sensitive <b>polymer<\\/b> additives and <b>fuel<\\/b> additives and\\u00a0<b>...<\\/b>"},{"title":"Albemarle to increase the price of ETHANOX 4703 antioxidant <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/news-article\\/6044851-albemarle-to-increase-the-price-of-ethanox-4703-antioxidant","desc":"Mar 25, 2013<b>...<\\/b> and extend the storage life of lubricants and <b>fuels<\\/b> used worldwide. The   Company is also a leading supplier of <b>polymer<\\/b> antioxidants. <b>...<\\/b> in its three   business segments, <b>Polymer<\\/b> Solutions, <b>Catalysts<\\/b> and Fine Chemistry."},{"title":"Albemarle Corporation (ALB) CEO Discusses Q2 2013 Results <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1556282-albemarle-corporation-alb-ceo-discusses-q2-2013-results-earnings-call-transcript","desc":"Jul 18, 2013 <b>...<\\/b> Albemarle Corporation (NYSE:ALB): Albemarle Corporation (ALB) CEO   Discusses Q2 2013 Results - Earnings Call Transcript."},{"title":"Tuesday''s Green News: IBM Eyes <b>Plastic<\\/b> Recycling, And More <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/192760-tuesdays-green-news-ibm-eyes-plastic-recycling-and-more","desc":"Mar 9, 2010 <b>...<\\/b> Ideally, these <b>catalysts<\\/b> could be used to recycle <b>plastic<\\/b> or develop new <b>...<\\/b> with   <b>plastic<\\/b>, oceans continue to get clogged with it, and the fossil <b>fuels<\\/b>\\u00a0<b>...<\\/b>"}]', 'polymer catalysts in fuel', 'polymerization catalysts ', '[{"title":"World <b>Catalysts<\\/b> - The Freedonia Group","link":"http:\\/\\/www.freedoniagroup.com\\/brochure\\/21xx\\/2125smwe.pdf"},{"title":"Download PRES-IntelligenceReport(May2012).pdf - The <b>Catalyst<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.catalystgrp.com\\/cmsAdmin\\/uploads\\/PRES-IntelligenceReport(May2012).pdf"},{"title":"Sample Chapter - Wiley-VCH","link":"http:\\/\\/www.wiley-vch.de\\/books\\/sample\\/3527317104_c01.pdf"},{"title":"Reactor Modeling for <b>Polymerization<\\/b> Processes - The Dow <b>...<\\/b>","link":"http:\\/\\/www.dow.com\\/innovation\\/pdf\\/Computational\\/Reactor_Modeling.pdf"}]', '', '', '', 100);
INSERT INTO `inventions` VALUES(104, '2013-10-25 06:32:16', 1, 'Oct 25 Dx testing', 'patent', '', '', 'gansh2', 'gansh14', 'gansh10_3', '', '', 'LINE-1', 'b', '', 'LINE-1', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '57', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'LINE-1 as biomarker for epithelial cancers', '', '', 0, '', '', '', '', 0, '', '', 0, '[{"title":"Methods for diagnosis and prognosis of epithelial cancers","link":"http:\\/\\/www.google.com\\/patents\\/EP1842065A2?cl=en&dq=LINE-1+as+biomarker+for+epithelial+cancers&source=uds;","filedate":"Mon, 30 Jan 2006 00:00:00 -0800","applicant":"Children''s Medical Center Corporation, The General Hospital Corporation","desc":"The method of claim <b>1<\\/b> or 2, wherein the <b>cancer<\\/b> of <b>epithelial<\\/b> origin is <b>...<\\/b> A kit for  detecting at least <b>one epithelial cancer biomarker<\\/b> in a urine sample <b>......<\\/b> tissue  and cell <b>lines<\\/b> for <b>biomarker<\\/b> discovery in transitional cell <b>carcinoma<\\/b>.","radio_11b":"Yes"},{"title":"Methods for diagnosis and prognosis of epithelial cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2009017475A1?cl=en&dq=LINE-1+as+biomarker+for+epithelial+cancers&source=uds;","filedate":"Fri, 27 Jul 2007 00:00:00 -0700","applicant":"Childrens Medical Center, Feldman Adam S, Gen Hospital Corp, Mcdougal W Scott, Zetter Bruce R","desc":"A kit for detecting at least <b>one epithelial cancer biomarker<\\/b> in a urine sample  comprising a <b>.....<\\/b> Perpendicular <b>lines<\\/b> indicate censored data.","radio_11b":"No"},{"title":"Methods for diagnosis and prognosis of epithelial cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2006081473A2?cl=en&dq=LINE-1+as+biomarker+for+epithelial+cancers&source=uds;","filedate":"Mon, 30 Jan 2006 00:00:00 -0800","applicant":"Childrens Medical Center, Adam S Feldman, Gen Hospital Corp, Scott W Mcdougal, Bruce R Zetter","desc":"The method of claim <b>1<\\/b> or 2, wherein the <b>cancer<\\/b> of <b>epithelial<\\/b> origin is selected  from <b>...<\\/b> A kit for detecting at least <b>one epithelial cancer biomarker<\\/b> in a <b>......<\\/b> tissue  and cell <b>lines<\\/b> for <b>biomarker<\\/b> discovery in transitional cell <b>carcinoma<\\/b>.","radio_11b":"duplicate"},{"title":"Biomarkers for epithelial cancer diagnosis and treatment","link":"http:\\/\\/www.google.com\\/patents\\/WO2012174498A2?cl=en&dq=LINE-1+as+biomarker+for+epithelial+cancers&source=uds;","filedate":"Sat, 16 Jun 2012 00:00:00 -0700","applicant":"Pitari Giovanni M, Zuzga David S","desc":"<b>Biomarkers for epithelial cancer<\\/b> diagnosis and treatment <b>...<\\/b> <b>1<\\/b>. A method for  diagnosing the state of an <b>epithelial<\\/b> tumor in a subject comprising,. a) measuring  the amount of <b>......<\\/b> Dotted <b>lines<\\/b> are 95% confidence limits. The curve\\u00a0<b>...<\\/b>","radio_11b":"duplicate"}]', '[{"title":"&lt;b&gt;LINE-1&lt;\\/b&gt; methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23216958","desc":"Matsunoki A, Kawakami K, Kotake M, Kaneko M, Kitamura H, Ooi A, Watanabe G, Minamoto T.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BMC cancer&quot;&gt;BMC Cancer&lt;\\/span&gt;. 2012 Dec 5;12:574. doi: 10.1186\\/1471-2407-12-574.","radio_11b2":"Yes"},{"title":"Aberrant overexpression of satellite repeats in pancreatic and other &lt;b&gt;epithelial&lt;\\/b&gt; &lt;b&gt;cancers&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/21233348","desc":"Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, Rivera MN, Bardeesy N, Maheswaran S, Haber DA.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Science (New York, N.Y.)&quot;&gt;Science&lt;\\/span&gt;. 2011 Feb 4;331(6017):593-6. doi: 10.1126\\/science.1200801. Epub 2011 Jan 13.","radio_11b2":"No"},{"title":"Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/20927778","desc":"Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;The Journal of pathology&quot;&gt;J Pathol&lt;\\/span&gt;. 2010 Dec;222(4):350-66. doi: 10.1002\\/path.2774. Review.","radio_11b2":"No"},{"title":"DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/20635146","desc":"Worthley DL, Whitehall VL, Le Leu RK, Irahara N, Buttenshaw RL, Mallitt KA, Greco SA, Ramsnes I, Winter J, Hu Y, Ogino S, Young GP, Leggett BA.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Digestive diseases and sciences&quot;&gt;Dig Dis Sci&lt;\\/span&gt;. 2011 Feb;56(2):387-96. doi: 10.1007\\/s10620-010-1312-4. Epub 2010 Jul 16.","radio_11b2":"Yes"},{"title":"A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and &lt;b&gt;epithelial&lt;\\/b&gt; biomarkers of colorectal cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/19640954","desc":"Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt KA, Hu Y, Irahara N, Ogino S, Leggett BA, Young GP.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;The American journal of clinical nutrition&quot;&gt;Am J Clin Nutr&lt;\\/span&gt;. 2009 Sep;90(3):578-86. doi: 10.3945\\/ajcn.2009.28106. Epub 2009 Jul 29.","radio_11b2":"May Be"}]', '', '', '', '[{"title":"Aberrant <b>Overexpression<\\/b> of <b>Satellite<\\/b> Repeats in <b>...<\\/b> - Science","link":"https:\\/\\/www.sciencemag.org\\/content\\/331\\/6017\\/593","desc":"Feb 4, 2011 <b>...<\\/b> 2Helicos BioSciences <b>Corporation<\\/b>, One Kendall Square, Cambridge, MA 02139,   USA. <b>...<\\/b> are greatly <b>overexpressed<\\/b> in mouse and human <b>epithelial cancers<\\/b>. In 8   of <b>...<\\/b> The <b>overexpression<\\/b> of <b>satellite<\\/b> transcripts in <b>cancer<\\/b> may reflect global <b>...<\\/b> and   could potentially be useful as a <b>biomarker<\\/b> for <b>cancer<\\/b> detection."},{"title":"Aberrant <b>Overexpression<\\/b> of <b>Satellite<\\/b> Repeats in Pancreatic and <b>...<\\/b>","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/pmc\\/articles\\/PMC3701432\\/","desc":"Jan 13, 2011 <b>...<\\/b> 2Helicos BioSciences <b>Corporation<\\/b>, One Kendall Square, Cambridge, MA 02139,   USA <b>...<\\/b> The <b>overexpression<\\/b> of <b>satellite<\\/b> transcripts in <b>cancer<\\/b> may reflect <b>....<\\/b>   <b>biomarker<\\/b> in diverse <b>epithelial cancers<\\/b> merits further clinical testing."},{"title":"<b>Overexpression<\\/b> of repetitive DNA sequences discovered in common <b>...<\\/b>","link":"http:\\/\\/www.sciencedaily.com\\/releases\\/2011\\/01\\/110113141603.htm","desc":"Jan 13, 2011 <b>...<\\/b> Researchers have discovered massive <b>overexpression<\\/b> of <b>satellite<\\/b> repeats <b>...<\\/b> MD,   of the MGH <b>Cancer<\\/b> Center, <b>co<\\/b>-lead author of the Science paper. <b>...<\\/b> and highly   specific <b>biomarker<\\/b> relevant to multiple types of <b>epithelial cancers<\\/b>."},{"title":"<b>Overexpressed satellite<\\/b> transcripts as <b>cancer biomarkers<\\/b> : SciBX <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/scibx\\/journal\\/v4\\/n5\\/full\\/scibx.2011.150.html","desc":"Feb 3, 2011 <b>...<\\/b> SciBX: Science-<b>Business<\\/b> eXchange homepage. home \\u00b7 current <b>...<\\/b> <b>Overexpressed<\\/b>   <b>satellite<\\/b> transcripts as <b>cancer biomarkers<\\/b> <b>...<\\/b> Next steps include investigating   specific <b>satellite<\\/b> transcripts as <b>biomarkers<\\/b> of <b>epithelial cancers<\\/b>."}]', '[{"title":"DNA overexpression might be cancer biomarker","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/dna-overexpression-might-be-cancer-biomarker\\/2011-01-18","desc":" <strong>satellite<\\/strong> repeats--had never previously been a suspect in <strong>cancers<\\/strong>. "},{"title":"Biomarkers could tag chemo heart risk","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/biomarkers-could-tag-chemo-heart-risk\\/2013-01-09","desc":" A combination of <strong>biomarkers<\\/strong> and imaging could tag chemotherapy-induced heart damage early on, cutting long-term heart risk in <strong>cancer<\\/strong> survivors, according to a study reported at the recent San Antonio ..."},{"title":"Cancer biomarker offers clues into when it will spread","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/cancer-biomarker-offers-clues-when-it-will-spread\\/2011-02-01","desc":" "},{"title":"Genomic biomarkers can tame the dragon of cancer","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/genomic-biomarkers-can-tame-dragon-cancer\\/2011-03-30","desc":" in <strong>cancer<\\/strong>,"},{"title":"Two new biomarkers for prostate cancer may improve faulty PSA tests","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/two-new-biomarkers-prostate-cancer-may-improve-faulty-psa-tests\\/2011-06-07","desc":" their promise as new <strong>biomarkers<\\/strong> for prostate <strong>cancer<\\/strong>.- read more at Johns Hopkins Special Report: Five Prostate ..."},{"title":"DNA overexpression might be cancer biomarker","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/dna-overexpression-might-be-cancer-biomarker\\/2011-01-18","desc":" <strong>satellite<\\/strong> repeats--had never previously been a suspect in <strong>cancers<\\/strong>. "},{"title":"Biomarkers could tag chemo heart risk","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/biomarkers-could-tag-chemo-heart-risk\\/2013-01-09","desc":" A combination of <strong>biomarkers<\\/strong> and imaging could tag chemotherapy-induced heart damage early on, cutting long-term heart risk in <strong>cancer<\\/strong> survivors, according to a study reported at the recent San Antonio ..."},{"title":"Cancer biomarker offers clues into when it will spread","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/cancer-biomarker-offers-clues-when-it-will-spread\\/2011-02-01","desc":" "},{"title":"Genomic biomarkers can tame the dragon of cancer","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/genomic-biomarkers-can-tame-dragon-cancer\\/2011-03-30","desc":" in <strong>cancer<\\/strong>,"},{"title":"Two new biomarkers for prostate cancer may improve faulty PSA tests","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/two-new-biomarkers-prostate-cancer-may-improve-faulty-psa-tests\\/2011-06-07","desc":" their promise as new <strong>biomarkers<\\/strong> for prostate <strong>cancer<\\/strong>.- read more at Johns Hopkins Special Report: Five Prostate ..."}]', 'Satellite overexpression as biomarker for epithelial cancers', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(105, '2013-10-25 09:02:22', 2, 'Olefin catalyst for polymerization', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'this is test23', 'a', '', 'this is a test', '', '', '', 'b', '', 'Jane Doe', '', '', '', '', '', 'field', '80', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '0000-00-00 00:00:00', 'Olefin catalyst in polymerization', '{"1":{"radio_11a1":"Yes","title":"testing 10-28-13","id":"106","status":"field"}}', '{"1":{"radio_11a2":"Yes","title":"testing 10-28-13","id":"106","status":"Disclosure Done & Under Review"}}', 76, '', '>1m', 'Not Sure', '', 0, '', 'Not Sure', 20, '[{"title":"Mixed transition metal catalyst systems for olefin polymerization","link":"http:\\/\\/www.google.com\\/patents\\/WO1997048735A1?cl=en&dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Tue, 17 Jun 1997 00:00:00 -0700","applicant":"Exxon Chemical Patents Inc","desc":"The invention encompasses a mixed transition metal <b>olefin polymerization<\\/b>  <b>catalyst<\\/b> system suitable for the <b>polymerization<\\/b> of <b>olefin<\\/b> monomers comprising  one\\u00a0<b>...<\\/b>","radio_11b":"Already Assigned"},{"title":"A method of catalyst transitions in olefin polymerizations","link":"http:\\/\\/www.google.com\\/patents\\/EP2216347A1?cl=en&dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Fri, 30 Jan 2009 00:00:00 -0800","applicant":"Borealis AG","desc":"The <b>olefin polymerization<\\/b>, utilizing a Ziegler <b>catalyst<\\/b>, is stopped by <b>...<\\/b> In <b>olefin<\\/b>  <b>polymerizations<\\/b> Ziegler-Natta <b>catalysts<\\/b> are frequently used.","radio_11b":"Already Assigned"},{"title":"Catalyst for polymerization of olefins comprising thienyl-substituted silanes","link":"http:\\/\\/www.google.com\\/patents\\/US8541332?dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Fri, 03 Jun 2011 00:00:00 -0700","applicant":"Petrochina Company Limited","desc":"Disclosed is a <b>catalyst<\\/b> for the <b>polymerization<\\/b> of <b>olefins<\\/b> comprising thienyl- substituted silanes, which comprises a solid titanium <b>catalyst<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Olefin polymerization catalyst and olefin polymerization process","link":"http:\\/\\/www.google.com\\/patents\\/EP0628574A1?cl=en&dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Tue, 07 Jun 1994 00:00:00 -0700","applicant":"Tosoh Corporation","desc":"A <b>catalyst<\\/b> is provided for <b>polymerization<\\/b> of <b>olefin<\\/b>. The <b>catalyst<\\/b> is formed by  bringing into contact a metallocene compound, an ionizing ionic compound,\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Solid catalyst component and catalyst for polymerization of olefins, and ...","link":"http:\\/\\/www.google.com\\/patents\\/US8426537?dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Fri, 26 Feb 2010 00:00:00 -0800","applicant":"Toho Titanium Co., Ltd.","desc":"A solid <b>catalyst<\\/b> component for <b>olefin polymerization<\\/b> is produced by causing (a) a  solid component that includes magnesium, titanium,\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Olefin polymerization catalyst component, olefin polymerization catalyst and ...","link":"http:\\/\\/www.google.com\\/patents\\/EP0363029A3?cl=en&dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Wed, 13 Sep 1989 00:00:00 -0700","applicant":"Mitsui Petrochemical Industries, Ltd.","desc":"In accordance with the present invention, there are provided <b>olefin<\\/b>  <b>polymerization catalyst<\\/b> components comprising an organoaluminum oxy- compound having\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"High activity olefin polymerization catalyst comprising boron-containing ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013036211A4?cl=en&dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Wed, 05 Sep 2012 00:00:00 -0700","applicant":"Ptt Global Chemical Public Company Limited","desc":"The present invention relates to a high activity <b>olefin polymerization catalyst<\\/b>  comprising a boron-containing silica support and the preparation\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Transition metal compound, olefin polymerization catalyst, and process for ...","link":"http:\\/\\/www.google.com\\/patents\\/WO1995009172A1?cl=en&dq=Olefin+catalyst+in+polymerizatio&source=uds;","filedate":"Fri, 30 Sep 1994 00:00:00 -0700","applicant":"Idemitsu Kosan Co, Nobuhiro Yabunouchi, Kiyohiko Yokota, Masami Watanabe, Takuji Okamoto, Noriyuki Tani","desc":"A novel transition metal compound useful as a compound of an <b>olefin<\\/b>  <b>polymerization catalyst<\\/b>, a compound usable as a ligand of the above compound, \\u00a0<b>...<\\/b>","radio_11b":"No"}]', '[{"title":"Photolithographic &lt;b&gt;Olefin&lt;\\/b&gt; Metathesis &lt;b&gt;Polymerization&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24171659","desc":"Weitekamp RA, Atwater HA, Grubbs RH.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of the American Chemical Society&quot;&gt;J Am Chem Soc&lt;\\/span&gt;. 2013 Oct 30. [Epub ahead of print]","radio_11b2":"No"},{"title":"A Hybrid Ring-Opening Metathesis &lt;b&gt;Polymerization&lt;\\/b&gt; &lt;b&gt;Catalyst&lt;\\/b&gt; Based on an Engineered Variant of the &Icirc;&sup2;-Barrel Protein FhuA.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23959581","desc":"Philippart F, Arlt M, Gotzen S, Tenne SJ, Bocola M, Chen HH, Zhu L, Schwaneberg U, Okuda J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Chemistry (Weinheim an der Bergstrasse, Germany)&quot;&gt;Chemistry&lt;\\/span&gt;. 2013 Oct 4;19(41):13865-71. doi: 10.1002\\/chem.201301515. Epub 2013 Aug 19.","radio_11b2":"Yes"},{"title":"Synthesis and study of &lt;b&gt;olefin&lt;\\/b&gt; metathesis catalysts supported by redox-switchable diaminocarbene[3]ferrocenophanes.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23884080","desc":"Varnado CD Jr, Rosen EL, Collins MS, Lynch VM, Bielawski CW.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Dalton transactions (Cambridge, England : 2003)&quot;&gt;Dalton Trans&lt;\\/span&gt;. 2013 Sep 28;42(36):13251-64. doi: 10.1039\\/c3dt51278a. Epub 2013 Jul 25.","radio_11b2":"No"},{"title":"Tandem ring-opening\\/ring-closing metathesis &lt;b&gt;polymerization&lt;\\/b&gt;: relationship between monomer structure and reactivity.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23845119","desc":"Park H, Lee HK, Choi TL.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of the American Chemical Society&quot;&gt;J Am Chem Soc&lt;\\/span&gt;. 2013 Jul 24;135(29):10769-75. doi: 10.1021\\/ja4039278. Epub 2013 Jul 11.","radio_11b2":"Yes"},{"title":"Readily accessible and easily modifiable Ru-based catalysts for efficient and Z-selective ring-opening metathesis &lt;b&gt;polymerization&lt;\\/b&gt; and ring-opening\\/cross-metathesis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23822154","desc":"Khan RK, Torker S, Hoveyda AH.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of the American Chemical Society&quot;&gt;J Am Chem Soc&lt;\\/span&gt;. 2013 Jul 17;135(28):10258-61. doi: 10.1021\\/ja404208a. Epub 2013 Jul 3.","radio_11b2":"Yes"}]', 'electrophillic vs neutrophillic interactions is better', 'catalyst serves this and that unmet need', 'test test test test test', '[{"title":"<b>Surfactant<\\/b> Manufacturing | Stepan <b>Company<\\/b>","link":"http:\\/\\/www.stepan.com\\/Products\\/Surfactants.aspx","desc":"Stepan <b>Company<\\/b> offers a broad <b>surfactant<\\/b> line that includes anionic, cationic, \\nnonionic and amphoteric <b>...<\\/b> Stepan engages in responsible <b>business<\\/b> practices \\nthat deliver sustainable value to our customers, <b>...<\\/b> Emulsion <b>Polymerization<\\/b>"},{"title":"DOW <b>Surfactants<\\/b> - The Dow <b>Chemical Company<\\/b>","link":"http:\\/\\/www.dow.com\\/surfactants\\/","desc":"Trademark of The Dow <b>Chemical Company<\\/b> (\\"Dow\\") or an affiliated <b>company<\\/b> of \\nDow. Recent Headlines. Learn more about our new innovation in the <b>surfactant<\\/b>\\u00a0<b>...<\\/b>"},{"title":"Dow <b>Surfactants<\\/b> - The Dow <b>Chemical Company<\\/b>","link":"http:\\/\\/www.dow.com\\/coating\\/surfactants\\/pdfs\\/surfactants_guide_products_performance.pdf","desc":"emulsifier and stabilizer that offers excellent particle size control in emulsion \\n<b>polymerization<\\/b>. TRITON X-200. <b>Surfactant<\\/b> is an excellent emulsion \\n<b>polymerization<\\/b>."},{"title":"Alkaline <b>Surfactant Polymer<\\/b> \\/ <b>Surfactant Polymer<\\/b> Technologies <b>...<\\/b>","link":"http:\\/\\/www.tiorco.com\\/tio\\/products\\/asp-sp.htm","desc":"Primary and Secondary Recovery techniques together are able to recover only \\nabout 35-50% of oil form the reservoir. This leaves a significant amount of oil\\u00a0<b>...<\\/b>"},{"title":"Homepage - AkzoNobel Surface Chemistry","link":"http:\\/\\/www.akzonobel.com\\/surface\\/","desc":"<b>Surfactant<\\/b> Capacity Expansion. Increase in Brazil <b>...<\\/b> AMPHOMER styling \\n<b>polymers<\\/b> are highly efficient and cost-effective hair spray ingredients... \\nAMPHOMER."},{"title":"Advanced CERT Canada | Behaviour of <b>Polymer<\\/b>\\/<b>Surfactant<\\/b> Mixture","link":"http:\\/\\/www.adcertcanada.com\\/polymersurfactant.html","desc":"EnergyApplication of <b>Surfactant<\\/b> and <b>Polymer<\\/b> and Their Mixture in Drag \\nReduction <b>...<\\/b> Such an important modification allows <b>companies<\\/b> to deliberately \\ndecrease\\u00a0<b>...<\\/b>"},{"title":"New Hyper-HASE <b>Polymer<\\/b> for Difficult-to-Thicken <b>Surfactant<\\/b> Systems","link":"http:\\/\\/newscenter.lubrizol.com\\/phoenix.zhtml?c=250972&p=irol-newsArticle&ID=1649941&highlight=","desc":"New Hyper-HASE <b>Polymer<\\/b> for Difficult-to-Thicken <b>Surfactant<\\/b> Systems. <b>...<\\/b> of The \\nLubrizol <b>Corporation<\\/b> (NYSE: LZ) introduces Novethix\\u2122 L-10 <b>polymer<\\/b>, a new\\u00a0<b>...<\\/b>"},{"title":"Performance Chemicals for Enhanced Oil Recovery - the <b>...<\\/b>","link":"http:\\/\\/www.performancechemicals.basf.com\\/ev-wcms-in\\/internet\\/en_GB\\/function\\/conversions:\\/publish\\/content\\/EV\\/EV5\\/oilfield\\/brochures-flyer\\/global-oilfield-solutions-Enhanced-Oil-Recovery.pdf","desc":"chemistry with BASF''s innovative <b>surfactants<\\/b> and <b>polymers<\\/b>. As the world''s \\nleading <b>chemical company<\\/b>, we can reliably supply high volume chemicals to you."}]', '[{"title":"Elk Petroleum To Start Injection Operations At Ash Creek Enhanced <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/instablog\\/485861-proactive-investor\\/1989852-elk-petroleum-to-start-injection-operations-at-ash-creek-enhanced-oil-recovery-pilot-in-late-2013","desc":"Jun 27, 2013 <b>...<\\/b> Elk Petroleum (ASX: ELK) expects to start by late 2013 an <b>surfactant<\\/b>\\/<b>polymer<\\/b> \\ninjection at its Ash Creek enhanced oil recovery pilot project on\\u00a0<b>...<\\/b>"},{"title":"Stepan Company (SCL) CEO Discusses Q2 2013 Results - Earnings <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1569292-stepan-company-scl-ceo-discusses-q2-2013-results-earnings-call-transcript","desc":"Jul 24, 2013 <b>...<\\/b> Stepan Company (NYSE:SCL): Stepan Company (SCL) CEO Discusses Q2 2013 \\nResults - Earnings Call Transcript."},{"title":"Stepan Company''s CEO Discusses Q1 2013 Results - Earnings Call <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1390581-stepan-companys-ceo-discusses-q1-2013-results-earnings-call-transcript","desc":"May 1, 2013 <b>...<\\/b> Stepan Company (NYSE:SCL): Stepan Company''s CEO Discusses Q1 2013 \\nResults - Earnings Call Transcript."},{"title":"Stepan Co: Steppin'' Up Dividend Growth - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1388681-stepan-co-steppin-up-dividend-growth","desc":"May 1, 2013 <b>...<\\/b> Stepan Co. also creates custom <b>surfactants<\\/b> based on the specific needs of \\ncustomers. \\u00b7 <b>Polymers<\\/b> - Includes the manufacture and sale of\\u00a0<b>...<\\/b>"},{"title":"Flotek Industries Announces Intent to Acquire Eclipse IOR Services <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/news-article\\/7174962-flotek-industries-announces-intent-to-acquire-eclipse-ior-services-llc-significantly-expanding-its-enhanced-oil-recovery-initiatives","desc":"Jul 29, 2013<b>...<\\/b> sweep improvement (<b>polymer<\\/b> gel) technology for waterfloods and CO2 <b>...<\\/b> \\npermanent clay stabilization, and alkaline-<b>surfactant<\\/b> processes for\\u00a0<b>...<\\/b>"},{"title":"BLACKPEARL RES INC (BLKPF): Carbonate Triangle''s Athabasca <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1668742-carbonate-triangles-athabasca-investment-guide-blackpearl-resources-edition","desc":"Sep 2, 2013 <b>...<\\/b> The increase in production was mainly attributable to higher production \\nassociated with the ASP (alkali <b>surfactant polymer<\\/b>) flood at Mooney as\\u00a0<b>...<\\/b>"},{"title":"Insiders Are Buying Zargon Oil & Gas - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1643862-insiders-are-buying-zargon-oil-gas","desc":"Aug 19, 2013 <b>...<\\/b> Little Bow Alkaline <b>Surfactant Polymer<\\/b> [ASP] Project. ASP capital expenditures in \\nthe second half of 2013 to complete phase 1 of the project are\\u00a0<b>...<\\/b>"},{"title":"Stepan Company (SCL): Stepan''s CEO Discusses Q3 2013 Results <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1758342-stepans-ceo-discusses-q3-2013-results-earnings-call-transcript","desc":"Oct 21, 2013 <b>...<\\/b> Stepan Company (NYSE:SCL): Stepan''s CEO Discusses Q3 2013 Results - \\nEarnings Call Transcript."}]', ' polymer surfactant ', 'polymerization catalysts in fuels', '[{"title":"<b>Polymer Fuel<\\/b> Cells \\u2013 Cost reduction and <b>market<\\/b> <b>...<\\/b> - Carbon Trust","link":"http:\\/\\/www.carbontrust.com\\/media\\/195742\\/pfcc-cost-reduction-and-market-potential.pdf"},{"title":"Can Available Membranes and <b>Catalysts<\\/b> Meet Automotive <b>Polymer<\\/b> <b>...<\\/b>","link":"http:\\/\\/web.anl.gov\\/PCS\\/acsfuel\\/preprint%20archive\\/Files\\/49_2_Philadelphia_10-04_1010.pdf"},{"title":"3.4 <b>Fuel<\\/b> Cells - Office of Energy Efficiency & Renewable Energy","link":"http:\\/\\/www1.eere.energy.gov\\/hydrogenandfuelcells\\/mypp\\/pdfs\\/fuel_cells.pdf"},{"title":"THE ADVANCED <b>CATALYTIC<\\/b> OLEFINS (ACO) PROCESS - KBR","link":"http:\\/\\/www.kbr.com\\/Newsroom\\/Publications\\/technical-papers\\/A-Catalytic-Cracking-Process-for-Ethylene-and-Propylene-from-Paraffin-Streams.pdf"}]', '', '', '', 100);
INSERT INTO `inventions` VALUES(106, '2013-10-28 07:18:25', 2, 'ASD questionnaire', 'patent', '', '', 'gansh1', 'gansh11', 'gansh11_5', '', '', 'ASD questionnaire', 'd', '', 'ASD Questionnaire', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '96', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'Autism spectrum disorder early screening', '{"1":{"radio_11a1":"No","title":"Biomarker Dx for cancer","id":"100","status":"field"}}', '{"2":{"radio_11a2":"No","title":"Biomarker Dx for cancer","id":"100","status":"field"},"3":{"radio_11a2":"May be","title":"test 10-29-13 ","id":"109","status":"field"}}', 29, '', '100k-1m', 'Yes', 'No', 3, '', 'Yes', 32, '{"0":{"title":"Methods and compositions for screening and treating developmental disorders","link":"http:\\/\\/www.google.com\\/patents\\/WO2013054200A2?cl=en&dq=Autism+spectrum+disorder+early+screening&source=uds;","desc":"A kit for <b>screening<\\/b> for aPDD or PDD-NOS in one or more subjects, the kit <b>....<\\/b>  assessment, <b>early<\\/b> diagnosis, establishing prognosis, monitoring <b>.....<\\/b> [0010] In  some embodiments, the PDD is <b>Autism Spectrum Disorder<\\/b> (ASD).","filedate":"Wed, 10 Oct 2012 00:00:00 -0700","applicant":"The Hospital For Sick Children","radio_11b":"May Be"},"1":{"title":"Methods and compositions for altering behavior associated with autism ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2009126939A1?cl=en&dq=Autism+spectrum+disorder+early+screening&source=uds;","desc":"Treatment for <b>autism spectrum disorder<\\/b> and symptoms of autism <b>...<\\/b> for Autism in  Toddlers (M-CHAT), the <b>Early Screening<\\/b> of Autistic Traits\\u00a0<b>...<\\/b>","filedate":"Fri, 10 Apr 2009 00:00:00 -0700","applicant":"The Children''s Mercy Hospital, The University Of Kansas","radio_11b":"No"},"3":{"title":"A genotyping test for assessing risk of autism","link":"http:\\/\\/www.google.com\\/patents\\/WO2013132074A2?cl=en&dq=Autism+spectrum+disorder+early+screening&source=uds;","desc":"<b>Autism spectrum disorders<\\/b> (ASDs) represent three of the PDDs: Autistic <b>...<\\/b>  However, no specific <b>screening<\\/b> tool for autism has been validated in children  less <b>...<\\/b> Applied <b>early<\\/b> enough some studies show that as many as 50% of\\u00a0<b>...<\\/b>","filedate":"Fri, 08 Mar 2013 00:00:00 -0800","applicant":"Integragen","radio_11b":"May Be"},"4":{"title":"Urinary porphyrins as biomarkers of autistic spectrum disorder risk","link":"http:\\/\\/www.google.com\\/patents\\/WO2012064880A2?cl=en&dq=Autism+spectrum+disorder+early+screening&source=uds;","desc":"In one aspect, the present invention provides a method of <b>screening<\\/b> a human <b>...<\\/b>  The method of Claim 1, wherein the <b>autistic spectrum disorder<\\/b> is at least <b>...<\\/b> of  trophoblastic anomaly assessments in the <b>early<\\/b> detection of ASD.","filedate":"Wed, 09 Nov 2011 00:00:00 -0800","applicant":"Battelle Memorial Institute, University Of Washington Through Its Center For Commercialization","radio_11b":"Yes"},"6":{"title":"Methods, compositions, and kits for treating and preventing neurological ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2012149472A2?cl=en&dq=Autism+spectrum+disorder+early+screening&source=uds;","desc":"a) diagnosing <b>autism spectrum disorder<\\/b> in a subject before the <b>......<\\/b> for Autism in  Toddlers (M-CHAT), the <b>Early Screening<\\/b> of Autistic Traits\\u00a0<b>...<\\/b>","filedate":"Fri, 27 Apr 2012 00:00:00 -0700","applicant":"Ignite Institute For Individualized Health","radio_11b":"No"},"7":{"title":"Methods for the diagnosis and treatment of neurological disorders","link":"http:\\/\\/www.google.com\\/patents\\/WO2013071285A1?cl=en&dq=Autism+spectrum+disorder+early+screening&source=uds;","desc":"In the cases of the subject with <b>autism spectrum disorders<\\/b>, the <b>.....<\\/b> for Autism in  Toddlers (M-CHAT), the <b>Early Screening<\\/b> of Autistic Traits\\u00a0<b>...<\\/b>","filedate":"Tue, 13 Nov 2012 00:00:00 -0800","applicant":"Rutgers, The State University Of New Jersey, Indiana University Research And Technology Corporation","radio_11b":"May Be"}}', '[{"title":"A review of the serotonin transporter and prenatal cortisol in the &lt;b&gt;development&lt;\\/b&gt; of &lt;b&gt;autism&lt;\\/b&gt; &lt;b&gt;spectrum&lt;\\/b&gt; &lt;b&gt;disorders&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24103554","desc":"Meyer RR.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Molecular autism&quot;&gt;Mol &lt;b&gt;Autism&lt;\\/b&gt;&lt;\\/span&gt;. 2013 Oct 8;4(1):37. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"Biomarkers in &lt;b&gt;autism spectrum disorder&lt;\\/b&gt;: the old and the new.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24096533","desc":"Ruggeri B, Sarkans U, Schumann G, Persico AM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Psychopharmacology&quot;&gt;Psychopharmacology (Berl)&lt;\\/span&gt;. 2013 Oct 6. [Epub ahead of print]","radio_11b2":"No"},{"title":"Recommendations for &lt;b&gt;early&lt;\\/b&gt; &lt;b&gt;diagnosis&lt;\\/b&gt; and intervention in &lt;b&gt;autism&lt;\\/b&gt; &lt;b&gt;spectrum&lt;\\/b&gt; &lt;b&gt;disorders&lt;\\/b&gt;: An Italian-Israeli consensus conference.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24095105","desc":"Zachor DA, Curatolo P; Participants of the Italian-Israeli Consensus Conference.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society&quot;&gt;Eur J Paediatr Neurol&lt;\\/span&gt;. 2013 Sep 25. doi:pii: S1090-3798(13)00137-2.  10.1016\\/j.ejpn.2013.09.002. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"Drug discovery for &lt;b&gt;autism spectrum disorder&lt;\\/b&gt;: challenges and opportunities.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24080699","desc":"Ghosh A, Michalon A, Lindemann L, Fontoura P, Santarelli L.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Nature reviews. Drug discovery&quot;&gt;Nat Rev Drug Discov&lt;\\/span&gt;. 2013 Oct 1;12(10):777-90. doi: 10.1038\\/nrd4102.","radio_11b2":"No"},{"title":"ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24077069","desc":"Turygin N, Matson JL, Tureck K.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Research in developmental disabilities&quot;&gt;Res Dev Disabil&lt;\\/span&gt;. 2013 Nov;34(11):4203-9. doi: 10.1016\\/j.ridd.2013.07.020. Epub 2013 Sep 27.","radio_11b2":"No"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>Autism<\\/b>: Tests and <b>diagnosis<\\/b> - MayoClinic.com","link":"http:\\/\\/www.mayoclinic.com\\/health\\/autism\\/DS00348\\/DSECTION=tests-and-diagnosis","radio_15b":"Yes","desc":"Free weekly e-newsletter; Mayo Clinic expertise; Recipes, <b>tools<\\/b> and other helpful \\n<b>...<\\/b> <b>Early diagnosis<\\/b> and intervention is most helpful and can improve skill and <b>...<\\/b> \\nmental conditions and by insurance <b>companies<\\/b> to reimburse for treatment."},{"title":"SynapDx","link":"http:\\/\\/www.synapdx.com\\/","radio_15b":"No","desc":"SynapDx is an <b>early<\\/b> stage laboratory services <b>company<\\/b> developing a blood \\nbased <b>test<\\/b> to enable earlier <b>detection<\\/b> of <b>Autism<\\/b> Spectrum Disorders (<b>ASDs<\\/b>). \\n<b>ASDs<\\/b>\\u00a0<b>...<\\/b>"},{"title":"Brain Chemistry in Children with <b>Autism<\\/b> Could Offer <b>Method<\\/b> of <b>Early<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.integratedlistening.com\\/brain-chemistry-in-children-with-autism-could-offer-method-of-early-detection\\/","radio_15b":"Yes","desc":"Aug 5, 2013 <b>...<\\/b> Brain Chemistry in Children with <b>Autism<\\/b> Could Offer <b>Method<\\/b> of <b>Early Detection<\\/b> <b>...<\\/b> \\nhad an <b>autism<\\/b> spectrum disorder diagnosis, a developmental delay, <b>...<\\/b> Annette \\nEstes, study <b>co<\\/b>-author and director of the UW <b>Autism<\\/b> Center\\u00a0<b>...<\\/b>"},{"title":"SynapDx <b>Corporation<\\/b> Licenses <b>Autism<\\/b> Diagnostic Discoveries From <b>...<\\/b>","link":"http:\\/\\/www.prnewswire.com\\/news-releases\\/synapdx-corporation-licenses-autism-diagnostic-discoveries-from-childrens-hospital-boston-121084179.html","radio_15b":"No","desc":"May 2, 2011<b>...<\\/b> Researchers Developed <b>Method<\\/b> for <b>Early Detection<\\/b> of <b>Autism<\\/b> <b>...<\\/b> the \\n<b>Company''s<\\/b> development of blood-based tests to enable the early\\u00a0<b>...<\\/b>"},{"title":"SynapDx undertakes study to verify <b>early<\\/b>-<b>detection<\\/b> test for <b>autism<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.bizjournals.com\\/boston\\/blog\\/bioflash\\/2013\\/05\\/synapdx-undertakes-study-to-verify.html","radio_15b":"No","desc":"May 9, 2013 <b>...<\\/b> Tribble said that with <b>early diagnosis<\\/b>, there''s a better chance of <b>...<\\/b> and the \\n<b>company<\\/b> plans to offer it to pediatricians, where a sample will be sent\\u00a0<b>...<\\/b>"},{"title":"Ga. <b>autism<\\/b> project looks to <b>early detection<\\/b> - USA Today","link":"http:\\/\\/www.usatoday.com\\/story\\/news\\/nation\\/2013\\/09\\/21\\/ga-autism-project-looks-to-early-detection\\/2846823\\/","radio_15b":"Yes","desc":"Sep 21, 2013 <b>...<\\/b> The first order of <b>business<\\/b> is finding professionals who know how to <b>....<\\/b> Ga. \\n<b>autism<\\/b> project looks to <b>early detection<\\/b> <b>...<\\/b> <b>Autism early detection<\\/b> <b>....<\\/b> \\"I feel like it will \\ngive us more <b>tools<\\/b> to educate them to be better able to work with our\\u00a0<b>...<\\/b>"},{"title":"<b>Autism<\\/b>, <b>ASD<\\/b>, PDD, Asperger''s Syndrome - Articles, Cases <b>...<\\/b>","link":"http:\\/\\/www.wrightslaw.com\\/info\\/autism.index.htm","radio_15b":"Yes","desc":"Without <b>early identification<\\/b> and diagnosis, children with <b>autism<\\/b> are unlikely to \\nlearn the skills they need <b>...<\\/b> analysis (ABA) teaching <b>methods<\\/b> with developmental \\n''relationship-based'' approaches. <b>...<\\/b> Analysis of Bucks <b>Co<\\/b> Dept of Mental Health v."},{"title":"VESDA by Xtralis Very <b>Early<\\/b> Warning Aspirating Smoke <b>Detection<\\/b> <b>...<\\/b>","link":"http:\\/\\/xtralis.com\\/p.cfm?s=22&p=244","radio_15b":"No","desc":"We invented VESDA very <b>early<\\/b> warning aspirating smoke <b>detection<\\/b> (<b>ASD<\\/b>), the <b>...<\\/b> \\nCustomers worldwide rely on VESDA by Xtralis when <b>business<\\/b> continuity is <b>...<\\/b> \\nVESDA systems are manufactured using targeted Six Sigma <b>techniques<\\/b> and ISO\\n\\u00a0<b>...<\\/b>"}]', '', 'ASD early detection methods', 'Autism spectrum disorders', '[{"title":"TOI","link":"http:\\/\\/honors.njit.edu\\/ids\\/presentations\\/IDS-AutoMind-Webversion.pdf"},{"title":"business case - Helen A. Kellar Institute for Human disAbilities","link":"http:\\/\\/kihd.gmu.edu\\/assets\\/docs\\/kihd\\/kihd_system\\/Prism_Team_Business_Case_Final.pdf"},{"title":"Eye Gaze PipeLinX Report","link":"http:\\/\\/pipelinx.com\\/download\\/pointofcare\\/NC%20-%20Eye%20Gaze%20Pipelinx%20Report.pdf"},{"title":"opening doors opening doors - The Southwest <b>Autism<\\/b> Research <b>...<\\/b>","link":"http:\\/\\/www.autismcenter.org\\/documents\\/openingdoorsprint.pdf"}]', '', '', '', 100);
INSERT INTO `inventions` VALUES(107, '2013-10-29 07:09:06', 2, 'laser excitation fluorescence', 'patent', '', '', 'gansh2', 'gansh14', 'gansh14_3', '', '', 'laser excitation fluorescence', 'c', '', 'test', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '70', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '0000-00-00 00:00:00', 'laser excitation fluorescence', '', '', 80, '', '100k-1m', 'Yes', 'No', 2, '', '', 21.5, '[{"title":"Laser excitation fluorescent microscope","link":"http:\\/\\/www.google.com\\/patents\\/US8310754?dq=laser+excitation+fluores&source=uds;","filedate":"Fri, 26 Mar 2010 00:00:00 -0700","applicant":"Nikon Corporation","desc":"The present application has a proposition to provide a highly efficient <b>laser<\\/b>  <b>excitation fluorescent<\\/b> microscope. Accordingly, a laser excitation\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"Laser-excitation fluorescence detection electrokinetic separation","link":"http:\\/\\/www.google.com\\/patents\\/CA1309058C?cl=en&dq=laser+excitation+fluores&source=uds;","filedate":"Wed, 17 Sep 1986 00:00:00 -0700","applicant":"Board Of Trustees Of Leland Stanford Junior University (The), Ernst Gassmann, Richard N. Zare","desc":"<b>LASER<\\/b>-<b>EXCITATION FLUORESCENCE<\\/b> DETECTION ELECTROKINETIC  SEPARATION Abstract of the Invention An electrokinetic process and\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Laser excitation fluorescence detection electrokinetic separation","link":"http:\\/\\/www.google.com\\/patents\\/EP0216600B1?cl=en&dq=laser+excitation+fluores&source=uds;","filedate":"Wed, 17 Sep 1986 00:00:00 -0700","applicant":"The Board Of Trustees Of The Leland Stanford Junior University","desc":"Flow cell 42 included an on-column <b>fluorescence<\\/b> detector which used a helium- cadmium <b>laser<\\/b> 46 (Liconix. Model 4240B, Sunnyvale, CA)\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Laser-excitation fluorescence detection electrokinetic separation","link":"http:\\/\\/www.google.com\\/patents\\/EP0485370A2?cl=en&dq=laser+excitation+fluores&source=uds;","filedate":"Wed, 17 Sep 1986 00:00:00 -0700","applicant":"The Board Of Trustees Of The Leland Stanford Junior University","desc":"Chiral compounds may be separated by a process comprising placing the  compounds in an electroosmotically pumpable chiral support\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"An optical system for laser excitation and collection of fluorescence emissions","link":"http:\\/\\/www.google.com\\/patents\\/WO2006120386A1?cl=en&dq=laser+excitation+fluores&source=uds;","filedate":"Thu, 04 May 2006 00:00:00 -0700","applicant":"Iti Scotland Ltd, Stanley Desmond Smith","desc":"An optical system for <b>laser excitation<\\/b> and collection of <b>fluorescence<\\/b> emissions.  WO 2006120386 A1. Abstract. An optical system, such as a\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Femtosecond laser excitation tagging anemometry","link":"http:\\/\\/www.google.com\\/patents\\/WO2012151411A1?cl=en&dq=laser+excitation+fluores&source=uds;","filedate":"Thu, 03 May 2012 00:00:00 -0700","applicant":"The Trustees Of Princeton University","desc":"The camera may also. simultaneously image the <b>fluorescence<\\/b> from different  angles. [0016] A Femtosecond <b>Laser<\\/b> Electronic <b>Excitation<\\/b> Tagging\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Apparatus and method for introducing multiwavelength laser excitation in ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2006133221A3?cl=en&dq=laser+excitation+fluores&source=uds;","filedate":"Tue, 06 Jun 2006 00:00:00 -0700","applicant":"Chung Johnson Cheng-Chun, Friedman Lawrence Jay, Gelles Jeff Daniel, Univ Brandeis","desc":"Apparatus and method for introducing multiwavelength <b>laser excitation<\\/b> in  <b>fluorescence<\\/b> microscopy. WO 2006133221 A3. Abstract.","radio_11b":"Yes"},{"title":"Modulated excitation fluorescence analysis","link":"http:\\/\\/www.google.com\\/patents\\/WO2005008212A2?cl=en&dq=laser+excitation+fluores&source=uds;","filedate":"Thu, 17 Jun 2004 00:00:00 -0700","applicant":"Achillefs Kapanidis, Ted A Laurence, Nam K Lee, Univ California, Shimon Weiss","desc":"SMFS uses <b>laser<\\/b>- <b>excitation<\\/b> sources to probe individual diffusing or surface- immobilized <b>fluorescent<\\/b> molecules and measure their <b>fluorescence<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"Yes"}]', '[{"title":"Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22847515","desc":"Tichauer KM, Holt RW, Samkoe KS, El-Ghussein F, Gunn JR, Jermyn M, Dehghani H, Leblond F, Pogue BW.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of visualized experiments : JoVE&quot;&gt;J Vis Exp&lt;\\/span&gt;. 2012 Jul 17;(65):e4050. doi: 10.3791\\/4050.","radio_11b2":"Yes"},{"title":"Optical fiber-based in vivo quantification of growth factor receptors.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22488668","desc":"Thomas TP, Chang YC, Ye JY, Kotlyar A, Cao Z, Shukla R, Qin S, Norris TB, Baker JR Jr.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancer&quot;&gt;Cancer&lt;\\/span&gt;. 2012 Apr 15;118(8):2148-56. doi: 10.1002\\/cncr.26487. Epub 2011 Aug 25.","radio_11b2":"Yes"},{"title":"Fiber &lt;b&gt;laser&lt;\\/b&gt; based two-photon FRET measurement of calmodulin and mCherry-E(0)GFP proteins.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22213386","desc":"Adany P, Johnson CK, Hui R.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Microscopy research and technique&quot;&gt;Microsc Res Tech&lt;\\/span&gt;. 2012 Jun;75(6):837-43. doi: 10.1002\\/jemt.22002. Epub 2011 Dec 30.","radio_11b2":"Yes"},{"title":"Two-color STED microscopy of living synapses using a single &lt;b&gt;laser&lt;\\/b&gt;-beam pair.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22098754","desc":"T&Atilde;&cedil;nnesen J, Nadrigny F, Willig KI, Wedlich-S&Atilde;&para;ldner R, N&Atilde;&curren;gerl UV.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biophysical journal&quot;&gt;Biophys J&lt;\\/span&gt;. 2011 Nov 16;101(10):2545-52. doi: 10.1016\\/j.bpj.2011.10.011. Epub 2011 Nov 15.","radio_11b2":"Yes"},{"title":"4D super-resolution microscopy with conventional fluorophores and single wavelength &lt;b&gt;excitation&lt;\\/b&gt; in optically thick cells and tissues.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/21655189","desc":"Baddeley D, Crossman D, Rossberger S, Cheyne JE, Montgomery JM, Jayasinghe ID, Cremer C, Cannell MB, Soeller C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2011;6(5):e20645. doi: 10.1371\\/journal.pone.0020645. Epub 2011 May 31.","radio_11b2":"Yes"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>Laser<\\/b>-induced <b>fluorescence excitation<\\/b> spectroscopy <b>...<\\/b> - ScienceDirect","link":"http:\\/\\/www.sciencedirect.com\\/science\\/article\\/pii\\/S0301010496002662\\/pdf?md5=0351beef0fd5745416732168b6f30a8f&pid=1-s2.0-S0301010496002662-main.pdf&_valck=1","desc":"<b>Laser<\\/b>-induced <b>fluorescence excitation<\\/b> spectrum of. TRN(OH). <b>CO<\\/b> in the region to   the red of the origin of bare. TRN(OH). The inset shows the features of the van\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Nikon MicroscopyU | <b>Fluorescence<\\/b> Microscopy","link":"http:\\/\\/www.microscopyu.com\\/articles\\/fluorescence\\/","desc":"Imaging with <b>laser excitation<\\/b> and pinhole detection of <b>fluorescence<\\/b>. Fluorophore   <b>Co<\\/b>-Localization Detecting the presence of two or more molecules at the same\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"Imaging of <b>Co<\\/b> and Co2 Using Infrared Planar <b>Laser<\\/b>-Induced <b>...<\\/b>","link":"http:\\/\\/www.kirbyresearch.com\\/pdf\\/200011kirbyproccombinst.pdf","desc":"theoretical framework for absorption and <b>fluorescence<\\/b> modeling is presented,   with most attention <b>...<\\/b> H2 flame is also presented using <b>laser excitation<\\/b> of <b>CO<\\/b> only  .","radio_15b":"Yes"},{"title":"<b>Fluorescence<\\/b> Fundamentals | Life Technologies","link":"http:\\/\\/www.lifetechnologies.com\\/us\\/en\\/home\\/references\\/molecular-probes-the-handbook\\/introduction-to-fluorescence-techniques.html","desc":"The <b>fluorescence excitation<\\/b> spectrum of a single fluorophore species in dilute <b>....<\\/b>   <b>Laser<\\/b>-scanning microscopes and flow cytometers, however, require probes that   <b>.....<\\/b> Handbook of Stains, Dyes and Indicators, Aldrich Chemical <b>Company<\\/b> (1990).","radio_15b":"No"},{"title":"<b>Fluorescence<\\/b> Filters are designed for <b>laser excitation<\\/b>., Semrock <b>Inc<\\/b>.","link":"http:\\/\\/news.thomasnet.com\\/fullstory\\/Fluorescence-Filters-are-designed-for-laser-excitation-818302","desc":"July 7, 2008 - Manufactured with hard-coated Ion-Beam Sputtering technology,   BrightLine\\u00ae <b>Laser Fluorescence<\\/b> filter sets are suited for use in <b>laser<\\/b>-scanning\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"DNA Staining for <b>Fluorescence<\\/b> and <b>Laser<\\/b> Confocal Microscopy","link":"http:\\/\\/jhc.sagepub.com\\/content\\/45\\/1\\/49.full.pdf","desc":"stained the nuclear DNA, and the other dyes <b>co<\\/b>-stained the cytoplasmic RNA. <b>...<\\/b>   under red <b>excitation<\\/b>. <b>....<\\/b> (568- or 488-nm <b>laser excitation<\\/b>, respectively), and.","radio_15b":"Yes"},{"title":"Yellow HeNe <b>Lasers<\\/b> for <b>Fluorescence Excitation<\\/b> - REO Precision <b>...<\\/b>","link":"http:\\/\\/www.reoinc.com\\/news-events\\/cat\\/91\\/press_releases\\/article\\/reo_introduces_yellow_hene_lasers_for_fluorescence_excitation\\/","desc":"Yellow HeNe <b>Lasers<\\/b> for <b>Fluorescence Excitation<\\/b>. 05\\/18\\/2012. An ideal source for   bio-applications including confocal microscopy, flow cytometry, drug discovery,\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Fluorescence<\\/b> Lifetime Spectrometer | PTI <b>LaserStrobe<\\/b>\\u2122","link":"http:\\/\\/www.pti-nj.com\\/products\\/Fluorescence-Lifetime-Spectrofluorometers\\/LaserStrobe\\/index.html","desc":"PTI, Photon Technology International, The <b>Fluorescence<\\/b> Solutions <b>Company<\\/b> <b>....<\\/b>   The <b>LaserStrobe<\\/b>\\u2122 base system includes PTI''s nitrogen\\/dye <b>laser excitation<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"No"}]', '', 'laser excitation fluorescence', '', '', '', '', '', 93);
INSERT INTO `inventions` VALUES(108, '2013-10-29 07:09:47', 1, 'pancreatic cancer', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_4', '', '', 'pancreatic cancer', 'g', '', 'pancreatic cancer', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '122', 'Yes', '2013-10-02 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-10-30 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'HDAC inhibitor for pancreatic cancer', '', '', -10, '', '100k-1m', '', '', 0, '', '', 15, '[{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the <b>...<\\/b> Use of  <b>hdac inhibitors for<\\/b> the treatment of gastrointestinal <b>cancers<\\/b>","radio_11b":"Already Assigned"},{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2547349A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","radio_11b":"Already Assigned"},{"title":"Metabolite derivatives of the hdac inhibitor fk228","link":"http:\\/\\/www.google.com\\/patents\\/CA2630216A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 17 Nov 2006 00:00:00 -0800","applicant":"Gloucester Pharmaceuticals, Inc., Mitchell Keegan, Yat Sun Or, Gregory L. Verdine","desc":"The present invention relates to <b>HDAC inhibitor<\\/b> derivatives, particularly <b>...<\\/b> cancer,  prostate cancer, colorectal and non-small cell lung cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","radio_11b":"Already Assigned"},{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/EP2142190A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Novartis Ag","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the <b>...<\\/b> Use of  <b>hdac inhibitors for<\\/b> the treatment of gastrointestinal <b>cancers<\\/b>","radio_11b":"Already Assigned"},{"title":"Cancer therapy with a parvovirus combined with an HDAC inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2366398A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Wed, 17 Mar 2010 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>HDAC inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","radio_11b":"Already Assigned"},{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/WO2011113600A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","radio_11b":"Already Assigned"},{"title":"Combination therapy using HDAC inhibitors and melphalan for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2500063A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited","desc":"The present invention pertains to a method for treating cancer, such as <b>...<\\/b>  Combination therapy using <b>HDAC inhibitors<\\/b> and melphalan for treating cancer <b>...<\\/b>  cancer, colon cancer, lung cancer, breast cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","radio_11b":"Already Assigned"},{"title":"Cancer therapy with combinations of fts with hdac inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2011056542A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Tue, 26 Oct 2010 00:00:00 -0700","applicant":"Ramot At Tel-Aviv University Ltd.","desc":"The method of any of claims 10-18, wherein the <b>HDAC inhibitor<\\/b> is <b>...<\\/b> of renal  carcinoma, skin cancer, <b>pancreatic cancer<\\/b>, colorectal cancer,\\u00a0<b>...<\\/b>","radio_11b":"Already Assigned"}]', '[{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Oct 14. doi:pii: S0006-291X(13)01670-7.  10.1016\\/j.bbrc.2013.10.010. [Epub ahead of print]","radio_11b2":"Already Assigned"},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17.","radio_11b2":"Already Assigned"},{"title":"The novel &lt;b&gt;HDAC inhibitor&lt;\\/b&gt; NDACI054 sensitizes human &lt;b&gt;cancer&lt;\\/b&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/span&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4.  10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]","radio_11b2":"Already Assigned"},{"title":"The anti-tumor effect of &lt;b&gt;HDAC&lt;\\/b&gt; inhibition in a human pancreas &lt;b&gt;cancer&lt;\\/b&gt; model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"Already Assigned"},{"title":"Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23994577","desc":"Farrelly LA, Savage NT, O''Callaghan C, Toulouse A, Yilmazer-Hanke DM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Regulatory peptides&quot;&gt;Regul Pept&lt;\\/span&gt;. 2013 Sep 10;186:123-30. doi: 10.1016\\/j.regpep.2013.08.005. Epub 2013 Aug 28.","radio_11b2":"Yes"}]', '', '', '', '[{"title":"<b>Histone deacetylase inhibitors<\\/b> in the treatment of <b>cancer<\\/b>: overview <b>...<\\/b>","link":"http:\\/\\/www.reactionbiology.com\\/webapps\\/main\\/press\\/20130128.pdf","desc":"Jan 28, 2013 <b>...<\\/b> perspectives. <b>Histone deacetylase inhibitors<\\/b> (HDACis) are one of the last   frontiers in pharmaceutical research. <b>...<\\/b> developed by Merck 56 <b>Co<\\/b>., <b>Inc<\\/b>. and, in.   November <b>......<\\/b> Gemcitabine <b>Pancreatic cancer<\\/b> or non-small-cell lung."},{"title":"Superior efficacy of <b>co<\\/b>-treatment with dual PI3K\\/mTOR <b>inhibitor<\\/b> NVP <b>...<\\/b>","link":"http:\\/\\/www.impactjournals.com\\/oncotarget\\/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=724","desc":"Superior efficacy of <b>co<\\/b>-treatment with dual PI3K\\/mTOR inhibitor NVP-BEZ235   and pan-<b>histone deacetylase inhibitor<\\/b> against human <b>pancreatic cancer<\\/b>."},{"title":"About Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/about_pharmacyclics.html","desc":"Pharmacyclics <b>Inc<\\/b>. is a clinical-stage biopharmaceutical <b>company<\\/b> focused on <b>...<\\/b>   factor expressing tumors in oncology (being investigated in <b>pancreatic cancer<\\/b>). <b>...<\\/b>   an oral Histone Deacetylase (<b>HDAC<\\/b>) <b>inhibitor<\\/b> being investigated in oncology\\u00a0<b>...<\\/b>"},{"title":"Abexinostat HCl (PCI-24781), <b>PanHDAC<\\/b>-<b>inhibitor<\\/b> - Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/clinical_trial_hdac_pcyc_pci24781.html","desc":"Abexinostat Hydrochloride is an oral <b>inhibitor<\\/b> of <b>histone deacetylase<\\/b> (<b>HDAC<\\/b>)   enzymes that shows anti-<b>tumor<\\/b> activity in vitro and in vivo. PCI-24781 treatment\\u00a0<b>...<\\/b>"},{"title":"Investor Relations: Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/ir.pharmacyclics.com\\/","desc":"Pharmacyclics, <b>Inc<\\/b>. is a biopharmaceutical <b>company<\\/b> that designs, develops and   <b>...<\\/b> factor expressing tumors in oncology (being investigated in <b>pancreatic cancer<\\/b>).   <b>...<\\/b> an oral Histone Deacetylase (<b>HDAC<\\/b>) <b>inhibitor<\\/b> being investigated in oncology\\u00a0<b>...<\\/b>"},{"title":"Pharmacyclics Announces Multiple Presentations at the American <b>...<\\/b>","link":"http:\\/\\/ir.pharmacyclics.com\\/releasedetail.cfm?ReleaseID=460491","desc":"Apr 15, 2010<b>...<\\/b> Btk inhibitor PCI-32765 in a mouse model of <b>pancreatic cancer<\\/b> (Soucek et al).   <b>...<\\/b> the <b>company''s HDAC inhibitor<\\/b>, PCI-24781 and the drug bortezomib in <b>...<\\/b> In   addition, our <b>HDAC inhibitor<\\/b> PCI-24781 is now showing synergy\\u00a0<b>...<\\/b>"},{"title":"Cell Death and Disease - The <b>HDAC inhibitor<\\/b>, MPT0E028 <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/cddis\\/journal\\/v4\\/n9\\/full\\/cddis2013330a.html","desc":"Sep 19, 2013 <b>...<\\/b> lung cancer; <b>HDAC<\\/b>; synergistic; EGFR; apoptosis; erlotinib <b>....<\\/b> However,   MPT0E028 and erlotinib <b>co<\\/b>-treatment synergistically induced the <b>......<\\/b> <b>inhibition<\\/b>   and enhances gemcitabine-induced cell death in <b>pancreatic cancer<\\/b>."},{"title":"Current evidence for <b>histone deacetylase inhibitors<\\/b> in <b>pancreatic<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.wjgnet.com\\/1007-9327\\/pdf\\/v19\\/i6\\/813.pdf","desc":"Feb 14, 2013 <b>...<\\/b> Key words: <b>Pancreatic cancer<\\/b>; Histone deacetylases;. <b>Histone deacetylase<\\/b>   <b>inhibitors<\\/b> <b>....<\\/b> Different <b>pancreatic cancer<\\/b> cell lines <b>co<\\/b>-express high-."}]', '[{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" cash for next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong> Florida Keys home to potential colon <strong>cancer<\\/strong> fighter Bracing for FDA ..."},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},{"title":"Enzyme inhibitor spurs breakthrough on pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/enzyme-inhibitor-spurs-breakthrough-pancreatic-cancer\\/2009-09-25","desc":" was useless in stopping <strong>pancreatic<\\/strong> <strong>cancer<\\/strong>, but the researchers said that in combination with the TAK-1 ..."},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ..."},{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ..."},{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" cash for next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong> Florida Keys home to potential colon <strong>cancer<\\/strong> fighter Bracing for FDA ..."},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},{"title":"Enzyme inhibitor spurs breakthrough on pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/enzyme-inhibitor-spurs-breakthrough-pancreatic-cancer\\/2009-09-25","desc":" was useless in stopping <strong>pancreatic<\\/strong> <strong>cancer<\\/strong>, but the researchers said that in combination with the TAK-1 ..."},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ..."},{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ..."}]', 'HDAC inhibitor for pancreatic cancer', 'HDAC inhibitor for pancreatic cancer', '[{"title":"<b>Histone deacetylase inhibitors<\\/b> in the treatment of <b>cancer<\\/b>: overview <b>...<\\/b>","link":"http:\\/\\/www.reactionbiology.com\\/webapps\\/main\\/press\\/20130128.pdf"},{"title":"PC News and Updates - <b>Pancreatic Cancer<\\/b> Action Network","link":"http:\\/\\/www.pancan.org\\/section_research\\/pdf\\/news_and_updates\\/PC%20News%20and%20Updates%20-%20May%202012.pdf"},{"title":"Role of Hydroxamate-Based <b>Histone Deacetylase Inhibitors<\\/b> (Hb <b>...<\\/b>","link":"http:\\/\\/www.researchgate.net\\/publication\\/257137858_Role_of_Hydroxamate-Based_Histone_Deacetylase_Inhibitors_(Hb-HDACIs)_in_the_Treatment_of_Solid_Malignancies\\/file\\/72e7e5246cc51d86b8.pdf"},{"title":"First-in-human, Pharmacokinetic and Pharmacodynamic Phase I <b>...<\\/b>","link":"http:\\/\\/clincancerres.aacrjournals.org\\/content\\/early\\/2013\\/09\\/13\\/1078-0432.CCR-13-0735.full.pdf"}]', '', '', '', 86);
INSERT INTO `inventions` VALUES(109, '2013-10-29 09:52:10', 2, 'test 10-29-13 ', 'cr_sw', '', '', 'gansh1', 'gansh11', 'gansh11_5', '', '', 'Autism screening tool', 'd', '', 'Autism screening tool', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '75', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '0000-00-00 00:00:00', 'test', '{"1":{"title":"testing questionnaire 10-9","id":"44","status":"field"},"2":{"title":"testing 10-10","id":"61","status":"field"},"3":{"title":"testing happy face","id":"62","status":"process"},"4":{"title":"testing happy head","id":"63","status":"field"},"5":{"title":"test","id":"80","status":"field"},"6":{"title":"testing 10-28-13","id":"106","status":"field"},"7":{"title":"laser excitation fluorescence","id":"107","status":"field"}}', '{"2":{"title":"testing questionnaire 10-9","id":"44","status":"field"},"3":{"title":"Testing for happy face","id":"58","status":"field"},"4":{"title":"testing 10-10","id":"61","status":"field"},"5":{"title":"testing happy face","id":"62","status":"process"},"6":{"title":"testing happy head","id":"63","status":"field"},"7":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"8":{"title":"test","id":"80","status":"field"},"9":{"title":"test","id":"81","status":"field"},"10":{"title":"test 24th Dx","id":"100","status":"process"},"11":{"title":"testing 10-24-13","id":"101","status":"field"}}', 20, '', '<100k', 'No', '', 0, '', 'Yes', 10, '', '[{"title":"Long-term behaviour of &lt;sup&gt;137&lt;\\/sup&gt;Cs in spruce bark in coniferous forests in the Czech Republic.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24172658","desc":"Rul&Atilde;&shy;k P, Pil&Atilde;&iexcl;tov&Atilde;&iexcl; H, Suchara I, Sucharov&Atilde;&iexcl; J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Environmental pollution (Barking, Essex : 1987)&quot;&gt;Environ Pollut&lt;\\/span&gt;. 2013 Oct 25;184C:511-514. doi: 10.1016\\/j.envpol.2013.10.012. [Epub ahead of print]"},{"title":"Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort &lt;b&gt;TE&lt;\\/b&gt; MRI.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24170416","desc":"Bianchi A, Dufort S, Lux F, Courtois A, Tillement O, Coll JL, Cr&Atilde;&copy;millieux Y.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Magma (New York, N.Y.)&quot;&gt;MAGMA&lt;\\/span&gt;. 2013 Oct 30. [Epub ahead of print]"},{"title":"Transposable elements and the penetrance of quantitative characters in Drosophila melanogaster.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24170002","desc":"Furman DP, Rodin SN, Kozhemiakina TA.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik&quot;&gt;Theor Appl Genet&lt;\\/span&gt;. 1995 Nov;91(6-7):1095-100. doi: 10.1007\\/BF00223925."},{"title":"Spring photosynthetic recovery of boreal Norway spruce under conditions of elevated [CO2] and air temperature.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24169104","desc":"Wallin G, Hall M, Slaney M, R&Atilde;&curren;ntfors M, Medhurst J, Linder S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Tree physiology&quot;&gt;Tree Physiol&lt;\\/span&gt;. 2013 Oct 28. [Epub ahead of print]"},{"title":"A novel application of ecological analyses to assess transposable element distributions in the genome of the domestic cow, Bos taurus.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24168673","desc":"Saylor B, Elliott TA, Linquist S, Kremer SC, Gregory TR, Cottenie K.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Genome \\/ National Research Council Canada = Genome \\/ Conseil national de recherches Canada&quot;&gt;Genome&lt;\\/span&gt;. 2013 Sep;56(9):521-33. doi: 10.1139\\/gen-2012-0162. Epub 2013 Aug 28."}]', 'a', 'a', 'a', '[{"title":"<b>sdfsdgf<\\/b> \\u00bb Archive \\u00bb AlliedNews.com - Grove City, Pennsylvania","link":"http:\\/\\/alliednews.com\\/archive\\/x1498154401","desc":"<b>sdfsdgf<\\/b>. Featured Ads: AP Video: New $100 Bill Touts Added Security Features \\u00b7   Raw: Boeing Completes First Unmanned F16 Flight \\u00b7 Oil Spill <b>...<\\/b> Find a <b>business<\\/b>.","radio_15b":"Yes"},{"title":"<b>Company<\\/b> Address GPS:eesdfsff,Sdfs <b>Sdfsdgf<\\/b> Sgs, Hong Kong","link":"http:\\/\\/gaobie.com\\/map\\/eesdfsff_78941.html","desc":"eesdfsff ,Sdfs <b>Sdfsdgf<\\/b> Sgs, Hong Kong ,Main Markets:","radio_15b":"Yes"},{"title":"FreakyLoveHarry : <b>SDFSDGF<\\/b> http:\\/\\/t.<b>co<\\/b>\\/kva2mm1f | Twicsy, the <b>...<\\/b>","link":"http:\\/\\/twicsy.com\\/i\\/sQT6ed","desc":"(it''s awesome) \\u00b7 RSS Feed \\u00b7 TOMLINSONGILLER.\\u25b3''s Twitter pic (@  FreakyLoveHarry) [FOLLOW] <b>SDFSDGF<\\/b> http:\\/\\/t.<b>co<\\/b>\\/kva2mm1f - 2013-01-31 18:45:  07\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"BelieberCashh : BU \\u00c7OK HO\\u015e LAN <b>SDFSDGF<\\/b> <b>...<\\/b> - Twicsy","link":"http:\\/\\/twicsy.com\\/i\\/L7BZoe","desc":"<b>...<\\/b> pic (@BelieberCashh) [FOLLOW] BU \\u00c7OK HO\\u015e LAN <b>SDFSDGF<\\/b> #  JustinPleaseComeBackToTurkeyAgain http:\\/\\/t.<b>co<\\/b>\\/7tR0MWcYw6 - 2013-10-17 16:  59:10\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>sdfsdgf<\\/b> by ~gmichelle on deviantART","link":"http:\\/\\/gmichelle.deviantart.com\\/art\\/sdfsdgf-175626242","desc":"<b>sdfsdgf<\\/b>by ~gmichelle <b>...<\\/b> Watch depthRADIUSAugust 16, 2013 \\/ by $  techgnoticLiam Sharp was and is one of the most sought after comic artists in the   <b>business<\\/b>.","radio_15b":"Yes"},{"title":"<b>Sdfsdgf<\\/b> Dsfdsfg | VK","link":"http:\\/\\/vk.com\\/id97280426","desc":"<b>Sdfsdgf<\\/b> Dsfdsfg. Log in or sign up to contact <b>Sdfsdgf<\\/b> Dsfdsfg or find more of your   friends. <b>...<\\/b> <b>Sdfsdgf<\\/b> Dsfdsfg. Show full information\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"kottabangarulokam Movie Review By <b>sdfsdgf<\\/b> - Movies - Sulekha.com","link":"http:\\/\\/movies.sulekha.com\\/kottabangarulokam-movie-review-by-sdfsdgf_15763_review","desc":"Dec 10, 2008 <b>...<\\/b> <b>sdfsdgf<\\/b>. Srikakulam. Follow. Unfollow. Send Message. 0Followers; 0Following <b>...<\\/b>   Register your trademark, incorporate your <b>company<\\/b>, prepare a\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>sdfsdgf<\\/b> | blog on Myspace","link":"http:\\/\\/www.myspace.com\\/103756124\\/blog","desc":"Apr 12, 2007 <b>...<\\/b> <b>sdfsdgf''s<\\/b> blog on Myspace. <b>...<\\/b> Photo of <b>sdfsdgf<\\/b> <b>....<\\/b> will get money from the   insurance <b>company<\\/b> when they are incapable to earn their livelihood.","radio_15b":"Yes"}]', '', 'sdfsdgf', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(112, '2013-10-31 12:26:10', 1, 'HDAC inhibitors for pancreatic cancer', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'HDAC inhibitors for pancreatic cancer', 'e', 'b', 'HDAC inhibitors for pancreatic cancer', '', '', '', 'a', '', 'John Smith', 'NIH', 'aaaa', '1 million over 3 years', '', '', 'field', '115', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-17 00:00:00', '', 'Yes', '2013-10-09 00:00:00', '', '', '0000-00-00 00:00:00', 'hdac inhibitors', '{"1":{"radio_11a1":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"radio_11a1":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"3":{"radio_11a1":"No","title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"4":{"radio_11a1":"No","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"}}', '{"2":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"3":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"4":{"title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"5":{"title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"},"6":{"title":"test nov 22","id":"170","status":"field"},"7":{"title":"HDAC inhibitor for alzheimers","id":"211","status":"field"},"8":{"title":"HDAC inhibitors","id":"227","status":"field"},"9":{"title":"hdac inhibitors","id":"228","status":"field"}}', 54, '', '100k-1m', 'Yes', 'No', 3, '', 'Yes', 32, '', '[{"title":"Impact of genetic variants of apolipoprotein e on lipid profile in patients with Parkinson''s disease.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24175296","desc":"Greg&Atilde;&sup3;rio ML, Pinhel MA, Sado CL, Longo GS, Oliveira FN, Amorim GS, Nakazone MA, Florim GM, Mazeti CM, Martins DP, Tognola WA, Brand&Atilde;&pound;o AC, J&Atilde;&ordm;nior SP, de Godoy MF, Souza DR.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BioMed research international&quot;&gt;Biomed Res Int&lt;\\/span&gt;. 2013;2013:641515. doi: 10.1155\\/2013\\/641515. Epub 2013 Sep 24.","radio_11b2":"least_relevant"},{"title":"Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24175256","desc":"Canavesi E, Alfieri C, Pelusi S, Valenti L.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;World journal of nephrology&quot;&gt;World J Nephrol&lt;\\/span&gt;. 2012 Dec 6;1(6):166-176. Review.","radio_11b2":"least_relevant"},{"title":"Evaluation of virus-specific cellular immune response in transplant patients.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24175220","desc":"Costa C, Saldan A, Cavallo R.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;World journal of virology&quot;&gt;World J Virol&lt;\\/span&gt;. 2012 Dec 12;1(6):150-3. doi: 10.5501\\/wjv.v1.i6.150.","radio_11b2":"least_relevant"},{"title":"Selection of RNAi-based inhibitors for anti-HIV gene therapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24175213","desc":"Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;World journal of virology&quot;&gt;World J Virol&lt;\\/span&gt;. 2012 Jun 12;1(3):79-90. Review.","radio_11b2":"least_relevant"},{"title":"Adherence to medication: A nation-wide study from the Children''s Cancer Hospital, Egypt.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24175183","desc":"El Malla H, Ylitalo Helm N, Wilder&Atilde;&curren;ng U, El Sayed Elborai Y, Steineck G, Kreicbergs U.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;World journal of psychiatry&quot;&gt;World J Psychiatry&lt;\\/span&gt;. 2013 Jun 22;3(2):25-33. doi: 10.5498\\/wjp.v3.i2.25.","radio_11b2":"least_relevant"}]', 'my compound is much more efficacious', 'much less side effects of the compound', 'mice data were very promising', '', '{"1":{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},"2":{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ..."},"3":{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ..."},"4":{"title":"UPDATED: Incyte shares soar on positive pancreatic cancer trial data for Jakafi","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/incyte-shares-surge-positive-pancreatic-cancer-trial-data-jakafi\\/2013-08-21","desc":" group of patients with refractory metastatic <strong>pancreatic<\\/strong> <strong>cancer<\\/strong> who can be identified without ..."},"5":{"title":"FDA clears Merck''s Januvia, sister meds of new pancreatitis worries","link":"http:\\/\\/www.fiercepharma.com\\/story\\/fda-clears-mercks-januvia-sister-meds-new-pancreatitis-worries\\/2013-07-31","desc":" <strong>pancreatitis<\\/strong> with the company''s big diabetes drug Januvia and other drugs in its category. The group ..."},"6":{"title":"Safety watchdog flags GLP-1 drugs for pancreatitis reports to FDA","link":"http:\\/\\/www.fiercepharma.com\\/story\\/safety-watchdog-flags-glp-1-drugs-pancreatitis-reports-fda\\/2013-04-18","desc":" of these maladies were about 25 times higher for the GLP-1 class. As individual drugs, Januvia, a DPP-4 <strong>inhibitor<\\/strong> ..."},"7":{"title":"Novartis'' Afinitor performs in pancreatic cancer trial","link":"http:\\/\\/www.fiercepharma.com\\/story\\/novartis-afinitor-performs-pancreatic-cancer-trial\\/2010-06-03","desc":" Novartis''\\u00a0(NYSE:NVS) <strong>cancer<\\/strong> drug Afinitor helps patients with <strong>pancreatic<\\/strong> <strong>cancer<\\/strong> live longer without tumor growth, a late-stage trial showed, giving\\u00a0the company\\u00a0a boost ahead of the biggest annual <strong>cancer<\\/strong> meeting. Release | Report  ..."},"8":{"title":"Vax-chemo combo offers some hope in pancreatic cancer","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/vax-chemo-combo-offers-some-hope-pancreatic-cancer\\/2012-05-24","desc":" altered <strong>pancreatic<\\/strong> <strong>cancer<\\/strong> cell lines that express the enzyme \\u03b1-1,3 galactosyl transferase, and these cells ..."},"9":{"title":"Cell-based pancreatic cancer vaccine increases survival","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/cell-based-pancreatic-cancer-vaccine-increases-survival\\/2012-03-01","desc":" Stephen Simes, BioSante''s president and CEO. GVAX Pancreas is made from <strong>pancreatic<\\/strong> <strong>cancer<\\/strong> cells ..."},"10":{"title":"Vaximm starts trial of oral pancreatic cancer vaccine; Hospital fined for improper vaccine storage;","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/vaximm-starts-trial-oral-pancreatic-cancer-vaccine-hospital-fined-improper-\\/2011-12-13","desc":" <strong>cancer<\\/strong> vaccines could be the key to defeating the disease. Article >\\u00a0GeoVax Labs'' gas inoculated ..."}}', 'HDAC inhibitors for pancreatic cancer', 'pancreatic cancer HDAC ', '[{"title":"KD5170, a novel mercaptoketone-based <b>histone deacetylase<\\/b> <b>...<\\/b>","link":"http:\\/\\/mct.aacrjournals.org\\/content\\/7\\/5\\/1054.full.pdf"},{"title":"<b>Histone Deacetylase<\\/b> Inhibitors: Overview and Perspectives","link":"http:\\/\\/mcr.aacrjournals.org\\/content\\/5\\/10\\/981.full.pdf"},{"title":"CCR - Clinical <b>Cancer<\\/b> Research - Aacrjournals.org","link":"http:\\/\\/clincancerres.aacrjournals.org\\/content\\/15\\/12\\/3947.full.pdf"},{"title":"129 CHAPTER VI SUMMARY AND FUTURE DIRECTIONS <b>...<\\/b> - ETD","link":"http:\\/\\/etd.library.vanderbilt.edu\\/available\\/etd-05222008-164304\\/unrestricted\\/07ChapterVIRefs.pdf"}]', '', '', '', 100);
INSERT INTO `inventions` VALUES(117, '2013-11-01 07:07:47', 13, 'test', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', '', 'a', '', '', '', '', '', '0', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 37);
INSERT INTO `inventions` VALUES(118, '2013-11-01 07:07:47', 13, 'anemia detection', 'cr_sw', '', '', 'gansh1', 'gansh10', 'gansh10_3', '', '', 'iron-deficient anemia detection', 'd', '', 'iron-deficient anemia detection', '', '', '', 'a', '', 'USK1', '', '', '', '', '', 'field', '75', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'iron-deficient anemia', '', '', 21, '', '>1m', 'Yes', 'No', 2, '', 'Yes', 44, '[{"title":"Automated soybean phenotyping for iron deficiency chlorosis","link":"http:\\/\\/www.google.com\\/patents\\/WO2011022719A1?cl=en&dq=iron-defi&source=uds;","filedate":"Mon, 23 Aug 2010 00:00:00 -0700","applicant":"Syngenta Participations Ag","desc":"A system for evaluating the susceptibility of a soybean plant to <b>iron deficiency<\\/b>  chlorosis is described, Soybean plants are planted in range and\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Oral iron deficiency therapy","link":"http:\\/\\/www.google.com\\/patents\\/WO2011156563A2?cl=en&dq=iron-defi&source=uds;","filedate":"Thu, 09 Jun 2011 00:00:00 -0700","applicant":"Emisphere Technologies, Inc.","desc":"Methods of normalizing iron levels, treating <b>iron deficiency<\\/b> and disorders related  thereto, such as anemia, as described. Pharmaceutical\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Methods and Compounds Regulating the Erythroid Response to Iron Deficiency","link":"http:\\/\\/www.google.com\\/patents\\/US20130072428?dq=iron-defi&source=uds;","filedate":"Mon, 19 Nov 2012 00:00:00 -0800","applicant":"University Of Virginia Patent Foundation","desc":"<b>Iron deficiency<\\/b> is an extremely common cause of anemia. However, the  pathophysiology of iron deficient anemia remains poorly understood.","radio_11b":"Yes"},{"title":"Methods of detection of iron deficiency and hemochromatosis","link":"http:\\/\\/www.google.com\\/patents\\/WO2007035916A2?cl=en&dq=iron-defi&source=uds;","filedate":"Fri, 22 Sep 2006 00:00:00 -0700","applicant":"Beckman Coulter Inc","desc":"New diagnostic parameters or indexes for detection of absolute <b>iron deficiency<\\/b>,  latent <b>iron deficiency<\\/b>, functional <b>iron deficiency<\\/b>, or latent\\u00a0<b>...<\\/b>","radio_11b":"Yes"}]', '', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>Iron Deficiency Anemia<\\/b> - Symptoms, <b>Diagnosis<\\/b>, Treatment of Iron <b>...<\\/b>","link":"http:\\/\\/health.nytimes.com\\/health\\/guides\\/disease\\/iron-deficiency-anemia\\/overview.html","desc":"Mar 3, 2013 <b>...<\\/b> <b>Iron deficiency anemia<\\/b> is the most common form of anemia. <b>...<\\/b> Most of the time, \\nsymptoms are mild at <b>first<\\/b> and develop slowly. <b>...<\\/b> Also reviewed by A.D.A.M. \\nHealth Solutions, Ebix, <b>Inc<\\/b>., Editorial Team: David Zieve, MD, MHA,\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Anemia Diagnosis<\\/b> - <b>Anemia<\\/b> Health Information - NY Times Health","link":"http:\\/\\/health.nytimes.com\\/health\\/guides\\/disease\\/anemia\\/diagnosis.html","desc":"Mar 18, 2013 <b>...<\\/b> The <b>first<\\/b> step in any <b>diagnosis<\\/b> is a physical examination to determine if the \\npatient <b>...<\\/b> Lower levels may indicate <b>iron<\\/b>-<b>deficiency anemia<\\/b> or anemia of chronic \\n<b>...<\\/b> A.D.A.M., <b>Inc<\\/b>. is accredited by URAC, also known as the American\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Iron<\\/b>-<b>deficiency Anemia<\\/b> Causes, <b>Diagnosis<\\/b> & Treatments - Clinical Key","link":"https:\\/\\/www.clinicalkey.com\\/topics\\/oncology\\/iron-deficiency-anemia.html","desc":"<b>Iron<\\/b>-<b>deficiency anemia<\\/b> results from decreased iron stores caused by <b>....<\\/b> milk and \\n<b>early<\\/b> introduction of cow''s milk into an infant''s diet - iron in human milk is more\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Iron Deficiency Anemia<\\/b>: Anemias Caused by Deficient <b>...<\\/b>","link":"http:\\/\\/www.merckmanuals.com\\/professional\\/hematology_and_oncology\\/anemias_caused_by_deficient_erythropoiesis\\/iron_deficiency_anemia.html","desc":"<b>Iron deficiency<\\/b> is the most common cause of <b>anemia<\\/b> and usually results from <b>...<\\/b> If \\nthe <b>diagnosis<\\/b> is made, occult blood loss is suspected. <b>....<\\/b> Levels increase in <b>early<\\/b> \\n<b>iron deficiency<\\/b> and with increased erythropoiesis. <b>....<\\/b> Copyright \\u00a9 2010-2013 \\nMerck Sharp & Dohme Corp., a subsidiary of Merck & <b>Co<\\/b>., <b>Inc<\\/b>., Whitehouse \\nStation,\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Iron<\\/b> dextran dosing calculator. Total dose infusion. <b>Iron deficiency<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.globalrph.com\\/irondextran.htm","desc":"Watson Pharma <b>Inc<\\/b>. INFeD (iron dextran) Injection [product information]. <b>...<\\/b> \\nDosage I. <b>Iron Deficiency Anemia<\\/b>: Periodic hematologic determination (\\nhemoglobin and <b>...<\\/b> of transferrin are other important tests for <b>detecting<\\/b> and \\nmonitoring the iron deficient state. <b>....<\\/b> INFeD should not normally be given in the \\n<b>first<\\/b> four months of life.","radio_15b":"Yes"},{"title":"<b>Iron deficiency<\\/b> in infants and young children: Screening, prevention <b>...<\\/b>","link":"http:\\/\\/www.uptodate.com\\/contents\\/iron-deficiency-in-infants-and-young-children-screening-prevention-clinical-manifestations-and-diagnosis","desc":"Sep 6, 2013 <b>...<\\/b> Iron deficiency (ID) is the most common nutritional deficiency in children. <b>...<\\/b> \\nIssues related to iron metabolism and the clinical manifestations, <b>diagnosis<\\/b>, and \\n<b>...<\\/b> iron deficiency (ID) and 2 to 3 percent have <b>iron deficiency anemia<\\/b> (IDA) [4-6]. \\n<b>...<\\/b> <b>early<\\/b> intervention to prevent iron deficiency during infancy and <b>early<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"What is Anemia? | Get Your Iron Up | <b>Iron Deficiency Anemia<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.getyourironup.com\\/are-you-anemic","desc":"There are many different types of anemia, but <b>Iron Deficiency Anemia<\\/b> (IDA) is a \\ncondition <b>...<\\/b> <b>Early detection<\\/b> is so very important. <b>...<\\/b> your doctor may not routinely \\ntest for iron and your insurance <b>company<\\/b> may not cover the costs of testing.","radio_15b":"Yes"},{"title":"Screening for Nutritional <b>Anemia<\\/b> - Midtown Surgical Center | Denver <b>...<\\/b>","link":"http:\\/\\/midtownsurgicalcenter.com\\/your-health\\/?\\/19077\\/Screening","desc":"The purpose of screening is <b>early diagnosis<\\/b> and treatment. <b>...<\\/b> Infants and children \\nare often screened for <b>iron deficiency anemia<\\/b> as part of a well child evaluation.","radio_15b":"Yes"}]', '[{"title":"Erythrocyte biomarker could be low-cost iron deficiency marker in anemia","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/erythrocyte-biomarker-could-be-low-cost-iron-deficiency-marker-anemia\\/2011-11-20","desc":" including neurological problems and stunted growth. It''s important to identify the <strong>iron-deficient<\\/strong> ...","radio_15":"No"},{"title":"Rockwell shares surge as iron deficiency study offers upbeat outcomes ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/rockwell-shares-surge-phiii-iron-deficiency-study-offers-upbeat-outcomes\\/2013-02-04","desc":" Two years ago Rockwell Medical had a tough time convincing investors that its lead drug for <strong>iron<\\/strong> <strong>deficiency<\\/strong> <strong>anemia<\\/strong> had a viable future ahead of it when investigators announced that the treatment had failed ...","radio_15":"No"},{"title":"Amag preps sNDA after Feraheme clears PhIII hurdles","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/amag-preps-snda-after-feraheme-clears-phiii-hurdles\\/2012-07-18","desc":" Amag Pharmaceuticals ($AMAG) has received a dose of good news. Its second late-stage study of Feraheme as a treatment for <strong>iron<\\/strong> <strong>deficiency<\\/strong> <strong>anemia<\\/strong> in a population of non-responders hit both primary endpoints, according to the company, laying the foundation for a supplemental NDA. Amag has been undergoing ...","radio_15":"Yes"},{"title":"UPDATED: Given wins FDA nod for next-gen PillCam device","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/given-wins-fda-nod-next-gen-pillcam-device\\/2013-08-13","desc":" Given''s stock hit $17.13 in <strong>early<\\/strong> trading on Aug. 13, up nearly 5%. PillCam SB 3 is cleared to <strong>detect<\\/strong> ...","radio_15":"Yes"},{"title":"Rockwell shares plunge after renal drug fails IIb endpoint","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/rockwell-shares-plunge-after-renal-drug-fails-iib-endpoint\\/2010-02-26","desc":" dose changes that violated the trial protocols. The drug is intended to treat or prevent <strong>iron<\\/strong> <strong>deficiency<\\/strong> <strong>anemia<\\/strong>, traveling to the bloodstream and avoiding the liver and reticuloendothelial system ...","radio_15":"Yes"},{"title":"Keryx jumps as kidney drug impresses in PhII, promises wider label","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/keryx-jumps-kidney-drug-impresses-phii-promises-wider-label\\/2013-11-05","desc":" can stretch that approval to include less-dire CKD patients with <strong>iron-deficiency<\\/strong> <strong>anemia<\\/strong>, Zerenex would ...","radio_15":"Yes"},{"title":"Amag pulls anemia drug batch after Swiss patient dies","link":"http:\\/\\/www.fiercepharma.com\\/story\\/amag-pulls-anemia-drug-batch-after-swiss-patient-dies\\/2013-05-22","desc":" Amag Pharmaceuticals and partner Takeda have run into a snag in Switzerland. Japan-based Takeda is recalling a batch of Amag''s <strong>anemia<\\/strong> drug Feraheme, sold as Rienso in the Swiss market, after several ...","radio_15":"Already Assigned"},{"title":"Goldman downgrades Watson Pharma","link":"http:\\/\\/www.fiercepharma.com\\/story\\/goldman-downgrades-watson-pharma\\/2008-09-16","desc":" Goldman Sachs dealt a blow to Watson Pharmaceuticals today, downgrading the generics maker to ","radio_15":"Yes"},{"title":"Compugen, Merck Serono form startup biomarker company; Did Amylin lie about ''concealed'' Byetta study?;","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/compugen-merck-serono-form-startup-biomarker-company-did-amylin-lie-about-c\\/2012-06-25","desc":" toxicity <strong>early<\\/strong>. More > Oracle rolls out cloud apps for clinical trial recruitment. Story > Bay Area ...","radio_15":"Yes"},{"title":"AMAG to cut staff by 24%, reports safety issues for kidney drug","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/safety-issues-force-amag-cut-staff-24\\/2010-10-29","desc":" approval make AMAG a buyout target? AMAG shares slump on new FDA letter FDA delays approval of AMAG <strong>anemia<\\/strong> ...","radio_15":"Already Assigned"}]', 'iron-deficient anemia early detection', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(124, '2013-11-05 05:28:02', 20, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(125, '2013-11-05 05:29:34', 18, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(131, '2013-11-06 05:27:23', 1, 'Nov 6 hdac inhibitor for colon cancer', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'test test', 'e', 'b', 'hdac inhibitor for colon cancer', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '115', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-11-20 00:00:00', '', 'Yes', '2013-10-01 00:00:00', '', '', '0000-00-00 00:00:00', 'hdac inhibitor for colon cancer', '{"1":{"radio_11a1":"Yes","title":"Testing for happy face","id":"58","status":"field"},"2":{"radio_11a1":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"3":{"radio_11a1":"No","title":"method for detecting cancer","id":"87","status":"field"},"4":{"radio_11a1":"May be","title":"pancreatic cancer drug","id":"92","status":"field"},"5":{"radio_11a1":"May be","title":"Pancreatic cancer drug","id":"98","status":"field"},"6":{"radio_11a1":"No","title":"test 24th Dx","id":"100","status":"field"},"7":{"radio_11a1":"No","title":"pancreatic cancer","id":"108","status":"field"},"8":{"radio_11a1":"Yes","title":"HDAC inhibitor for alzheimers","id":"110","status":"field"},"9":{"radio_11a1":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"10":{"radio_11a1":"No","title":"HDAC inhibitor for alzheimers","id":"128","status":"field"}}', '{"1":{"radio_11a2":"Yes","title":"Testing for happy face","id":"58","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"No","title":"testing happy face","id":"62","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"May be","title":"method for detecting cancer","id":"87","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"May be","title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"No","title":"Pancreatic cancer drug","id":"98","status":"Disclosure Done & Under Review"},"7":{"radio_11a2":"No","title":"test 24th Dx","id":"100","status":"Disclosure Done & Under Review"},"8":{"radio_11a2":"May be","title":"pancreatic cancer","id":"108","status":"Disclosure Done & Under Review"},"9":{"radio_11a2":"Yes","title":"HDAC inhibitor for alzheimers","id":"110","status":"Disclosure Done & Under Review"},"10":{"radio_11a2":"Yes","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"}}', 150, '', '100k-1m', 'Yes', 'No', 3, '', 'Maybe', 42.5, '[{"title":"Methods for determining cancer resistance to histone deacetylase inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/CA2677000A1?cl=en&dq=hdac+inhibitor+for+colon+cancer&source=uds;","filedate":"Wed, 30 Jan 2008 00:00:00 -0800","applicant":"Pharmacyclics, Inc., Joseph J. Buggy, Sriram Balasubramanian","desc":"The method of claim 1, wherein the <b>HDAC inhibitor<\\/b> is PCI-24781. 11. <b>...<\\/b> The  method of claim 12, wherein the cancer is a <b>colon cancer<\\/b>. 20.","radio_11b":"No"},{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=hdac+inhibitor+for+colon+cancer&source=uds;","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the <b>...<\\/b> Use of  <b>hdac inhibitors for<\\/b> the treatment of gastrointestinal <b>cancers<\\/b>","radio_11b":"Yes"},{"title":"Combination therapy using HDAC inhibitors and melphalan for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2500063A1?cl=en&dq=hdac+inhibitor+for+colon+cancer&source=uds;","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited","desc":"The present invention pertains to a method for treating cancer, such as <b>...<\\/b>  Combination therapy using <b>HDAC inhibitors<\\/b> and melphalan for treating cancer <b>....<\\/b>  cancer, <b>colon cancer<\\/b>, lung cancer, breast cancer, pancreatic cancer,\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Combination therapies using HDAC inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/EP2522395A1?cl=en&dq=hdac+inhibitor+for+colon+cancer&source=uds;","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited","desc":"Use of a <b>histone deacetylase inhibitor<\\/b> in the manufacture of a <b>...<\\/b> rectal cancer,  <b>colon cancer<\\/b>, lung cancer, breast cancer, pancreatic cancer,\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Combination therapy using HDAC inhibitors and erlotinib for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2502649A1?cl=en&dq=hdac+inhibitor+for+colon+cancer&source=uds;","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited","desc":"The present invention pertains to a method for treating cancer, such as <b>...<\\/b>  Combination therapy using <b>HDAC inhibitors<\\/b> and erlotinib for treating cancer <b>....<\\/b>  cancer, <b>colon cancer<\\/b>, lung cancer, breast cancer, pancreatic cancer,\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2007054719A2?cl=en&dq=hdac+inhibitor+for+colon+cancer&source=uds;","filedate":"Fri, 10 Nov 2006 00:00:00 -0800","applicant":"Topotarget Uk Ltd, Curagen Corp, Henri Lichtenstein, Nicholas Edwards, James Ritchie, Kamille Dumong Petersen, Jane Plumb","desc":"A <b>histone deacetylase inhibitor<\\/b> for use in the treatment of cancer, <b>....<\\/b> one of claims  4 to 20, wherein the cancer is rectal cancer or <b>colon cancer<\\/b>.","radio_11b":"Yes"}]', '[{"title":"Different Effects of Epigenetic Modifiers on the Cytotoxicity Induced by 5-Fluorouracil, Irinotecan or Oxaliplatin in &lt;b&gt;Colon Cancer&lt;\\/b&gt; Cells.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24172061","desc":"Ikehata M, Ogawa M, Yamada Y, Tanaka S, Ueda K, Iwakawa S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biological &amp; pharmaceutical bulletin&quot;&gt;Biol Pharm Bull&lt;\\/span&gt;. 2013 Oct 29. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"An intact immune system is required for the anti-&lt;b&gt;cancer&lt;\\/b&gt; activities of &lt;b&gt;histone deacetylase inhibitors&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24158093","desc":"West AC, Mattarollo SR, Shortt J, Cluse LA, Christiansen AJ, Smyth MJ, Johnstone RW.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancer research&quot;&gt;&lt;b&gt;Cancer&lt;\\/b&gt; Res&lt;\\/span&gt;. 2013 Oct 24. [Epub ahead of print]","radio_11b2":"No"},{"title":"Inhibition of autophagy induced by TSA sensitizes &lt;b&gt;colon cancer&lt;\\/b&gt; cell to radiation.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24122231","desc":"He G, Wang Y, Pang X, Zhang B.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine&quot;&gt;Tumour Biol&lt;\\/span&gt;. 2013 Oct 13. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"The discovery and optimization of novel dual &lt;b&gt;inhibitors&lt;\\/b&gt; of topoisomerase ii and &lt;b&gt;histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24095018","desc":"Zhang X, Bao B, Yu X, Tong L, Luo Y, Huang Q, Su M, Sheng L, Li J, Zhu H, Yang B, Zhang X, Chen Y, Lu W.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Bioorganic &amp; medicinal chemistry&quot;&gt;Bioorg Med Chem&lt;\\/span&gt;. 2013 Nov 15;21(22):6981-95. doi: 10.1016\\/j.bmc.2013.09.023. Epub 2013 Sep 18.","radio_11b2":"Yes"},{"title":"&lt;b&gt;Histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt; (&lt;b&gt;HDAC&lt;\\/b&gt;) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as &lt;b&gt;HDAC inhibitor&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24053181","desc":"Senawong T, Misuna S, Khaopha S, Nuchadomrong S, Sawatsitang P, Phaosiri C, Surapaitoon A, Sripa B.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BMC complementary and alternative medicine&quot;&gt;BMC Complement Altern Med&lt;\\/span&gt;. 2013 Sep 22;13(1):232. [Epub ahead of print]","radio_11b2":"May Be"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>HDAC Inhibitors<\\/b> - References - Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/hdac_references.html","desc":"AACR 2009 Annual Meeting, Denver, <b>CO<\\/b>, April 2009. <b>...<\\/b> Poster: \\u201cActivity of a \\nnovel <b>HDAC inhibitor<\\/b> PCI-24781 in <b>colorectal cancer<\\/b>: Discovery and validation of\\n\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"Cell Death and Disease - The <b>HDAC inhibitor<\\/b>, MPT0E028 <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/cddis\\/journal\\/v4\\/n9\\/full\\/cddis2013330a.html","desc":"Sep 19, 2013 <b>...<\\/b> lung <b>cancer<\\/b>; <b>HDAC<\\/b>; synergistic; EGFR; apoptosis; erlotinib <b>...<\\/b> range of <b>cancer<\\/b> cell \\ntypes, including lung, ovarian, <b>colon<\\/b>, breast, prostate, and renal <b>cancer<\\/b> cells. <b>...<\\/b> \\nHowever, MPT0E028 and erlotinib <b>co<\\/b>-treatment synergistically\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Dietary phytochemicals, <b>HDAC inhibition<\\/b>, and DNA damage\\/repair","link":"http:\\/\\/www.clinicalepigeneticsjournal.com\\/content\\/3\\/1\\/4","desc":"Thus, <b>HDAC inhibitors<\\/b>, in addition to unsilencing tumor suppressor genes, also <b>...<\\/b> \\nfrom acetyl <b>co<\\/b>-enzyme A to lysine residues, and HDACs remove the acetyl \\ngroups. <b>.....<\\/b> DSBs also were triggered in <b>colon cancer<\\/b> cell lines SW620 at 10-50 \\n\\u03bcM\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Histone deacetylase inhibitors<\\/b> in the treatment of <b>cancer<\\/b>: overview <b>...<\\/b>","link":"http:\\/\\/www.reactionbiology.com\\/webapps\\/main\\/press\\/20130128.pdf","desc":"Jan 28, 2013 <b>...<\\/b> <b>Histone deacetylase inhibitors<\\/b> (HDACis) are one of the last frontiers in \\npharmaceutical research. <b>...<\\/b> developed by Merck 56 <b>Co<\\/b>., <b>Inc<\\/b>. and, in <b>.....<\\/b> \\n<b>Colorectal cancer<\\/b>: upregulation in polyps, associated with poor prognosis;\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>HDAC Inhibitors<\\/b> in <b>Cancer<\\/b> Care | <b>Cancer<\\/b> Network","link":"http:\\/\\/www.cancernetwork.com\\/cancer-and-genetics\\/hdac-inhibitors-cancer-care","desc":"Feb 8, 2010 <b>...<\\/b> Although the use of <b>HDAC inhibitors<\\/b> has generated great enthusiasm, <b>...<\\/b> lung \\ncancer,[13] <b>colorectal cancer<\\/b>,[14] prostate cancer,[15] and\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Spectrum Pharmaceuticals, <b>Inc<\\/b>.- Product Portfolio - Late Stage <b>...<\\/b>","link":"http:\\/\\/www.sppirx.com\\/322-spectrum-products-late-stage-belinostat.html","desc":"Belinostat (PXD 101) is an <b>HDAC inhibitor<\\/b> in late stage clinical development with \\n<b>...<\\/b> multiple <b>cancers<\\/b> by inhibiting cell proliferation (inhibiting <b>cancer<\\/b> growth) and\\u00a0<b>...<\\/b>","radio_15b":"May Be"},{"title":"Executive Summary - Insight Pharma Reports","link":"http:\\/\\/www.insightpharmareports.com\\/uploadedFiles\\/Reports\\/Reports\\/Epigenetic_Drug_and_Diagnostic_Pipelines\\/Epigenomics_Executive_Summary.pdf","desc":"and Quest Diagnostics offer competing tests for <b>colorectal cancer<\\/b> screening. <b>...<\\/b> \\nMany <b>companies<\\/b> are developing novel <b>HDAC inhibitors<\\/b>, as discussed in. \\nChapter\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"DNA microarray profiling of genes differentially regulated by the <b>...<\\/b>","link":"http:\\/\\/link.springer.com\\/article\\/10.1186%2F1755-8794-2-67","desc":"DNA microarray profiling of genes differentially regulated by the <b>histone<\\/b> \\n<b>deacetylase inhibitors<\\/b> vorinostat and LBH589 in <b>colon cancer<\\/b> cell lines. Melissa \\nJ\\u00a0<b>...<\\/b>","radio_15b":"Yes"}]', '[{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" Swedish researchers believe that <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong>,\\u00a0substances common to some <strong>cancer<\\/strong> and epilepsy drugs, may also be used to help prevent heart attacks. <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> are used to treat <strong>cancer<\\/strong> because ...","radio_15":"Yes"},{"title":"Florida Keys home to potential colon cancer fighter","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/florida-keys-home-potential-colon-cancer-fighter\\/2010-10-05","desc":" for further preclinical testing, which indicates it is a potent <strong>inhibitor<\\/strong> of <strong>cancer<\\/strong> cells that has the right ...","radio_15":"No"},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ...","radio_15":"May Be"},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ...","radio_15":"No"},{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ...","radio_15":"Already Assigned"},{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ...","radio_15":"Yes"},{"title":"Basque scientists stop colon cancer metastasis","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/basque-scientists-stop-colon-cancer-metastasis\\/2013-02-19","desc":" Genentech, U. Minnesota scientists discover new <strong>colon<\\/strong> <strong>cancer<\\/strong> red flags Gene in the <strong>colon<\\/strong> appears to spur ...","radio_15":"No"},{"title":"Sanofi, Regeneron buoyed by Ph3 colon cancer success for aflibercept","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/sanofi-regeneron-buoyed-ph3-colon-cancer-success-aflibercept\\/2011-04-27","desc":" <strong>colon<\\/strong> <strong>cancer<\\/strong> success for aflibercept Sanofi, Regeneron''s aflibercept flunks PhIII trial Aflibercept ...","radio_15":"Yes"},{"title":"Acetylon raises $12.4M in new venture round ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-raises-124m-new-venture-round\\/2011-02-23","desc":" million round to back its work developing <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> for inflammatory and neurological diseases as well as <strong>cancer<\\/strong>. Its technology builds on the work of four top scientists at Dana-Farber <strong>Cancer<\\/strong> ...","radio_15":"Yes"},{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" working on <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> include MEI Pharma ($MEIP) and 4SC, and gene therapy can flip the switch ...","radio_15":"No"}]', 'hdac inhibitors for colon cancer', 'hdac inhibitor for colon cancer', '[{"title":"ON THE PATH TO <b>MARKET<\\/b> MATURITY - 4SC","link":"http:\\/\\/www.4sc.de\\/sites\\/default\\/files\\/financial-reports\\/4SC-HJB2012-EN-codiert.pdf"},{"title":"Microsatellite instability in <b>colorectal cancer<\\/b>\\u2014the stable evidence","link":"http:\\/\\/fishercenter.georgetown.edu\\/docs\\/Gruber_Microsatellite%20Instability%20in%20Colorectal%20Cancer--The%20Stable%20Evidence.pdf"},{"title":"First-in-human, Pharmacokinetic and Pharmacodynamic Phase I <b>...<\\/b>","link":"http:\\/\\/clincancerres.aacrjournals.org\\/content\\/early\\/2013\\/09\\/13\\/1078-0432.CCR-13-0735.full.pdf"},{"title":"Pharmacodynamic Evaluation of the Target Efficacy of SB939, an <b>...<\\/b>","link":"http:\\/\\/mct.aacrjournals.org\\/content\\/10\\/7\\/1207.full.pdf"}]', '', '', '', 100);
INSERT INTO `inventions` VALUES(132, '2013-11-06 06:20:36', 1, 'aavishkar', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'test ', 'd', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '110', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'KRAS mutant colon cancer', '{"1":{"radio_11a1":"Yes","title":"Testing for happy face","id":"58","status":"field"},"2":{"radio_11a1":"Yes","title":"method for detecting cancer","id":"87","status":"field"},"3":{"radio_11a1":"No","title":"pancreatic cancer drug","id":"92","status":"field"},"4":{"radio_11a1":"No","title":"test 24th Dx","id":"100","status":"field"},"5":{"radio_11a1":"May be","title":"pancreatic cancer","id":"108","status":"field"},"6":{"radio_11a1":"May be","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"7":{"radio_11a1":"May be","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"}}', '', 95, '', '100k-1m', 'No', '', 0, '', 'Maybe', 25, '[{"title":"Chemoradiotherapy for kras-mutant colorectal cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2012016050A2?cl=en&dq=KRAS+mutant+colon+c&source=uds;","filedate":"Thu, 28 Jul 2011 00:00:00 -0700","applicant":"The General Hospital Corporation","desc":"Chemoradiotherapy for <b>KRAS<\\/b>-<b>Mutant Colorectal Cancer<\\/b>. CLAIM OF PRIORITY.  This application claims the benefit of U.S. Provisional Patent\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Detection of k-ras mutations in cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO1999004037A1?cl=en&dq=KRAS+mutant+colon+c&source=uds;","filedate":"Wed, 15 Jul 1998 00:00:00 -0700","applicant":"Zeneca Ltd, Richard Mark Ferrie, Gillian Ellison, Kay Callaghan, Jayne Catherine Fox","desc":"This invention relates to a diagnostic method for the detection of <b>K-ras mutations<\\/b>  in cancer, particularly <b>colorectal cancer<\\/b>, using the\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Treatment of cancer involving mutated kras or braf genes","link":"http:\\/\\/www.google.com\\/patents\\/WO2011054030A1?cl=en&dq=KRAS+mutant+colon+c&source=uds;","filedate":"Fri, 29 Oct 2010 00:00:00 -0700","applicant":"Cephalon Australia Pty Ltd","desc":"The <b>KRAS mutations<\\/b> are of particular medical significance as they occur in 35%- 45% of <b>colorectal cancer<\\/b> patients; BRAF mutations occur in\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Treatment of cancers having k-ras mutations","link":"http:\\/\\/www.google.com\\/patents\\/EP2557923A1?cl=en&dq=KRAS+mutant+colon+c&source=uds;","filedate":"Fri, 15 Apr 2011 00:00:00 -0700","applicant":"Curis, Inc.","desc":"In particular, <b>K-ras mutations<\\/b> are prevalent in pancreatic, <b>colorectal<\\/b>, thyroid, lung,  cervical and endometrial <b>cancer<\\/b>. <b>K- ras mutations<\\/b> have also\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Multiplexed kras mutation detection assay","link":"http:\\/\\/www.google.com\\/patents\\/WO2013058868A2?cl=en&dq=KRAS+mutant+colon+c&source=uds;","filedate":"Fri, 24 Aug 2012 00:00:00 -0700","applicant":"Exact Sciences Corporation","desc":"The method of claim 13, further comprising making a diagnosis of <b>colon cancer<\\/b> or  adenoma based on whether <b>mutant<\\/b> copies of said <b>KRAS<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Multiplex genotyping assay for detecting mutations in k-ras","link":"http:\\/\\/www.google.com\\/patents\\/WO2010048691A1?cl=en&dq=KRAS+mutant+colon+c&source=uds;","filedate":"Wed, 09 Sep 2009 00:00:00 -0700","applicant":"British Columbia Cancer Agency Branch","desc":"A method for detecting <b>k-ras mutations<\\/b> in a sample from a subject comprising: <b>...<\\/b>  The method of claim 21 , wherein the subject has <b>colon cancer<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Combination therapy","link":"http:\\/\\/www.google.com\\/patents\\/US20130273061?dq=KRAS+mutant+colon+c&source=uds;","filedate":"Wed, 13 Mar 2013 00:00:00 -0700","applicant":"Amgen, Inc., Novartis Pharma Ag","desc":"Approximately 15% of human cancers carry activating <b>RAS mutations<\\/b>, including  <b>colorectal cancer<\\/b> (CRC) (40% <b>KRAS mutations<\\/b>), pancreatic\\u00a0<b>...<\\/b>","radio_11b":"Yes"}]', '[{"title":"The S492R EGFR ectodomain mutation is never detected in &lt;b&gt;KRAS&lt;\\/b&gt; wild type colorectal carcinoma before exposure to EGFR monoclonal antibodies.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24025416","desc":"Esposito &lt;b&gt;C&lt;\\/b&gt;, Rachiglio AM, La Porta ML, Sacco A, Roma &lt;b&gt;C&lt;\\/b&gt;, Iannaccone A, Tatangelo F, Forgione L, Pasquale R, Barbaro A, Botti G, Ciardiello F, Normanno N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancer biology &amp; therapy&quot;&gt;Cancer Biol Ther&lt;\\/span&gt;. 2013 Sep 11;14(12). [Epub ahead of print]","radio_11b2":"Yes"},{"title":"The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant &lt;b&gt;colon&lt;\\/b&gt; cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23555026","desc":"Allen JE, Gallant JN, Dicker DT, Amin S, Irby RB, Sharma AK, El-Deiry WS.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013;8(3):e59380. doi: 10.1371\\/journal.pone.0059380. Epub 2013 Mar 12.","radio_11b2":"Yes"},{"title":"A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of &lt;b&gt;mutant&lt;\\/b&gt; &lt;b&gt;KRAS&lt;\\/b&gt; metastatic colorectal cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23510984","desc":"Cohn AL, Tabernero J, Maurel J, Nowara E, Sastre J, Chuah BY, Kopp MV, Sakaeva DD, Mitchell EP, Dubey S, Suzuki S, Hei YJ, Galimi F, McCaffery I, Pan Y, Loberg R, Cottrell S, Choo SP.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Annals of oncology : official journal of the European Society for Medical Oncology \\/ ESMO&quot;&gt;Ann Oncol&lt;\\/span&gt;. 2013 Jul;24(7):1777-85. doi: 10.1093\\/annonc\\/mdt057. Epub 2013 Mar 19.","radio_11b2":"No"},{"title":"Resistance to BRAF inhibition in BRAF-&lt;b&gt;mutant&lt;\\/b&gt; &lt;b&gt;colon&lt;\\/b&gt; cancer can be overcome with PI3K inhibition or demethylating agents.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23251002","desc":"Mao M, Tian F, Mariadason JM, Tsao CC, Lemos R Jr, Dayyani F, Gopal YN, Jiang ZQ, Wistuba II, Tang XM, Bornman WG, Bollag G, Mills GB, Powis G, Desai J, Gallick GE, Davies MA, Kopetz S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Clinical cancer research : an official journal of the American Association for Cancer Research&quot;&gt;Clin Cancer Res&lt;\\/span&gt;. 2013 Feb 1;19(3):657-67. doi: 10.1158\\/1078-0432.CCR-11-1446. Epub 2012 Dec 18.","radio_11b2":"Yes"},{"title":"Knockdown of PAK4 or PAK1 inhibits the proliferation of &lt;b&gt;mutant&lt;\\/b&gt; &lt;b&gt;KRAS&lt;\\/b&gt; &lt;b&gt;colon&lt;\\/b&gt; cancer cells independently of RAF\\/MEK\\/ERK and PI3K\\/AKT signaling.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23233484","desc":"Tabusa H, Brooks T, Massey AJ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Molecular cancer research : MCR&quot;&gt;Mol Cancer Res&lt;\\/span&gt;. 2013 Feb;11(2):109-21. doi: 10.1158\\/1541-7786.MCR-12-0466. Epub 2012 Dec 10.","radio_11b2":"No"}]', 'test test test test test', 'test test test test test', 'test test test test test', '', '', '', '', '', '', '', '', 86);
INSERT INTO `inventions` VALUES(133, '2013-11-06 09:41:36', 1, 'Hemophilia drug', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_4', '', '', 'clotting agent for hemophilia', 'f', '', 'Hemophilia drug', '', '', '', 'b', '', 'John Smith', 'Jagdale', 'NIHqqqq11', '1 million over 3 years', '', '', 'field', '132', 'Yes', '2013-08-01 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'botropase as clotting agent', '', '', 19, '', '>1m', 'Yes', 'No', 5, '', 'Maybe', 56, '[{"title":"Method for reducing obstructive hydrocephalus","link":"http:\\/\\/www.google.com\\/patents\\/WO2003101281A2?cl=en&dq=botropase+as+clotti&source=uds;","filedate":"Tue, 03 Jun 2003 00:00:00 -0700","applicant":"Uab Research Foundation, Jay M Meythaler, Winfield S Fisher","desc":"<b>...<\\/b> gyroxin, acutin, venzyme, asperase, reptilase, <b>botropase<\\/b>, defibrase, <b>.....<\\/b>  typically treated following a hemorrhage that results in <b>clotting<\\/b> which\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Mutated nucleotide sequences of batroxobin, mutated alpha factor secretion ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2009084841A2?cl=en&dq=botropase+as+clotti&source=uds;","filedate":"Tue, 23 Dec 2008 00:00:00 -0800","applicant":"Biobud Co Ltd, Kwang Hoe Chung, Sung Yu Hong, Jae Hoon Hwang, Bum Joon Kim, Kyoung Jun Kim, Ok Hwan Kim, Ji Hun Shin, Young-Doug Sohn","desc":"<b>Botropase<\\/b> (for hemostasis, Italian Ravizza Company) isolated from venom of  Latin venomous snake <b>.....<\\/b> 13) and whole blood <b>clotting<\\/b> time (Fig.","radio_11b":"Yes"},{"title":"Hemostasis composition containing batroxobin and preparation method thereof","link":"http:\\/\\/www.google.com\\/patents\\/CN101797378A?cl=en&dq=botropase+as+clotti&source=uds;","filedate":"Wed, 11 Feb 2009 00:00:00 -0800","applicant":"\\u5317\\u4eac\\u8d5b\\u751f\\u836f\\u4e1a\\u6709\\u9650\\u516c\\u53f8","desc":"[0002] human and animal blood <b>clotting<\\/b> process, including fibrin formation and  cross-linking <b>.....<\\/b> <b>Botropase<\\/b> B jararaca A <b>Botropase<\\/b> B jararaca A.","radio_11b":"No"},{"title":"Thrombin-like recombinant batroxobin expressed by pichia sp.and production ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2005045022A1?cl=en&dq=botropase+as+clotti&source=uds;","filedate":"Fri, 31 Oct 2003 00:00:00 -0800","applicant":"Biobud Co Ltd, Won-Seok Choi, Kwang-Hoe Chung, Seung-Woo Kang, You-Seok Koh, Weon-Kyoo You","desc":"<b>Botropase<\\/b> (for hemostasis, Italian Ravizza Company) isolated from venom <b>...<\\/b> '' native thrombin-like enzyme by measuring plasma <b>clotting<\\/b> time.","radio_11b":"No"},{"title":"A process for preparing an autologous platelet gel and membrane thereof","link":"http:\\/\\/www.google.com\\/patents\\/WO2001043787A2?cl=en&dq=botropase+as+clotti&source=uds;","filedate":"Wed, 13 Dec 2000 00:00:00 -0800","applicant":"Maria Cristina Sacchi, Marco Bellanda","desc":"<b>...<\\/b> solution having 1 thrombin international unit and is sold under the commercial  name <b>Botropase<\\/b> by Ravizza Farmaceutici S.p.A.. 2. <b>...<\\/b> <b>clotting<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"An agent for reducing a side effect of an anticancer drug","link":"http:\\/\\/www.google.com\\/patents\\/CN101896193A?cl=en&dq=botropase+as+clotti&source=uds;","filedate":"Fri, 12 Dec 2008 00:00:00 -0800","applicant":"\\u4e1c\\u83f1\\u836f\\u54c1\\u5de5\\u4e1a\\u682a\\u5f0f\\u4f1a\\u793e","desc":"<b>...<\\/b> Crowe he enzymes, flavoxobin, asperase, acutin, <b>botropase<\\/b>, clotase, <b>...<\\/b> to the  action of thrombin on fibrinogen <b>clotting<\\/b> factors other than the.","radio_11b":"Yes"},{"title":"A therapeutic agent for a lower urinary tract disease and an agent for ...","link":"http:\\/\\/www.google.com\\/patents\\/CN102056621A?cl=en&dq=botropase+as+clotti&source=uds;","filedate":"Wed, 01 Jul 2009 00:00:00 -0700","applicant":"\\u4e1c\\u83f1\\u836f\\u54c1\\u5de5\\u4e1a\\u682a\\u5f0f\\u4f1a\\u793e","desc":"<b>...<\\/b> Acutobin (acutin), wave summarized enzyme (<b>botropase<\\/b>), g mouth of <b>....<\\/b> to  fibrinogen <b>clotting<\\/b> factors, in addition to fibrinogen and thrombin,\\u00a0<b>...<\\/b>","radio_11b":"duplicate"}]', '[{"title":"[Platelet rich plasma (PRP): potentialities and techniques of extraction].","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/12434129","desc":"Pacifici L, Casella F, Maggiore C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Minerva stomatologica&quot;&gt;Minerva Stomatol&lt;\\/span&gt;. 2002 Jul-Aug;51(7-8):341-50. Review. Italian. ","radio_11b2":"No"},{"title":"Efficacy of intravitreal hemocoagulase for control of bleeding in rabbit experimental model of vitrectomy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/8145382","desc":"Kim SH, Lee HS, Kim IT, Jung BH, Cho JH, Kwak JS.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Japanese journal of ophthalmology&quot;&gt;Jpn J Ophthalmol&lt;\\/span&gt;. 1993;37(4):379-84.","radio_11b2":"Yes"},{"title":"Effects of procoagulants on wound healing.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/2365407","desc":"Ramesh KV, Rao CM, Bairy KL, Ramanarayan K, Kulkarni DR.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Indian journal of experimental biology&quot;&gt;Indian J Exp Biol&lt;\\/span&gt;. 1990 Jan;28(1):43-5.","radio_11b2":"No"},{"title":"[Clinical prescription of &lt;b&gt;botropase&lt;\\/b&gt;, an antihaemorrhagic drug (author''s transl)].","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/1219710","desc":"Marti T.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis&quot;&gt;Schweiz Rundsch Med Prax&lt;\\/span&gt;. 1975 Oct 14;64(41):1324-8. German.  No abstract available. ","radio_11b2":"No"},{"title":"[Influence of &lt;b&gt;botropase&lt;\\/b&gt;, a snake venom extract from Bothrops jararaca, on blood coagulation].","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/5625130","desc":"Donner L, Houskov&Atilde;&iexcl; J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Vnitrni lekarstvi&quot;&gt;Vnitr Lek&lt;\\/span&gt;. 1967 Jul;13(7):647-53. Czech.  No abstract available. ","radio_11b2":"No"}]', 'this has fewer side effects', 'broad applications of my protein', 'a lot of human clinical work is on-going', '[{"title":"Physiology and Pathology of Blood Coagulation - Karger","link":"https:\\/\\/www.karger.com\\/Article\\/Pdf\\/204299","desc":"plasma and that the hyalomer contains the factor that initiates <b>clot<\\/b> retraction <b>....<\\/b> is \\nalmost constant and also superior to that of <b>Botropase<\\/b> regarding time. <b>....<\\/b> factor is \\napparently deficient in <b>hemophilia<\\/b>. <b>......<\\/b> Lab., Upjohn <b>Co<\\/b>., Kala-mazoo, Mich.","radio_15b":"Yes"},{"title":"Download Book (13341 KB) - Springer","link":"http:\\/\\/link.springer.com\\/content\\/pdf\\/10.1007%2F978-94-010-1106-8.pdf","desc":"bleeding disorder e.g. : chronic thrombocytopenia, <b>haemophilia<\\/b>,. Rendu-Osler <b>....<\\/b> \\nReport on apreparation of snake venom: <b>Botropase<\\/b>\\u00ae. 89. Comments on\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Enzymes, 6. Enzymes in Therapy - Wiley Online Library","link":"http:\\/\\/onlinelibrary.wiley.com\\/doi\\/10.1002\\/14356007.m09_m05\\/full;jsessionid=7C98FC97E2EDA8C5E3751873BD6E6BC5.d03t03?globalMessage=0","desc":"Oct 15, 2008 <b>...<\\/b> coagulation factor VIII, porcine plasma, Hyate C, <b>hemophilia<\\/b> A <b>...<\\/b> 3.4.21.74, \\nbatroxobin, Bothrops atrox venom, Defibrase, <b>Botropase<\\/b>, Reptilase, Vivostat <b>....<\\/b> in \\norder to liquefy blood <b>clots<\\/b> and dead tissue so that these can be easily removed. \\n<b>....<\\/b> This gives the originator <b>companies<\\/b> a good chance to pay off the\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Enzymes - Ullmann''s Encyclopedia of Industrial Chemistry - Perham <b>...<\\/b>","link":"http:\\/\\/onlinelibrary.wiley.com\\/doi\\/10.1002\\/14356007.a09_341\\/full","desc":"Jun 15, 2000 <b>...<\\/b> The BCA metod of the <b>company<\\/b> Pierce is used for many protein samples. <b>......<\\/b> of \\nBothrops atrox (trade names: Defibrase, <b>Botropase<\\/b>, Reptilase). <b>....<\\/b> Congenital \\ndeficiencies of blood <b>clotting<\\/b> factors, e.g., of Factor VIII (<b>hemophilia<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Enzymes in industry - Docstoc","link":"http:\\/\\/www.docstoc.com\\/docs\\/33814327\\/Enzymes-in-industry","desc":"Edited by Wolfgang Aehle Copyright \\u00df 2007 WILEY-VCH Verlag GmbH & <b>Co<\\/b>. <b>......<\\/b> \\nThe milk <b>clotting<\\/b> to proteinase (also called caseinase) ratio (MC\\/PA) is used as a \\n<b>......<\\/b> BHK cells NovoSeven <b>hemophilia<\\/b> A and B recombinant \\u2013 coagulation factor \\n<b>...<\\/b> Bothrops atrox venom De\\ufb01brase, <b>Botropase<\\/b>, improvement of blood rheology;\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Enzymes in Industry - Scribd","link":"http:\\/\\/www.scribd.com\\/doc\\/150752846\\/Enzymes-in-Industry","desc":"O. Antrim Grain Processing <b>Corporation<\\/b> 1600 Oregon Street Muscatine. <b>......<\\/b> \\n<b>Botropase<\\/b>. ischemic stroke acute myocardial infarction acute myocardial \\ninfarction <b>.....<\\/b> <b>Hemophilia<\\/b> A. which prevents <b>clotting<\\/b>.4. septic shock. which is not \\nan enzyme\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"Enzymes in Industry Production and Applications - Scribd","link":"http:\\/\\/www.scribd.com\\/doc\\/80184404\\/Enzymes-in-Industry-Production-and-Applications","desc":"Feb 2, 2012 <b>...<\\/b> BCA Method [110] The BCA method of the <b>company<\\/b> Pierce is used for many \\nprotein samples. <b>......<\\/b> Cheesemaking Process A basic element in the process of \\ncheesemaking is the <b>clotting<\\/b> of the milk. <b>......<\\/b> C. factor VII de\\ufb01ciency <b>hemophilia<\\/b> A \\nand B <b>hemophilia<\\/b> A <b>hemophilia<\\/b> A \\u2013 \\u2013 thrombin plasmin <b>...<\\/b> <b>Botropase<\\/b>.","radio_15b":"Yes"}]', '[{"title":"FDA approves Wyeth''s hemophilia therapy","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/fda-approves-wyeth-s-hemophilia-therapy\\/2008-02-22","desc":" for <strong>clotting<\\/strong>. ","radio_15":"No"},{"title":"RNAi therapy improves hemophilia in mice; NIH dishes out $12.8M in grants;","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/rnai-therapy-improves-hemophilia-mice-nih-dishes-out-128m-grants\\/2013-07-09","desc":" Blood Disorders > A research team from Alnylam ($ALNY) developed an RNAi therapeutic agent that can improve <strong>clotting<\\/strong> in hemophiliac mice. Release Cancer >\\u00a0BPI France donated \\u20ac1 million for the preclincal development of a liver cancer detection system that tracks a fluorescent substance carried ...","radio_15":"Yes"},{"title":"Pro Bono Bio wraps round of hemophilia trials; Eaton develops first non-hormonal menopause patch;","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/pro-bono-bio-wraps-round-hemophilia-trials-eaton-develops-first-non-hormona\\/2012-09-12","desc":" > Pro Bono Bio has completed its first series of trials of subcutaneous treatments for <strong>hemophilia<\\/strong>, showing that the therapies improve blood <strong>clotting<\\/strong> for extended periods. These would make self-administration of blood-<strong>clotting<\\/strong> factors simpler and reduce the need for intravenous infusions, potentially ...","radio_15":"Yes"},{"title":"NovoSeven","link":"http:\\/\\/www.fiercepharma.com\\/special-reports\\/novoseven\\/top-20-orphan-drugs-2018","desc":" ($NVO) NovoSeven is getting old. The <strong>hemophilia<\\/strong> drug has been on the market for years, and sales ...","radio_15":"No"},{"title":"Biogen streak lives on with upbeat PhIII results for hemophilia A therapy","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/biogen-streak-lives-upbeat-phiii-results-hemophilia-therapy\\/2012-10-31","desc":" The company''s win comes as other developers of new <strong>hemophilia<\\/strong> therapies falter. Just this morning Ipsen ...","radio_15":"No"},{"title":"Novo Nordisk completes PhIII hemophilia trial with positive results","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/novo-nordisk-completes-phiii-hemophilia-trial-positive-results\\/2013-05-17","desc":" is ahead of Novo in development of a long-acting Factor IX product for <strong>hemophilia<\\/strong> B.\\u00a0 Release  ...","radio_15":"No"},{"title":"Maxygen inks $120M deal for hemophilia program","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/maxygen-inks-120m-deal-hemophilia-program\\/2008-07-02","desc":" Maxygen has inked a deal to sell its <strong>hemophilia<\\/strong> drug development program to Bayer for $90 million upfront and up to $30 million in milestone payments. The program is still in the preclinical stage, with the blood <strong>clotting<\\/strong> protein MAXY-VII scheduled for Phase I human trials in a matter of weeks. Bayer also ...","radio_15":"No"},{"title":"Press Release: Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/5527","desc":" Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop <strong>Hemophilia<\\/strong> Therapies ...","radio_15":"Already Assigned"},{"title":"Novo Nordisk scuttles late-stage hemophilia drug over patient risk ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/novo-nordisk-scuttles-late-stage-hemophilia-drug-over-patient-risk\\/2012-09-28","desc":" Danish drugmaker Novo Nordisk ($NVO) has killed development of a <strong>hemophilia<\\/strong> med once hailed ...","radio_15":"Already Assigned"},{"title":"UPDATED: Biogen races to FDA with positive PhIII data for hemophilia B drug","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/biogen-races-fda-positive-phiii-data-hemophilia-b-drug\\/2012-09-26","desc":" of <strong>hemophilia<\\/strong> B, Dr. Glenn Pierce, the medical chief of Biogen''s <strong>hemophilia<\\/strong> unit, told FierceBiotech ...","radio_15":"Already Assigned"}]', 'botropase for clotting and hemophilia', 'hemophilia ', '[{"title":"The <b>Hemophilia Market<\\/b> - Morningstar","link":"http:\\/\\/corporate.morningstar.com\\/us\\/html\\/pdf\\/Healthcare-Observer-Jan-2013.pdf"},{"title":"The World Federation of <b>Hemophilia''s<\\/b> Sixth Global Forum <b>...<\\/b> - Home","link":"http:\\/\\/www1.wfh.org\\/publications\\/files\\/pdf-1274.pdf"},{"title":"The Canadian <b>Hemophilia<\\/b> Society","link":"http:\\/\\/www.hemophilia.ca\\/files\\/HT%20March%202013%20-%20FINAL%20reduced.pdf"},{"title":"<b>Hemophilia<\\/b> Renaissance - LA Kelley Communications, Inc.","link":"http:\\/\\/www.kelleycom.com\\/pen\\/may2012_PEN.pdf"}]', '2', '2', '', 100);
INSERT INTO `inventions` VALUES(134, '2013-11-07 08:37:29', 17, 'research tool device', 'patent', '', '', 'gansh1', 'gansh11', 'gansh11_3', '', '', 'mf device for burn injuries therapeutic screening', 'c', '', 'microfluidic device for burn injuries drug screening', '', '', '', 'a', '', 'Gee kaun', '', '', '', '', '', 'field', '64', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-11-28 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'microfluidic device for cell motility assessment', '', '{"1":{"radio_11a2":"Yes","title":"testing questionnaire 10-9","id":"44","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"Yes","title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"Yes","title":"method for detecting cancer","id":"87","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"Yes","title":"cell line for better expression","id":"88","status":"Disclosure Done & Under Review"}}', 71, '', '100k-1m', 'Yes', 'No', 5, '', 'Yes', 20.5, '[{"title":"Microfluidic device having stable static gradient for analyzing chemotaxis","link":"http:\\/\\/www.google.com\\/patents\\/WO2009062095A1?cl=en&dq=microfluidic+device+for+cell+motility+asse&source=uds;","filedate":"Fri, 07 Nov 2008 00:00:00 -0800","applicant":"Bellbrook Labs Llc, Steven Hayes, John Majer, Ivar Meyvantsson","desc":"A <b>microfluidic<\\/b> gradient <b>device<\\/b> comprising: a source <b>assembly<\\/b> adapted <b>......<\\/b> The  <b>cell movement<\\/b> in response to that gradient is recorded via video\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"Method for sperm motility evaluation and screening and its microfluidic device","link":"http:\\/\\/www.google.com\\/patents\\/WO2012163087A1?cl=en&dq=microfluidic+device+for+cell+motility+asse&source=uds;","filedate":"Fri, 01 Jun 2012 00:00:00 -0700","applicant":"Capitalbio Corporation, Tsinghua University","desc":"The <b>microfluidic device<\\/b> comprises a fluid inlet, a sample inlet and a <b>...<\\/b> The  present invention provides a <b>microfluidic device<\\/b> and its use for <b>cell motility<\\/b> <b>....<\\/b> [ 0002] The <b>assessment<\\/b> of sperm motility is an indispensable means in\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Microfluidic cell motility assay","link":"http:\\/\\/www.google.com\\/patents\\/WO2010108095A2?cl=en&dq=microfluidic+device+for+cell+motility+asse&source=uds;","filedate":"Fri, 19 Mar 2010 00:00:00 -0700","applicant":"The General Hospital Corporation","desc":"Certain isolated <b>motile cells<\\/b> spontaneously migrate unidirectionally through a  mechanically <b>...<\\/b> 14A-F show results of an <b>assessment<\\/b> of <b>...<\\/b> In the first <b>microfluidic<\\/b>  <b>device<\\/b> 100, the microcapillary 130 extends along a length to a\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Microfabricated cellular traps based on three-dimensional micro-scale flow ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2006025858A2?cl=en&dq=microfluidic+device+for+cell+motility+asse&source=uds;","filedate":"Wed, 16 Feb 2005 00:00:00 -0800","applicant":"Hur Koser, Univ Yale","desc":"A <b>microfluidic device<\\/b> for measuring natural <b>motile<\\/b> response of a living <b>....<\\/b> to claim  16, where the <b>microfluidic device<\\/b> is used to study stem <b>cell<\\/b> populations. <b>.....<\\/b> 2010,  Celix Limited, A biochip <b>assembly<\\/b> and assay method thereof\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Device for high throughput investigations of cellular interactions","link":"http:\\/\\/www.google.com\\/patents\\/EP2622342A1?cl=en&dq=microfluidic+device+for+cell+motility+asse&source=uds;","filedate":"Thu, 29 Sep 2011 00:00:00 -0700","applicant":"Massachusetts Institute of Technology","desc":"Provided herein are <b>microfluidic devices<\\/b> that can be used as a 3D bioassay, <b>...<\\/b>  <b>Cells<\\/b>, such as endothelial <b>cells<\\/b>, can be cultured and observed as they grow <b>...<\\/b> b)  determining whether <b>motility<\\/b> of the cancerous tissue is inhibited in the <b>...<\\/b> Adding  drugs to these devices allow a qualitative <b>assessment<\\/b> of the effect\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Microfluidic manipulation and sorting of particles using tunable standing ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013116311A1?cl=en&dq=microfluidic+device+for+cell+motility+asse&source=uds;","filedate":"Wed, 30 Jan 2013 00:00:00 -0800","applicant":"The Penn State Research Foundation","desc":"[0008] An example <b>device<\\/b> structure includes a channel adjacent a <b>...<\\/b> (such as a  blood cell), microorganism, particle <b>assembly<\\/b>, or other object having an <b>.....<\\/b> used  for active control of <b>cell movement<\\/b> or flow in <b>microfluidic<\\/b> sorters.","radio_11b":"Yes"},{"title":"Assembly for cell-based assays","link":"http:\\/\\/www.google.com\\/patents\\/WO2003060056A2?cl=en&dq=microfluidic+device+for+cell+motility+asse&source=uds;","filedate":"Fri, 26 Jul 2002 00:00:00 -0700","applicant":"Dmitri Kashanin, Dermot Kelleher, Igor Shvets, Trinity College Dublin, Vivienne Williams","desc":"A cell based assay <b>assembly<\\/b> (1) comprising a biochip <b>assembly<\\/b> (2), a liquid <b>...<\\/b>  and recording <b>equipment<\\/b> (4) is used for conducting an assay on a biological cell  as <b>...<\\/b> Below we describe a number of assays related to <b>cell motility<\\/b>, <b>.....<\\/b> based on  <b>microfluidic<\\/b> chip format capable of performing cell- based assays\\u00a0<b>...<\\/b>","radio_11b":"Yes"}]', '', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"Assessing Neural Stem <b>Cell Motility<\\/b> Using an Agarose Gel-based <b>...<\\/b>","link":"http:\\/\\/www.jove.com\\/video\\/674\\/","desc":"Feb 11, 2008 <b>...<\\/b> Prior to the assembling of the <b>microfluidic device<\\/b>, sterilize glass <b>...<\\/b> <b>Test<\\/b> the device \\nfor leaks and blockages in the microchannels using a 1ml syringe. <b>...<\\/b> and \\nresuspend the pellet of <b>cell<\\/b> in 500 \\u03bcl of <b>CO<\\/b>2-independent media.","radio_15b":"Yes"},{"title":"<b>Cell Migration<\\/b> and Invasion <b>Assays<\\/b> as Tools for Drug <b>...<\\/b> - MDPI.com","link":"http:\\/\\/www.mdpi.com\\/1999-4923\\/3\\/1\\/107\\/pdf","desc":"Mar 11, 2011 <b>...<\\/b> Abstract: <b>Cell migration<\\/b> and invasion are processes that offer rich targets <b>...<\\/b> \\nscratch <b>assays<\\/b>, transmembrane <b>assays<\\/b>, <b>microfluidic devices<\\/b> and cell <b>....<\\/b> \\ncommercialized by several <b>manufacturers<\\/b> such as BD Biosciences, Costar\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Cell Migration<\\/b>: probing <b>cell movement<\\/b> with smarter tools","link":"http:\\/\\/www.ddw-online.com\\/enabling-technologies\\/p205976-cell-migration:probing-cell-movement-with-smarter-tools-winter-12.html","desc":"Most commercial activity around <b>cell migration assays<\\/b> has been directed towards \\n<b>...<\\/b> of cell culture inserts, stoppers, specialised microplates, <b>microfluidic devices<\\/b>, \\n<b>....<\\/b> among <b>cell migration assay manufacturers<\\/b> by providing kits in both formats.","radio_15b":"No"},{"title":"<b>Cell<\\/b>-laden Hydrogels in Integrated <b>Microfluidic Devices<\\/b> for Long <b>...<\\/b>","link":"http:\\/\\/onlinelibrary.wiley.com\\/doi\\/10.1002\\/smll.201203030\\/pdf","desc":"Jan 5, 2013 <b>...<\\/b> 2013 Wiley-VCH Verlag GmbH & <b>Co<\\/b>. KGaA, Weinheim <b>...<\\/b> in Integrated \\n<b>Microfluidic Devices<\\/b> for Long-Term Cell Culture and Tubulogenesis <b>Assays<\\/b> <b>...<\\/b> \\nanalysis of <b>cell motility<\\/b> or rolling under a variety of chem- ically-controlled\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Keren Hulkower | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/pub\\/keren-hulkower\\/10\\/197\\/378","desc":"Helped grow sales of Oris\\u2122 <b>Cell Motility Assay<\\/b> products from start-up to <b>...<\\/b> <b>Co<\\/b>-\\nauthor\\/PI on NIH funded IMAT and SBIR grant proposals which raised $1.5MM <b>....<\\/b> \\n<b>cell motility<\\/b>: scratch <b>assays<\\/b>, transmembrane <b>assays<\\/b>, <b>microfluidic devices<\\/b> and cell\\n\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Rowena Mittal | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/in\\/rowenamittal","desc":"Integrated Plasmonics is a venture-backed nanotechnology <b>company<\\/b> developing \\na <b>...<\\/b> Fluidic Circuit Dynamic Array and BioMark HD system using DELTAgene \\n<b>assays<\\/b> <b>...<\\/b> Designed, functionalized, and fabricated <b>microfluidic devices<\\/b> for HeLa \\n<b>cell motility<\\/b> <b>...<\\/b> studies in devices for 3D reconstruction of cell mechanics and \\nmotility\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Cell Migration Assays<\\/b>: Gaining Traction to Move Forward <b>...<\\/b>","link":"http:\\/\\/www.biocompare.com\\/Editorial-Articles\\/41818-Cell-Migration-Assays-Gaining-Traction-to-Move-Forward\\/","desc":"May 16, 2011 <b>...<\\/b> An editorial article discussing <b>Cell Migration Assays<\\/b>: Gaining Traction to <b>...<\\/b> More \\nrecently, <b>companies<\\/b> such as Essen BioScience have offered an <b>...<\\/b> <b>Cell migration<\\/b> \\n<b>assays<\\/b> based on <b>microfluidic devices<\\/b> are gaining popularity.","radio_15b":"Yes"},{"title":"A Sensitive Chemotaxis <b>Assay<\\/b> Using a Novel <b>Microfluidic Device<\\/b>","link":"http:\\/\\/www.hindawi.com\\/journals\\/bmri\\/2013\\/373569\\/","desc":"Jul 18, 2013 <b>...<\\/b> A Sensitive Chemotaxis <b>Assay<\\/b> Using a Novel <b>Microfluidic Device<\\/b> <b>...<\\/b> We describe \\nhere a novel <b>microfluidic device<\\/b> for sensitive <b>assay<\\/b> of <b>cellular migration<\\/b> <b>....<\\/b> the \\n<b>manufacturer''s<\\/b> recommendation, and transmigrated cells on the\\u00a0<b>...<\\/b>","radio_15b":"Yes"}]', '', 'cell motility assay with microfluidic device', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(135, '2013-11-07 09:15:55', 17, 'Therapeutic Device - Catheter for drug delivery', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_2', '', '', 'Catheter for drug delivery', 'b', '', 'Catheter for drug delivery', '', '', '', 'a', '', 'Gee Kaun', '', '', '', '', '', 'field', '95', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'drug delivery catheter', '{"1":{"radio_11a1":"No","title":"research tool device","id":"134","status":"field"}}', '{"2":{"radio_11a2":"No","title":"CDx without drug on market","id":"58","status":"field"},"3":{"radio_11a2":"No","title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"4":{"radio_11a2":"No","title":"pancreatic cancer drug","id":"92","status":"field"},"5":{"radio_11a2":"No","title":"Hemophilia drug","id":"133","status":"field"},"6":{"radio_11a2":"No","title":"research tool device","id":"134","status":"field"}}', 18, '', '>1m', 'Yes', 'No', 3, '', 'Yes', 34.5, '{"0":{"title":"Ultrasonic catheter drug delivery method and device","link":"http:\\/\\/www.google.com\\/patents\\/CA2448808C?cl=en&dq=drug+delivery+catheter&source=uds;","desc":"An ultrasonic <b>catheter drug delivery<\\/b> device comprises an ultrasound transducer  to produce ultrasonic waves, which transducer is mechanically\\u00a0<b>...<\\/b>","filedate":"Thu, 21 Mar 2002 00:00:00 -0800","applicant":"Advanced Medical Applications, Inc., Eilaz Babaev, Celleration, Inc.","radio_11b":"Yes"},"1":{"title":"Drug delivery catheter with soluble balloon coating containing releasable ...","link":"http:\\/\\/www.google.com\\/patents\\/US8460238?dq=drug+delivery+catheter&source=uds;","desc":"A <b>drug delivery catheter<\\/b> and method for delivering microcapsules or  microspheres containing a drug, pharmacological or other bioactive agent\\u00a0<b>...<\\/b>","filedate":"Mon, 22 Mar 2010 00:00:00 -0700","applicant":"Medtronic Vascular, Inc.","radio_11b":"No"},"2":{"title":"Composite drug delivery catheter","link":"http:\\/\\/www.google.com\\/patents\\/CA2371798C?cl=en&dq=drug+delivery+catheter&source=uds;","desc":"The present invention features a composite <b>catheter<\\/b> comprising an elongate  outer member and an elongate inner member positioned within\\u00a0<b>...<\\/b>","filedate":"Wed, 03 May 2000 00:00:00 -0700","applicant":"Durect Corporation, Edward M. Gillis, Felix Theeuwes","radio_11b":"No"},"3":{"title":"Multi-balloon catheter for extravasated drug delivery","link":"http:\\/\\/www.google.com\\/patents\\/US8540667?dq=drug+delivery+catheter&source=uds;","desc":"A method of extravasated <b>delivery<\\/b> of a therapeutic and\\/or diagnostic agent to  tissue is provided including inserting a <b>catheter<\\/b> with a first balloon\\u00a0<b>...<\\/b>","filedate":"Tue, 08 Mar 2011 00:00:00 -0800","applicant":"Sanovas, Inc.","radio_11b":"duplicate"},"4":{"title":"Nested balloon catheter for localized drug delivery","link":"http:\\/\\/www.google.com\\/patents\\/US8348890?dq=drug+delivery+catheter&source=uds;","desc":"A balloon <b>catheter<\\/b> for <b>delivering<\\/b> a therapeutic and\\/or diagnostic agent to tissue is  described including an outer balloon having a wall with an\\u00a0<b>...<\\/b>","filedate":"Tue, 01 Mar 2011 00:00:00 -0800","applicant":"Sanovas, Inc.","radio_11b":"Yes"},"5":{"title":"Abrading balloon catheter for extravasated drug delivery","link":"http:\\/\\/www.google.com\\/patents\\/WO2012118919A1?cl=en&dq=drug+delivery+catheter&source=uds;","desc":"A method of extravasated <b>drug delivery<\\/b> is disclosed, including inserting a  <b>catheter<\\/b> with a first balloon, a second balloon, and a third balloon\\u00a0<b>...<\\/b>","filedate":"Thu, 01 Mar 2012 00:00:00 -0800","applicant":"Sanovas Inc.","radio_11b":"Yes"},"7":{"title":"A dilation-drug delivery catheter","link":"http:\\/\\/www.google.com\\/patents\\/CA2186493C?cl=en&dq=drug+delivery+catheter&source=uds;","desc":"A dilation-<b>drug delivery catheter<\\/b> (10) comprises a dilation portion (20) for dilating  a stenosis and a drug delivery portion (50) for delivering\\u00a0<b>...<\\/b>","filedate":"Mon, 23 Jan 1995 00:00:00 -0800","applicant":"Michael R. Forman, Schneider (Usa) Inc.","radio_11b":"Yes"}}', '[{"title":"&lt;b&gt;Drug&lt;\\/b&gt;-coated balloon therapy in coronary and peripheral artery disease.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24189405","desc":"Byrne RA, Joner M, Alfonso F, Kastrati A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Nature reviews. Cardiology&quot;&gt;Nat Rev Cardiol&lt;\\/span&gt;. 2013 Nov 5. doi: 10.1038\\/nrcardio.2013.165. [Epub ahead of print]","radio_11b2":"No"},{"title":"Analysis of adverse events with essure hysteroscopic sterilization reported to the manufacturer and user facility device experience database.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24183273","desc":"Al-Safi ZA, Shavell VI, Hobson DT, Berman JM, Diamond MP.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of minimally invasive gynecology&quot;&gt;J Minim Invasive Gynecol&lt;\\/span&gt;. 2013 Nov-Dec;20(6):825-9. doi: 10.1016\\/j.jmig.2013.05.006.","radio_11b2":"Yes"},{"title":"Optical coherence tomography evaluation of late strut coverage patterns between first-generation &lt;b&gt;drug&lt;\\/b&gt;-eluting stents and everolimus-eluting stent.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24174291","desc":"Toledano Delgado FJ, Alvarez-Ossorio MP, de Lezo Cruz-Conde JS, Bellido FM, Romero Moreno MA, Fern&Atilde;&iexcl;ndez-Aceytuno AM, de Lezo Herrerosde Tejada JS, Pineda SO, Saint-Gerons JM, Pavlovic D.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions&quot;&gt;&lt;b&gt;Catheter&lt;\\/b&gt; Cardiovasc Interv&lt;\\/span&gt;. 2013 Oct 6. doi: 10.1002\\/ccd.25235. [Epub ahead of print]","radio_11b2":"No"},{"title":"Role of &lt;b&gt;Catheter&lt;\\/b&gt;''s Position for Final Results in Intrathecal &lt;b&gt;Drug Delivery&lt;\\/b&gt;. Analysis Based on CSF Dynamics and Specific Drugs Profiles.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24155999","desc":"Jose DA, Luciano P, Vicente V, Juan Marcos AS, Gustavo FC.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;The Korean journal of pain&quot;&gt;Korean J Pain&lt;\\/span&gt;. 2013 Oct;26(4):336-346. Epub 2013 Oct 2. Review.","radio_11b2":"Yes"},{"title":"A Detailed Assessment of the Human Coronary Venous System using Contrast-Computed Tomography of Perfusion-fixed Specimens.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24144884","desc":"Spencer JH, Larson AA, Drake R, Iaizzo PA.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Heart rhythm : the official journal of the Heart Rhythm Society&quot;&gt;Heart Rhythm&lt;\\/span&gt;. 2013 Oct 18. doi:pii: S1547-5271(13)01212-5.  10.1016\\/j.hrthm.2013.10.038. [Epub ahead of print]","radio_11b2":"Yes"}]', 'test test test test test', 'much better', 'much safer', '[{"title":"Sanovas Awarded Patent for Extravasated <b>Drug Delivery<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.prnewswire.com\\/news-releases\\/sanovas-awarded-patent-for-extravasated-drug-delivery-229670241.html","desc":"Oct 29, 2013 <b>...<\\/b> The patent is foundational to the <b>company''s<\\/b> NanoVas\\u2122 portfolio of Interventional \\n<b>Drug Delivery Catheters<\\/b>. Sanovas'' ''Smart <b>Catheter<\\/b>''\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"What is a Drug Pump? <b>Drug Delivery<\\/b> Therapy from Medtronic for <b>...<\\/b>","link":"http:\\/\\/www.medtronic.com\\/patients\\/chronic-pain\\/device\\/drug-pumps\\/","desc":"Sep 24, 2013 <b>...<\\/b> The pump sends the medication through the <b>catheter<\\/b> to the spinal area <b>...<\\/b> of \\n<b>companies<\\/b> that offer <b>drug delivery<\\/b> therapy for severe chronic pain.","radio_15b":"Yes"},{"title":"EViTAR Neurological Devices - NexGen Medical Systems, <b>Inc<\\/b>.","link":"http:\\/\\/nexgenmedsystem.com\\/our-products\\/evitar-neurological-products\\/","desc":"NexGen''s acute cell and <b>drug delivery catheter<\\/b>, EViTARTM is a proprietary <b>...<\\/b> The \\n<b>Company<\\/b> expects to commercialize the EViTARTM infusion <b>catheters<\\/b> in\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Cancer-<b>drug catheter<\\/b> maker Surefire Medical raises $16.4 million <b>...<\\/b>","link":"http:\\/\\/www.bizjournals.com\\/denver\\/blog\\/boosters_bits\\/2013\\/09\\/surefire-medical-growing-cancer-drug.html","desc":"Sep 23, 2013 <b>...<\\/b> Surefire Medical <b>Inc<\\/b>., a startup making cancer-<b>drug delivery catheters<\\/b>, raised \\n$16.4 million from 30 investors, funding the <b>company''s<\\/b> expansion.","radio_15b":"No"},{"title":"Sanovas, <b>Inc<\\/b>. Receives Patent Allowance for Nested Balloon <b>...<\\/b>","link":"http:\\/\\/www.bizjournals.com\\/prnewswire\\/press_releases\\/2012\\/11\\/19\\/SF15682","desc":"Nov 19, 2012 <b>...<\\/b> Sanovas, <b>Inc<\\/b>. Receives Patent Allowance for Nested Balloon <b>Catheter<\\/b> for \\nLocalized <b>Drug Delivery<\\/b>. Patent protects minimally invasive system\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Sanovas, <b>Inc<\\/b>. Receives Patent Allowance for Nested <b>...<\\/b> - redOrbit","link":"http:\\/\\/www.redorbit.com\\/news\\/health\\/1112733997\\/sanovas-inc-receives-patent-allowance-for-nested-balloon-catheter-for\\/","desc":"Sanovas, <b>Inc<\\/b>. Receives Patent Allowance for Nested Balloon <b>Catheter<\\/b> for \\nLocalized <b>Drug Delivery<\\/b>. November 19, 2012. SAUSALITO, Calif., Nov. 19, 2012\\n\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Mercator MedSystems Announces European Market Clearance for <b>...<\\/b>","link":"http:\\/\\/www.mercatormed.com\\/pressreleases\\/022713-CEMark.html","desc":"Feb 27, 2013<b>...<\\/b> for its Groundbreaking Adventitial <b>Drug Delivery Catheters<\\/b> <b>...<\\/b> <b>Inc<\\/b>., a privately-\\nheld medical technology <b>company<\\/b>, today announced it has\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Pain Pump - <b>Drug Delivery<\\/b> Therapy | Chronic Pain Relief | Medtronic","link":"http:\\/\\/www.tamethepain.com\\/about-medtronic-pain-therapies\\/pain-pump-drug-delivery-system\\/","desc":"Oct 1, 2013 <b>...<\\/b> Learn how the Medtronic <b>drug delivery<\\/b> therapy system, using a pain pump, <b>...<\\/b> The \\ndrug pump is connected to a thin, flexible tube called a <b>catheter<\\/b>. <b>...<\\/b> your choice of \\n<b>companies<\\/b> that offer <b>drug delivery<\\/b> therapy for chronic pain.","radio_15b":"Yes"}]', '[{"title":"Nano-delivery vehicle houses drugs in separate compartments; RenovoRx catheter delivers drugs straight to the pancreas;","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/nano-delivery-vehicle-houses-drugs-separate-compartments-renovorx-catheter\\/2013-04-24","desc":" to coat the bladder. More > While gold nanoparticles have been used recently as <strong>drug-delivery<\\/strong> ...","radio_15":"Yes"},{"title":"Mercator micro-infusion drug delivery catheter snags CE mark","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/mercator-micro-infusion-drug-delivery-catheter-snags-ce-mark\\/2013-03-05","desc":" raises $10M to develop Moxy <strong>drug<\\/strong>-coated <strong>catheter<\\/strong>  ...","radio_15":"No"},{"title":"Mercator snags FDA patent for blood-pressure drug delivery catheters","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/mercator-snags-fda-patent-blood-pressure-drug-delivery-catheters\\/2013-07-30","desc":" Bullfrog <strong>catheter<\\/strong>, which received a CE mark in Europe in March. Mercator recently completed a clinical ...","radio_15":"Already Assigned"},{"title":"Patent office nixes MonoSol claim against BDSI over soluble film pain drug; Vascular Magnetics nails $7M series A for PAD drug delivery system;","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/patent-office-nixes-monosol-claim-against-bdsi-over-soluble-film-pain-drug\\/2012-02-16","desc":" Bio<strong>Delivery<\\/strong> Sciences ($BDSI) earned a $15 million milestone payment from <strong>drug<\\/strong> development partner Endo ...","radio_15":"Yes"},{"title":"Delcath''s cancer drug delivery system hits FDA holdup ","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/delcaths-cancer-drug-delivery-system-hits-fda-holdup\\/2011-02-23","desc":" involves a <strong>catheter<\\/strong> that is inserted into the femoral artery and advanced to the liver, where ...","radio_15":"Yes"},{"title":"ClearPoint MRI-guided device sheds light on drug delivery to the brain","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/clearpoint-mri-guided-device-sheds-light-drug-delivery-brain\\/2013-05-01","desc":" placement of instruments and devices guided by an MRI. For the <strong>delivery<\\/strong> of <strong>drugs<\\/strong>, ClearPoint can be used ...","radio_15":"Yes"},{"title":"Covidien launches new catheter in U.S. and EU; Meridian gets FDA OK for strep throat Dx;","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/covidien-launches-new-catheter-us-and-eu-meridian-gets-fda-ok-strep-throat\\/2012-09-18","desc":" <strong>delivery<\\/strong> tech to frustrated pharmas.\\u00a0 Story > Software mogul commits $104M to CureVac''s cancer vax ...","radio_15":"No"},{"title":"Google dives into life sciences; Biotronik launches ablation catheter;","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/google-dives-life-sciences-biotronik-launches-ablation-catheter\\/2013-09-19","desc":" has launched its AlCath Flutter Gold ablation <strong>catheter<\\/strong> in Europe, looking to capitalize on the market ...","radio_15":"No"},{"title":"Mercator wins CE mark for micro-infusion catheters; MIT reveals solar-powered med equipment sterilization tool;","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/mercator-wins-ce-mark-micro-infusion-catheters-mit-reveals-solar-powered-me\\/2013-03-04","desc":" diagnostic assays that rapidly evaluate human pluripotent stem cells for use in <strong>drug<\\/strong> discovery and research. ...","radio_15":"Already Assigned"},{"title":"Medtronic, Lilly combine forces on Parkinson''s drug delivery","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/medtronic-lilly-combine-forces-parkinsons-drug-delivery\\/2011-04-27","desc":" have tried and failed to deliver the <strong>drug<\\/strong>. Ros Smith, senior director of regenerative biology at Lilly, ...","radio_15":"Yes"}]', 'drug delivery catheter', 'drug delivery catheter', '[{"title":"Nanocomposites for <b>Drug Delivery Catheters<\\/b> - Foster Corporation","link":"http:\\/\\/www.fostercomp.com\\/sites\\/default\\/files\\/pdf\\/Drug%20Development%20%26%20Delivery%20Sept%202013_Nanocomposites%20for%20Drug%20Delivery%20Catheters.pdf"},{"title":"392 kB - Smiths Group plc","link":"http:\\/\\/www.smiths.com\\/ar12\\/siteFiles\\/resources\\/pdf\\/report\\/26-31.pdf"},{"title":"Catheterisation - indwelling <b>catheters<\\/b> in adults - European <b>...<\\/b>","link":"http:\\/\\/www.uroweb.org\\/fileadmin\\/EAUN\\/guidelines\\/EAUN_Paris_Guideline_2012_LR_online_file.pdf"},{"title":"Annual Report","link":"http:\\/\\/www.bostonscientific.jp\\/templatedata\\/imports\\/collateral\\/AboutBSC\\/oth_2010_annual_jp.pdf"}]', '', '', '', 100);
INSERT INTO `inventions` VALUES(136, '2013-11-07 10:19:41', 17, 'Mouse model for research use', 'bio_organism', '', '', 'gansh1', 'gansh11', 'gansh11_2', '', '', 'mouse model for pancreatic cancer', 'd', '', 'mouse model for pancreatic cancer', '', '', '', 'a', '', 'Gee Kaun', '', '', '', '', '', 'field', '57.5', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'pancreatic cancer mouse model', '', '{"2":{"title":"CDx without drug on market","id":"58","status":"field"},"3":{"title":"Cancer Target screening tools","id":"61","status":"field"},"4":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"5":{"title":"method for detecting cancer","id":"87","status":"field"},"6":{"title":"pancreatic cancer drug","id":"92","status":"field"},"7":{"title":"pancreatic diseases","id":"94","status":"field"},"8":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"9":{"title":"pancreatic cancer","id":"108","status":"field"},"10":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"11":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"}}', 57, '', '<100k', 'Yes', 'No', 6, '', 'Maybe', 6.5, '{"0":{"title":"New tumor mouse models using lentiviral vectors","link":"http:\\/\\/www.google.com\\/patents\\/WO2008109127A2?cl=en&dq=pancreatic+cancer+mouse+model&source=uds;","desc":"[0025] <b>Mouse models<\\/b> of <b>pancreatic cancers<\\/b> have faithfully mimicked the human  disease genetically and morphologically, a testament to the\\u00a0<b>...<\\/b>","filedate":"Wed, 05 Mar 2008 00:00:00 -0800","applicant":"Tomotoshi Marumoto, Salk Inst For Biological Studi, Yasushi Soda, Inder Verma, Yifeng Xia","radio_11b":"May Be"},"1":{"title":"Cxcl4l1 as a biomarker of pancreatic cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2010060920A1?cl=en&dq=pancreatic+cancer+mouse+model&source=uds;","desc":"Expression analysis in <b>mouse models<\\/b> of <b>pancreatic carcinoma<\\/b>: To ascertain that  the up-regulation of CXCL4L1 was not specific to the chicken\\u00a0<b>...<\\/b>","filedate":"Wed, 25 Nov 2009 00:00:00 -0800","applicant":"INSERM (Institut National de la Sant\\u00e9 et de la Recherche M\\u00e9dicale)","radio_11b":"Yes"},"2":{"title":"Compounds inhibiting cd95 signaling for the treatment of pancreatic cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2011058175A1?cl=en&dq=pancreatic+cancer+mouse+model&source=uds;","desc":"Furthermore, the method of the current invention can be performed in vivo, e.g. in  a non-human <b>animal model<\\/b> of <b>pancreatic cancer<\\/b> (example 7)\\u00a0<b>...<\\/b>","filedate":"Mon, 15 Nov 2010 00:00:00 -0800","applicant":"Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universit\\u00e4t Heidelberg","radio_11b":"Yes"},"3":{"title":"Methods for treating pancreatic cancer using combination therapies ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013138371A1?cl=en&dq=pancreatic+cancer+mouse+model&source=uds;","desc":"Provided are methods for treating <b>pancreatic cancer<\\/b> in a patient by <b>...<\\/b> <b>pancreatic<\\/b>  <b>tumor<\\/b> growth is measured in a <b>mouse<\\/b> xenograft <b>model<\\/b> using\\u00a0<b>...<\\/b>","filedate":"Tue, 12 Mar 2013 00:00:00 -0700","applicant":"Merrimack Pharmaceuticals, Inc.","radio_11b":"Yes"},"4":{"title":"Pancreatic cancer treatment","link":"http:\\/\\/www.google.com\\/patents\\/WO2005000204A2?cl=en&dq=pancreatic+cancer+mouse+model&source=uds;","desc":"Example 2 Effect on Survival Efficacy of CS-682 Adjuvant Therapy in a <b>Mouse<\\/b>  <b>Model<\\/b> of Metastatic <b>Pancreatic Cancer<\\/b> [0053] The efficacy of oral\\u00a0<b>...<\\/b>","filedate":"Fri, 21 May 2004 00:00:00 -0700","applicant":"Anticancer Inc, Jin Wei Wang, Xiaoen Wang","radio_11b":"Yes"},"6":{"title":"Pik3ca h1047r knock-in non-human animal breast cancer model","link":"http:\\/\\/www.google.com\\/patents\\/WO2013015833A2?cl=en&dq=pancreatic+cancer+mouse+model&source=uds;","desc":"M. Genetically engineered <b>mouse models<\\/b> in cancer research. <b>.....<\\/b> <b>pancreatic<\\/b>  <b>cancer<\\/b>, glioblastoma, cervical cancer, ovarian cancer, liver cancer,\\u00a0<b>...<\\/b>","filedate":"Thu, 26 Jul 2012 00:00:00 -0700","applicant":"Genentech, Inc, F. Hoffmann-La Roche Ag","radio_11b":"No"},"7":{"title":"Compounds inhibiting CD95 signaling for the treatment of pancreatic cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2322927A1?cl=en&dq=pancreatic+cancer+mouse+model&source=uds;","desc":"Furthermore, the method of the current invention can be performed in vivo, e.g. in  a non-human <b>animal model<\\/b> of <b>pancreatic cancer<\\/b> (example 7)\\u00a0<b>...<\\/b>","filedate":"Mon, 16 Nov 2009 00:00:00 -0800","applicant":"Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universit\\u00e4t Heidelberg","radio_11b":"Yes"}}', '[{"title":"Development and histopathological characterization of tumorgraft models of &lt;b&gt;pancreatic&lt;\\/b&gt; ductal adenocarcinoma.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24194913","desc":"Garcia PL, Council LN, Christein JD, Arnoletti JP, Heslin MJ, Gamblin TL, Richardson JH, Bjornsti MA, Yoon KJ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Oct 23;8(10):e78183. doi: 10.1371\\/journal.pone.0078183.","radio_11b2":"Yes"},{"title":"Oral glutamine supplement inhibits ascites formation in peritoneal carcinomatosis &lt;b&gt;mouse&lt;\\/b&gt; &lt;b&gt;model&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24194753","desc":"Chen MJ, Wang TE, Tsai SJ, Lin CC, Liu CY, Wang HY, Shih SC, Chen YJ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Gastroenterology research and practice&quot;&gt;Gastroenterol Res Pract&lt;\\/span&gt;. 2013;2013:814054. doi: 10.1155\\/2013\\/814054. Epub 2013 Sep 30.","radio_11b2":"Yes"},{"title":"Efficient targeting and tumor retardation effect of &lt;b&gt;pancreatic&lt;\\/b&gt; adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in &lt;b&gt;pancreatic cancer&lt;\\/b&gt; &lt;b&gt;mouse&lt;\\/b&gt; &lt;b&gt;model&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24189457","desc":"Kim YH, Moon JY, Kim EO, Lee SJ, Kang SH, Kim SK, Heo K, Lee Y, Kim H, Kim K, Kim D, Song MS, Lee SW, Lee Y, Koh SS, Kim IH.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancer letters&quot;&gt;&lt;b&gt;Cancer&lt;\\/b&gt; Lett&lt;\\/span&gt;. 2013 Nov 1. doi:pii: S0304-3835(13)00783-0.  10.1016\\/j.canlet.2013.10.028. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"Twinkling artifact of Doppler imaging for cavitation detection during high-intensity focused ultrasound therapy: Sensitivity and resolution.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24180892","desc":"Li T, Khokhlova TD, Sapozhnikov OA, Sapozhnikov OA, Hwang JH.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;The Journal of the Acoustical Society of America&quot;&gt;J Acoust Soc Am&lt;\\/span&gt;. 2013 Nov;134(5):3976. doi: 10.1121\\/1.4830486.","radio_11b2":"Yes"},{"title":"Pathogenesis of &lt;b&gt;Pancreatic Cancer&lt;\\/b&gt;: Lessons from Animal Models.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24178582","desc":"Murtaugh LC.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Toxicologic pathology&quot;&gt;Toxicol Pathol&lt;\\/span&gt;. 2013 Oct 31. [Epub ahead of print]","radio_11b2":"No"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>Pancreatic cancer<\\/b>: Fibroblast <b>co<\\/b>-conspirators : Article : Nature <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/nrc\\/journal\\/v11\\/n11\\/full\\/nrc3157.html","desc":"Sep 19, 2011 <b>...<\\/b> <b>Pancreatic cancerFibroblast co<\\/b>-conspirators <b>...<\\/b> Using a <b>mouse model<\\/b> of \\npancreatic ductal adenocarcinoma (PDAC), Hideaki Ijichi and\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Mouse models of pancreatic cancer<\\/b>","link":"http:\\/\\/www.wjgnet.com\\/1007-9327\\/full\\/v18\\/i12\\/1286.htm","desc":"Mar 28, 2012 <b>...<\\/b> Here, we will focus only on <b>pancreatic cancer mouse models<\\/b> as PanIN <b>...<\\/b> of \\ngenes and pathways, environmental conditions, <b>co<\\/b>-morbidities and\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"Bitter melon juice prevents <b>pancreatic cancer<\\/b> in <b>mouse models<\\/b>","link":"http:\\/\\/medicalxpress.com\\/news\\/2013-03-bitter-melon-juice-pancreatic-cancer.html","desc":"Mar 12, 2013 <b>...<\\/b> Bitter melon juice prevents <b>pancreatic cancer<\\/b> in <b>mouse models<\\/b> <b>...<\\/b> PhD, <b>co<\\/b>-\\nprogram leader of Cancer Prevention and Control at the CU Cancer\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Pancreatic tumor<\\/b> mass in a xenograft <b>mouse model<\\/b> is decreased by <b>...<\\/b>","link":"http:\\/\\/www.spandidos-publications.com\\/10.3892\\/or.2013.2564","desc":"Jun 25, 2013 <b>...<\\/b> <b>Pancreatic tumor<\\/b> mass in a xenograft <b>mouse model<\\/b> is decreased by <b>...<\\/b> In the <b>co<\\/b>-\\nculture and MTT assay, antitumor activity of the therapeutic\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Preclinical study finds drug helps against <b>pancreatic cancer<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.hispanicbusiness.com\\/2013\\/11\\/6\\/preclinical_study_finds_drug_helps_against.htm","desc":"17 hours ago <b>...<\\/b> By a News Reporter-Staff News Editor at <b>Cancer<\\/b> Gene Therapy Week <b>...<\\/b> In \\nexperiments involving a <b>mouse model<\\/b> of <b>pancreatic<\\/b> neuroendocrine <b>tumors<\\/b>, <b>...<\\/b> \\nThe drug is made by OXiGENE, <b>Inc<\\/b>. , a biotech <b>company<\\/b> based in San\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Developing improved <b>mouse models of cancer<\\/b> for drug discovery <b>...<\\/b>","link":"http:\\/\\/biopharmconsortium.com\\/blog\\/2010\\/04\\/15\\/developing-improved-mouse-models-of-cancer-for-drug-discovery-and-development\\/","desc":"Apr 15, 2010 <b>...<\\/b> Current <b>mouse models of<\\/b> cancer, mainly xenograft <b>models<\\/b> in which <b>...<\\/b> The \\nScientist article focuses on the ongoing \\u201c<b>co<\\/b>-clinical <b>mouse<\\/b>\\/human trials\\u201d now <b>....<\\/b> \\nUsing a genetically engineered <b>mouse model<\\/b> of <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"Orthotopic <b>tumor models<\\/b> - CELLVAX","link":"http:\\/\\/www.cellvax-pharma.com\\/content.php?idcontent=animalmodels","desc":"Oct 31, 2013 <b>...<\\/b> <b>animal<\\/b> cancer <b>models<\\/b>. <b>...<\\/b> <b>COMPANY<\\/b> OVERVIEW <b>...<\\/b> tumor <b>models<\\/b> in <b>animal<\\/b> in \\nwhich we induce lung cancer, colon cancer, <b>pancreas<\\/b> cancer,\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"LPTA <b>Animal Model<\\/b> EL1-Luc\\/EL1-TAg - Taconic","link":"http:\\/\\/www.taconic.com\\/user-assets\\/Documents\\/EL1-luc_EL1-TAg.pdf","desc":"(Light Producing Transgenic <b>Animal Model<\\/b> of Tag-Driven <b>Pancreatic Cancer<\\/b>) <b>...<\\/b> \\nnoninvasive monitoring of spontaneous tumorogenesis in the <b>pancreas<\\/b> and <b>...<\\/b> \\nThis product is provided under license from Promega <b>Corporation<\\/b> and The \\nRegents\\u00a0<b>...<\\/b>","radio_15b":"No"}]', '', 'mouse model for pancreatic cancer', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(137, '2013-11-07 10:37:05', 15, 'Cadherin antibodies', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_4', '', '', 'cadherin antibodies for cancer', 'd', '', 'cadherin antibodies for cancer', '', '', '', 'a', '', 'Sm01', 'NIH', '', '', '', '', 'field', '85', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'cadherin antibodies for cancer', '', '{"1":{"radio_11a2":"No","title":"CDx without drug on market","id":"58","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"No","title":"Cancer Target screening tools","id":"61","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"No","title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"No","title":"method for detecting cancer","id":"87","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"No","title":"cell line for better expression","id":"88","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"No","title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"7":{"radio_11a2":"No","title":"Biomarker Dx for cancer","id":"100","status":"Disclosure Done & Under Review"},"8":{"radio_11a2":"No","title":"pancreatic cancer","id":"108","status":"Disclosure Done & Under Review"},"9":{"radio_11a2":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"},"10":{"radio_11a2":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"Disclosure Done & Under Review"}}', 36, '', '>1m', 'Yes', 'No', 3, '', 'Yes', 33.5, '[{"title":"P-Cadherin antibodies","link":"http:\\/\\/www.google.com\\/patents\\/EP2444419A1?cl=en&dq=cadherin+antibodies&source=uds;","filedate":"Thu, 13 Apr 2006 00:00:00 -0700","applicant":"Pfizer Inc","desc":"The present invention relates to <b>antibodies<\\/b> including human <b>antibodies<\\/b> and  antigen-binding portions thereof that bind to P-<b>cadherin<\\/b>, and that\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"P-cadherin antibodies","link":"http:\\/\\/www.google.com\\/patents\\/CA2604357C?cl=en&dq=cadherin+antibodies&source=uds;","filedate":"Thu, 13 Apr 2006 00:00:00 -0700","applicant":"Christopher Todd Bauer, Maureen Jeri Bourner, Melanie Boyle, Gerald Fries Casperson, David William Griggs, Richard David Head, William Dean Joy, Richard Allen Mazzarella, Ralph Raymond Minter, Mark Allen Moffat, Pfizer Inc., Barrett Richard Thiele, Todd Lee Vanarsdale","desc":"The present invention relates to <b>antibodies<\\/b> including human <b>antibodies<\\/b> and  antigen- binding portions thereof that bind to P-<b>cadherin<\\/b>, and that\\u00a0<b>...<\\/b>","radio_11b":"Yes"}]', '[{"title":"Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24142157","desc":"L&Atilde;&sup3;pez JI, Schiavo-Lena M, Corominas-Cishek A, Yag&Atilde;&frac14;e A, Bauleth K, Guarch R, Hes O, Tardanico R.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Virchows Archiv : an international journal of pathology&quot;&gt;Virchows Arch&lt;\\/span&gt;. 2013 Oct 19. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"Digestion of epithelial tight junction proteins by the commensal Clostridium perfringens.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24072681","desc":"Pruteanu M, Shanahan F.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;American journal of physiology. Gastrointestinal and liver physiology&quot;&gt;Am J Physiol Gastrointest Liver Physiol&lt;\\/span&gt;. 2013 Sep 26. [Epub ahead of print]","radio_11b2":"No"},{"title":"The utility of immunohistochemistry for providing genetic information on tumors.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24065374","desc":"Chan JK, Ip YT, Cheuk W.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of surgical pathology&quot;&gt;Int J Surg Pathol&lt;\\/span&gt;. 2013 Oct;21(5):455-75. doi: 10.1177\\/1066896913502529.","radio_11b2":"Yes"},{"title":"Auto-&lt;b&gt;antibodies&lt;\\/b&gt; to vascular endothelial &lt;b&gt;cadherin&lt;\\/b&gt; in humans: association with autoimmune diseases.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24061286","desc":"Bouillet L, Baudet AE, Deroux A, Sidib&Atilde;&copy; A, Dumestre-Perard C, Mannic T, Treillard B, Arboleas MA, Chiquet CA, Gulino-Debrac DG, Vilgrain IY.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Laboratory investigation; a journal of technical methods and pathology&quot;&gt;Lab Invest&lt;\\/span&gt;. 2013 Nov;93(11):1194-202. doi: 10.1038\\/labinvest.2013.106. Epub 2013 Sep 23.","radio_11b2":"Yes"},{"title":"Oncostatin M stimulates cell migration and proliferation by down-regulating E-&lt;b&gt;cadherin&lt;\\/b&gt; in HTR8\\/SVneo cell line through STAT3 activation.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060241","desc":"Ko HS, Choi SK, Kang HK, Kim HS, Jeon JH, Park IY, Shin JC.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Reproductive biology and endocrinology : RB&amp;E&quot;&gt;Reprod Biol Endocrinol&lt;\\/span&gt;. 2013 Sep 24;11(1):93. [Epub ahead of print]","radio_11b2":"Yes"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>N<\\/b>-<b>Cadherin<\\/b> block against prostate <b>cancer<\\/b> - Nature","link":"http:\\/\\/www.nature.com\\/scibx\\/journal\\/v3\\/n46\\/full\\/scibx.2010.1370.html","desc":"Dec 2, 2010 <b>...<\\/b> UCLA researchers have shown that mAbs targeting <b>N<\\/b>-<b>cadherin<\\/b> can inhibit \\nprostate <b>...<\\/b> license and develop <b>N<\\/b>-<b>cadherin<\\/b>-specific <b>antibodies<\\/b> for use in <b>cancer<\\/b>, \\nit could <b>...<\\/b> If Emtx Therapeutics <b>Inc<\\/b>. exercises its option to license and develop <b>...<\\/b> \\nis one of the mainstays for <b>treating<\\/b> prostate <b>cancer<\\/b>, many patients still\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Breast carcinoma cells re-express E-<b>cadherin<\\/b> <b>...<\\/b> - Molecular <b>Cancer<\\/b>","link":"http:\\/\\/www.molecular-cancer.com\\/content\\/9\\/1\\/179","desc":"Jul 7, 2010 <b>...<\\/b> In most intraductal breast carcinomas E-cadherin is regulated epigenetically via \\nmethylation of the promoter. <b>...<\\/b> Upregulation of <b>N<\\/b>-<b>cadherin<\\/b> has been observed in \\nEMT, but because <b>....<\\/b> <b>co<\\/b>-cultures using a human-specific <b>antibody<\\/b>. <b>....<\\/b> <b>cancer<\\/b> \\ncells with mitomycin-C. This <b>treatment<\\/b> completely prevented loss of\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Molecular <b>Cancer<\\/b> | Full text | Non-small cell lung <b>cancer<\\/b> cells <b>...<\\/b>","link":"http:\\/\\/www.molecular-cancer.com\\/content\\/12\\/1\\/94","desc":"Aug 16, 2013 <b>...<\\/b> We demonstrated that lung <b>cancer<\\/b> stem cells that survived <b>treatment<\\/b> with <b>...<\\/b> EMT \\ntransition in epithelial cells leads to switching from E- cadherin to <b>N<\\/b>- <b>cadherin<\\/b> [31]\\n. <b>...<\\/b> Oct-4 and E-Cadherin <b>antibodies<\\/b> were purchased from Cell Signaling <b>...<\\/b> (0\\u2013\\n10 Gy) and maintained at 37\\u00b0C in the incubator with 5% <b>CO<\\/b>2.","radio_15b":"Yes"},{"title":"UCLA prostate <b>cancer<\\/b> researchers get renewed funding - Los <b>...<\\/b>","link":"http:\\/\\/www.examiner.com\\/article\\/ucla-prostate-cancer-researchers-get-renewed-funding","desc":"Jul 31, 2013 <b>...<\\/b> UCLA''s Jonsson Comprehensive <b>Cancer<\\/b> Center (JCCC) is <b>...<\\/b> with the goal of \\nimproving the way we diagnose and <b>treat<\\/b> prostate <b>cancer<\\/b>. <b>...<\\/b> is to translate <b>N<\\/b>-\\n<b>cadherin<\\/b>-targeted <b>antibody<\\/b> therapy into the clinic. <b>....<\\/b> <b>Company<\\/b> Links.","radio_15b":"Yes"},{"title":"The role of <b>N<\\/b>-<b>cadherin<\\/b> in the multiple myeloma <b>cancer<\\/b> <b>...<\\/b> - Umi.com","link":"http:\\/\\/gradworks.umi.com\\/15\\/30\\/1530379.html","desc":"Therefore, targeting the niche components may help <b>treat cancer<\\/b>. <b>...<\\/b> An in vitro <b>co<\\/b>\\n-culture assay containing mesenchymal stem cells (MSCs) and myeloma cells <b>...<\\/b> \\n<b>N<\\/b>-<b>cadherin<\\/b> functional blocking <b>antibodies<\\/b> and peptides were used to assay the\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>N<\\/b>-<b>Cadherin<\\/b> Protein & <b>Antibody<\\/b> (<b>CD325<\\/b>, <b>CDH2<\\/b>) - Sino Biological <b>Inc<\\/b>.","link":"http:\\/\\/www.sinobiological.com\\/N-Cadherin-CDH2-Cadherin-2-Protein-a-388.html","desc":"<b>N<\\/b>-<b>Cadherin<\\/b>\\/<b>CD325<\\/b>\\/<b>CDH2<\\/b>\\/Cadherin 2 Protein. We offer <b>...<\\/b> WB, ELISA, FCM, <b>N<\\/b>-\\n<b>Cadherin<\\/b> \\/ <b>CD325<\\/b> \\/ <b>CDH2 Antibody<\\/b>, 11039-R020 <b>....<\\/b> Breast <b>Cancer<\\/b> Res <b>Treat<\\/b>.","radio_15b":"No"},{"title":"Patent WO2011119888A2 - <b>N<\\/b>-<b>cadherin<\\/b>: target for <b>cancer<\\/b> diagnosis <b>...<\\/b>","link":"http:\\/\\/www.google.com\\/patents\\/WO2011119888A2","desc":"Sep 29, 2011 <b>...<\\/b> An <b>N<\\/b>-<b>cadherin antibody<\\/b> that binds to the <b>N<\\/b>-<b>cadherin<\\/b> epitope <b>...<\\/b> A method <b>of<\\/b> \\n<b>treating<\\/b> a <b>cancer<\\/b> which expresses or overexpresses <b>N<\\/b>- <b>cadherin<\\/b> in a <b>......<\\/b> <b>Inc<\\/b>. \\n1987); Thorpe, \\"<b>Antibody<\\/b> Carriers Of Cytotoxic Agents In <b>Cancer<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Patent WO2010054377A2 - Fully human <b>antibodies<\\/b> against <b>n<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.google.com\\/patents\\/WO2010054377A2","desc":"May 14, 2010 <b>...<\\/b> A method <b>of treating<\\/b> a <b>cancer<\\/b> patient, comprising the steps of: (a) obtaining a test \\ntissue <b>....<\\/b> NF-\\u03baB activity after <b>N<\\/b>-<b>Cadherin antibodies treatment<\\/b>. <b>......<\\/b> Protocols, A \\nGuide to Methods and Applications, Academic Press, <b>Inc<\\/b>. N. Y.).","radio_15b":"Yes"}]', '[{"title":"Researchers discover way to delay prostate cancer progression","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/researchers-discover-way-delay-prostate-cancer-progression\\/2010-11-29","desc":" with prostate <strong>cancer<\\/strong> is the development of metastatic disease that is resistant to androgen-deprivation therapy. ...","radio_15":"Yes"},{"title":"Roche''s souped-up breast cancer drug steps on FDA fast track","link":"http:\\/\\/www.fiercepharma.com\\/story\\/roches-souped-breast-cancer-drug-steps-fda-fast-track\\/2012-11-07","desc":" Roche got the inside track in its final lap toward FDA approval for the armed <strong>antibody<\\/strong> T-DM1. A new approach to <strong>treating<\\/strong> HER2-positive breast <strong>cancer<\\/strong>, the <strong>antibody<\\/strong>-drug conjugate is seen as a significant advance for patients. The FDA put T-DM1 up for priority review, with a decision due by Feb. 26. ...","radio_15":"Yes"},{"title":"Prostate cancer vaccine teams up with antibody","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/prostate-cancer-vaccine-teams-antibody\\/2012-02-23","desc":" Sometimes, the sum of the parts is greater than the whole, and this can be true for <strong>cancer<\\/strong> therapies as well. Researchers are hoping that combining Prostvac, the investigational therapeutic <strong>cancer<\\/strong> vaccine, with\\u00a0ipilimumab,\\u00a0a monoclonal <strong>antibody<\\/strong>,\\u00a0will enhance treatment effects. And results from an early ...","radio_15":"Yes"},{"title":"CytomX''s antibody therapies target cancer, leave healthy tissue intact","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/cytomxs-antibody-therapies-target-cancer-leave-healthy-tissue-intact\\/2013-04-16","desc":" approval\\u00a0for its <strong>antibody<\\/strong>-drug conjugate breast <strong>cancer<\\/strong> therapy\\u00a0Kadcyla, one company is developing a new class of <strong>antibodies<\\/strong> to combat <strong>cancer<\\/strong>. At the American Association for <strong>Cancer<\\/strong> Research (AACR) annual meeting ...","radio_15":"No"},{"title":"New HPV vax could treat cancer rather than prevent it","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/new-hpv-vax-could-treat-cancer-rather-prevent-it\\/2012-06-14","desc":" is expressed in cervical <strong>cancer<\\/strong>, as well as anti-CD40 <strong>antibodies<\\/strong> to trigger an immune response and an adjuvant ...","radio_15":"Yes"},{"title":"Bayer beefs up cancer drug pipeline with $520M armed antibody deal with Seattle Genetics","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/bayer-beefs-cancer-drug-pipeline-520m-armed-antibody-deal-seattle-genetics\\/2013-06-25","desc":" anti-<strong>cancer<\\/strong> ''warheads'' T-DM1 results push Genentech''s armed <strong>antibody<\\/strong> tech into ASCO''s ...","radio_15":"Yes"},{"title":"Roche trial buoys antibody-based delivery of cancer drugs ","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/roche-trial-buoys-antibody-based-delivery-cancer-drugs\\/2011-09-27","desc":" PhII data T-DM1- 10 promising late-stage <strong>cancer<\\/strong> drugs ImmunoGen touts new drug-delivering <strong>antibodies<\\/strong>  ...","radio_15":"Yes"},{"title":"BMS grabs bigger market territory for cancer antibody; Biotech vet Dionne joins Third Rock entrepreneur team;","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/bms-grabs-bigger-market-territory-cancer-antibody-biotech-vet-dionne-joins-\\/2011-09-21","desc":" with a therapeutic alternative to bariatric surgery in <strong>treating<\\/strong> obesity, named Dr. Dennis Kim as its chief medical ...","radio_15":"Yes"},{"title":"''Theragnostic'' nanoparticle detects and treats tumors","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/theragnostic-nanoparticle-detects-and-treats-tumors\\/2011-05-31","desc":" a therapy will work. It''s a class of nanocarriers that can both diagnose <strong>cancer<\\/strong> cells and deliver ...","radio_15":"Yes"},{"title":"Genmab shares up on new antibody tech","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genmab-shares-up-on-new-antibody-tech\\/2006-10-18","desc":" potential partners for HuMax-CD20. ","radio_15":"No"}]', 'n-cadherin antibodies to treat cancer', 'cadherin antibodies for cancer treatment', '[{"title":"1 Epithelial junction opener JO-1 improves <b>...<\\/b> - <b>Cancer<\\/b> Research","link":"http:\\/\\/cancerres.aacrjournals.org\\/content\\/early\\/2011\\/10\\/10\\/0008-5472.CAN-11-2009.full.pdf"},{"title":"Epithelial Junction Opener JO-1 Improves <b>...<\\/b> - <b>Cancer<\\/b> Research","link":"http:\\/\\/cancerres.aacrjournals.org\\/content\\/early\\/2011\\/11\\/04\\/0008-5472.CAN-11-2009.full.pdf"},{"title":"<b>Tumor<\\/b> Markers in Liver <b>Cancer<\\/b> - American Association for Clinical <b>...<\\/b>","link":"http:\\/\\/www.aacc.org\\/members\\/nacb\\/LMPG\\/OnlineGuide\\/PublishedGuidelines\\/LiverTumorMarkerLMPG\\/Documents\\/LiverTumorMarkersCh2.pdf"},{"title":"Angiogenesis Brochure - Cell Signaling Technology","link":"http:\\/\\/www.cellsignal.com\\/about\\/marketing\\/pdfs\\/bro-angiogenesis.pdf"}]', '2', '3', '', 100);
INSERT INTO `inventions` VALUES(138, '2013-11-07 11:01:00', 15, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '0', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(139, '2013-11-07 14:52:36', 1, 'HDAC Inhibitor for colon cancer', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'HDAC inhibitor for KRAS mutant colon cancer', 'e', 'b', 'HDAC inhibitor for kras mutant colon cancer', '', '', '', 'a,b', '', 'John Smith', 'NIH,company', 'qqqq', '2 million over 3 years', '', '', 'field', '115', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-11-21 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'HDAC inhibitor pancreatic cancer', '{"1":{"radio_11a1":"Yes","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"radio_11a1":"No","title":"method for detecting cancer","id":"87","status":"field"},"3":{"radio_11a1":"May be","title":"pancreatic cancer drug","id":"92","status":"field"},"4":{"radio_11a1":"May be","title":"pancreatic diseases","id":"94","status":"field"},"5":{"radio_11a1":"No","title":"Biomarker Dx for cancer","id":"100","status":"field"},"6":{"radio_11a1":"No","title":"pancreatic cancer","id":"108","status":"field"},"7":{"radio_11a1":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"8":{"radio_11a1":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"}}', '{"2":{"radio_11a2":"No","title":"CDx without drug on market","id":"58","status":"field"},"3":{"radio_11a2":"No","title":"Cancer Target screening tools","id":"61","status":"field"},"4":{"radio_11a2":"Yes","title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"5":{"radio_11a2":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"6":{"radio_11a2":"No","title":"method for detecting cancer","id":"87","status":"field"},"7":{"radio_11a2":"No","title":"pancreatic cancer drug","id":"92","status":"field"},"8":{"radio_11a2":"No","title":"pancreatic diseases","id":"94","status":"field"},"9":{"radio_11a2":"May be","title":"Biomarker Dx for cancer","id":"100","status":"field"},"10":{"radio_11a2":"Yes","title":"pancreatic cancer","id":"108","status":"field"},"11":{"radio_11a2":"Yes","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"}}', 116, '', '100k-1m', 'Yes', 'No', 3, '', 'Yes', 40.5, '{"0":{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2547349A1?cl=en&dq=HDAC+inhibitor+pancreatic+cancer&source=uds;","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","radio_11b":"No"},"1":{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=HDAC+inhibitor+pancreatic+cancer&source=uds;","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the preparation  of <b>...<\\/b> cancer is hepatocellular carcinoma or <b>pancreatic cancer<\\/b>.","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag","radio_11b":"Yes"},"2":{"title":"Metabolite derivatives of the hdac inhibitor fk228","link":"http:\\/\\/www.google.com\\/patents\\/CA2630216A1?cl=en&dq=HDAC+inhibitor+pancreatic+cancer&source=uds;","desc":"The present invention relates to <b>HDAC inhibitor<\\/b> derivatives, particularly <b>...<\\/b> cancer,  prostate cancer, colorectal and non-small cell lung cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","filedate":"Fri, 17 Nov 2006 00:00:00 -0800","applicant":"Gloucester Pharmaceuticals, Inc., Mitchell Keegan, Yat Sun Or, Gregory L. Verdine","radio_11b":"Yes"},"4":{"title":"Cancer therapy with a parvovirus combined with an HDAC inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2366398A1?cl=en&dq=HDAC+inhibitor+pancreatic+cancer&source=uds;","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>HDAC inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","filedate":"Wed, 17 Mar 2010 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","radio_11b":"No"},"6":{"title":"Cancer therapy with combinations of fts with hdac inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2011056542A1?cl=en&dq=HDAC+inhibitor+pancreatic+cancer&source=uds;","desc":"The method of any of claims 10-18, wherein the <b>HDAC inhibitor<\\/b> is <b>...<\\/b> of renal  carcinoma, skin cancer, <b>pancreatic cancer<\\/b>, colorectal cancer,\\u00a0<b>...<\\/b>","filedate":"Tue, 26 Oct 2010 00:00:00 -0700","applicant":"Ramot At Tel-Aviv University Ltd.","radio_11b":"Yes"},"7":{"title":"Combination therapy using HDAC inhibitors and melphalan for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2500063A1?cl=en&dq=HDAC+inhibitor+pancreatic+cancer&source=uds;","desc":"The present invention pertains to a method for treating cancer, such as <b>...<\\/b>  Combination therapy using <b>HDAC inhibitors<\\/b> and melphalan for treating cancer <b>...<\\/b>  cancer, colon cancer, lung cancer, breast cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited","radio_11b":"No"}}', '[{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Oct 14. doi:pii: S0006-291X(13)01670-7.  10.1016\\/j.bbrc.2013.10.010. [Epub ahead of print]","radio_11b2":"No"},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17.","radio_11b2":"No"},{"title":"The novel &lt;b&gt;HDAC inhibitor&lt;\\/b&gt; NDACI054 sensitizes human &lt;b&gt;cancer&lt;\\/b&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/span&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4.  10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"The anti-tumor effect of &lt;b&gt;HDAC&lt;\\/b&gt; inhibition in a human pancreas &lt;b&gt;cancer&lt;\\/b&gt; model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"Yes"},{"title":"Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23994577","desc":"Farrelly LA, Savage NT, O''Callaghan C, Toulouse A, Yilmazer-Hanke DM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Regulatory peptides&quot;&gt;Regul Pept&lt;\\/span&gt;. 2013 Sep 10;186:123-30. doi: 10.1016\\/j.regpep.2013.08.005. Epub 2013 Aug 28.","radio_11b2":"Yes"}]', 'the r groups are different', 'the side effects will be less', 'method of making is easier', '[{"title":"4SC Announces First Patient Dosed in Phase I\\/II SHORE Study in <b>...<\\/b>","link":"http:\\/\\/www.bloomberg.com\\/apps\\/news?pid=newsarchive&sid=ac0Nugu3.n6I","desc":"<b>...<\\/b> in <b>KRAS<\\/b>-<b>Mutant Colorectal Cancer<\\/b> Patients with Resminostat <b>Business<\\/b> Wire <b>...<\\/b> \\noral pan-histone deacetylase (<b>HDAC<\\/b>) <b>inhibitor<\\/b> resminostat as a second-line\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Ras in <b>Cancer<\\/b> and Developmental Diseases - Genes & <b>Cancer<\\/b>","link":"http:\\/\\/gan.sagepub.com\\/content\\/2\\/3\\/344.full","desc":"<b>K-ras mutations<\\/b> are common events detected in 40-45% of all <b>colorectal<\\/b> <b>....<\\/b> is \\nstimulated upon treatment with histone deacetylase (<b>HDAC<\\/b>) <b>inhibitors<\\/b>,106 an <b>.....<\\/b> \\nin pyramidal neurons in Alzheimer''s disease is highly <b>co<\\/b>-localized with p21ras \\nand\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Cell Death and Disease - The <b>HDAC inhibitor<\\/b>, MPT0E028 <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/cddis\\/journal\\/v4\\/n9\\/full\\/cddis2013330a.html","desc":"Sep 19, 2013 <b>...<\\/b> The <b>HDAC inhibitor<\\/b>, MPT0E028, enhances erlotinib-induced cell <b>...<\\/b> These effects \\nwere independent of the <b>mutation<\\/b> status of the genes encoding EGFR or <b>K-Ras<\\/b>. \\n<b>....<\\/b> of <b>cancer<\\/b> cell types, including lung, ovarian, <b>colon<\\/b>, breast, prostate, and <b>...<\\/b> \\nHowever, MPT0E028 and erlotinib <b>co<\\/b>-treatment synergistically\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"4SC Presents Update on Phase II SHELTER trial <b>...<\\/b> - <b>Business<\\/b> Wire","link":"http:\\/\\/www.businesswire.com\\/news\\/home\\/20110120006924\\/en","desc":"Jan 21, 2011 <b>...<\\/b> <b>HDAC inhibitors<\\/b> modify the DNA structure of tumour cells to cause their <b>...<\\/b> for \\nadvanced hepatocellular <b>carcinoma<\\/b> and <b>KRAS<\\/b>-<b>mutant colorectal<\\/b>\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Valproic acid enhances bosutinib cytotoxicity in <b>colon cancer<\\/b> cells","link":"http:\\/\\/onlinelibrary.wiley.com\\/doi\\/10.1002\\/ijc.24158\\/pdf","desc":"proic acid (VPA) is a <b>HDAC inhibitor<\\/b> used for the treatment of epilepsy. <b>...<\\/b> tinib led \\nto massive apoptosis of <b>colon cancer<\\/b> cells, irrespective of their genetic <b>...<\\/b> 2008 \\nWiley-Liss, <b>Inc<\\/b>. Key words: <b>...<\\/b> activating <b>mutations<\\/b> in <b>KRAS<\\/b> gene. Antibodies that\\n\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"4SC and Yakult Honsha Announce Exclusive License Agreement for <b>...<\\/b>","link":"http:\\/\\/www.firstwordpharma.com\\/node\\/855312?tsid=17","desc":"Apr 14, 2011 <b>...<\\/b> Resminostat, an oral, pan-histone deacetylase (<b>HDAC<\\/b>) <b>inhibitor<\\/b>, is currently <b>...<\\/b> \\nHodgkin lymphoma (HL) and <b>colorectal cancer<\\/b> in <b>KRAS<\\/b>-<b>mutant<\\/b> patients (CRC). \\n<b>...<\\/b> Yakult Honsha is a leading Japanese <b>company<\\/b> focused on the\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>KRAS<\\/b>-<b>mutated<\\/b> non-small cell lung <b>cancer<\\/b> cells are responsive to <b>...<\\/b>","link":"http:\\/\\/www.spandidos-publications.com\\/or\\/25\\/4\\/1021\\/download","desc":"in combination with the <b>histone deacetylase inhibitors<\\/b> (HDACi) vorinostat and \\nsodium butyrate in the <b>KrAs<\\/b>-<b>mutated<\\/b> nsclc cell line A549. <b>...<\\/b> to either <b>co<\\/b>-treatment \\nwith erlotinib or gefitinib and histone <b>.....<\\/b> and metastatic <b>colorectal cancer<\\/b>. Lancet\\n\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"4SC Presents Update on Phase II SHELTER trial with Oral Pan <b>...<\\/b>","link":"http:\\/\\/www.drugs.com\\/clinical_trials\\/4sc-presents-update-phase-ii-shelter-trial-oral-pan-hdac-resminostat-2011-gastrointestinal-cancer-11047.html","desc":"Jan 21, 2011 <b>...<\\/b> <b>HDAC inhibitors<\\/b> modify the DNA structure of tumour cells to cause their <b>...<\\/b> for \\nadvanced hepatocellular <b>carcinoma<\\/b> and <b>KRAS<\\/b>-<b>mutant colorectal<\\/b> <b>...<\\/b> and \\ndevelopment <b>company<\\/b> focused on autoimmune and <b>cancer<\\/b> indications.","radio_15b":"Yes"}]', '[{"title":"Erbitux, KRAS gene star at ASCO","link":"http:\\/\\/www.fiercepharma.com\\/story\\/erbitux-kras-gene-star-asco\\/2008-06-02","desc":" as a first-line <strong>colon<\\/strong> <strong>cancer<\\/strong> treatment--but only for those with the non-mutated <strong>KRAS<\\/strong> gene.) The Novartis bone drug ...","radio_15":"No"},{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" Swedish researchers believe that <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong>,\\u00a0substances common to some <strong>cancer<\\/strong> and epilepsy drugs, may also be used to help prevent heart attacks. <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> are used to treat <strong>cancer<\\/strong> because ...","radio_15":"Yes"},{"title":"FDA lets KRAS gene narrow drug use","link":"http:\\/\\/www.fiercepharma.com\\/story\\/fda-lets-kras-gene-narrow-drug-use\\/2009-07-20","desc":" Society of Clinical Oncology recommended that patients with <strong>mutant<\\/strong> <strong>KRAS<\\/strong> shouldn''t get this type ...","radio_15":"Yes"},{"title":"Florida Keys home to potential colon cancer fighter","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/florida-keys-home-potential-colon-cancer-fighter\\/2010-10-05","desc":" for further preclinical testing, which indicates it is a potent <strong>inhibitor<\\/strong> of <strong>cancer<\\/strong> cells that has the right ...","radio_15":"No"},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ...","radio_15":"Yes"},{"title":"AstraZeneca inks cancer deals with Bind Therapeutics, Horizon Discovery","link":"http:\\/\\/www.fiercepharma.com\\/story\\/astrazeneca-inks-cancer-deals-bind-therapeutics-horizon-discovery\\/2013-04-22","desc":" AstraZeneca ($AZN) forged two oncology development deals on either side of the Atlantic. It teamed up with the U.K.''s Horizon Discovery on a program to target <strong>K-Ras<\\/strong> <strong>mutant<\\/strong> tumors, and tapped Bind Therapeutics for its nanotech <strong>cancer<\\/strong> treatment.\\u00a0 Report | Report  ...","radio_15":"No"},{"title":"Amgen asks FDA to narrow Vectibix use","link":"http:\\/\\/www.fiercepharma.com\\/story\\/amgen-asks-fda-narrow-ital-vectibix-use\\/2008-12-16","desc":" for instance, Erbitux, Forbes suggests. Or Amgen''s Vectibix. Both drugs were approved for advanced <strong>colon<\\/strong> ...","radio_15":"Yes"},{"title":"Amgen touts KRAS results for Vectibix","link":"http:\\/\\/www.fiercepharma.com\\/story\\/amgen-touts-kras-results-vectibix\\/2009-08-07-0","desc":" with <strong>KRAS<\\/strong> <strong>mutant<\\/strong> tumors were negatively affected when Vectibix was added to a standard chemotherapy ...","radio_15":"Yes"},{"title":"Merck KGaA eyes KRAS-gene focus to boost Erbitux sales","link":"http:\\/\\/www.fiercepharma.com\\/story\\/merck-kgaa-eyes-kras-gene-focus-boost-erbitux-sales\\/2013-10-07","desc":" In 2009, the FDA allowed Merck KGaA to narrow Erbitux ''s indication for advanced <strong>colon<\\/strong> <strong>cancer<\\/strong>. Its label was changed to recommend the drug for treatment for EGFR-expressing tumors only ...","radio_15":"No"},{"title":"BMS, Lilly''s targeted drug Erbitux gets new FDA nod","link":"http:\\/\\/www.fiercepharma.com\\/story\\/bms-lillys-targeted-drug-erbitux-gets-new-fda-nod\\/2012-07-09","desc":" after <strong>colon-cancer<\\/strong> surgery. Merck had hoped that positive data in the stomach <strong>cancer<\\/strong> study would lead ...","radio_15":"Yes"}]', 'hdac inhibitors for kras mutant colon cancers', 'hdac inhibitor for colon cancer', '[{"title":"<b>Histone deacetylases<\\/b>: salesmen and customers <b>...<\\/b> - Biology of the Cell","link":"http:\\/\\/www.biolcell.org\\/boc\\/101\\/0193\\/1010193.pdf"},{"title":"EPIGENETICS & CHROMATIN MODIFICATION - Enzo Life Sciences","link":"http:\\/\\/www.enzolifesciences.com\\/fileadmin\\/files\\/catalog\\/enzo_catalog_epigenetics_np_final.pdf"},{"title":"129 CHAPTER VI SUMMARY AND FUTURE DIRECTIONS <b>...<\\/b> - ETD","link":"http:\\/\\/etd.library.vanderbilt.edu\\/available\\/etd-05222008-164304\\/unrestricted\\/07ChapterVIRefs.pdf"},{"title":"Pharmacodynamic Evaluation of the Target Efficacy of SB939, an <b>...<\\/b>","link":"http:\\/\\/mct.aacrjournals.org\\/content\\/10\\/7\\/1207.full.pdf"}]', '2', '4', '', 100);
INSERT INTO `inventions` VALUES(140, '2013-11-08 08:32:58', 1, 'HDAC inhibitor for pancreatic cancer', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'treatment of KRAS mutant cancer patients', 'e', 'b', 'Kras mutant cancer drug', '', '', '', 'a,b', '', 'John Smith', 'NIH,Foundation', '1111', '2 million over 3 years', '', '', 'field', '115', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'hdac inhibitor for pancreatic cancer', '{"1":{"radio_11a1":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"radio_11a1":"No","title":"method for detecting cancer","id":"87","status":"field"},"3":{"radio_11a1":"Yes","title":"pancreatic cancer drug","id":"92","status":"field"},"4":{"radio_11a1":"Yes","title":"pancreatic diseases","id":"94","status":"field"},"5":{"radio_11a1":"Yes","title":"Biomarker Dx for cancer","id":"100","status":"field"},"6":{"radio_11a1":"No","title":"pancreatic cancer","id":"108","status":"field"},"7":{"radio_11a1":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"8":{"radio_11a1":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"9":{"radio_11a1":"No","title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"}}', '{"1":{"radio_11a2":"Yes","title":"CDx without drug on market","id":"58","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"Yes","title":"Cancer Target screening tools","id":"61","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"No","title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"May be","title":"method for detecting cancer","id":"87","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"May be","title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"7":{"radio_11a2":"No","title":"pancreatic diseases","id":"94","status":"Disclosure Done & Under Review"},"8":{"radio_11a2":"No","title":"Biomarker Dx for cancer","id":"100","status":"Disclosure Done & Under Review"},"9":{"radio_11a2":"No","title":"pancreatic cancer","id":"108","status":"Disclosure Done & Under Review"},"10":{"radio_11a2":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"}}', 60, '', '100k-1m', 'Yes', 'No', 2, '', 'Yes', 24, '[{"title":"Treatment of non-localized inflammation with pan-hdac inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2010123507A1?cl=en&dq=hdac+inhibitor+for+panc&source=uds;","filedate":"Wed, 07 Oct 2009 00:00:00 -0700","applicant":"Pharmacyclics, Inc.","desc":"The method of claim 1 , wherein the <b>pan<\\/b>-<b>HDAC inhibitor<\\/b> is a short-chain <b>....<\\/b> A <b>pan<\\/b> -<b>HDAC inhibitor<\\/b> for treating sepsis in a human. 21.","radio_11b":"duplicate"},{"title":"Hdac 6 inhibitor-based methods for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2011005688A1?cl=en&dq=hdac+inhibitor+for+panc&source=uds;","filedate":"Fri, 02 Jul 2010 00:00:00 -0700","applicant":"Memorial Sloan-Kettering Cancer Center","desc":"Suberyl hydroxamic Acid (SAHA) (vorinostat) , a <b>pan HDAC inhibitor<\\/b> similar in its  activity to TSA, at 1.5 and 2.0 \\u03bcM caused an increase in\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Hdac inhibitors to treat charcot-marie-tooth disease","link":"http:\\/\\/www.google.com\\/patents\\/EP2624832A1?cl=en&dq=hdac+inhibitor+for+panc&source=uds;","filedate":"Thu, 06 Oct 2011 00:00:00 -0700","applicant":"Vib Vzw, Life Sciences Research Partners VZW","desc":"Using <b>HDAC inhibitors<\\/b>, it is shown herein that the symptoms of the <b>...<\\/b> type II  <b>HDAC inhibitor<\\/b>, a less specific <b>HDAC inhibitor<\\/b> or even a <b>pan<\\/b>-HDAC\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Histone deacetylase inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2012117421A1?cl=en&dq=hdac+inhibitor+for+panc&source=uds;","filedate":"Thu, 01 Mar 2012 00:00:00 -0800","applicant":"Orchid Research Laboratories Ltd","desc":"Most of the above mentioned compounds are <b>pan<\\/b>-<b>HDAC inhibitors<\\/b>. At present,  isoform selective <b>HDAC inhibitors<\\/b> are gaining importance in\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Methods of inhibiting cancer cell growth with hdac inhibitors and methods of ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2010056677A1?cl=en&dq=hdac+inhibitor+for+panc&source=uds;","filedate":"Tue, 10 Nov 2009 00:00:00 -0800","applicant":"Duke University","desc":"The method of claim 2, wherein the <b>pan<\\/b> HDAClO inhibitor is selected from  hydroxamic acid based <b>HDAC inhibitors<\\/b>, suberoylanilide hydroxamic\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8","link":"http:\\/\\/www.google.com\\/patents\\/WO2013101600A1?cl=en&dq=hdac+inhibitor+for+panc&source=uds;","filedate":"Wed, 19 Dec 2012 00:00:00 -0800","applicant":"Pharmacyclics, Inc.","desc":"Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8 <b>......<\\/b> been  reported in several clinical trials using <b>pan<\\/b>-<b>HDAC inhibitors<\\/b>.","radio_11b":"duplicate"},{"title":"Combination treatment comprising a hdac6 inhibitor and an akt inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/WO2012175973A1?cl=en&dq=hdac+inhibitor+for+panc&source=uds;","filedate":"Thu, 21 Jun 2012 00:00:00 -0700","applicant":"Imperial Innovations Limited","desc":"LBH-589 (Panabinostat; see Atadja ef al (2009) Cancer Letters 280: 233-41), for  example, is a <b>pan<\\/b>-<b>HDAC inhibitor<\\/b> that mostly inhibits HDACs 1\\u00a0<b>...<\\/b>","radio_11b":"duplicate"}]', '[{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Oct 14. doi:pii: S0006-291X(13)01670-7.  10.1016\\/j.bbrc.2013.10.010. [Epub ahead of print]","radio_11b2":"duplicate"},{"title":"The anti-tumor effect of &lt;b&gt;HDAC&lt;\\/b&gt; inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"duplicate"},{"title":"Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23743198","desc":"Wang B, Wang XB, Chen LY, Huang L, Dong RZ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Jul 19;437(1):1-6. doi: 10.1016\\/j.bbrc.2013.05.090. Epub 2013 Jun 4.","radio_11b2":"duplicate"},{"title":"Chidamide, a novel &lt;b&gt;histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt; &lt;b&gt;inhibitor&lt;\\/b&gt;, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23541946","desc":"Qiao Z, Ren S, Li W, Wang X, He M, Guo Y, Sun L, He Y, Ge Y, Yu Q.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Apr 26;434(1):95-101. doi: 10.1016\\/j.bbrc.2013.03.059. Epub 2013 Mar 27.","radio_11b2":"duplicate"},{"title":"Experimental in vivo and in vitro treatment with a new &lt;b&gt;histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt; &lt;b&gt;inhibitor&lt;\\/b&gt; belinostat inhibits the growth of pancreatic cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22681698","desc":"Dovzhanskiy DI, Arnold SM, Hackert T, Oehme I, Witt O, Felix K, Giese N, Werner J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BMC cancer&quot;&gt;BMC Cancer&lt;\\/span&gt;. 2012 Jun 8;12:226. doi: 10.1186\\/1471-2407-12-226.","radio_11b2":"duplicate"}]', 'the r groups are different', 'it has less side effects', 'test test est test test', '[{"title":"Balkanbuy.com - <b>KRAS<\\/b> SWEETS & SNACKS","link":"http:\\/\\/balkanbuy.com\\/shop\\/index.php?l=product_list&c=32","desc":"<b>Kras<\\/b> is a Croatian <b>company<\\/b> based in Zagreb, specializing in\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"<b>KRAS<\\/b>.JK: Summary for Krakatau Steel (Persero) Tbk.- Yahoo! Finance","link":"http:\\/\\/finance.yahoo.com\\/q?s=KRAS.JK","desc":"View the basic <b>KRAS<\\/b>.JK stock chart on Yahoo! Finance. Change the date range, \\nchart type and compare Krakatau Steel (Persero) Tbk. against other <b>companies<\\/b>.","radio_15b":"duplicate"},{"title":"<b>KRAS<\\/b> Mutation Analysis - Quest Diagnostics","link":"http:\\/\\/www.questdiagnostics.com\\/testcenter\\/testguide.action?dc=TS_KRAS","desc":"Mutations in the RAS gene family (HRAS, <b>KRAS<\\/b>, and NRAS) have been \\nobserved in a variety of cancers (Table 1). They are activating mutations that \\nresult in\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"<b>K-Ras<\\/b> and B-Raf Mutation Analysis Kits | EntroGen, <b>Inc<\\/b>","link":"http:\\/\\/www.entrogen.com\\/web2\\/k-ras-braf-mutation-test-kit","desc":"<b>K-Ras<\\/b> Mutation Analysis Kit for Real-Time PCR (codons 12, 13 & 61). 50 <b>...<\\/b> The \\n<b>KRAS<\\/b> gene encodes a small GTPase that plays a key role in transducing signals\\n\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"KRAKATAU STEEL TBK PT (<b>KRAS<\\/b>:Indonesia): Stock Quote <b>...<\\/b>","link":"http:\\/\\/investing.businessweek.com\\/research\\/stocks\\/snapshot\\/snapshot.asp?ticker=KRAS:IJ","desc":"PT Krakatau Steel (Persero) Tbk., together with its subsidiaries, engages in the \\nproduction and trading of iron and steel products in Indonesia and internationally.","radio_15b":"duplicate"},{"title":"EGFR & <b>KRAS<\\/b> - GENEWIZ, <b>Inc<\\/b>.","link":"http:\\/\\/www.genewiz.com\\/public\\/TG-EGFR_KRAS.aspx","desc":"GENEWIZ provides clinically relevant genomic information for physicians, \\npathologists, and clinical researchers.","radio_15b":"duplicate"},{"title":"<b>KRAS<\\/b> Technical Note - Pathology, <b>Inc<\\/b>.","link":"http:\\/\\/www.pathologyinc.com\\/assets\\/pdfs\\/kras_technote.pdf","desc":"2010 Pathology,<b>Inc<\\/b>. Pathology,<b>Inc<\\/b>. Welcome to Excellence. Overview - <b>KrAS<\\/b> \\nMutations. The <b>KRAS<\\/b> and BRAF genes are part of the Ras oncogene family \\nwhose\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Products - GS GType Assays - TET2\\/CBL\\/<b>KRAS<\\/b> : 454 Life Sciences <b>...<\\/b>","link":"http:\\/\\/454.com\\/products\\/assays\\/tet2-cbl-kras.asp","desc":"High Sensitivity Variant Detection for <b>KRAS<\\/b>, TET2 and RUNX1 Genes. Figure: \\nDistribution of <b>...<\\/b> 1996-2013 Roche Diagnostics <b>Corporation<\\/b>. For life science\\u00a0<b>...<\\/b>","radio_15b":"duplicate"}]', '[{"title":"Amgen touts KRAS results for Vectibix","link":"http:\\/\\/www.fiercepharma.com\\/story\\/amgen-touts-kras-results-vectibix\\/2009-08-07-0","desc":" in patients without a <strong>KRAS<\\/strong> gene mutation. In patients with the mutation, Vectibix actually made their cancers worse. It was the first trial in which almost all patients were screened for <strong>KRAS<\\/strong> status. ","radio_15":"duplicate"},{"title":"FDA lets KRAS gene narrow drug use","link":"http:\\/\\/www.fiercepharma.com\\/story\\/fda-lets-kras-gene-narrow-drug-use\\/2009-07-20","desc":" the bill. ","radio_15":"duplicate"},{"title":"Qiagen''s KRAS RGQ PCR Kit","link":"http:\\/\\/www.fiercemedicaldevices.com\\/special-reports\\/qiagens-kras-rgq-pcr-kit","desc":" ","radio_15":"duplicate"},{"title":"Erbitux, KRAS gene star at ASCO","link":"http:\\/\\/www.fiercepharma.com\\/story\\/erbitux-kras-gene-star-asco\\/2008-06-02","desc":" as a first-line colon cancer treatment--but only for those with the non-mutated <strong>KRAS<\\/strong> gene.) The Novartis bone drug ...","radio_15":"duplicate"},{"title":"Merck KGaA eyes KRAS-gene focus to boost Erbitux sales","link":"http:\\/\\/www.fiercepharma.com\\/story\\/merck-kgaa-eyes-kras-gene-focus-boost-erbitux-sales\\/2013-10-07","desc":" The drug, unlike its megablockbuster competitor, comes with a genetic test for <strong>KRAS<\\/strong> mutations that''s ...","radio_15":"duplicate"},{"title":"KRAS marks poor survival and response in ovarian cancer; NIH funds scleroderma biomarker research; ","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/kras-marks-poor-survival-and-response-ovarian-cancer-nih-funds-scleroderma-\\/2011-12-13","desc":" > <strong>KRAS<\\/strong>-gene variant is a biomarker of poor survival and worse response to treatment for patients with ovarian cancer. Release > Researchers have found pharmacogenetic and pharmacokinetic biomarker for drug-induced liver injury in patients treated with efavirenz and rifampicin for TB and HIV ...","radio_15":"duplicate"},{"title":"AZ sues Watson to stop copycat Crestor; Erbitux study raises KRAS questions;","link":"http:\\/\\/www.fiercepharma.com\\/also-noted\\/az-sues-watson-stop-copycat-crestor-erbitux-study-raises-kras-questions\\/2010-10-27","desc":"@FiercePharma: NICE to be sidelined, minister confirms. Report | Follow @FiercePharma > AstraZeneca has sued Watson Pharmaceuticals to block the launch of a generic version of Crestor, a ...","radio_15":"duplicate"},{"title":"ASCO: Narrow use of Erbitux, Vectibix","link":"http:\\/\\/www.fiercepharma.com\\/story\\/asco-narrow-use-erbitux-vectibix\\/2009-01-15","desc":" to be defined by the state of a patient''s <strong>KRAS<\\/strong>. As you know, studies have repeatedly shown that patients with a mutated form of <strong>KRAS<\\/strong> don''t benefit from expensive new meds such as Erbitux, marketed by ImClone\\/Eli ...","radio_15":"duplicate"},{"title":"Study validates gene variant in ovarian cancer","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/study-validates-gene-variant-ovarian-cancer\\/2012-05-29","desc":" professor of therapeutic radiology who led the team that originally discovered the <strong>KRAS<\\/strong>-variant. A previous ...","radio_15":"duplicate"},{"title":"Mixed results for Amgen''s cancer drug Vectibix","link":"http:\\/\\/www.fiercepharma.com\\/story\\/mixed-results-amgens-cancer-drug-vectibix\\/2009-08-18","desc":" treatment had no impact on the progression of cancer or overall survival of patients with a mutated <strong>KRas<\\/strong> ...","radio_15":"duplicate"}]', 'kras mutant pancreatic cancer', 'ptau alzheimer', '[{"title":"<b>alzheimer''s<\\/b> disease biomarkers: from concept to clinical utility","link":"http:\\/\\/www.alzforum.org\\/res\\/com\\/protocol\\/trojanowski\\/VandersticheleBiofluidsSampleCollectionProtocol.pdf"},{"title":"2013 <b>Alzheimer''s<\\/b> Disease Facts and Figures - <b>Alzheimer''s<\\/b> Association","link":"http:\\/\\/www.alz.org\\/downloads\\/facts_figures_2013.pdf"},{"title":"MCI Criteria - <b>Alzheimer''s<\\/b> Association","link":"http:\\/\\/www.alz.org\\/research\\/diagnostic_criteria\\/mci_reccomendations.pdf"},{"title":"Personalized Medicine Challenges in <b>Alzheimer''s<\\/b> Disease 2nd <b>...<\\/b>","link":"http:\\/\\/www.booz.com\\/media\\/file\\/BoozCo_Personalized-Medicine-Challenges-in-Alzheimers-Disease.pdf"}]', '2', '2', '', 100);
INSERT INTO `inventions` VALUES(141, '2013-11-08 12:46:01', 17, 'Better plastics', 'patent', '', '', 'gansh3', 'gansh17', 'gansh16_2', '', '', 'plastics for labware', 'c', '', 'plastics testing', '', '', '', 'a', '', 'Gee Kaun', 'NIH', '', '', '', '', 'field', '55', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'alginic acid ', '', '', 18, '', '>1m', 'Dont know', '', 0, '', 'Maybe', 22.5, '[{"title":"Dairy product containing functional alginic acid beads, and preparation ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013009105A3?cl=en&dq=alginic+acid&source=uds;","desc":"According to the present invention, since <b>alginic acid<\\/b> beads containing a  functional dietary fiber material are in themselves contained, and a\\u00a0<b>...<\\/b>","filedate":"Thu, 12 Jul 2012 00:00:00 -0700","applicant":"Palm Dream Co.,Ltd., \\ud31c\\ub4dc\\ub9bc\\uc8fc\\uc2dd\\ud68c\\uc0ac","radio_11b":"No"},{"title":"Vegetable alginic acid short fiber","link":"http:\\/\\/www.google.com\\/patents\\/CN203021695U?cl=en&dq=alginic+acid&source=uds;","desc":"The utility model provides vegetable <b>alginic acid<\\/b> short fiber. The short fiber  comprises a calcium <b>alginate<\\/b> fiber skin layer and a natural\\u00a0<b>...<\\/b>","filedate":"Fri, 05 Oct 2012 00:00:00 -0700","applicant":"\\u664b\\u6c5f\\u5e02\\u5747\\u5229\\u65e0\\u7eba\\u5236\\u54c1\\u6709\\u9650\\u516c\\u53f8","radio_11b":"No"},{"title":"Alginic acid-containing aqueous composition, dental alginate impression ...","link":"http:\\/\\/www.google.com\\/patents\\/US20130032058?dq=alginic+acid&source=uds;","desc":"Provided is an aqueous composition containing <b>alginic acid<\\/b> or a derivative  thereof, the composition having a viscosity retained stably over a\\u00a0<b>...<\\/b>","filedate":"Wed, 20 Apr 2011 00:00:00 -0700","applicant":"Tokuyama Dental Corporation","radio_11b":"No"},{"title":"Ophthalmic composition containing alginic acid or salt thereof","link":"http:\\/\\/www.google.com\\/patents\\/US8501822?dq=alginic+acid&source=uds;","desc":"An ophthalmic composition that, despite containing <b>alginic acid<\\/b> and\\/or a salt  thereof, has improved tackiness during use and provides a\\u00a0<b>...<\\/b>","filedate":"Tue, 27 Mar 2012 00:00:00 -0700","applicant":"Rohto Pharmaceutical Co., Ltd.","radio_11b":"No"},{"title":"Alginic acid-containing aqueous composition, alginate impression material ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2561852A1?cl=en&dq=alginic+acid&source=uds;","desc":"Provided is an aqueous composition containing <b>alginic acid<\\/b> or a derivative  thereof, the composition having a viscosity retained stably over a\\u00a0<b>...<\\/b>","filedate":"Wed, 20 Apr 2011 00:00:00 -0700","applicant":"Tokuyama Dental Corporation","radio_11b":"May Be"},{"title":"Solid oral dosage forms containing alginic acid and famotidine","link":"http:\\/\\/www.google.com\\/patents\\/WO2000025754A2?cl=en&dq=alginic+acid&source=uds;","desc":"SOLID ORAL DOSAGE FORMS CONTAINING <b>ALGINIC ACID<\\/b> AND FAMOTIDINE . Field of the Invention. This invention relates to solid oral\\u00a0<b>...<\\/b>","filedate":"Wed, 03 Nov 1999 00:00:00 -0800","applicant":"Mcneil Ppc Inc","radio_11b":"No"},{"title":"Procedure for producing uronic acid blocks from alginate","link":"http:\\/\\/www.google.com\\/patents\\/EP0980391B1?cl=en&dq=alginic+acid&source=uds;","desc":"A new procedure for producing block fractions from <b>alginate<\\/b>, mainly G block <b>...<\\/b> A  process as claimed in any one of claims 1 to 8, wherein an <b>alginic acid<\\/b> with a\\u00a0<b>...<\\/b>","filedate":"Fri, 08 May 1998 00:00:00 -0700","applicant":"FMC Biopolymer AS","radio_11b":"May Be"},{"title":"Particulate compositions comprising alginate and\\/or alginic acid","link":"http:\\/\\/www.google.com\\/patents\\/EP1919487B1?cl=en&dq=alginic+acid&source=uds;","desc":"An ingestible particulate composition comprises: a. an <b>alginate<\\/b> and\\/or <b>alginic<\\/b>  <b>acid<\\/b>; b. a bicarbonate and\\/or carbonate; c. an organic acid; and d.","filedate":"Thu, 27 Jul 2006 00:00:00 -0700","applicant":"Reckitt Benckiser Healthcare (UK) Limited","radio_11b":"May Be"}]', '[{"title":"Facile preparation of ammonium alginate-derived nanofibers carrying diverse therapeutic cargo.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24132070","desc":"Pegg CE, Jones GH, Athauda TJ, Ozer RR, Chalker JM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Chemical communications (Cambridge, England)&quot;&gt;Chem Commun (Camb)&lt;\\/span&gt;. 2013 Oct 17. [Epub ahead of print]","radio_11b2":"No"},{"title":"Facile synthesis of a new fluorogenic metal scavenging interpolymeric diamide based on cellulose and alginic acids.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24080591","desc":"Sanandiya ND, Siddhanta AK.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Carbohydrate research&quot;&gt;Carbohydr Res&lt;\\/span&gt;. 2013 Nov 15;381:93-100. doi: 10.1016\\/j.carres.2013.08.027. Epub 2013 Sep 10.","radio_11b2":"No"},{"title":"Synthesis and characterization of new derivatives of &lt;b&gt;alginic acid&lt;\\/b&gt; and evaluation of their iron(III)-crosslinked beads as potential controlled release matrices.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24032476","desc":"Abulateefeh SR, Khanfar MA, Al Bakain RZ, Taha MO.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Pharmaceutical development and technology&quot;&gt;Pharm Dev Technol&lt;\\/span&gt;. 2013 Sep 13. [Epub ahead of print]","radio_11b2":"No"},{"title":"An analytic study on the effect of alginate on the velocity profiles of blood in rectangular microchannels using microparticle image velocimetry.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24023655","desc":"Pitts KL, Fenech M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Aug 30;8(8):e72909. doi: 10.1371\\/journal.pone.0072909.","radio_11b2":"May Be"},{"title":"The mixing effect of amine and carboxyl groups on electrorheological properties and its analysis by in situ FT-IR under an electric field.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23945542","desc":"Ko YG, Lee HJ, Park YS, Woo JW, Choi US.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Physical chemistry chemical physics : PCCP&quot;&gt;Phys Chem Chem Phys&lt;\\/span&gt;. 2013 Oct 21;15(39):16527-32. doi: 10.1039\\/c3cp51907d. Epub 2013 Aug 15.","radio_11b2":"Yes"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>Alginic Acid<\\/b> and Its Derivatives (interim Report: <b>Plastic<\\/b> Products, Etc <b>...<\\/b>","link":"http:\\/\\/books.google.com\\/books\\/about\\/Alginic_Acid_and_Its_Derivatives_interim.html?id=y-FGHQAACAAJ","desc":"books.google.comhttp:\\/\\/books.google.com\\/books\\/about\\/\\nAlginic_Acid_and_Its_Derivatives_interim.html?id=y-FGHQAACAAJ&utm_source\\n=gb-gplus-share\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"sodium alginate,<b>alginic acid<\\/b> monosodium salt, View <b>alginic acid<\\/b> <b>...<\\/b>","link":"http:\\/\\/broadseaweed.en.alibaba.com\\/product\\/1188539243-0\\/sodium_alginate_alginic_acid_monosodium_salt.html","desc":"sodium alginate,<b>alginic acid<\\/b> monosodium salt,US $ 3000 - 10000 \\/ Ton, \\nChemical Auxiliary <b>...<\\/b> Business Type: Manufacturer, Trading <b>Company<\\/b> <b>...<\\/b> \\nChemicals,Petroleum Additives,<b>Plastic<\\/b> Auxiliary Agents,Rubber Auxiliary Agents,\\nSurfactants\\u00a0<b>...<\\/b>","radio_15b":"No"},{"title":"<b>alginic acid<\\/b>, aluminum hydroxide, and magnesium carbonate <b>...<\\/b>","link":"http:\\/\\/www.kleimanmd.com\\/ent\\/hw-view.php?DOCHWID=d03591a1","desc":"<b>Alginic acid<\\/b> is a natural carbohydrate that comes from algae in seaweed (kelp) \\nand is used in many processed foods. It helps this medication create a foam\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>alginic acid<\\/b> - Definition of <b>alginic acid<\\/b> - YourDictionary","link":"http:\\/\\/www.yourdictionary.com\\/alginic-acid","desc":"<b>alginic acid<\\/b> <b>...<\\/b> extracted from brown seaweed or kelp: used in jellies, <b>plastics<\\/b>, \\ndentistry, etc. <b>...<\\/b> Published by Houghton Mifflin Harcourt Publishing <b>Company<\\/b>.","radio_15b":"No"},{"title":"Industry Trade Sodium Alginate <b>Alginic acid<\\/b> Na-Alginnate, View <b>...<\\/b>","link":"http:\\/\\/ytxinwang.en.alibaba.com\\/product\\/789223274-210357107\\/Industry_Trade_Sodium_Alginate_Alginic_acid_Na_Alginnate.html","desc":"Industry Trade Sodium Alginate <b>Alginic acid<\\/b> Na-Alginnate,US $ 10 - 19 <b>...<\\/b> Source \\nfrom Yantai Xinwang Seaweed <b>Co<\\/b>., Ltd. on Alibaba.com. <b>...<\\/b> Packaging Details: \\n25kg \\/ composite <b>plastic<\\/b> woven bag 25kg \\/ composite <b>plastic<\\/b> woven bag a.","radio_15b":"Yes"},{"title":"Shandong Jiejing Group <b>Corp<\\/b>: sodium <b>alginate<\\/b>(9005-38-3 <b>...<\\/b>","link":"http:\\/\\/www.chinasodiumalginate.com\\/","desc":"Shandong Jiejing Group <b>Corporation<\\/b>. <b>...<\\/b> Degradable ''safe <b>plastic<\\/b>'' seaweed used \\nin medical industry \\u00b7 <b>Alginic acid<\\/b> uses \\u00b7 propylene glycol alginate application \\u00b7 \\nFucoidan <b>...<\\/b> Manufacturers and Suppliers of <b>Alginic Acid<\\/b>,Sodium Alginate,\\nPrinting","radio_15b":"No"},{"title":"<b>Alginic Acid<\\/b> products,China <b>Alginic Acid<\\/b> supplier","link":"http:\\/\\/www.21food.com\\/products\\/alginic-acid-773881.html","desc":"<b>Alginic Acid<\\/b>,complete details about <b>Alginic Acid<\\/b> provided by IRO Alginate <b>...<\\/b> IRO \\nAlginate Industry <b>Co<\\/b>., Ltd. China; Contact: Ms.Sunn Sun; Tel: 86-532- <b>...<\\/b> bag (a \\npolyethylene bag as liner and a compound <b>plastic<\\/b> woven bag as the outer layer).","radio_15b":"No"},{"title":"Shenyang <b>alginic acid<\\/b> fast water soluble fertilizer flakes, View <b>...<\\/b>","link":"http:\\/\\/humatechina.en.alibaba.com\\/product\\/710369499-209603235\\/Shenyang_alginic_acid_fast_water_soluble_fertilizer_flakes.html","desc":"Shenyang <b>alginic acid<\\/b> fast water soluble fertilizer flakes,US $ 1 - 100000 \\/ Metric \\nTon, Phosphate Fertilizer, Organic <b>...<\\/b> Business Type: Manufacturer, Trading \\n<b>Company<\\/b> <b>...<\\/b> Packaging Details: In 25kg Paper Bag, lined with <b>plastic<\\/b> bag inside.","radio_15b":"Yes"}]', '', 'alginic acid plastics', 'thermo stable plastics', '[{"title":"DISPOSABLE <b>BIOPLASTICS<\\/b> - Soy New Uses","link":"http:\\/\\/soynewuses.org\\/wp-content\\/uploads\\/pdf\\/DisposalblePlasticsMOS.PDF"},{"title":"Download - DuPont","link":"http:\\/\\/www2.dupont.com\\/Titanium_Technologies\\/en_US\\/tech_info\\/literature\\/Plastics\\/PL_B_Polymers_Light_Science.pdf"},{"title":"colored inorganic pigmented long fiber <b>thermoplastics<\\/b> abstract <b>...<\\/b>","link":"http:\\/\\/www.speautomotive.com\\/SPEA_CD\\/SPEA2011\\/pdf\\/TP\\/TP5.pdf"},{"title":"BASF Performance Polymers is the innovative <b>...<\\/b> - BASF.com","link":"http:\\/\\/www.basf.com\\/group\\/corporate\\/...\\/function\\/conversions:\\/publish\\/content\\/investor-relations\\/news-publications\\/presentations\\/2007\\/download\\/070910_BASF_Handouts_Dr._Lauke.pdf"}]', '2', '3', '', 100);
INSERT INTO `inventions` VALUES(142, '2013-11-10 16:18:05', 17, 'Metal nanoparticles as therapeutics', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'blood iron disorders', 'f', '', 'iron disorders ', '', '', '', 'a', '', 'Gee Kaun', '', '', '', '', '', 'field', '190', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'metal nanoparticle therapy for blood disorders', '', '', 60, '', '>1m', 'Yes', 'No', 5, '', 'Yes', 40, '[{"title":"Polymer nanoparticles coated by magnetic metal oxide and uses thereof","link":"http:\\/\\/www.google.com\\/patents\\/EP2591804A2?cl=en&dq=metal+nanoparticle+therapy+for+iron+related+blood+disorders&source=uds;","filedate":"Wed, 24 Sep 2008 00:00:00 -0700","applicant":"Bar-Ilan University, Henry Ford Hospital","desc":"wherein said magnetic <b>metal<\\/b> oxide is an <b>iron<\\/b> oxide or a ferrite derived <b>...<\\/b> cell  growth, affinity chromatography, diagnostics, specific <b>blood<\\/b> purification by <b>...<\\/b> <b>Due<\\/b>  to their magnetic properties, these particles have several <b>.....<\\/b> Remicade is a  monoclonal antibody used for <b>treatment<\\/b> of autoimmune <b>disorders<\\/b> by\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Single-domain antibodies and graphene coated magnetic metal nanoparticles ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013014538A2?cl=en&dq=metal+nanoparticle+therapy+for+iron+related+blood+disorders&source=uds;","filedate":"Wed, 25 Jul 2012 00:00:00 -0700","applicant":"American University In Cairo","desc":"Methods for using magnetic <b>nanoparticles<\\/b> for <b>treatment<\\/b> of parasitic <b>...<\\/b> The  <b>nanoparticle<\\/b> of claim 1 , wherein the magnetic <b>metal<\\/b> is <b>iron<\\/b>, <b>iron<\\/b>-platinum, <b>.....<\\/b> or  more additional functional elements attached to, or <b>associated<\\/b> with, its surface.  <b>.....<\\/b> the <b>blood<\\/b> or serum of the subject) and further purified by well-known\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Nanotherapeutic colloidal metal compositions and methods","link":"http:\\/\\/www.google.com\\/patents\\/EP2200932A1?cl=en&dq=metal+nanoparticle+therapy+for+iron+related+blood+disorders&source=uds;","filedate":"Mon, 22 Sep 2008 00:00:00 -0700","applicant":"Cytimmune Sciences, Inc.","desc":"CROSS REFERENCE TO <b>RELATED<\\/b> APPLICATIONS <b>....<\\/b> Colloidal <b>gold<\\/b>  <b>nanoparticles<\\/b> represent a completely novel technology in the <b>...<\\/b> complete  snapshot of <b>blood<\\/b> chemistries, hormones and growth factors in both normal <b>....<\\/b>  The delivery of agents is used for <b>treatments<\\/b> of biological <b>conditions<\\/b>, including,  but\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Compositions and methods to modulate cell activity","link":"http:\\/\\/www.google.com\\/patents\\/WO2013029025A1?cl=en&dq=metal+nanoparticle+therapy+for+iron+related+blood+disorders&source=uds;","filedate":"Fri, 24 Aug 2012 00:00:00 -0700","applicant":"The Rockefeller University","desc":"The method of claim 6, wherein the <b>nanoparticles<\\/b> comprise <b>metallic<\\/b> or <b>metal<\\/b>  oxide <b>....<\\/b> <b>Similar<\\/b> methods are used for production of other transgenic animals. <b>...<\\/b> ( A) Bulk heating effects of <b>treating iron<\\/b> oxide <b>nanoparticle<\\/b> <b>.....<\\/b> hormonal disorders,  metabolic diseases, <b>blood disorders<\\/b> or immune disorders.","radio_11b":"Yes"},{"title":"Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof","link":"http:\\/\\/www.google.com\\/patents\\/EP2396039A2?cl=en&dq=metal+nanoparticle+therapy+for+iron+related+blood+disorders&source=uds;","filedate":"Thu, 11 Feb 2010 00:00:00 -0800","applicant":"University Of Houston","desc":"The magnetic <b>nanoparticle<\\/b> of claim 1, further comprising a <b>metal<\\/b> <b>...<\\/b> A method for  <b>treating<\\/b> metastatic or primary cancer in a subject, <b>....<\\/b> Poor prognosis of the  disease is directly <b>related<\\/b> to late detection <b>...<\\/b> MRI is a powerful imaging modality  for detection of cancer and other <b>diseases<\\/b> because it provides high\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Prussian blue based nanoparticle as multimodal imaging contrast material","link":"http:\\/\\/www.google.com\\/patents\\/WO2012110835A2?cl=en&dq=metal+nanoparticle+therapy+for+iron+related+blood+disorders&source=uds;","filedate":"Wed, 15 Feb 2012 00:00:00 -0800","applicant":"Semmelweis Egyetem","desc":"There are many forms of <b>iron<\\/b> oxide <b>nanoparticles<\\/b> used in academic and clinical  <b>...<\\/b> safe and effective in gastrointestinal decontamination <b>therapy<\\/b> of certain <b>metal<\\/b>  <b>...<\\/b> primary <b>metal<\\/b> coat and optionally secondary <b>associated<\\/b> biomaterials. <b>.....<\\/b> or the  great number of <b>blood<\\/b>\\/plasma\\/serum components and opsonins\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Neurophilic nanoparticles","link":"http:\\/\\/www.google.com\\/patents\\/WO2013151650A1?cl=en&dq=metal+nanoparticle+therapy+for+iron+related+blood+disorders&source=uds;","filedate":"Wed, 06 Mar 2013 00:00:00 -0800","applicant":"University Of Florida Research Foundation, Inc.","desc":"Novel liposomal <b>nanoparticle<\\/b> that has been engineered to be <b>...<\\/b> system, and to  endothelial cells that form the <b>blood<\\/b> brain barrier. <b>...<\\/b> <b>disorders<\\/b> is in delivering  imaging , diagnostic and <b>therapeutic<\\/b> reagents to the disease sites. <b>.....<\\/b> Typically, a  chelating agent containing a paramagnetic <b>metal<\\/b> is <b>associated<\\/b> with\\u00a0<b>...<\\/b>","radio_11b":"No"}]', '[{"title":"Preventive efficacy of bulk and nanocurcumin against lead-induced oxidative stress in mice.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23292317","desc":"Flora G, Gupta D, Tiwari A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biological trace element research&quot;&gt;Biol Trace Elem Res&lt;\\/span&gt;. 2013 Apr;152(1):31-40. doi: 10.1007\\/s12011-012-9586-3. Epub 2013 Jan 6.","radio_11b2":"Yes"},{"title":"Studies on silver &lt;b&gt;nanoparticle&lt;\\/b&gt;-glycyrrhizic acid complex as a radioprotector and an adjuvant in radiotherapy under in vivo conditions.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22974210","desc":"Chandrasekharan DK, Nair CK.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancer biotherapy &amp; radiopharmaceuticals&quot;&gt;Cancer Biother Radiopharm&lt;\\/span&gt;. 2012 Dec;27(10):642-51. doi: 10.1089\\/cbr.2012.1286. Epub 2012 Sep 13.","radio_11b2":"Yes"},{"title":"Delivery of gold &lt;b&gt;nanoparticles&lt;\\/b&gt; to the brain by conjugation with a peptide that recognizes the transferrin receptor.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22795856","desc":"Prades R, Guerrero S, Araya E, Molina C, Salas E, Zurita E, Selva J, Egea G, L&Atilde;&sup3;pez-Iglesias C, Teixid&Atilde;&sup3; M, Kogan MJ, Giralt E.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biomaterials&quot;&gt;Biomaterials&lt;\\/span&gt;. 2012 Oct;33(29):7194-205. doi: 10.1016\\/j.biomaterials.2012.06.063. Epub 2012 Jul 15.","radio_11b2":"Yes"},{"title":"Strong neuroprotection with a novel platinum &lt;b&gt;nanoparticle&lt;\\/b&gt; against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22766232","desc":"Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Abe K.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Neuroscience&quot;&gt;Neuroscience&lt;\\/span&gt;. 2012 Sep 27;221:47-55. doi: 10.1016\\/j.neuroscience.2012.06.060. Epub 2012 Jul 3.","radio_11b2":"Yes"},{"title":"Multifunctional magnetic Fe3O4 &lt;b&gt;nanoparticles&lt;\\/b&gt; combined with chemotherapy and hyperthermia to overcome multidrug resistance.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22619560","desc":"Ren Y, Zhang H, Chen B, Cheng J, Cai X, Liu R, Xia G, Wu W, Wang S, Ding J, Gao C, Wang J, Bao W, Wang L, Tian L, Song H, Wang X.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of nanomedicine&quot;&gt;Int J Nanomedicine&lt;\\/span&gt;. 2012;7:2261-9. doi: 10.2147\\/IJN.S29357. Epub 2012 May 3.","radio_11b2":"No"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"<b>Metal<\\/b>-<b>based ayurvedic treatment<\\/b> can <b>cure<\\/b> leukemia - Times Of India","link":"http:\\/\\/articles.timesofindia.indiatimes.com\\/2011-02-25\\/varanasi\\/28633423_1_blood-cancer-cancer-patients-vaidya-balendu-prakash","desc":"Feb 25, 2011 <b>...<\\/b> VARANASI: Can <b>metal<\\/b>-<b>based treatment<\\/b> in <b>ayurveda<\\/b> provide <b>cure<\\/b> for blood \\ncancer (leukemia)? \\"The <b>metal<\\/b>-<b>based treatment<\\/b> in <b>ayurveda<\\/b> can do\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"JAMA Network | JAMA | <b>Metal<\\/b> Content in <b>Ayurvedic Medicines<\\/b>","link":"http:\\/\\/jama.jamanetwork.com\\/content\\/301\\/3\\/271.extract","desc":"Jan 21, 2009 <b>...<\\/b> Jun J. Mao, MD, MSCE; Krupali Desai, MD (<b>Ayurveda<\\/b>) <b>...<\\/b> Although the efforts to \\nestablish that <b>metal<\\/b> content in these products may potentially <b>....<\\/b> names and \\npasswords necessary to access subscription-<b>based<\\/b> content with a\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Are <b>Ayurvedic Medicine<\\/b> Safe? - Welcome To Light On <b>Ayurveda<\\/b> <b>...<\\/b>","link":"http:\\/\\/www.loaj.com\\/aam_safe.html","desc":"The Harvard <b>based<\\/b> study reported that one in five <b>Ayurvedic medicines<\\/b> that <b>...<\\/b> \\nAccording to the research team, these products put users at risk for <b>metal<\\/b> \\npoisoning. <b>...<\\/b> different <b>Ayurvedic medicines<\\/b> produced by 27 <b>companies<\\/b>, mainly \\nfrom India,\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"''Assess risk of <b>metal<\\/b>-<b>based medicines<\\/b>'' - Deccan Herald","link":"http:\\/\\/www.deccanherald.com\\/content\\/124487\\/assess-risk-metal-based-medicines.html","desc":"Dec 28, 2010 <b>...<\\/b> However, <b>Ayurveda<\\/b> doesn''t have evidence <b>based<\\/b> data in the <b>...<\\/b> 11 Indian \\n<b>companies<\\/b> and found that one third of the <b>medicines<\\/b> had high lead,\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>ayurveda treatment<\\/b> FAQ''s - Ayurvedahimachal.com","link":"http:\\/\\/www.ayurvedahimachal.com\\/index.php?page=faq","desc":"Do You Have Some Queries About <b>Ayurveda<\\/b> ????? if yes then visit <b>...<\\/b> Q: I''ve \\nheard <b>ayurvedic medicine<\\/b> is <b>metal<\\/b>\\/chemical <b>based<\\/b> but aren''t <b>metals<\\/b>\\/chemicals \\nbad\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>Metal Based Ayurvedic Treatment<\\/b> for Acute Promyelocytic <b>...<\\/b> - Docstoc","link":"http:\\/\\/www.docstoc.com\\/docs\\/102782818\\/Metal-Based-Ayurvedic-Treatment-for-Acute-Promyelocytic-Leukemia---PowerPoint---PowerPoint","desc":"Dec 11, 2011 <b>...<\\/b> <b>BUSINESS<\\/b> TOOLS \\u00b7 DOCUMENTS <b>...<\\/b> <b>Metal Based Ayurvedic Treatment<\\/b> for Acute \\nPromyelocytic Leukemia - PowerPoint - PowerPoint.","radio_15b":"Yes"},{"title":"<b>Ayurvedic medicines<\\/b> contain heavy <b>metals<\\/b> - Skeptico","link":"http:\\/\\/skeptico.blogs.com\\/skeptico\\/2005\\/03\\/ayurvedic_medic.html","desc":"Mar 8, 2005 <b>...<\\/b> Of course, even many evidence <b>based medicines<\\/b> can have bad effects, <b>...<\\/b> i used \\ntwo <b>ayurvedic medicine<\\/b> both by Hamdard <b>company<\\/b> known as\\u00a0<b>...<\\/b>","radio_15b":"Yes"}]', '[{"title":"Platinum drug delivery method snuffs cancer''s power source","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/platinum-drug-delivery-method-snuffs-cancers-power-source\\/2013-11-06","desc":" cellular consequences <strong>metal-based<\\/strong> drugs elicit.","radio_15":"Yes"},{"title":"BASF adds fine chemical catalysts manufacturing in India","link":"http:\\/\\/www.fiercepharmamanufacturing.com\\/story\\/basf-adds-fine-chemical-catalysts-manufacturing-india\\/2012-10-09","desc":" for precious <strong>metal-based<\\/strong> fine chemical catalysts in India, we will expand our offerings to meet the needs ...","radio_15":"Yes"},{"title":"BASF reorg leaves pharma biz generally unchanged","link":"http:\\/\\/www.fiercepharmamanufacturing.com\\/story\\/basf-reorg-leaves-pharma-biz-generally-unchanged\\/2012-11-06","desc":" The company last month said it would open its first precious <strong>metal-based<\\/strong> fine chemical catalysts line ...","radio_15":"Yes"},{"title":"India arrests two in week of counterfeit drug raids","link":"http:\\/\\/www.fiercepharmamanufacturing.com\\/story\\/india-conducts-week-drug-manufacturer-raids-find-counterfeits-arrests-two\\/2010-05-24","desc":" Perhaps the FDA was watching last week as India''s Central Bureau of Investigation arrested the heads of two drug companies for allegedly manufacturing adulterated medicines. Gurbachan Singh of J P Herbal Pharmacy and Navin Gadekar of Nalini <strong>Ayurvedic<\\/strong> Co. have been taken into custody. Bureau director ...","radio_15":"Yes"},{"title":"Clearside picks up $7.9M for microneedle blindness treatment; Ampio embarks on clinical trials for oral diabetic treatment;","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/clearside-picks-79-microneedle-blindness-treatment-ampio-embarks-clinical-t\\/2013-02-27","desc":" in asthma patients who have allergies that affect their reactions to other <strong>treatments<\\/strong>. Release  ...","radio_15":"Yes"},{"title":"Respiratory virus tried as targeted cancer treatment","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/respiratory-virus-tried-targeted-cancer-treatment\\/2012-09-06","desc":" disclaimer applies here of course. This cancer <strong>treatment<\\/strong> concept could be immensely useful and efficient ...","radio_15":"Yes"},{"title":"Avatar mice up ante for personalized drug treatment research","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/avatar-mice-ante-personalized-drug-treatment-research\\/2012-09-27","desc":" though companies are beginning to commercialize the idea for both drug development and medical <strong>treatment<\\/strong> ...","radio_15":"Yes"},{"title":"FDA clears Stryker''s next-gen stroke treatment device","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/fda-clears-strykers-next-gen-stroke-treatment-device\\/2012-08-13","desc":" with <strong>treatment<\\/strong>-resistant (refractory atherosclerotic disease with a 50% or higher narrowing of the intracranial arteries and also for patients who have had two or more strokes even with aggressive medical <strong>treatment<\\/strong>.- read ...","radio_15":"Yes"},{"title":"Cardium pulls in $4M financing as it rolls out wound treatment gel","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/cardium-pulls-4m-financing-it-rolls-out-wound-treatment-gel\\/2013-04-05","desc":" rollout of Excellagen, an FDA-cleared wound <strong>treatment<\\/strong> gel. The initial goal--to get the product ...","radio_15":"Yes"},{"title":"Immunomedics promotes 2 cancer treatments to later-stage trials","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/immunomedics-promotes-two-cancer-treatments-later-stage-trials\\/2011-12-14","desc":" at least one other <strong>treatment<\\/strong>. Ohio State University researchers who conducted the study said 14 of 18 ...","radio_15":"Yes"}]', 'metal-based ayurvedic treatment', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(146, '2013-11-11 14:18:51', 1, 'Cancer drug', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'drug for non-small cell lung cancer ', 'e', 'b', 'Drug for cancer.', '', '', '', 'a,b', '', 'John Smith', 'NIH,Company', 'nn', '', '', '', 'field', '95', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'HDAC inhibitor for pancreatic cancer', '{"1":{"radio_11a1":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"radio_11a1":"Yes","title":"method for detecting cancer","id":"87","status":"field"},"3":{"radio_11a1":"Yes","title":"pancreatic cancer drug","id":"92","status":"field"},"4":{"radio_11a1":"No","title":"pancreatic diseases","id":"94","status":"field"},"5":{"radio_11a1":"No","title":"Biomarker Dx for cancer","id":"100","status":"field"},"6":{"radio_11a1":"No","title":"pancreatic cancer","id":"108","status":"field"},"7":{"radio_11a1":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"8":{"radio_11a1":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"9":{"radio_11a1":"May be","title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"10":{"radio_11a1":"May be","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"}}', '{"1":{"radio_11a2":"Yes","title":"CDx without drug on market","id":"58","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"No","title":"Cancer Target screening tools","id":"61","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"May be","title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"Yes","title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"Yes","title":"method for detecting cancer","id":"87","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"Yes","title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"7":{"radio_11a2":"No","title":"pancreatic diseases","id":"94","status":"Disclosure Done & Under Review"},"8":{"radio_11a2":"No","title":"Biomarker Dx for cancer","id":"100","status":"Disclosure Done & Under Review"},"9":{"radio_11a2":"No","title":"pancreatic cancer","id":"108","status":"Disclosure Done & Under Review"},"10":{"radio_11a2":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"}}', 117, '', '100k-1m', 'Yes', 'No', 3, '', 'Yes', 44, '[{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the <b>...<\\/b> Use of  <b>hdac inhibitors for<\\/b> the treatment of gastrointestinal <b>cancers<\\/b>","radio_11b":"No"},{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2547349A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","radio_11b":"May Be"},{"title":"Cancer therapy with a parvovirus combined with an HDAC inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2366398A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Wed, 17 Mar 2010 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>HDAC inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"A pharmaceutical composition comprising a hdac inhibitor and a steroid and ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2012128709A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Tue, 20 Mar 2012 00:00:00 -0700","applicant":"Valcuria Ab","desc":"Said <b>HDAC inhibitor<\\/b> or steroid may alternatively be administrated <b>...<\\/b> renal cancer,  colon and colorectal cancer, <b>pancreatic cancer<\\/b>, head and\\u00a0<b>...<\\/b>","radio_11b":"Yes"},{"title":"Combination therapy using HDAC inhibitors and melphalan for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2500063A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited","desc":"The present invention pertains to a method for treating cancer, such as lung <b>...<\\/b>  therapy using <b>HDAC inhibitors<\\/b> and melphalan for treating cancer <b>...<\\/b> rectal cancer,  colon cancer, lung cancer, breast cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","radio_11b":"No"},{"title":"Cancer therapy with combinations of fts with hdac inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2011056542A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","filedate":"Tue, 26 Oct 2010 00:00:00 -0700","applicant":"Ramot At Tel-Aviv University Ltd.","desc":"The method of any of claims 10-18, wherein the <b>HDAC inhibitor<\\/b> is <b>...<\\/b> of renal  carcinoma, skin cancer, <b>pancreatic cancer<\\/b>, colorectal cancer,\\u00a0<b>...<\\/b>","radio_11b":"Yes"}]', '[{"title":"Role of Hydroxamate-Based &lt;b&gt;Histone Deacetylase Inhibitors&lt;\\/b&gt; (Hb-HDACIs) in the Treatment of Solid Malignancies.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24202327","desc":"Grassadonia A, Cioffi P, Simiele F, Iezzi L, Zilli M, Natoli C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancers&quot;&gt;Cancers (Basel)&lt;\\/span&gt;. 2013 Jul 25;5(3):919-42. doi: 10.3390\\/cancers5030919.","radio_11b2":"Yes"},{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Oct 14. doi:pii: S0006-291X(13)01670-7.  10.1016\\/j.bbrc.2013.10.010. [Epub ahead of print]","radio_11b2":"No"},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17.","radio_11b2":"Yes"},{"title":"The novel &lt;b&gt;HDAC inhibitor&lt;\\/b&gt; NDACI054 sensitizes human &lt;b&gt;cancer&lt;\\/b&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/span&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4.  10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]","radio_11b2":"Yes"},{"title":"The anti-tumor effect of &lt;b&gt;HDAC&lt;\\/b&gt; inhibition in a human pancreas &lt;b&gt;cancer&lt;\\/b&gt; model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"No"}]', 'electrophillic vs neutrophillic interactions is better', 'the side effects will be less', 'the product works much better', '[{"title":"<b>HDAC<\\/b> Inhibitors - Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/hdac_inhibitors.html","desc":"Description of Pan <b>HDAC<\\/b> Inhibitors within Pharmacyclics'' therapeutic programs.","radio_15b":"No"},{"title":"<b>HDAC<\\/b> Activity Colorimetric Assay Kit | BioVision <b>Inc<\\/b>.","link":"http:\\/\\/www.biovision.com\\/hdac-activity-colorimetric-assay-kit-2849.html","desc":"Colorimetric <b>HDAC<\\/b> Activity Assay Kit: Measure <b>Histone Deacetylase<\\/b> (<b>HDAC<\\/b>) \\nActivity in Just Two Easy Steps. Convenient, High-Throughput Adaptable\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>HDAC<\\/b> Activity Fluorometric Assay Kit | BioVision <b>Inc<\\/b>.","link":"http:\\/\\/www.biovision.com\\/hdac-activity-fluorometric-assay-kit-2848.html","desc":"Fluorometric <b>HDAC<\\/b> Activity Assay Kit: Measure <b>Histone Deacetylase<\\/b> (<b>HDAC<\\/b>) \\nActivity within an Hour. Convenient, High-Throughput Adaptable\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>HDAC<\\/b> Inhibitor Drug Screening Kit (Fluorometric) | BioVision <b>Inc<\\/b>.","link":"http:\\/\\/www.biovision.com\\/hdac-inhibitor-drug-screening-kit-fluorometric-2854.html","desc":"<b>HDAC<\\/b> Inhibitor Drug Screening Kit: High-Throughput Adaptable Fluorometric \\nAssay Kit to Screen <b>Histone Deacetylase<\\/b> (<b>HDAC<\\/b>) Inhibitors. Rapid, Simple\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Closer to class IIa <b>HDAC<\\/b> inhibitors - Nature","link":"http:\\/\\/www.nature.com\\/scibx\\/journal\\/v6\\/n13\\/full\\/scibx.2013.301.html","desc":"Apr 4, 2013 <b>...<\\/b> At least 23 <b>companies<\\/b> have <b>HDAC<\\/b> inhibitors in clinical trials, mostly for cancer, \\nand the majority are nonselective. For example, the two\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>HDAC<\\/b> Fluorometric Activity Assay Kit || Cayman Chemical | Supplier","link":"http:\\/\\/www.caymanchem.com\\/catalog\\/10011563","desc":"A 96-well fluorometric assay for <b>HDAC<\\/b>. <b>...<\\/b> <b>HDAC<\\/b> Fluorometric Activity Assay Kit <b>...<\\/b> \\nCayman Chemical <b>Company<\\/b> regularly evaluates our shipping methods to\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"<b>HDAC<\\/b> Cell-Based Activity Assay Kit - Cayman Chemical","link":"http:\\/\\/www.caymanchem.com\\/catalog\\/600150","desc":"An easy tool for studying <b>HDAC<\\/b> activity modulators in whole cells. <b>...<\\/b> Cayman \\nChemical <b>Company<\\/b> regularly evaluates our shipping methods to ensure product\\n\\u00a0<b>...<\\/b>","radio_15b":"Yes"},{"title":"Next-Generation <b>Histone Deacetylase<\\/b> Inhibitors - Day 1 - Discovery <b>...<\\/b>","link":"http:\\/\\/www.discoveryontarget.com\\/HDAC-Inhibitors\\/","desc":"<b>Histone deacetylases<\\/b> (<b>HDAC<\\/b>) Inhibitors HDI Cancer, Inflammation, CNS \\nconference\\/meeting <b>Histone deacetylases<\\/b> (<b>HDACs<\\/b>) have proven to be a \\npromising\\u00a0<b>...<\\/b>","radio_15b":"Yes"}]', '[{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" Swedish researchers believe that <strong>HDAC<\\/strong> inhibitors,\\u00a0substances common to some cancer and epilepsy drugs, may also be used to help prevent heart attacks. <strong>HDAC<\\/strong> inhibitors are used to treat cancer because <strong>HDAC<\\/strong> proteins regulate how DNA behaves, and cancer can make <strong>HDAC<\\/strong> proteins turn off genes that keep ...","radio_15":"Yes"},{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" at the 54th annual meeting of the American Society of Hematology (ASH). <strong>HDACs<\\/strong> are members of a group of enzymes that help regulate gene expression. Acetylon''s lead drug, the <strong>HDAC<\\/strong>6 inhibitor ACY-1215, ...","radio_15":"No"},{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" and Stuart Schreiber at Harvard University. ","radio_15":"Yes"},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" additional selective <strong>HDAC<\\/strong> inhibitor drug candidates for non-cancer disease indications including autoimmune ...","radio_15":"Yes"},{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> inhibitors can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ...","radio_15":"Yes"},{"title":"Gloucester Pharmaceuticals- Top 20 VC deals of 2008","link":"http:\\/\\/www.fiercebiotech.com\\/special-reports\\/gloucester-pharmaceuticals-top-20-vc-deals-2008","desc":" deacetylase (<strong>HDAC<\\/strong>) inhibitor in Phase III trials for T-cell lymphomas.  ...","radio_15":"No"},{"title":"Acetylon raises $12.4M in new venture round ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-raises-124m-new-venture-round\\/2011-02-23","desc":" Boston upstart Acetylon Pharmaceuticals has raised $12.4 million in new venture funds, according to MassHighTech. Citing SEC documents the news service revealed that Acetylon is in the process of raising a $30 million round to back its work developing <strong>HDAC<\\/strong> inhibitors for inflammatory and neurological diseases ...","radio_15":"Already Assigned"},{"title":"Celgene pays $15M for front-row seat on Acetylon myeloma program","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/celgene-pays-15m-front-row-seat-acetylon-myeloma-program\\/2012-02-08","desc":" strategy, Ogier tells FierceBiotech. A Phase Ib study that combines its <strong>HDAC<\\/strong>6 inhibitor ...","radio_15":"Yes"},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" azacitidine. Role of <strong>HDAC<\\/strong> inhibitors in cancer Genes that regulate cell growth are frequently silenced ...","radio_15":"No"},{"title":"4SC surges on positive midstage data for advanced liver cancer","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-surges-positive-midstage-data-advanced-liver-cancer\\/2012-01-19","desc":" autoimmune disease. A number of biotechs are working on <strong>HDAC<\\/strong> inhibitors, including Curis and Acetylon.- ...","radio_15":"Yes"}]', 'hdac inhibitor pancreatic cancer', 'hdac inhibitor for pancreatic cancer', '[{"title":"<b>Histone deacetylase inhibitors<\\/b> in the treatment of <b>cancer<\\/b>: overview <b>...<\\/b>","link":"http:\\/\\/www.reactionbiology.com\\/webapps\\/main\\/press\\/20130128.pdf"},{"title":"PC News and Updates - <b>Pancreatic Cancer<\\/b> Action Network","link":"http:\\/\\/www.pancan.org\\/section_research\\/pdf\\/news_and_updates\\/PC%20News%20and%20Updates%20-%20May%202012.pdf"},{"title":"1 For consideration of publication in <b>Cancer<\\/b> Research <b>HDAC6<\\/b> <b>...<\\/b>","link":"http:\\/\\/cancerres.aacrjournals.org\\/content\\/early\\/2013\\/01\\/31\\/0008-5472.CAN-12-2938.full.pdf"},{"title":"Role of Hydroxamate-Based <b>Histone Deacetylase Inhibitors<\\/b> (Hb <b>...<\\/b>","link":"http:\\/\\/www.researchgate.net\\/publication\\/257137858_Role_of_Hydroxamate-Based_Histone_Deacetylase_Inhibitors_(Hb-HDACIs)_in_the_Treatment_of_Solid_Malignancies\\/file\\/72e7e5246cc51d86b8.pdf"}]', '', '', '', 100);
INSERT INTO `inventions` VALUES(147, '2013-11-12 10:34:09', 19, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(148, '2013-11-13 07:22:54', 1, 'KRAS mutant colon cancer therapy', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'KRAS mutant colon cancer', 'c', '', 'KRAS mutant colon cancer', '', '', '', 'a', '', 'John Smith', 'NIH', '222', '1 million over 2 years', '', '', 'field', '105', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-11-29 00:00:00', '', 'Yes', '2013-11-06 00:00:00', '', '', '0000-00-00 00:00:00', 'HDAC inhibitor for pancreatic cancer', '{"1":{"radio_11a1":"Yes","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"radio_11a1":"No","title":"method for detecting cancer","id":"87","status":"field"},"3":{"radio_11a1":"No","title":"pancreatic cancer drug","id":"92","status":"field"},"4":{"radio_11a1":"No","title":"pancreatic diseases","id":"94","status":"field"},"5":{"radio_11a1":"No","title":"Biomarker Dx for cancer","id":"100","status":"field"},"6":{"radio_11a1":"No","title":"pancreatic cancer","id":"108","status":"field"},"7":{"radio_11a1":"May be","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"8":{"radio_11a1":"May be","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"9":{"radio_11a1":"May be","title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"10":{"radio_11a1":"May be","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"}}', '{"1":{"radio_11a2":"Yes","title":"CDx without drug on market","id":"58","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"Yes","title":"Cancer Target screening tools","id":"61","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"No","title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"No","title":"method for detecting cancer","id":"87","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"May be","title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"7":{"radio_11a2":"May be","title":"pancreatic diseases","id":"94","status":"Disclosure Done & Under Review"},"8":{"radio_11a2":"No","title":"Biomarker Dx for cancer","id":"100","status":"Disclosure Done & Under Review"},"9":{"radio_11a2":"No","title":"pancreatic cancer","id":"108","status":"Disclosure Done & Under Review"},"10":{"radio_11a2":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"}}', 99, '', '100k-1m', 'Yes', 'No', 3, '', 'Maybe', 33.5, '', '[{"title":"Role of Hydroxamate-Based &lt;B&gt;Histone Deacetylase Inhibitors&lt;\\/B&gt; (Hb-HDACIs) in the Treatment of Solid Malignancies.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24202327","desc":"Grassadonia A, Cioffi P, Simiele F, Iezzi L, Zilli M, Natoli C.","details":"&lt;SPAN class=jrnl title=Cancers&gt;Cancers (Basel)&lt;\\/SPAN&gt;. 2013 Jul 25;5(3):919-42. doi: 10.3390\\/cancers5030919.","radio_11b2":"No"},{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in &lt;B&gt;pancreatic cancer&lt;\\/B&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;SPAN class=jrnl title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/SPAN&gt;. 2013 Nov 8;441(1):102-7. doi: 10.1016\\/j.bbrc.2013.10.010. Epub 2013 Oct 14.","radio_11b2":"No"},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;B&gt;pancreatic&lt;\\/B&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;SPAN class=jrnl title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/SPAN&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17.","radio_11b2":"May Be"},{"title":"The novel &lt;B&gt;HDAC inhibitor&lt;\\/B&gt; NDACI054 sensitizes human &lt;B&gt;cancer&lt;\\/B&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;SPAN class=jrnl title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/SPAN&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4. 10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]","radio_11b2":"No"},{"title":"The anti-tumor effect of &lt;B&gt;HDAC&lt;\\/B&gt; inhibition in a human pancreas &lt;B&gt;cancer&lt;\\/B&gt; model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;SPAN class=jrnl title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/SPAN&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"No"}]', 'test test test test test test', 'test test test test test test', 'test test test test test test', '[{"title":"<b>HDAC<\\/b> Inhibitors - Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/hdac_inhibitors.html","radio_15b":"No","desc":"Description of Pan <b>HDAC<\\/b> Inhibitors within Pharmacyclics'' therapeutic programs."},{"title":"<b>HDAC<\\/b> Activity Colorimetric Assay Kit | BioVision <b>Inc<\\/b>.","link":"http:\\/\\/www.biovision.com\\/hdac-activity-colorimetric-assay-kit-2849.html","radio_15b":"Yes","desc":"Colorimetric <b>HDAC<\\/b> Activity Assay Kit: Measure <b>Histone Deacetylase<\\/b> (<b>HDAC<\\/b>) \\nActivity in Just Two Easy Steps. Convenient, High-Throughput Adaptable\\u00a0<b>...<\\/b>"},{"title":"<b>HDAC<\\/b> Activity Fluorometric Assay Kit | BioVision <b>Inc<\\/b>.","link":"http:\\/\\/www.biovision.com\\/hdac-activity-fluorometric-assay-kit-2848.html","radio_15b":"No","desc":"Fluorometric <b>HDAC<\\/b> Activity Assay Kit: Measure <b>Histone Deacetylase<\\/b> (<b>HDAC<\\/b>) \\nActivity within an Hour. Convenient, High-Throughput Adaptable\\u00a0<b>...<\\/b>"},{"title":"Closer to class IIa <b>HDAC<\\/b> inhibitors - Nature","link":"http:\\/\\/www.nature.com\\/scibx\\/journal\\/v6\\/n13\\/full\\/scibx.2013.301.html","radio_15b":"Already Assigned","desc":"Apr 4, 2013 <b>...<\\/b> At least 23 <b>companies<\\/b> have <b>HDAC<\\/b> inhibitors in clinical trials, mostly for cancer, \\nand the majority are nonselective. For example, the two\\u00a0<b>...<\\/b>"},{"title":"<b>HDAC<\\/b> Fluorometric Activity Assay Kit || Cayman Chemical | Supplier","link":"http:\\/\\/www.caymanchem.com\\/catalog\\/10011563","radio_15b":"Yes","desc":"A 96-well fluorometric assay for <b>HDAC<\\/b>. <b>...<\\/b> <b>HDAC<\\/b> Fluorometric Activity Assay Kit <b>...<\\/b> \\nCayman Chemical <b>Company<\\/b> regularly evaluates our shipping methods to\\u00a0<b>...<\\/b>"},{"title":"<b>HDAC<\\/b> Cell-Based Activity Assay Kit - Cayman Chemical","link":"http:\\/\\/www.caymanchem.com\\/catalog\\/600150","radio_15b":"Yes","desc":"An easy tool for studying <b>HDAC<\\/b> activity modulators in whole cells. <b>...<\\/b> Cayman \\nChemical <b>Company<\\/b> regularly evaluates our shipping methods to ensure product\\n\\u00a0<b>...<\\/b>"},{"title":"Next-Generation <b>Histone Deacetylase<\\/b> Inhibitors - Day 1 - Discovery <b>...<\\/b>","link":"http:\\/\\/www.discoveryontarget.com\\/HDAC-Inhibitors\\/","radio_15b":"Yes","desc":"<b>Histone deacetylases<\\/b> (<b>HDAC<\\/b>) Inhibitors HDI Cancer, Inflammation, CNS \\nconference\\/meeting <b>Histone deacetylases<\\/b> (<b>HDACs<\\/b>) have proven to be a \\npromising\\u00a0<b>...<\\/b>"},{"title":"<b>HDAC<\\/b> Program - Envivo Pharmaceuticals","link":"http:\\/\\/www.envivopharma.com\\/pipeline-hdac.php","radio_15b":"No","desc":"<b>Histone deacetylase<\\/b> (<b>HDAC<\\/b>) inhibition results in increases and normalization in \\ngene transcription. EnVivo is currently investigating how this unique activity can\\u00a0<b>...<\\/b>"}]', '{"1":{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" Swedish researchers believe that <strong>HDAC<\\/strong> inhibitors,\\u00a0substances common to some cancer and epilepsy drugs, may also be used to help prevent heart attacks. <strong>HDAC<\\/strong> inhibitors are used to treat cancer because <strong>HDAC<\\/strong> proteins regulate how DNA behaves, and cancer can make <strong>HDAC<\\/strong> proteins turn off genes that keep ...","radio_15":"Yes"},"2":{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" at the 54th annual meeting of the American Society of Hematology (ASH). <strong>HDACs<\\/strong> are members of a group of enzymes that help regulate gene expression. Acetylon''s lead drug, the <strong>HDAC<\\/strong>6 inhibitor ACY-1215, ...","radio_15":"Yes"},"3":{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" and Stuart Schreiber at Harvard University. ","radio_15":"No"},"4":{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" additional selective <strong>HDAC<\\/strong> inhibitor drug candidates for non-cancer disease indications including autoimmune ...","radio_15":"Yes"},"5":{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> inhibitors can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ...","radio_15":"No"},"6":{"title":"Gloucester Pharmaceuticals- Top 20 VC deals of 2008","link":"http:\\/\\/www.fiercebiotech.com\\/special-reports\\/gloucester-pharmaceuticals-top-20-vc-deals-2008","desc":" deacetylase (<strong>HDAC<\\/strong>) inhibitor in Phase III trials for T-cell lymphomas.  ...","radio_15":"Yes"},"7":{"title":"Acetylon raises $12.4M in new venture round ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-raises-124m-new-venture-round\\/2011-02-23","desc":" Boston upstart Acetylon Pharmaceuticals has raised $12.4 million in new venture funds, according to MassHighTech. Citing SEC documents the news service revealed that Acetylon is in the process of raising a $30 million round to back its work developing <strong>HDAC<\\/strong> inhibitors for inflammatory and neurological diseases ...","radio_15":"Already Assigned"},"8":{"title":"Celgene pays $15M for front-row seat on Acetylon myeloma program","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/celgene-pays-15m-front-row-seat-acetylon-myeloma-program\\/2012-02-08","desc":" strategy, Ogier tells FierceBiotech. A Phase Ib study that combines its <strong>HDAC<\\/strong>6 inhibitor ...","radio_15":"No"},"9":{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" azacitidine. Role of <strong>HDAC<\\/strong> inhibitors in cancer Genes that regulate cell growth are frequently silenced ...","radio_15":"Yes"},"10":{"title":"4SC surges on positive midstage data for advanced liver cancer","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-surges-positive-midstage-data-advanced-liver-cancer\\/2012-01-19","desc":" autoimmune disease. A number of biotechs are working on <strong>HDAC<\\/strong> inhibitors, including Curis and Acetylon.- ...","radio_15":"No"}}', 'hdac inhibitor pancreatic cancer', 'hdac inhibitor for colon cancer', '[{"title":"<b>Histone deacetylases<\\/b>: salesmen and customers <b>...<\\/b> - Biology of the Cell","link":"http:\\/\\/www.biolcell.org\\/boc\\/101\\/0193\\/1010193.pdf"},{"title":"EPIGENETICS & CHROMATIN MODIFICATION - Enzo Life Sciences","link":"http:\\/\\/www.enzolifesciences.com\\/fileadmin\\/files\\/catalog\\/enzo_catalog_epigenetics_np_final.pdf"},{"title":"129 CHAPTER VI SUMMARY AND FUTURE DIRECTIONS <b>...<\\/b> - ETD","link":"http:\\/\\/etd.library.vanderbilt.edu\\/available\\/etd-05222008-164304\\/unrestricted\\/07ChapterVIRefs.pdf"},{"title":"Pharmacodynamic Evaluation of the Target Efficacy of SB939, an <b>...<\\/b>","link":"http:\\/\\/mct.aacrjournals.org\\/content\\/10\\/7\\/1207.full.pdf"}]', '3', '2', '', 100);
INSERT INTO `inventions` VALUES(149, '2013-11-14 00:40:53', 2, 'test14nov', 'patent', '', '', 'gansh3', 'gansh16', 'gansh16_1', '', '', 'test', 'a', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '140', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 58);
INSERT INTO `inventions` VALUES(150, '2013-11-14 01:57:27', 33, 'test', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'photo catalysis', 'c', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '1 million over 3 years', '', '', 'field', '83', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-11-19 00:00:00', '', '', '0000-00-00 00:00:00', 'photocatalysis fuel industry', '', '{"2":{"title":"testing 15a, 15b and analytics","id":"168","status":"field"}}', 20, '', '>1m', 'Not Sure', '', 0, '', 'Maybe', 15, '{"0":{"title":"Photocatalyst","link":"http:\\/\\/www.google.com\\/patents\\/WO2013144660A2?cl=en&dq=photocatalysis+fuel+industry&source=uds;","desc":"The present invention relates to a <b>photocatalyst<\\/b> and a method of <b>...<\\/b> of microbial  <b>fuel<\\/b> cells for treatment of <b>industrial<\\/b> wastewater very limited.","filedate":"Thu, 30 May 2013 00:00:00 -0700","applicant":"Keronite International Limited","radio_11b":"duplicate"},"1":{"title":"Multi-external-field-coupled two-dimensional photocatalytic fluidized bed device","link":"http:\\/\\/www.google.com\\/patents\\/CN203002212U?cl=en&dq=photocatalysis+fuel+industry&source=uds;","desc":"A multi-dimensional field coupling <b>photocatalytic<\\/b> fluidized bed <b>...<\\/b> and  transportation <b>fuel<\\/b> combustion produces <b>industrial<\\/b> emissions, car exhaust,\\u00a0<b>...<\\/b>","filedate":"Thu, 27 Dec 2012 00:00:00 -0800","applicant":"\\u6d4e\\u5b81\\u5b66\\u9662","radio_11b":"duplicate"},"2":{"title":"Photocatalytic electrode and fuel cell","link":"http:\\/\\/www.google.com\\/patents\\/WO2007145827A2?cl=en&dq=photocatalysis+fuel+industry&source=uds;","desc":"The adatoms or clusters of adatoms form sites for <b>photocatalysis<\\/b> of <b>...<\\/b> The high  cost of <b>fuel<\\/b> cell energy <b>production<\\/b> is attributable to the need for\\u00a0<b>...<\\/b>","filedate":"Tue, 29 May 2007 00:00:00 -0700","applicant":"John J Mcmahon, Univ Fordham","radio_11b":"duplicate"},"4":{"title":"A photocatalyst for hydrogen production","link":"http:\\/\\/www.google.com\\/patents\\/WO2009070000A2?cl=en&dq=photocatalysis+fuel+industry&source=uds;","desc":"A <b>photocatalyst<\\/b> comprising general formula (I); wherein X is a <b>...<\\/b> The combustion  of fossil <b>fuels<\\/b> which takes place mainly in the <b>industrial<\\/b> areas,\\u00a0<b>...<\\/b>","filedate":"Fri, 02 Jan 2009 00:00:00 -0800","applicant":"Rusli Daik, Mohammad Kassim, Fadhli Hadana Rahman, Universiti Kebangsaan Malaysia, Daud Wan Ramli Wan","radio_11b":"duplicate"},"5":{"title":"High purity graphene synthesis melted in water through photocatalytic reaction","link":"http:\\/\\/www.google.com\\/patents\\/WO2013062306A2?cl=en&dq=photocatalysis+fuel+industry&source=uds;","desc":"<b>Photocatalyst<\\/b> charged anions and manufactured by irradiating light to a solution  <b>....<\\/b> Yeah, nevertheless, reduced pin oxide (RGO), which can be used in many  areas, such as <b>photocatalyst<\\/b>, <b>fuel<\\/b> cells, batteries, <b>.....<\\/b> <b>production<\\/b>\\u00a0<b>...<\\/b>","filedate":"Wed, 24 Oct 2012 00:00:00 -0700","applicant":"Postech Academy-Industry Foundation, \\ud3ec\\ud56d\\uacf5\\uacfc\\ub300\\ud559\\uad50 \\uc0b0\\ud559\\ud611\\ub825\\ub2e8","radio_11b":"duplicate"},"6":{"title":"Photocatalyst for water splitting comprising gallium selenide and ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2012121034A1?cl=en&dq=photocatalysis+fuel+industry&source=uds;","desc":"The <b>photocatalyst<\\/b> for water splitting of the present invention <b>...<\\/b> However,  <b>industrial production<\\/b> of hydrogen has depended on fossil <b>fuels<\\/b>, and\\u00a0<b>...<\\/b>","filedate":"Mon, 20 Feb 2012 00:00:00 -0800","applicant":"The University Of Tokyo, Toyota Jidosha Kabushiki Kaisha","radio_11b":"duplicate"},"7":{"title":"Visible light photocatalyst containing amorphous MgAl2O4 and preparation ...","link":"http:\\/\\/www.google.com\\/patents\\/CN102198395A?cl=en&dq=photocatalysis+fuel+industry&source=uds;","desc":"The invention discloses a visible light <b>photocatalyst<\\/b> containing <b>...<\\/b> comprises the  following steps: 1, treating urea as a <b>fuel<\\/b> A and selecting one of glycine, <b>...<\\/b> time  and low cost, and is suitable for <b>industrial<\\/b> large-scale <b>production<\\/b>.","filedate":"Fri, 15 Apr 2011 00:00:00 -0700","applicant":"\\u6cb3\\u5317\\u79d1\\u6280\\u5927\\u5b66","radio_11b":"duplicate"}}', '[{"title":"Photophysical Property and Photocatalytic Activity of New Gd&lt;sub&gt;2&lt;\\/sub&gt;InSbO&lt;sub&gt;7&lt;\\/sub&gt; and Gd&lt;sub&gt;2&lt;\\/sub&gt;FeSbO&lt;sub&gt;7&lt;\\/sub&gt; Compounds under Visible Light Irradiation","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3565303\\/","desc":"Jingfei Luan, Yong Xu","details":null,"radio_11b2":"duplicate"},{"title":"The design, fabrication, and photocatalytic utility of nanostructured semiconductors: focus on TiO&lt;sub&gt;2&lt;\\/sub&gt;-based nanostructures","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3781710\\/","desc":"Arghya Narayan Banerjee","details":null,"radio_11b2":"duplicate"},{"title":"Facile hydrothermal preparation of titanium dioxide decorated reduced graphene oxide nanocomposite","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3405890\\/","desc":null,"details":null,"radio_11b2":"duplicate"},{"title":"Hydrogen production by Tuning the Photonic Band Gap with the Electronic Band Gap of TiO&lt;sub&gt;2&lt;\\/sub&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3794377\\/","desc":"G. I. N. Waterhouse, A. K. Wahab, M. Al-Oufi, V. Jovic, D. H. Anjum, D. Sun-Waterhouse, J. Llorca, H. Idriss","details":"Sci Rep. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;3: 2849.  &lt;span class=&quot;&quot;&gt;Published online 2013 October 10. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1038\\/srep02849&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"Thin Layer Drying Kinetics of By-Products from Olive Oil Processing","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3233445\\/","desc":"Irene Montero, Teresa Miranda, Jose Ignacio Arranz, Carmen Victoria Rojas","details":null,"radio_11b2":"duplicate"},{"title":"Effects of Nanotoxicity on Female Reproductivity and Fetal Development in Animal Models","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3676785\\/","desc":"Jianling Sun, Qiu Zhang, Zhiping Wang, Bing Yan","details":null,"radio_11b2":"duplicate"},{"title":"Polyhydroxy Fullerenes (Fullerols or Fullerenols): Beneficial Effects on Growth and Lifespan in Diverse Biological Models","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3103525\\/","desc":"Jie Gao, Yihai Wang, Kevin M. Folta, Vijay Krishna, Wei Bai, Paul Indeglia, Angelina Georgieva, Hideya Nakamura, Ben Koopman, Brij Moudgil","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2011; &lt;\\/span&gt;6(5): e19976.  &lt;span class=&quot;&quot;&gt;Published online 2011 May 27. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0019976&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"Recent Applications of Carbon-Based Nanomaterials in Analytical Chemistry: Critical Review","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3088727\\/","desc":"Karen Scida, Patricia W. Stege, Gabrielle Haby, Germ&Atilde;&iexcl;n A. Messina, Carlos D. Garc&Atilde;&shy;a","details":null,"radio_11b2":"duplicate"},{"title":"Nanotechnology, nanotoxicology, and neuroscience","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2728462\\/","desc":"Won Hyuk Suh, Kenneth S. Suslick, Galen D. Stucky, Yoo-Hun Suh","details":null,"radio_11b2":"duplicate"}]', 'test test test test test', 'test test test test test', 'test test test test test', '[{"title":"The <b>Company Corporation<\\/b>: LLC & Incorporation - Small Business <b>...<\\/b>","link":"https:\\/\\/www.incorporate.com\\/","radio_15b":"duplicate","desc":"Protect your assets by forming an LLC or incorporating online today. The \\n<b>Company Corporation''s<\\/b> affordable services can help you easily incorporate your \\nsmall\\u00a0<b>...<\\/b>"},{"title":"The <b>Company Company<\\/b> - producing uplifting musical theatre for the <b>...<\\/b>","link":"http:\\/\\/www.thecompanycompany.com\\/","radio_15b":"duplicate","desc":"The <b>Company Company<\\/b> dedicated to inspiring audiences, nurturing artists and \\nuplifting the community. A new production for us as we help present The Sound\\u00a0<b>...<\\/b>"},{"title":"About Bain - Bain & <b>Company<\\/b> - About","link":"http:\\/\\/www.bain.com\\/about\\/","radio_15b":"duplicate","desc":"Bain & <b>Company<\\/b> is one of the world''s leading <b>business<\\/b> consulting firms. We work \\nwith top executives to help them make better decisions, convert those\\u00a0<b>...<\\/b>"},{"title":"<b>Co<\\/b>.Design | <b>business<\\/b> + design","link":"http:\\/\\/www.fastcodesign.com\\/","radio_15b":"duplicate","desc":"Inspiring stories about innovation and <b>business<\\/b> seen through the lens of design."},{"title":"Disney History | The Walt Disney <b>Company<\\/b>","link":"http:\\/\\/thewaltdisneycompany.com\\/about-disney\\/disney-history","radio_15b":"duplicate","desc":"From humble beginnings as a cartoon studio in the 1920s to today''s global \\n<b>corporation<\\/b>, The Walt Disney <b>Company<\\/b> continues to proudly provide quality\\u00a0<b>...<\\/b>"},{"title":"Welcome to Noodles & <b>Company<\\/b>","link":"http:\\/\\/www.noodles.com\\/","radio_15b":"duplicate","desc":"Noodles, Salads, and Sandwiches from around the world. The best dishes from \\nAsia, the Mediterranean and America - prepared to your liking, the Noodles way."},{"title":"Turner Broadcasting System, <b>Inc<\\/b>. Atlanta, Georgia","link":"http:\\/\\/www.turner.com\\/company","radio_15b":"duplicate","desc":"<b>Company<\\/b> information, history and awards for Turner Broadcasting."},{"title":"McKinsey & <b>Company<\\/b> | Home Page","link":"http:\\/\\/www.mckinsey.com\\/","radio_15b":"duplicate","desc":"McKinsey & <b>Company<\\/b> is the trusted advisor and counselor to many of the world''s \\nmost influential businesses and institutions."}]', '[{"title":"The Southern <b>Company<\\/b> (SO): High Dividend Yield And Compelling <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1864121-high-dividend-yield-and-compelling-valuations-set-southern-company-apart","desc":"11 hours ago <b>...<\\/b> The Southern <b>Company<\\/b> (NYSE:SO), Dominion Resources, Inc. (NYSE:D), Duke \\nEnergy Corp (NYSE:DUK), Consolidated Edison, Inc.","radio_15":"duplicate"},{"title":"Chinese <b>Company<\\/b> Analyst - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/author\\/chinese-company-analyst","desc":"I take long and short positions in the public securities of <b>companies<\\/b> that I discuss \\non Seeking Alpha. Although I choose to remain anonymous, I provide full\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"Xerox: Emerging As A Leading Services <b>Company<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1864821-xerox-emerging-as-a-leading-services-company?source=google_news","desc":"7 hours ago <b>...<\\/b> Xerox Corporation (NYSE:XRX): Xerox: Emerging As A Leading Services \\n<b>Company<\\/b>.","radio_15":"duplicate"},{"title":"Is SO a buy? - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/symbol\\/so","desc":"Up to date analysis of Southern <b>Company<\\/b> (SO) and its stock by hedge fund <b>...<\\/b> \\nFind out what Southern <b>Company<\\/b> is saying about its business from the latest SO\\n\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"IBM Is Not A Technology <b>Company<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1861451-ibm-is-not-a-technology-company","desc":"1 day ago <b>...<\\/b> International Business Machines Corp. (NYSE:IBM), Amazon.com, Inc. (NASDAQ\\n:AMZN), Google Inc (NASDAQ:GOOG): IBM Is Not A\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"The Southern <b>Company<\\/b> (SO): Southern <b>Company<\\/b> - Are The Risks <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1857841-southern-company-are-the-risks-greater-than-the-return","desc":"4 days ago <b>...<\\/b> The Southern <b>Company<\\/b> (NYSE:SO): Southern <b>Company<\\/b> - Are The Risks Greater \\nThan The Return?","radio_15":"duplicate"},{"title":"Is DE a buy? - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/symbol\\/de","desc":"Up to date analysis of Deere & <b>Company<\\/b> (DE) and its stock by hedge fund <b>...<\\/b> Find \\nout what Deere & <b>Company<\\/b> is saying about its business from the latest DE\\u00a0<b>...<\\/b>","radio_15":"duplicate"},{"title":"High Yielding Southern <b>Company<\\/b> Doesn''t Excite Me - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1740022-high-yielding-southern-company-doesnt-excite-me","desc":"Oct 11, 2013 <b>...<\\/b> The Southern <b>Company<\\/b> (NYSE:SO): High Yielding Southern <b>Company<\\/b> Doesn''t \\nExcite Me.","radio_15":"duplicate"}]', 'company', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(152, '2013-11-14 02:20:08', 2, 'test', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'test', 'd', '', 'test', '', '', '', 'a', '', 'test', '', '', '', '', '', 'field', '123', 'Yes', '2013-11-01 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'test', '', '{"2":{"title":"testing happy head","id":"63","status":"field"},"3":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"4":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"5":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"6":{"title":"laser excitation fluorescence","id":"107","status":"field"},"7":{"title":"test 10-29-13 ","id":"109","status":"field"},"8":{"title":"test","id":"117","status":"process"},"9":{"title":"aavishkar","id":"132","status":"field"},"10":{"title":"Better plastics","id":"141","status":"field"},"11":{"title":"test14nov","id":"149","status":"field"}}', -1, '', '100k-1m', 'Yes', 'No', 4, '', 'Maybe', 22, '[{"title":"Test mode control circuit in semiconductor memory device and test mode ...","link":"http:\\/\\/www.google.com\\/patents\\/US8537628?dq=test&source=uds;","desc":"A <b>test<\\/b> mode control circuit is provided to strictly allow entry into a <b>test<\\/b> mode or  prevent a boot failure from occurring during a boot operation for a\\u00a0<b>...<\\/b>","filedate":"Wed, 22 Jun 2011 00:00:00 -0700","applicant":"Samsung Electronics Co., Ltd.","radio_11b":"duplicate"},{"title":"Immune chromatographic test piece and chromatographic analysis method","link":"http:\\/\\/www.google.com\\/patents\\/WO2001031340A1?cl=en&dq=test&source=uds;","desc":"An immune chromatographic <b>test<\\/b> piece which enables accurate qualitative or  quantitative analysis of a sample containing color components (for example,\\u00a0<b>...<\\/b>","filedate":"Wed, 25 Oct 2000 00:00:00 -0700","applicant":"Kitawaki Fumihisa, Matsushita Electric Ind Co Ltd, Nadaoka Masataka, Nakayama Hiroshi, Shigeto Nobuyuki, Takahashi Mie, Tanaka Hirotaka","radio_11b":"duplicate"},{"title":"Scalable scan-based test architecture with reduced test time and test power","link":"http:\\/\\/www.google.com\\/patents\\/US8510616?dq=test&source=uds;","desc":"A scalable scan-based architecture with reduced <b>test<\\/b> time, <b>test<\\/b> power and <b>test<\\/b> pin -count in scan based <b>testing<\\/b> of ICs. In an embodiment, a <b>test<\\/b>\\u00a0<b>...<\\/b>","filedate":"Thu, 14 Feb 2008 00:00:00 -0800","applicant":"Nvidia Corporation","radio_11b":"duplicate"},{"title":"Thermal resistor test apparatus","link":"http:\\/\\/www.google.com\\/patents\\/US8550708?dq=test&source=uds;","desc":"A <b>test<\\/b> apparatus for a thermal resistor includes a control device, a temperature  processing circuit, a voltage regulating circuit and a temperature\\u00a0<b>...<\\/b>","filedate":"Wed, 29 Jun 2011 00:00:00 -0700","applicant":"Hong Fu Jin Precision Industry (Shenzhen) Co., Ltd., Hon Hai Precision Industry Co., Ltd.","radio_11b":"duplicate"},{"title":"Test apparatus, additional circuit and test board for calculating load ...","link":"http:\\/\\/www.google.com\\/patents\\/US8558559?dq=test&source=uds;","desc":"Provided is a <b>test<\\/b> apparatus that measures charge\\/discharge current of an  intermediate capacitor provided between a transmission path\\u00a0<b>...<\\/b>","filedate":"Fri, 03 Sep 2010 00:00:00 -0700","applicant":"Advantest Corporation","radio_11b":"duplicate"},{"title":"Systems and methods for test development process automation for a test harness","link":"http:\\/\\/www.google.com\\/patents\\/US20130275946?dq=test&source=uds;","desc":"Systems and methods for automatic generation of one or more\\u00a0<b>...<\\/b>","filedate":"Mon, 16 Apr 2012 00:00:00 -0700","applicant":"Oracle International Corporation","radio_11b":"duplicate"},{"title":"Adaptive regression test selection within testing environments","link":"http:\\/\\/www.google.com\\/patents\\/US8276123?dq=test&source=uds;","desc":"In general, techniques are described for intelligently selecting <b>test<\\/b> cases within  <b>testing<\\/b> environments. Specifically, a computing device may\\u00a0<b>...<\\/b>","filedate":"Fri, 09 Jan 2009 00:00:00 -0800","applicant":"Juniper Networks, Inc.","radio_11b":"duplicate"},{"title":"Container for dispensing a single test strip","link":"http:\\/\\/www.google.com\\/patents\\/US8550295?dq=test&source=uds;","desc":"The <b>test<\\/b> strip containers accurately dispense one <b>test<\\/b> strip for easy removal. One  <b>test<\\/b> strip container includes a slider with a slot that catches a\\u00a0<b>...<\\/b>","filedate":"Mon, 22 Feb 2010 00:00:00 -0800","applicant":"Roche Diagnostics Operations, Inc.","radio_11b":"duplicate"}]', '[{"title":"Lateral pharyngotomy for selected invasive squamous cell carcinoma of the lateral oropharynx--part I: how.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24325020","desc":"Laccourreye O, Benito J, Menard M, Garcia D, Malinvaud D, Holsinger C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;The Laryngoscope&quot;&gt;Laryngoscope&lt;\\/span&gt;. 2013 Nov;123(11):2712-7. Epub 2013 Jul 8.","radio_11b2":"duplicate"},{"title":"Evaluating squints in children.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24324989","desc":"O''Dowd C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Australian family physician&quot;&gt;Aust Fam Physician&lt;\\/span&gt;. 2013 Dec;42(12):872-4.","radio_11b2":"duplicate"},{"title":"Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24324975","desc":"Bimonte S, Barbieri A, Palma G, Luciano A, Rea D, Arra C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BioMed research international&quot;&gt;Biomed Res Int&lt;\\/span&gt;. 2013;2013:810423. doi: 10.1155\\/2013\\/810423. Epub 2013 Nov 10.","radio_11b2":"duplicate"},{"title":"Prolonged delivery of ciprofloxacin and diclofenac sodium from a polymeric fibre device for the treatment of peridontal disease.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24324962","desc":"Johnston D, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BioMed research international&quot;&gt;Biomed Res Int&lt;\\/span&gt;. 2013;2013:460936. doi: 10.1155\\/2013\\/460936. Epub 2013 Nov 14.","radio_11b2":"duplicate"},{"title":"Evaluation Metrics for Biostatistical and Epidemiological Collaborations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3139813\\/","desc":"Doris McGartland Rubio, Deborah J. del Junco, Rafia Bhore, Christopher J. Lindsell, Robert A. Oster, Knut M. Wittkowski, Leah J. Welty, Yi-Ju Li, Dave DeMets, the Biostatistics, Epidemiology, and &lt;b&gt;Research Design&lt;\\/b&gt; (BERD) Key Function Committee of the Clinical and Translational Science Awards (CTSA) Consortium","details":null,"radio_11b2":"duplicate"},{"title":"Study\\/Experimental\\/&lt;b&gt;Research Design&lt;\\/b&gt;: Much More Than Statistics","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2808761\\/","desc":"Kenneth L. Knight","details":null,"radio_11b2":"duplicate"},{"title":"Analysis of Combined Data from Heterogeneous Study Designs: A Methodological Proposal from the Patient Navigation &lt;b&gt;Research&lt;\\/b&gt; program","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3679186\\/","desc":"Richard G. Roetzheim, Karen M. Freund, Don K. Corle, David M. Murray, Frederick R. Snyder, Andrea C. Kronman, Pascal Jean-Pierre, Peter C. Raich, Alan E. C. Holden, Julie S. Darnell, Victoria Warren-Mears, Steven Patierno, PNRP &lt;b&gt;Design&lt;\\/b&gt;, Analysis Committee","details":null,"radio_11b2":"duplicate"},{"title":"&lt;b&gt;Research design&lt;\\/b&gt; considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3617214\\/","desc":null,"details":null,"radio_11b2":"duplicate"},{"title":"Boh''s pharmacy practice manual : a guide to the clinical experience","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101616447","desc":"Stein, Susan M (Susan Marie), 1966-.","details":"&lt;span class=&quot;src&quot;&gt;Fourth edition. &lt;br&gt;Philadelphia : Wolters Kluwer Health\\/Lippincott Williams &amp; Wilkins, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"Clinical epidemiology : principles, methods, and applications for clinical &lt;b&gt;research&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101613792","desc":"Grobbee, D E; Hoes, Arno W.","details":"&lt;span class=&quot;src&quot;&gt;Second edition. &lt;br&gt;Burlington, Massachusetts : Jones &amp; Bartlett Learning, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"}]', 'a a a a a a', 'a a a a aa ', 'a a a aa a a ', '[{"title":"<b>test company<\\/b> | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/company\\/test-company","desc":"Welcome to the company profile of <b>test company<\\/b> on LinkedIn. test description."},{"title":"My <b>Test Company<\\/b> | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/company\\/my-test-company","desc":"Welcome to the company profile of My <b>Test Company<\\/b> on LinkedIn. Not sure yet."},{"title":"Create <b>Tests<\\/b> for Organizational Training and Certification Programs <b>...<\\/b>","link":"http:\\/\\/www.test.com\\/","desc":"<b>Test<\\/b>.com provides a complete software solution for creating online <b>tests<\\/b> and \\nmanaging enterprise and specialist <b>...<\\/b> Online <b>testing<\\/b>, training and <b>company<\\/b> news\\n\\u00a0<b>...<\\/b>"},{"title":"DNA <b>test company<\\/b> told to stop selling kits - FT.com","link":"http:\\/\\/www.ft.com\\/cms\\/s\\/0\\/09894400-562a-11e3-b6e7-00144feabdc0.html","desc":"Nov 26, 2013 <b>...<\\/b> 23andMe, a DNA <b>testing company<\\/b> that came to symbolise Silicon Valley''s \\nambition of grabbing a leading position in the emerging world of\\u00a0<b>...<\\/b>"},{"title":"Example Domain","link":"http:\\/\\/example.com\\/","desc":"Example Domain. This domain is established to be used for illustrative examples \\nin documents. You may use this domain in examples without prior coordination\\u00a0<b>...<\\/b>"},{"title":"Software <b>Testing<\\/b> | uTest | www.utest.com","link":"http:\\/\\/www.utest.com\\/","desc":"By using uTest''s in-the-wild <b>testing<\\/b> services, real estate <b>company<\\/b> Trulia has \\ndecreased their time to market, increased their app quality and reduced their \\n<b>testing<\\/b>\\u00a0<b>...<\\/b>"},{"title":"Software <b>Testing<\\/b> and Software Quality Assurance (QA) | TESTCO","link":"http:\\/\\/testco.com\\/","desc":"TESTCo occupies a unique niche in the world-wide group of software <b>testing<\\/b> \\n<b>companies<\\/b>. TESTCo is specifically designed to provide as few as one high \\nquality\\u00a0<b>...<\\/b>"},{"title":"Deutsche Post latest <b>company<\\/b> to <b>test<\\/b> out drone deliveries | Digital <b>...<\\/b>","link":"http:\\/\\/www.digitaltrends.com\\/international\\/deutsche-post-dhl-drone-deliveries\\/","desc":"20 hours ago <b>...<\\/b> Following in the footsteps of Amazon and UPS \\u2013 and, while we''re on the subject, \\nDomino''s Pizza \\u2013 German postal services <b>company<\\/b> Deutsche\\u00a0<b>...<\\/b>"}]', '[{"title":"The Stock Market''s November <b>Test<\\/b> [PowerShares QQQ Trust, Series <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1792842-the-stock-markets-november-test","desc":"Oct 31, 2013 <b>...<\\/b> FedEx Corporation (NYSE:FDX), ProShares UltraShort QQQ (ETF) (NYSEARCA:\\nQID), PowerShares QQQ Trust, Series 1 (ETF)\\u00a0<b>...<\\/b>"},{"title":"Posts on European Stress <b>Test<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/author\\/jeb-handwerger\\/instablog\\/tag\\/european%20stress%20test","desc":"Posts on European Stress <b>Test<\\/b>. Posts by Jeb Handwerger. Jeb Handwerger \\ndoesn''t have any Instablog posts on European Stress <b>Test<\\/b>\\u00a0<b>...<\\/b>"},{"title":"<b>Test<\\/b> Environment - Steve Auger - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/instablog\\/318104-steve-auger\\/2355542-test-environment","desc":"Oct 28, 2013 <b>...<\\/b> First of all, I decided not to <b>test<\\/b> every sector for every factor. Instead I will <b>test<\\/b> the \\nentire target universe for all 107 factors, then afterwards\\u00a0<b>...<\\/b>"},{"title":"4G Awards To <b>Test<\\/b> China In 2014 [Alcatel Lucent SA (ADR), China <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1872801-4g-awards-to-test-china-in-2014","desc":"Dec 3, 2013 <b>...<\\/b> Alcatel Lucent SA (ADR) (NYSE:ALU), China Telecom Corporation Limited (ADR\\n) (NYSE:CHA), China Mobile Ltd. (ADR) (NYSE:CHL), China\\u00a0<b>...<\\/b>"},{"title":"Angie''s List <b>testing<\\/b> price cuts, shares -4.2% AH - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/currents\\/post\\/1311452","desc":"Oct 2, 2013 <b>...<\\/b> Angie''s List (ANGI) CEO William Oesterle tells the WSJ his company is running \\"a \\nreduced price-<b>test<\\/b>\\" for subscriptions in markets including\\u00a0<b>...<\\/b>"},{"title":"A Rorschach <b>Test<\\/b> For Bulls And Bears [SPDR S&P 500 ETF Trust <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1716572-a-rorschach-test-for-bulls-and-bears","desc":"Sep 27, 2013 <b>...<\\/b> iShares Barclays Aggregate Bond Fund (NYSEARCA:AGG), SPDR S&P 500 ETF \\nTrust (NYSEARCA:SPY): A Rorschach <b>Test<\\/b> For Bulls And\\u00a0<b>...<\\/b>"},{"title":"Aehr <b>Test<\\/b> Systems'' CEO Discusses F1Q 2014 Results - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1716442-aehr-test-systems-ceo-discusses-f1q-2014-results-earnings-call-transcript","desc":"Sep 26, 2013 <b>...<\\/b> Aehr <b>Test<\\/b> Systems (NASDAQ:AEHR): Aehr <b>Test<\\/b> Systems'' CEO Discusses F1Q \\n2014 Results - Earnings Call Transcript."},{"title":"CardioDX IPO Might <b>Test<\\/b> Well For Aggressive Investors [Quest <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1839232-cardiodx-ipo-might-test-well-for-aggressive-investors","desc":"Nov 14, 2013 <b>...<\\/b> CardioDx, Inc. (), Quest Diagnostics Inc (NYSE:DGX): CardioDX IPO Might <b>Test<\\/b> \\nWell For Aggressive Investors."}]', 'test', 'test', '[{"title":"<b>Market<\\/b> Trends in Genetic Services - Booz Allen Hamilton","link":"http:\\/\\/www.boozallen.com\\/media\\/file\\/GeneticTesting_VP.pdf"},{"title":"U.S. Laboratory Reference <b>Testing<\\/b>: <b>Market<\\/b> Profiles <b>...<\\/b> - G2 Intelligence","link":"http:\\/\\/www.g2intelligence.com\\/g2_media\\/research\\/US-Lab-Reference-Testing-2012.pdf"},{"title":"Global Vitamin D <b>Testing Market<\\/b> 2014 - 2018 <b>...<\\/b> - TwileShare","link":"http:\\/\\/twileshare.com\\/uploads\\/Global_Vitamin_D_Testing_Market_2014_-_2018.pdf"},{"title":"<b>MARKET<\\/b> ANALYSIS Worldwide Security and <b>...<\\/b> - Qualys, Inc.","link":"http:\\/\\/www.qualys.com\\/docs\\/idc_VM_forecast2012.pdf"}]', '2', '1', '', 100);
INSERT INTO `inventions` VALUES(156, '2013-11-14 07:22:31', 1, 'silver and gold clusters in zinc oxide nanocrystals', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'photo catalysis', 'c', '', 'silver and gold clusters in zinc oxide nanocrystals', '', '', '', 'a', '', 'P.T. Manoharan', 'DST', '1111', 'Rs. 3.6 million over 3 years', '', '', 'field', '88', 'Yes', '2013-10-22 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'silver and gold clusters in zinc oxide nanocrystals in photo catalysis', '', '', -2, '', '>1m', 'Yes', 'No', 4, '', 'Maybe', 15, '[{"title":"Conductive nanowire films","link":"http:\\/\\/www.google.com\\/patents\\/WO2013128458A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"The film according to claim 3, wherein the nanowires in said <b>clusters<\\/b> are co- <b>....<\\/b>  The film according to claim 47, wherein the <b>gold<\\/b>:<b>silver<\\/b> ratio is between 7:3 to 3:7.  49. <b>....<\\/b> indium tin <b>oxide<\\/b> (ITO), <b>zinc oxide<\\/b> (<b>ZnO<\\/b>) and fluorine-doped tin <b>oxide<\\/b> <b>.....<\\/b> In  some embodiments, the amount of said nanoparticles is <b>catalytic<\\/b>.","filedate":"Thu, 28 Feb 2013 00:00:00 -0800","applicant":"Ramot At Tel-Aviv University Ltd., P.V. Nano Cell Ltd."},{"title":"CATALYSTS AND METHODS FOR LOW-TEMPERATURE DESTRUCTION OF VOCs IN AIR AND ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2001045833A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"<b>Catalyst<\\/b> compositions provided may be single-phase, mixed-metal <b>oxides<\\/b>, <b>...<\\/b>  <b>Photos<\\/b> <b>.....<\\/b> or more members ofthe group consisting of: copper, manganese and  <b>gold<\\/b> <b>....<\\/b> and cerium <b>oxide<\\/b> (doped with Zr or La as above)-supported <b>silver<\\/b> (2-5%  Ag) or <b>....<\\/b> Sekizawa et al. reported that the water-gas shift <b>catalyst<\\/b> Cu\\/Al2O3- <b>ZnO<\\/b>  has\\u00a0<b>...<\\/b>","filedate":"Wed, 20 Dec 2000 00:00:00 -0800","applicant":"Eltron Research Inc"},{"title":"Core shell nanoparticles and preparation method thereof","link":"http:\\/\\/www.google.com\\/patents\\/WO2009040553A2?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"A nanoparticle according to claim 18, wherein the iron <b>oxide<\\/b> has a <b>...<\\/b> is selected  from the group consisting of copper, <b>silver and gold<\\/b>. <b>.....<\\/b> The resulting structures  exhibited clear confinement of <b>photo<\\/b>-excited carriers in the HgS layer. <b>....<\\/b> Cd or  <b>Zn<\\/b>) were thermolysised, whereby fragmentation of some <b>clusters<\\/b>\\u00a0<b>...<\\/b>","filedate":"Fri, 26 Sep 2008 00:00:00 -0700","applicant":"Steven Matthew Daniels, Imrana Mushtaq, Nanoco Technologies Ltd, Nigel Pickett"},{"title":"Contact and method of fabrication","link":"http:\\/\\/www.google.com\\/patents\\/WO2008143526A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"(a) providing a substrate that comprises <b>zinc oxide<\\/b> material; and <b>....<\\/b> A method as  claimed in Claim 62, wherein the metallic capping layer comprises platinum, <b>gold<\\/b>  or <b>silver<\\/b>. <b>.....<\\/b> <b>nanocrystalline<\\/b> and polycrystalline. <b>....<\\/b> based vapor deposition  technique in which particles (atoms and atomic <b>clusters<\\/b>) are ejected\\u00a0<b>...<\\/b>","filedate":"Mon, 19 May 2008 00:00:00 -0700","applicant":"Canterprise Ltd, Martin Ward Allen, Steven Michael Durbin"},{"title":"Precious metal-metal oxide composite cluster","link":"http:\\/\\/www.google.com\\/patents\\/EP1522341A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"A precious metal - metal <b>oxide<\\/b> composite <b>cluster<\\/b> forming a single particle <b>...<\\/b> Ce,  Pr, Nd, Pm, Sm, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, <b>Zn<\\/b>, Cd, Hg, B, Al, Ga, In, Tl, <b>...<\\/b>  Then, the <b>catalyst<\\/b> consisting of fine <b>cluster<\\/b> particles densely <b>.....<\\/b> Suitable metal  salts for preparing a <b>gold<\\/b> colloid include chloroauric <b>.....<\\/b> Original <b>Image<\\/b>.","filedate":"Wed, 22 Sep 2004 00:00:00 -0700","applicant":"Tanaka Kikinzoku Kogyo K.K."},{"title":"Core shell nanoparticles","link":"http:\\/\\/www.google.com\\/patents\\/EP2341117A2?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"The second material is an <b>oxide<\\/b> of a metal selected from group 8 of the periodic  table. <b>...<\\/b> in the range 2-50 nm, often referred to as ''quantum dots'' or <b>nanocrystals<\\/b>.  <b>....<\\/b> Cd or <b>Zn<\\/b>) were thermolysised, whereby fragmentation of some <b>clusters<\\/b> <b>.....<\\/b> be  selected from the group consisting of copper, <b>silver and gold<\\/b>.","filedate":"Fri, 26 Sep 2008 00:00:00 -0700","applicant":"Nanoco Technologies Ltd"},{"title":"Non-spherical semiconductor nanocrystals and methods of making them","link":"http:\\/\\/www.google.com\\/patents\\/EP1969164A2?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"Second, the presence of trioctylphosphine <b>oxide<\\/b> and phosponic acids are <b>...<\\/b> is to  slow the growth of CdSe and prevent the formation of \\"large\\" CdSe <b>clusters<\\/b>. <b>...<\\/b>  The nanoparticles include <b>gold<\\/b> (Au) (Figure 2A), <b>silver<\\/b> (Ag) (Figure 2B), <b>...<\\/b> [0025]  Figure 11 is a TEM <b>image<\\/b> of PbSe <b>nanocrystals<\\/b> prepared in the\\u00a0<b>...<\\/b>","filedate":"Thu, 21 Dec 2006 00:00:00 -0800","applicant":"The Research Foundation Of State University Of New York"},{"title":"Color selective photodetector and methods of making","link":"http:\\/\\/www.google.com\\/patents\\/WO2012141745A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanocrystals+in+photo+catalysis&source=uds;","desc":"The method of claim 12, wherein the <b>catalyst<\\/b> includes a seed particle. 19. <b>...<\\/b> J- aggregates are <b>clusters<\\/b> of coherently-coupled molecular dyes. <b>....<\\/b> <b>nanocrystalline<\\/b>  grains <b>...<\\/b> palladium, <b>silver<\\/b>, <b>gold<\\/b>, titanium, molybdenum, tungsten, zirconium, <b>...<\\/b>  <b>zinc<\\/b> hydroxide, <b>zinc<\\/b> carbonate, <b>zinc<\\/b> acetate, <b>zinc oxide<\\/b>, magnesium.","filedate":"Tue, 29 Nov 2011 00:00:00 -0800","applicant":"Massachusetts Institute Of Technology"}]', '', 'cluster size as a function of fuel concentration', 'photo luminescent properties of particles', 'possibility for production of hydrogen', '', '', 'photocatalysis ', 'photo catalyst ', '[{"title":"<b>Photocatalyst<\\/b>","link":"http:\\/\\/www.aist.go.jp\\/aist_e\\/research_results\\/publications\\/pamphlet\\/today\\/photocatalyst_e.pdf"},{"title":"<b>Photo<\\/b>-Functionalized Materials Using Nanoparticles: Photocatalysis\\u2020","link":"http:\\/\\/www.kona.or.jp\\/search\\/23_205.pdf"},{"title":"comparative study on cementitious products containing titanium <b>...<\\/b>","link":"http:\\/\\/sts.bwk.tue.nl\\/josbrouwers\\/publications\\/conference26.pdf"},{"title":"singapore going for green products using <b>photo<\\/b>-<b>catalytic<\\/b> technologies","link":"http:\\/\\/www.nano-globe.biz\\/News\\/SIMTechSPRINGPhotocatalysticseminarJan10.pdf"}]', '3', '2', '', 100);
INSERT INTO `inventions` VALUES(158, '2013-11-14 07:47:41', 17, 'mf device for chemotasis assays', 'patent', '', '', 'gansh1', 'gansh11', 'gansh11_2', '', '', 'microfluidic device for chemotasis assays', 'c', '', 'microfluidic device for chemotasis assays', '', '', '', 'a', '', 'NIH', '', '', '', '', '', 'field', '75', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-11-05 00:00:00', '', '', '0000-00-00 00:00:00', 'microfluidic device for chemotasis assays', '', '{"1":{"radio_11a2":"Yes","title":"research tool device","id":"134","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"No","title":"Therapeutic Device - Catheter for drug delivery","id":"135","status":"Disclosure Done & Under Review"}}', 63, '', '100k-1m', 'Yes', 'No', 3, '', 'Yes', 17.5, '[{"title":"Methods and materials for fabricating microfluidic devices","link":"http:\\/\\/www.google.com\\/patents\\/WO2007021762A2?cl=en&dq=microfluidic+device+for+chemotasis+assays&source=uds;","filedate":"Wed, 09 Aug 2006 00:00:00 -0700","applicant":"Univ North Carolina, Joseph M Desimone, Jason P Rolland, Ginger M Denison Rothrock, Paul Resnick","desc":"A micro device, comprising: a <b>microfluidic device<\\/b> including a first <b>......<\\/b> <b>Chemotatic<\\/b>  stimuli include chemorepellants and chemoattractants. <b>....<\\/b> antibodies need to be  absorbed to the surface, as in the case of many ELISA <b>assays<\\/b>.","radio_11b":"somewhat_relevant"},{"title":"Substrates, devices, and methods for cellular assays","link":"http:\\/\\/www.google.com\\/patents\\/WO2005047863A2?cl=en&dq=microfluidic+device+for+chemotasis+assays&source=uds;","filedate":"Wed, 10 Nov 2004 00:00:00 -0800","applicant":"Platypus Technologies Llc, Christopher Murphy, Barbara Israel, Nicholas Abbott","desc":"The <b>assay<\\/b> apparatus of Claim 3, wherein said matrix further comprises <b>...<\\/b> least  one reservoir is fluidically connected to at least one <b>microfluidic<\\/b> channel. <b>......<\\/b>  Granulocyte <b>chemotatic<\\/b> factor [GCF], Neufrophil-activating peptide 1\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Functional materials and novel methods for the fabrication of microfluidic ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2005084191A2?cl=en&dq=microfluidic+device+for+chemotasis+assays&source=uds;","filedate":"Mon, 14 Feb 2005 00:00:00 -0800","applicant":"Univ North Carolina State, Joseph M Desimone, Jason P Rolland, Ginger M Denison","desc":"The <b>microfluidic device<\\/b> of Claim 1 , wherein the liquid PFPE precursor is <b>......<\\/b>  <b>Chemotatic<\\/b> stimuli include chemorepellants and chemoattractants. <b>....<\\/b> need to be  absorbed to the surface, as in the case of many ELISA <b>assays<\\/b>.","radio_11b":"somewhat_relevant"}]', '[{"title":"A sensitive &lt;b&gt;chemotaxis&lt;\\/b&gt; assay using a novel &lt;b&gt;microfluidic device&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24151597","desc":"Zhang C, Jang S, Amadi OC, Shimizu K, Lee RT, Mitchell RN.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BioMed research international&quot;&gt;Biomed Res Int&lt;\\/span&gt;. 2013;2013:373569. doi: 10.1155\\/2013\\/373569. Epub 2013 Sep 14.","radio_11b2":"relevant"},{"title":"Effects of Clostridium difficile toxin A and B on human T lymphocyte migration.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23645153","desc":"Wu D, Joyee AG, Nandagopal S, Lopez M, Ma X, Berry J, Lin F.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Toxins&quot;&gt;Toxins (Basel)&lt;\\/span&gt;. 2013 May 3;5(5):926-38. doi: 10.3390\\/toxins5050926.","radio_11b2":"somewhat_relevant"},{"title":"High-throughput gene expression analysis at the level of single proteins using a &lt;b&gt;microfluidic&lt;\\/b&gt; turbidostat and automated cell tracking.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23267179","desc":"Ullman G, Wallden M, Marklund EG, Mahmutovic A, Razinkov I, Elf J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Philosophical transactions of the Royal Society of London. Series B, Biological sciences&quot;&gt;Philos Trans R Soc Lond B Biol Sci&lt;\\/span&gt;. 2012 Dec 24;368(1611):20120025. doi: 10.1098\\/rstb.2012.0025. Print 2013 Feb 5.","radio_11b2":"least_relevant"},{"title":"Microfluidics for in vitro biomimetic shear stress-dependent leukocyte adhesion &lt;b&gt;assays&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23200903","desc":"Bianchi E, Molteni R, Pardi R, Dubini G.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of biomechanics&quot;&gt;J Biomech&lt;\\/span&gt;. 2013 Jan 18;46(2):276-83. doi: 10.1016\\/j.jbiomech.2012.10.024. Epub 2012 Nov 30. Review.","radio_11b2":"somewhat_relevant"},{"title":"Study on Invadopodia Formation for Lung Carcinoma Invasion with a &lt;b&gt;Microfluidic&lt;\\/b&gt; 3D Culture &lt;b&gt;Device&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3575410\\/","desc":"Shanshan Wang, Encheng Li, Yanghui Gao, Yan Wang, Zhe Guo, Jiarui He, Jianing Zhang, Zhancheng Gao, Qi Wang","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(2): e56448.  &lt;span class=&quot;&quot;&gt;Published online 2013 February 18. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0056448&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Microfluidics for Mammalian Cell &lt;b&gt;Chemotaxis&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3424276\\/","desc":"Beum Jun Kim, Mingming Wu","details":"","radio_11b2":"somewhat_relevant"},{"title":"&lt;b&gt;Microfluidic&lt;\\/b&gt; Technologies for Temporal Perturbations of &lt;b&gt;Chemotaxis&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3153854\\/","desc":"Daniel Irimia","details":"","radio_11b2":"somewhat_relevant"},{"title":"Burn Injury Reduces Neutrophil Directional Migration Speed in &lt;b&gt;Microfluidic&lt;\\/b&gt; Devices","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2912851\\/","desc":"Kathryn L. Butler, Vijayakrishnan Ambravaneswaran, Nitin Agrawal, Maryelizabeth Bilodeau, Mehmet Toner, Ronald G. Tompkins, Shawn Fagan, Daniel Irimia","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2010; &lt;\\/span&gt;5(7): e11921.  &lt;span class=&quot;&quot;&gt;Published online 2010 July 30. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0011921&lt;\\/span&gt;","radio_11b2":"relevant"},{"title":"&lt;b&gt;Microfluidic&lt;\\/b&gt; diagnostics : methods and protocols","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101603343","desc":"Jenkins, Gareth, (Microbiologist); Mansfield, Colin D (Colin David).","details":"&lt;span class=&quot;src&quot;&gt;New York : Humana Press ; Springer, c2013.&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Unravelling single cell genomics : micro and nanotools","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101569079","desc":"Bontoux, Nathalie; Dauphinot, Luce; Potier, Marie-Claude; Royal Society of Chemistry (Great Britain).","details":"&lt;span class=&quot;src&quot;&gt;Cambridge : Royal Society of Chemistry, c2010.&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"least_relevant"}]', 'the r groups are different', ' A A  A  A A  A ', 'A A A A A A ', '[{"title":"A hybrid <b>microfluidic<\\/b>-vacuum <b>device<\\/b> for direct interfacing with <b>...<\\/b>","link":"http:\\/\\/www.biomedcentral.com\\/1472-6750\\/7\\/60\\/","radio_15b":"least_likely","desc":"Sep 20, 2007 <b>...<\\/b> We have developed and validated a novel <b>microfluidic device<\\/b> that can directly <b>...<\\/b> \\nUnfortunately, these conventional <b>assays<\\/b> are not capable of generating <b>.....<\\/b> The \\nPetri dish was placed on a time-lapse microsope with a 37\\u00b0C, 5% <b>CO<\\/b>2 chamber. \\n<b>....<\\/b> Boyden SV: The <b>chemotatic<\\/b> effect of mixtures of antibody and\\u00a0<b>...<\\/b>"},{"title":"A hybrid <b>microfluidic<\\/b>-vacuum <b>device<\\/b> for direct interfacing <b>...<\\/b> - Springer","link":"http:\\/\\/link.springer.com\\/article\\/10.1186%2F1472-6750-7-60","radio_15b":"least_likely","desc":"We have developed and validated a novel <b>microfluidic device<\\/b> that can <b>...<\\/b> the \\nadvantages of a microfluidic approach to biological <b>assays<\\/b> without changing\\u00a0<b>...<\\/b>"},{"title":"\\u00b5-Slide I","link":"http:\\/\\/n-genetics.com\\/catalog\\/ibidicatalog.pdf","radio_15b":"least_likely","desc":"<b>assays<\\/b> and <b>co<\\/b>-cultivation of cells <b>......<\\/b> A \\u00b5-Slide for switchable <b>chemotatic<\\/b> \\ngradients that merges 3 <b>...<\\/b> <b>Microfluidic<\\/b> bi-directional gradient generator <b>.....<\\/b> open \\narchitecture using the Luer connectors allows the use of any kind of flow <b>devices<\\/b>."},{"title":"Patent EP2537657A2 - Methods and materials for fabricating <b>...<\\/b>","link":"http:\\/\\/www.google.com\\/patents\\/EP2537657A2","radio_15b":"somewhat_likely","desc":"Dec 26, 2012 <b>...<\\/b> <b>Microfluidic devices<\\/b> developed in the early 1990s were fabricated from hard <b>......<\\/b> \\nreactive <b>co<\\/b>-monomers, and functionalization agents, examples of which are <b>......<\\/b> \\n<b>Chemotatic<\\/b> stimuli include chemorepellants and chemoattractants. <b>....<\\/b> need to be \\nabsorbed to the surface, as in the case of many ELISA <b>assays<\\/b>."},{"title":"ACTC Acquires the IP Rights to a Japanese \\"Cell Observation <b>...<\\/b>","link":"http:\\/\\/investorstemcell.com\\/forum\\/act-sec-documents-legal-matters-patents\\/31410.htm","radio_15b":"somewhat_likely","desc":"A solution temperature control <b>device<\\/b> in a biological cell observing chamber <b>...<\\/b> \\nMedical \\/ Chemistry & Physics <b>device<\\/b> | Products Info | HIRATA <b>Corporation<\\/b>. <b>.....<\\/b> If \\nso, would an apparatus enabling scientists to isolate <b>chemotatic<\\/b> cells aid in <b>....<\\/b> or \\nhow about creating an <b>assay<\\/b> in the form of a portable chemotaxis\\u00a0<b>...<\\/b>"},{"title":"Anthony Ka Lun Cheung | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/pub\\/anthony-ka-lun-cheung\\/61\\/86a\\/bb7","radio_15b":"least_likely","desc":"LinkedIn is the world''s largest <b>business<\\/b> network, helping professionals like \\nAnthony <b>...<\\/b> a rotating disk <b>device<\\/b> incorporating centrifugal <b>microfluidics<\\/b> for \\nperforming actuation <b>...<\\/b> ionomycin or <b>chemotatic<\\/b> peptide formyl-methionine-\\nleucine-pheylalanine <b>...<\\/b> The overall efficiency of the <b>assay<\\/b> is 80.6%, which is \\ncomparable to other\\u00a0<b>...<\\/b>"},{"title":"Qiang Chen, JoVE Author","link":"http:\\/\\/www.jove.com\\/author\\/Qiang_Chen","radio_15b":"somewhat_likely","desc":"A Compact Disk-like Centrifugal <b>Microfluidic<\\/b> System for High-throughput <b>...<\\/b> In this \\nstudy, polymerase chain reaction (PCR) was used to <b>assay<\\/b> several tumor <b>....<\\/b> \\nIntraoperative <b>Device<\\/b> Closure of Doubly Committed Subarterial Ventricular \\nSeptal <b>.....<\\/b> <b>Co<\\/b>-expression of the GP1-heavy chain fusion and the 6D8 light chain \\nusing a\\u00a0<b>...<\\/b>"},{"title":"Tennessee : 160 650 : Micro 650 Compilation - Course Hero","link":"http:\\/\\/www.coursehero.com\\/file\\/1249997\\/Micro-650-Compilation\\/","radio_15b":"least_likely","desc":"<b>...<\\/b> (such as alterations in metabolism, <b>chemotatic<\\/b> components, pigment \\ncomposition, etc.). <b>....<\\/b> 1.3 <b>Microfluidic Devices<\\/b> 1.3.1 Theory <b>Microfluidic devices<\\/b> (\\nlab on chip devices) <b>....<\\/b> A sensitive, versatile microfluidic <b>assay<\\/b> for bacterial \\nchemotaxis. <b>....<\\/b> but also a trademarked name owned by Biotage (a <b>company<\\/b> that \\nuntil 2003, was\\u00a0<b>...<\\/b>"}]', '', 'microfluidic device for chemotasis assay', 'microfluidic chemotasis devices', '', '3', '3', '', 100);
INSERT INTO `inventions` VALUES(160, '2013-11-14 07:57:09', 17, 'testing 11-19-13', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'Reagents for photocatalysis', 'c', '', 'Photo catalysis reagents', '', '', '', 'a', '', 'P.T. Manoharan', 'DST', '15111', 'Rs. 3.6 million over 3 years', '', '', 'field', '88', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-11-07 00:00:00', '', '', '0000-00-00 00:00:00', 'silver and gold clusters in zinc oxide nanoclusters in photo catalysis', '', '{"1":{"radio_11a2":"Yes","title":"silver and gold clusters in zinc oxide nanocrystals","id":"156","status":"Disclosure Done & Under Review"}}', 27, '', '>1m', 'Yes', 'No', 4, '', 'Maybe', 15, '[{"title":"Method for the preparation of thin film metal oxide cluster fluid sensors","link":"http:\\/\\/www.google.com\\/patents\\/WO2008143534A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Thu, 22 May 2008 00:00:00 -0700","applicant":"Simon Anthony Brown, Andreas Lassesson, Monica Schulze, Lith Joris Van","desc":"Method for the preparation of thin film metal <b>oxide cluster<\\/b> fluid sensors <b>...<\\/b>  molybdenum, <b>zinc<\\/b>, indium, tantalum, copper, gadolinium, palladium, <b>silver<\\/b>,  platinum, <b>gold<\\/b>, rhodium, ruthenium, yttrium and\\/or nickel and their <b>oxides<\\/b>. <b>....<\\/b> In  this invention the active component constitutes a Pd <b>nanocluster<\\/b> film having\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Nanostructures, systems, and methods for photocatalysis","link":"http:\\/\\/www.google.com\\/patents\\/WO2012145622A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Fri, 20 Apr 2012 00:00:00 -0700","applicant":"Sun Catalytix Corporation","desc":"This energy may be provided in the form of light, and <b>photocatalysis<\\/b> <b>.....<\\/b> including,  but not limited to,Ti02, SrTi03, <b>ZnO<\\/b>, indium tin oxide (ITO), <b>.....<\\/b> how uniform the  <b>nanoclusters<\\/b> are) are used as the catalytic <b>cluster<\\/b>, <b>......<\\/b> Suitable oxygen evolving  catalysts include RuC>2, Ir02, <b>gold<\\/b>, palladium, platinum, <b>silver<\\/b>,\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Metallic nano cluster\\/silicon dioxide hollow nuclear shell structured ...","link":"http:\\/\\/www.google.com\\/patents\\/CN102019431B?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Thu, 30 Sep 2010 00:00:00 -0700","applicant":"\\u5927\\u8fde\\u7406\\u5de5\\u5927\\u5b66","desc":"A method of metal <b>nano-clusters<\\/b> \\/ Hollow Silica Nanoparticles <b>....<\\/b> that said The  metal nano-family as V, W, Ru, Rh, Fe, Co, N1, Cu, <b>Zn<\\/b>, Pd, Pt, Au, Ag, <b>...<\\/b> metal  core - shell of silica nano-reactor of the <b>catalytic<\\/b> material, the sensor <b>...<\\/b> or solid Au \\/SiO2 for selective removal of <b>gold<\\/b> nuclei obtained hollow Au\\/Si02.","radio_11b":"somewhat_relevant"},{"title":"External modification of composite organic inorganic nanoclusters","link":"http:\\/\\/www.google.com\\/patents\\/WO2007018551A2?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Fri, 02 Sep 2005 00:00:00 -0700","applicant":"Intel Corp, Sun Lei, Xing Su, Jingwu Zhang","desc":"The <b>nanocluster<\\/b> of claim 1 wherein the metal particles are comprised of a metal  selected from group consisting of <b>silver<\\/b>, <b>gold<\\/b>, copper,\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Method for depositing nanoparticles on substrates","link":"http:\\/\\/www.google.com\\/patents\\/EP2611948A2?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Thu, 01 Sep 2011 00:00:00 -0700","applicant":"Facult\\u00e9s Universitaires Notre-Dame de la Paix, Universit\\u00e9 Libre de Bruxelles, Centre de Recherche Public - Gabriel Lippmann","desc":"In other words, no agglomeration of nanoparticles (or <b>nanoclusters<\\/b>) or no <b>...<\\/b>  carbide (SiC), silicon <b>dioxide<\\/b> (S1O2), tungsten carbide (WC) , <b>gold<\\/b> (Au) , eudragit , <b>....<\\/b> iron acetylacetonate, <b>silver<\\/b> acetylacetonate, <b>zinc<\\/b> acetylacetonate, <b>....<\\/b> for  visible-light- activated <b>photocatalysis<\\/b> using different bacterial indicators .","radio_11b":"somewhat_relevant"},{"title":"Process for the recovery of natural nanoclusters of metals and other ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2001094650A2?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Mon, 28 May 2001 00:00:00 -0700","applicant":"Birch Mountain Resources Ltd, Hugh J Abercrombie","desc":"Desorbing the <b>nanoclusters<\\/b> from the surface of host substrates in an aqueous <b>...<\\/b>  from the group consisting of oxygen, sulfur <b>dioxide<\\/b>, and nitrous <b>oxide<\\/b>. <b>...<\\/b> nickel,  copper and <b>zinc<\\/b>, and the precious metals including <b>gold<\\/b>, <b>silver<\\/b> and the <b>...<\\/b> <b>clusters<\\/b>  or nanoparticles, although the more apt term <b>nanocluster<\\/b> is now\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"A metal particle, its preparation and use, and a material or device ...","link":"http:\\/\\/www.google.com\\/patents\\/WO1999001766A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Fri, 04 Jul 1997 00:00:00 -0700","applicant":"Univ Utrecht","desc":"For the ultrasmall <b>gold clusters<\\/b>, the on-growth of <b>silver<\\/b> depends strongly on the  cluster size. <b>....<\\/b> ion-exchange resins, and semi-conductors such as p-GaAs, Ti02,  <b>ZnO<\\/b>, CdS and Cd3P2. <b>....<\\/b> Future applications of quantum-sized metal  <b>nanoclusters<\\/b> can be thought of as <b>...<\\/b> Applications in (<b>photo<\\/b>) <b>catalysis<\\/b>.","radio_11b":"somewhat_relevant"},{"title":"Methods and systems useful for solar energy storage","link":"http:\\/\\/www.google.com\\/patents\\/WO2013006427A1?cl=en&dq=silver+and+gold+clusters+in+zinc+oxide+nanoclusters+in+photo+catalysis&source=uds;","filedate":"Fri, 29 Jun 2012 00:00:00 -0700","applicant":"Sun Catalytix Corporation","desc":"<b>Photocatalysis<\\/b> (e.g., involving an <b>oxidation<\\/b> and\\/or reduction <b>......<\\/b> on how uniform  the <b>nanoclusters<\\/b> are) are used as the catalytic <b>cluster<\\/b>, <b>...<\\/b> A nanostructure-forming  catalyst can be, for example, <b>gold<\\/b> or a <b>gold<\\/b>-containing material in certain <b>...<\\/b> a  transition metal such as <b>silver<\\/b>, copper, <b>zinc<\\/b>, cadmium, iron, nickel,\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"}]', '[{"title":"Anisotropic nanomaterials: structure, growth, assembly, and functions","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3215190\\/","desc":"Panikkanvalappil R. Sajanlal, Theruvakkattil S. Sreeprasad, Akshaya K. Samal, Thalappil Pradeep","details":"Nano Rev. &lt;span class=&quot;citation-publication-date&quot;&gt;2011; &lt;\\/span&gt;2: 10.3402\\/nano.v2i0.5883.  &lt;span class=&quot;&quot;&gt;Published online 2011 February 16. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3402\\/nano.v2i0.5883&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Nanocomposites of polymer and inorganic nanoparticles for optical and magnetic applications","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3215211\\/","desc":"Shanghua Li, Meng Meng Lin, Muhammet S. Toprak, Do Kyung Kim, Mamoun Muhammed","details":"Nano Rev. &lt;span class=&quot;citation-publication-date&quot;&gt;2010; &lt;\\/span&gt;1: 10.3402\\/nano.v1i0.5214.  &lt;span class=&quot;&quot;&gt;Published online 2010 August 2. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3402\\/nano.v1i0.5214&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Electrochemical Sensors and Biosensors","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3264821\\/","desc":"Danielle W. Kimmel, Gabriel LeBlanc, Mika E. Meschievitz, David E. Cliffel","details":"","radio_11b2":"somewhat_relevant"}]', 'niche uses due to use of zinc oxide', 'catalyst serves this and that unmet need', 'accelerates process by several fold', '[{"title":"A hybrid <b>microfluidic<\\/b>-vacuum device for direct interfacing with <b>...<\\/b>","link":"http:\\/\\/www.biomedcentral.com\\/1472-6750\\/7\\/60\\/","desc":"Sep 20, 2007 <b>...<\\/b> <b>Microfluidics<\\/b> is an enabling technology with a number of <b>...<\\/b> These gradient-\\ngenerating <b>microfluidic<\\/b> devices allow miniaturized real-time <b>cellular assays<\\/b> <b>.....<\\/b> \\nThe Petri dish was placed on a time-lapse microsope with a 37\\u00b0C, 5% <b>CO<\\/b>2 \\nchamber. <b>....<\\/b> Boyden SV: The <b>chemotatic<\\/b> effect of mixtures of antibody and\\u00a0<b>...<\\/b>"},{"title":"\\u00b5-Slide III 3in1 - Ibidi","link":"http:\\/\\/ibidi.com\\/xtproducts\\/en\\/ibidi-Labware\\/Chemotaxis-Slides\\/m-Slide-III-3in1","desc":"A \\u03bc-Slide for switchable <b>chemotatic<\\/b> gradients that merges 3 separated liquids \\ninto one channel. Dynamic fluidic gradients with a maximum time resolution\\u00a0<b>...<\\/b>"},{"title":"A hybrid <b>microfluidic<\\/b>-vacuum device for direct interfacing <b>...<\\/b> - Springer","link":"http:\\/\\/link.springer.com\\/article\\/10.1186%2F1472-6750-7-60","desc":"<b>Microfluidics<\\/b> is an enabling technology with a number of advantages over \\ntraditional <b>...<\\/b> allows reversible application of <b>microfluidic<\\/b> gradients onto wet <b>cell<\\/b> \\nculture surfaces. <b>...<\\/b> the advantages of a <b>microfluidic<\\/b> approach to biological \\n<b>assays<\\/b> without changing <b>....<\\/b> Springer, Part of Springer Science+<b>Business<\\/b> Media \\nPrivacy Policy,\\u00a0<b>...<\\/b>"},{"title":"<b>cells<\\/b> in focus","link":"http:\\/\\/n-genetics.com\\/catalog\\/ibidicatalog.pdf","desc":"ibidi has developed two <b>cell<\\/b> culture products for <b>co<\\/b>-cultivation <b>assays<\\/b>. When \\nusing the \\u00b5-Slide <b>......<\\/b> A \\u00b5-Slide for switchable <b>chemotatic<\\/b> gradients that merges 3 \\nseparated liquids <b>...<\\/b> <b>Microfluidic<\\/b> bi-directional gradient generator. \\u2022 Fully \\ncompatible\\u00a0<b>...<\\/b>"},{"title":"ACTC Acquires the IP Rights to a Japanese \\"<b>Cell<\\/b> Observation <b>...<\\/b>","link":"http:\\/\\/investorstemcell.com\\/forum\\/act-sec-documents-legal-matters-patents\\/31410.htm","desc":"Since the state and quantity of <b>cells<\\/b> moving from one well to the other <b>...<\\/b> Medical \\/ \\nChemistry & Physics device | Products Info | HIRATA <b>Corporation<\\/b>. <b>.....<\\/b> an \\napparatus enabling scientists to isolate <b>chemotatic cells<\\/b> aid in this approach? <b>....<\\/b> \\nor how about creating an <b>assay<\\/b> in the form of a portable chemotaxis\\u00a0<b>...<\\/b>"},{"title":"Anthony Ka Lun Cheung | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/pub\\/anthony-ka-lun-cheung\\/61\\/86a\\/bb7","desc":"LinkedIn is the world''s largest <b>business<\\/b> network, helping professionals like \\nAnthony <b>...<\\/b> At the same time our group had developed a centrifugal <b>microfluidic<\\/b> <b>...<\\/b> \\nDegranulation in basophils or mast <b>cells<\\/b> is an indicator to demonstrate allergic \\nreaction. <b>...<\\/b> The overall efficiency of the <b>assay<\\/b> is 80.6%, which is comparable to \\nother\\u00a0<b>...<\\/b>"},{"title":"Qiang Chen, JoVE Author","link":"http:\\/\\/www.jove.com\\/author\\/Qiang_Chen","desc":"A Compact Disk-like Centrifugal <b>Microfluidic<\\/b> System for High-throughput <b>...<\\/b> of p53 \\nexons 7 and 8 of these novel tumor <b>cell<\\/b> lines were <b>assayed<\\/b> by sequencing, and \\nthe <b>......<\\/b> In HeLa <b>cells<\\/b> expressing Parkin, <b>co<\\/b>-immunoprecipitation of endogenous \\n<b>......<\\/b> [Phylogenic Diversity of Soil <b>Chemotatic<\\/b> Bacteria in a Phosphorous-rich Area\\n\\u00a0<b>...<\\/b>"},{"title":"Functional Materials and Novel Methods for the Fabrication of <b>...<\\/b>","link":"http:\\/\\/www.freepatentsonline.com\\/y2007\\/0275193.html","desc":"Nov 29, 2007 <b>...<\\/b> The <b>microfluidic<\\/b> device of claim 1, wherein the liquid PFPE <b>......<\\/b> The method of \\nclaim 187, wherein the sample comprises one or more of an antibody, a <b>cell<\\/b> \\nreceptor, <b>.....<\\/b> the judicious choice of additives, fillers, reactive <b>co<\\/b>-monomers, and \\n<b>......<\\/b> High throughput screening <b>assays<\\/b> of synthesized molecules and\\u00a0<b>...<\\/b>"}]', '', 'microfluidic cell assay for chemotasis', 'Photo catalysts', '[{"title":"Photocatalyst","link":"http:\\/\\/www.aist.go.jp\\/aist_e\\/research_results\\/publications\\/pamphlet\\/today\\/photocatalyst_e.pdf"},{"title":"<b>Photo<\\/b>-Functionalized Materials Using Nanoparticles: Photocatalysis\\u2020","link":"http:\\/\\/www.kona.or.jp\\/search\\/23_205.pdf"},{"title":"\\u2013 Final Report \\u2013 - European Commission - Europa","link":"http:\\/\\/ec.europa.eu\\/research\\/industrial_technologies\\/pdf\\/eu-asia-report_en.pdf"},{"title":"singapore going for green products using <b>photo<\\/b>-<b>catalytic<\\/b> technologies","link":"http:\\/\\/www.nano-globe.biz\\/News\\/SIMTechSPRINGPhotocatalysticseminarJan10.pdf"}]', '2', '1', '', 93);
INSERT INTO `inventions` VALUES(162, '2013-11-17 14:49:57', 1, 'yyy', 'patent', '', '', 'gansh2', 'gansh12', 'gansh16_2', '', '', 'hhhh', 'b', '', 'bbbb', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '105', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'silver and gold clusters in zinc oxide nanocrystals in photo catalysis', '', '{"2":{"title":"silver and gold clusters in zinc oxide nanocrystals","id":"156","status":"field"}}', 0, '', '>1m', 'Not Sure', '', 0, '', 'No', 11, '{"0":{"title":"Method of reducing electromigration of silver and article made thereby","link":"http:\\/\\/www.google.com\\/patents\\/EP2640572A2?cl=en&dq=silver+and&source=uds;","desc":"A method includes: providing a <b>silver<\\/b>-containing conductive member disposed  on a portion of a surface of chemically-strengthened glass,\\u00a0<b>...<\\/b>","filedate":"Fri, 28 Oct 2011 00:00:00 -0700","applicant":"3M Innovative Properties Company","radio_11b":"Yes"},"1":{"title":"Silver and silver oxide catalysts for the oxidation of carbon monoxide in ...","link":"http:\\/\\/www.google.com\\/patents\\/US8360073?dq=silver+and&source=uds;","desc":"A component of a cigarette comprises a <b>silver<\\/b>-based catalyst for the conversion  of carbon monoxide to carbon dioxide. The <b>silver<\\/b>-based\\u00a0<b>...<\\/b>","filedate":"Tue, 18 May 2010 00:00:00 -0700","applicant":"Philip Morris Usa Inc.","radio_11b":"No"},"2":{"title":"Gold-based alloy, free of silver and tin, for dental copings or abutments","link":"http:\\/\\/www.google.com\\/patents\\/EP2606159A1?cl=en&dq=silver+and&source=uds;","desc":"Alloys and dental copings or abutments formed of alloys include 50-60 wt% gold,  5-14 wt% platinum, 0.1-3.0 wt% iridium and the remainder\\u00a0<b>...<\\/b>","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deringer-Ney, Inc.","radio_11b":"No"},"3":{"title":"Method for protecting silver and silver alloy surfaces against tarnishing","link":"http:\\/\\/www.google.com\\/patents\\/EP2539487A1?cl=en&dq=silver+and&source=uds;","desc":"A method for protecting <b>silver and silver<\\/b> alloy surfaces against tarnishing,  characterised by: - initially subjecting the surface to be treated to\\u00a0<b>...<\\/b>","filedate":"Wed, 23 Feb 2011 00:00:00 -0800","applicant":"Mesa S.A.S. Di Malimpensa Simona E Davide E C.","radio_11b":"Yes"},"5":{"title":"Silver or mercury exchanged macroporous organofunctional polysiloxane resins","link":"http:\\/\\/www.google.com\\/patents\\/WO2000056454A1?cl=en&dq=silver+and&source=uds;","desc":"There is provided a macroporous, strong-acid polysiloxane ion exchange resin  wherein at least one percent of the active sites have been converted to the <b>silver<\\/b> \\u00a0<b>...<\\/b>","filedate":"Tue, 21 Mar 2000 00:00:00 -0800","applicant":"Celanese Int Corp","radio_11b":"No"},"6":{"title":"Method of using colloidal silver and gold anti-microbial items to create ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2012088399A3?cl=en&dq=silver+and&source=uds;","desc":"Gelatinous foam, coated paper, fabric, and polymer materials combined with the  Colloidal <b>Silver or<\\/b> Gold additive to formulate products with\\u00a0<b>...<\\/b>","filedate":"Thu, 22 Dec 2011 00:00:00 -0800","applicant":"Harris Franco Dokmanovich","radio_11b":"Yes"},"7":{"title":"Silver and titanium containing catalyst and process for the direct oxidation ...","link":"http:\\/\\/www.google.com\\/patents\\/WO1999000188A1?cl=en&dq=silver+and&source=uds;","desc":"A process and catalysts for the direct oxidation of an olefin having three or more  carbon atoms, such as propylene, by oxygen to an olefin oxide, such as\\u00a0<b>...<\\/b>","filedate":"Thu, 18 Dec 1997 00:00:00 -0800","applicant":"Robert G Bowman, Howard W Clark, Dow Chemical Co, George E Hartwell, Alex Kuperman, Garmt R Meima","radio_11b":"May Be"}}', '[{"title":"Image quality characteristics of handheld display devices for medical imaging.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24236113","desc":"Yamazaki A, Liu P, Cheng WC, Badano A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Nov 13;8(11):e79243. doi: 10.1371\\/journal.pone.0079243.","radio_11b2":"No"},{"title":"Depletion of Spleen Macrophages Delays AA Amyloid Development: A Study Performed in the Rapid Mouse Model of AA Amyloidosis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24236094","desc":"Lundmark K, Vahdat Shariatpanahi A, Westermark GT.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Nov 13;8(11):e79104. doi: 10.1371\\/journal.pone.0079104.","radio_11b2":"Yes"},{"title":"Antiviral activity of mycosynthesized &lt;b&gt;silver&lt;\\/b&gt; nanoparticles against herpes simplex virus and human parainfluenza virus type 3.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24235828","desc":"Gaikwad S, Ingle A, Gade A, Rai M, Falanga A, Incoronato N, Russo L, Galdiero S, Galdiero M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of nanomedicine&quot;&gt;Int J Nanomedicine&lt;\\/span&gt;. 2013;8:4303-14. doi: 10.2147\\/IJN.S50070. Epub 2013 Nov 6.","radio_11b2":"No"},{"title":"Synthesis, optimization, and characterization of &lt;b&gt;silver&lt;\\/b&gt; nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24235826","desc":"Singh R, Wagh P, Wadhwani S, Gaidhani S, Kumbhar A, Bellare J, Chopade BA.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of nanomedicine&quot;&gt;Int J Nanomedicine&lt;\\/span&gt;. 2013;8:4277-90. doi: 10.2147\\/IJN.S48913. Epub 2013 Nov 6.","radio_11b2":"No"},{"title":"Solid-source growth and atomic-scale characterization of graphene on Ag(111).","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24231905","desc":"Kiraly B, Iski EV, Mannix AJ, Fisher BL, Hersam MC, Guisinger NP.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Nature communications&quot;&gt;Nat Commun&lt;\\/span&gt;. 2013 Nov 15;4:2804. doi: 10.1038\\/ncomms3804.","radio_11b2":"Yes"}]', 'ccc', 'vv', 'vv', '[{"title":"Superior efficacy of <b>co<\\/b>-treatment with dual PI3K\\/mTOR <b>inhibitor<\\/b> NVP <b>...<\\/b>","link":"http:\\/\\/www.impactjournals.com\\/oncotarget\\/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=724","radio_15b":"No","desc":"Superior efficacy of <b>co<\\/b>-treatment with dual PI3K\\/mTOR inhibitor NVP-BEZ235 \\nand pan-<b>histone deacetylase inhibitor<\\/b> against human <b>pancreatic cancer<\\/b>."},{"title":"About Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/about_pharmacyclics.html","radio_15b":"No","desc":"Pharmacyclics, <b>Inc<\\/b>. is a biopharmaceutical <b>company<\\/b> that designs, develops and \\n<b>...<\\/b> factor expressing tumors in oncology (being investigated in <b>pancreatic cancer<\\/b>). \\n<b>...<\\/b> an oral Histone Deacetylase (<b>HDAC<\\/b>) <b>inhibitor<\\/b> being investigated in oncology\\u00a0<b>...<\\/b>"},{"title":"Abexinostat HCl (PCI-24781), <b>PanHDAC<\\/b>-<b>inhibitor<\\/b> - Pharmacyclics, <b>Inc<\\/b>.","link":"http:\\/\\/www.pharmacyclics.com\\/clinical_trial_hdac_pcyc_pci24781.html","radio_15b":"Yes","desc":"Abexinostat Hydrochloride is an oral <b>inhibitor<\\/b> of <b>histone deacetylase<\\/b> (<b>HDAC<\\/b>) \\nenzymes that shows anti-<b>tumor<\\/b> activity in vitro and in vivo. PCI-24781 treatment\\u00a0<b>...<\\/b>"},{"title":"Pharmacyclics Announces Multiple Presentations at the American <b>...<\\/b>","link":"http:\\/\\/ir.pharmacyclics.com\\/releasedetail.cfm?ReleaseID=460491","radio_15b":"Yes","desc":"Apr 15, 2010<b>...<\\/b> Btk inhibitor PCI-32765 in a mouse model of <b>pancreatic cancer<\\/b> (Soucek et al). \\n<b>...<\\/b> In addition, our <b>HDAC inhibitor<\\/b> PCI-24781 is now showing synergy with <b>...<\\/b> Mast \\ncell inhibition by Btk inhibitor PCI-32765 as a Title: potential cancer therapy <b>...<\\/b> \\nPharmacyclics(R) is a clinical-stage biopharmaceutical <b>company<\\/b>\\u00a0<b>...<\\/b>"},{"title":"<b>Histone deacetylase inhibitors<\\/b> in the treatment of <b>cancer<\\/b>: overview <b>...<\\/b>","link":"http:\\/\\/www.reactionbiology.com\\/webapps\\/main\\/press\\/20130128.pdf","radio_15b":"Yes","desc":"Jan 28, 2013 <b>...<\\/b> perspectives. <b>Histone deacetylase inhibitors<\\/b> (HDACis) are one of the last \\nfrontiers in pharmaceutical research. <b>...<\\/b> developed by Merck 56 <b>Co<\\/b>., <b>Inc<\\/b>. and, in. \\nNovember <b>......<\\/b> Gemcitabine <b>Pancreatic cancer<\\/b> or non-small-cell lung."},{"title":"Cell Death and Disease - The <b>HDAC inhibitor<\\/b>, MPT0E028 <b>...<\\/b>","link":"http:\\/\\/www.nature.com\\/cddis\\/journal\\/v4\\/n9\\/full\\/cddis2013330a.html","radio_15b":"Yes","desc":"Sep 19, 2013 <b>...<\\/b> lung cancer; <b>HDAC<\\/b>; synergistic; EGFR; apoptosis; erlotinib <b>....<\\/b> However, \\nMPT0E028 and erlotinib <b>co<\\/b>-treatment synergistically induced the <b>......<\\/b> <b>inhibition<\\/b> \\nand enhances gemcitabine-induced cell death in <b>pancreatic cancer<\\/b>."},{"title":"Dietary phytochemicals, <b>HDAC inhibition<\\/b>, and DNA damage\\/repair","link":"http:\\/\\/www.clinicalepigeneticsjournal.com\\/content\\/3\\/1\\/4","radio_15b":"Yes","desc":"Thus, <b>HDAC inhibitors<\\/b>, in addition to unsilencing tumor suppressor genes, also <b>...<\\/b> \\nacetyl <b>co<\\/b>-enzyme A to lysine residues, and HDACs remove the acetyl groups. <b>.....<\\/b> \\nas well as NF\\u03baB inactivation, in <b>pancreatic cancer<\\/b> cells but not normal cells."},{"title":"Pharmacyclics <b>Inc<\\/b> (PCYC.O) <b>Company<\\/b> Profile | Reuters.com","link":"http:\\/\\/www.reuters.com\\/finance\\/stocks\\/companyProfile?symbol=PCYC.O","radio_15b":"Yes","desc":"The <b>Company''s<\\/b> clinical development and product candidates are <b>...<\\/b> II clinical trial \\nin <b>pancreatic cancer<\\/b>, and a histone deacetylase (<b>HDAC<\\/b>) <b>inhibitor<\\/b> (PCI-24781)\\u00a0<b>...<\\/b>"}]', '[{"title":"Curis: Potential Blockbuster Application In <b>Pancreatic Cancer<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/445871-curis-potential-blockbuster-application-in-pancreatic-cancer","desc":"Mar 20, 2012 <b>...<\\/b> CUDC-101, a proprietary novel compound designed to <b>inhibit HDAC<\\/b>, EGFR, and \\nHer2. <b>...<\\/b> <b>Pancreatic cancer<\\/b> often has a poor prognosis: for all stages <b>...<\\/b> Hedgehog \\n<b>Inhibition<\\/b> for Pancreatic Ductal Adenocarcinoma in the\\u00a0<b>...<\\/b>"},{"title":"Pharmacyclics, Inc. (PCYC): Pharmacyclics: Product Pipeline <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/672461-pharmacyclics-product-pipeline-overshadows-stock-market-influence","desc":"Jun 20, 2012 <b>...<\\/b> Ibrutinib is the first and most advanced drug designed to inhibit <b>....<\\/b> clinical trial for \\n<b>pancreatic cancer<\\/b> and a histone deacetylase (<b>HDAC<\\/b>) <b>inhibitor<\\/b>\\u00a0<b>...<\\/b>"},{"title":"Curis, Inc. (CRIS): Curis'' CEO Presents at Citi 2013 Global <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1222831-curis-ceo-presents-at-citi-2013-global-healthcare-conference-transcript","desc":"Feb 25, 2013 <b>...<\\/b> CUDC-907 is a PI3 kinase <b>HDAC inhibitor<\\/b>. <b>....<\\/b> And these 2 models, one is a \\nbreast cancer model with 5-FU; the other is a <b>pancreatic cancer<\\/b>\\u00a0<b>...<\\/b>"},{"title":"CRIS: Curis, Inc. Market Currents - On the Move - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/symbol\\/cris\\/currents\\/on-the-move","desc":"Curis: New Data Shows Efficacy In Advanced <b>Pancreatic Cancer<\\/b> <b>....<\\/b> Issuance \\nStrengthening Intellectual Property Position of PI3K-<b>HDAC Inhibitor<\\/b> CUDC-907."},{"title":"Curis, Inc. (CRIS): Curis Management Discusses Q2 2012 Results <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/780431-curis-management-discusses-q2-2012-results-earnings-call-transcript","desc":"Aug 2, 2012 <b>...<\\/b> The percentage of <b>pancreatic<\\/b> circulating stem cells decreased in 56% of patients. \\n<b>...<\\/b> We view the head and neck <b>cancer<\\/b> indication to be an ideal initial <b>...<\\/b> Synergy \\nhas been reported with <b>HDAC inhibition<\\/b> and radiation, and our\\u00a0<b>...<\\/b>"},{"title":"Following The Crashing Biotechs - 4 Stocks Ready For Spring [Curis <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1326101-following-the-crashing-biotechs-4-stocks-ready-for-spring","desc":"Apr 8, 2013 <b>...<\\/b> Threshold is currently testing TH-302 for treating <b>pancreatic cancer<\\/b> and has <b>...<\\/b> a \\nPI3K and <b>HDAC inhibitor<\\/b> for treating advanced lymphoma and\\u00a0<b>...<\\/b>"},{"title":"Celgene''s Gloucester Buy: Finding Opportunity in Blood <b>Cancer<\\/b> <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/176935-celgenes-gloucester-buy-finding-opportunity-in-blood-cancer-treatment","desc":"Dec 7, 2009 <b>...<\\/b> By buying Gloucester, Celgene extends its own blood cancer <b>...<\\/b> phase II research \\nprojects in renal, prostate and <b>pancreatic cancer<\\/b> that <b>...<\\/b> What also might be \\nreactivated is interest in <b>histone deacetylase inhibitors<\\/b> (HDACs),\\u00a0<b>...<\\/b>"},{"title":"Is CRIS a buy? - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/symbol\\/cris","desc":"Curis: New Data Shows Efficacy In Advanced <b>Pancreatic Cancer<\\/b> <b>...<\\/b> Curis'' ''\\nHedgehog'' <b>Inhibitor<\\/b> to Offer Hope for Basal Cell Carcinoma Sufferers \\u00b7 \\nChemistfrog\\u00a0<b>...<\\/b>"}]', 'hdac inhibitor pancreatic cancer', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(164, '2013-11-18 07:56:06', 35, 'test nov 18th', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'test nov 18', 'c', '', 'test ', '', '', '', 'a', '', 'Jill Murthi', '', '', '', '', '', 'field', '83', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-11-27 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'laser excitation for semiconductor wafer inspection', '', '{"2":{"title":"laser excitation fluorescence","id":"107","status":"field"}}', 34, '', '>1m', 'Yes', 'No', 5, '', 'Maybe', 16.25, '{"0":{"title":"Optoacoustic inspection device for inspection of semiconductor wafers","link":"http:\\/\\/www.google.com\\/patents\\/EP2630480A1?cl=en&dq=laser+excitation+for+semiconductor+wafer+inspection&source=uds;","desc":"An optical <b>excitation<\\/b> input is in optical communication with the cell for exciting the  target. <b>...<\\/b> <b>inspection<\\/b> device for <b>inspection<\\/b> of <b>semiconductor wafers<\\/b> Patent <b>....<\\/b> A  device as claimed in claim 42, wherein the <b>laser<\\/b> light source is\\u00a0<b>...<\\/b>","filedate":"Wed, 18 May 2011 00:00:00 -0700","applicant":"Dublin City University","radio_11b":"somewhat_relevant"},"2":{"title":"Silicon wafer defect detecting device","link":"http:\\/\\/www.google.com\\/patents\\/CN203011849U?cl=en&dq=laser+excitation+for+semiconductor+wafer+inspection&source=uds;","desc":"Through the <b>silicon wafer<\\/b> defect detecting device, the defects of self <b>...<\\/b> said  <b>silicon<\\/b> photoluminescence <b>excitation<\\/b> mechanism comprises a <b>laser<\\/b> and a <b>....<\\/b> OF  DRAWINGS [0008] Figure 1 is a <b>wafer<\\/b> defect <b>inspection<\\/b> of the utility\\u00a0<b>...<\\/b>","filedate":"Tue, 13 Nov 2012 00:00:00 -0800","applicant":"\\u4e0a\\u6d77\\u592a\\u9633\\u80fd\\u5de5\\u7a0b\\u6280\\u672f\\u7814\\u7a76\\u4e2d\\u5fc3\\u6709\\u9650\\u516c\\u53f8","radio_11b":"somewhat_relevant"},"3":{"title":"Optical imaging system with laser droplet plasma illuminator","link":"http:\\/\\/www.google.com\\/patents\\/WO2012112290A2?cl=en&dq=laser+excitation+for+semiconductor+wafer+inspection&source=uds;","desc":"A <b>wafer inspection<\\/b> system includes a <b>laser<\\/b> droplet plasma (LDP) light source <b>...<\\/b>  An <b>excitation<\\/b> light generated by a <b>laser<\\/b> is focused on a droplet of the feed  material. <b>...<\\/b> A system for <b>semiconductor wafer inspection<\\/b> comprising :.","filedate":"Mon, 30 Jan 2012 00:00:00 -0800","applicant":"Kla-Tencor Corporation","radio_11b":"somewhat_relevant"},"5":{"title":"\\u6fc0\\u5149\\u52a0\\u5de5\\u88c5\\u7f6e\\u7684\\u6fc0\\u5149\\u52a0\\u5de5\\u65b9\\u6cd5 The laser processing apparatus the laser ...","link":"http:\\/\\/www.google.com\\/patents\\/CN101422849B?cl=en&dq=laser+excitation+for+semiconductor+wafer+inspection&source=uds;","desc":"Then, by cutting the <b>semiconductor wafer<\\/b> to split along the channel of the <b>....<\\/b>  <b>inspection<\\/b> station; held in the <b>wafer<\\/b> stage of the detection <b>laser<\\/b>\\u00a0<b>...<\\/b>","filedate":"Fri, 31 Oct 2008 00:00:00 -0700","applicant":"\\u682a\\u5f0f\\u4f1a\\u793e\\u8fea\\u601d\\u79d1","radio_11b":"somewhat_relevant"},"6":{"title":"Method for inspecting semiconductor device","link":"http:\\/\\/www.google.com\\/patents\\/EP1498727B1?cl=en&dq=laser+excitation+for+semiconductor+wafer+inspection&source=uds;","desc":"The <b>inspection<\\/b> of the <b>laser<\\/b> diode includes an electrical and optical <b>...<\\/b> Incidentally,  a <b>semiconductor<\\/b> device <b>wafer<\\/b> is constructed to include <b>.....<\\/b> generate  electromotive force due to photo-<b>excitation<\\/b> while the <b>laser<\\/b> light is scanned.","filedate":"Mon, 05 Jul 2004 00:00:00 -0700","applicant":"Canon Kabushiki Kaisha","radio_11b":"least_relevant"},"7":{"title":"Photoluminescence imaging of doping variations in semiconductor wafers","link":"http:\\/\\/www.google.com\\/patents\\/WO2013023241A1?cl=en&dq=laser+excitation+for+semiconductor+wafer+inspection&source=uds;","desc":"Each <b>wafer<\\/b> can additionally be <b>inspected<\\/b> via photoluminescence imaging <b>...<\\/b> (a)  illuminating a <b>semiconductor wafer<\\/b> with <b>excitation<\\/b> light suitable for <b>....<\\/b> using a  <b>laser<\\/b> (as described in US patent No 6429037 and published US\\u00a0<b>...<\\/b>","filedate":"Fri, 10 Aug 2012 00:00:00 -0700","applicant":"Bt Imaging Pty Ltd","radio_11b":"least_relevant"}}', '', 'a a a a a ', 'a a a a a ', 'a a a a a ', '[{"title":"Coherent Inc. Diode-Pumped Solid-State <b>Lasers<\\/b>: CW and Pulsed","link":"http:\\/\\/www.coherent.com\\/products\\/?765\\/Diode-Pumped-Solid-State-Lasers","radio_15b":"least_likely","desc":"<b>Company<\\/b> \\u00b7 Careers \\u00b7 Coherent in the News \\u00b7 Corporate Governance \\u00b7 Corporate \\nSustainability and <b>...<\\/b> Picosecond <b>laser<\\/b> portfolio with output powers up to 50W and \\nwavelengths from 355 nm to 1064 nm. <b>...<\\/b> Fluorescence <b>Excitation<\\/b> <b>....<\\/b> \\n<b>Semiconductor Wafer Inspection<\\/b>. <b>Semiconductor Wafer Inspection<\\/b>. \\nMicroelectronics. Wafer."},{"title":"Coherent Inc. Compass <b>Lasers<\\/b> For Bioinstrumentation Applications","link":"http:\\/\\/www.coherent.com\\/products\\/?871\\/Compass-Lasers","radio_15b":"duplicate","desc":"Compass (COMpact All Solid State <b>lasers<\\/b>) is a family of solid-state <b>lasers<\\/b> emitting \\nup to 150 mW CW in the <b>...<\\/b> including biohazard detection, <b>semiconductor<\\/b> \\n<b>inspection<\\/b>, metrology, imaging, and reprographics printing. <b>...<\\/b> Fluorescence \\n<b>Excitation<\\/b> <b>...<\\/b> Disk Drive, Electronic Component Surface, FPD, LCD, PC Board, \\nReticle, <b>Wafer<\\/b>."},{"title":"Patent EP2630480A1 - Optoacoustic <b>inspection<\\/b> device for <b>...<\\/b> - Google","link":"http:\\/\\/www.google.com\\/patents\\/EP2630480A1","radio_15b":"least_likely","desc":"Aug 28, 2013 <b>...<\\/b> An optical <b>excitation<\\/b> input is in optical communication with the cell for exciting the \\ntarget. <b>...<\\/b> <b>inspection<\\/b> device for <b>inspection<\\/b> of <b>semiconductor wafers<\\/b> Patent <b>....<\\/b> such \\nthat an upper major surface thereof is <b>co<\\/b>-planar with a horizontal plane. 31 . <b>...<\\/b> A \\ndevice as claimed in claim 42, wherein the <b>laser<\\/b> light source is\\u00a0<b>...<\\/b>"},{"title":"Vision Systems Design Article: DALSA cameras inspect solar cells","link":"http:\\/\\/teledynedalsa.com\\/public\\/mv\\/appnotes\\/Solar_Cell%20Inspection%20Article_Feb2010.pdf","radio_15b":"least_likely","desc":"<b>Silicon<\\/b>-wafer-based solar cells currently represent <b>...<\\/b> An incoming <b>wafer<\\/b> \\n<b>inspection<\\/b> system <b>....<\\/b> uses a similar method but with <b>laser excitation<\\/b> <b>...<\\/b> <b>Company<\\/b> \\nInfo."},{"title":"Runchuan Zhao | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/in\\/rczhao","radio_15b":"least_likely","desc":"LinkedIn is the world''s largest <b>business<\\/b> network, helping professionals like <b>...<\\/b> \\nmedical device and <b>Semiconductor<\\/b> industries involving research, conceptual \\ndesign, simulation <b>...<\\/b> Create advanced <b>wafer inspection<\\/b> equipment and have a \\nhigh level of <b>...<\\/b> Studied molecular dynamics with multi-<b>laser excitation<\\/b> and high \\nresolution\\u00a0<b>...<\\/b>"},{"title":"Bright terahertz sources : Nature Photonics : Nature Publishing Group","link":"http:\\/\\/www.nature.com\\/nphoton\\/journal\\/v7\\/n9\\/full\\/nphoton.2013.231.html","radio_15b":"least_likely","desc":"Aug 29, 2013<b>...<\\/b> from an unbiased <b>semiconductor wafer<\\/b> using femtosecond <b>laser excitation<\\/b>. <b>...<\\/b> \\nis non-destructive evaluation for quality control and defect <b>inspection<\\/b>. <b>...<\\/b> \\nApproximately 300 <b>companies<\\/b> have contacted me regarding this\\u00a0<b>...<\\/b>"},{"title":"Ion <b>laser<\\/b>: Definition from Answers.com","link":"http:\\/\\/www.answers.com\\/topic\\/ion-laser","radio_15b":"least_likely","desc":"ion <b>laser<\\/b> ( n lzr ) ( optics ) A gas <b>laser<\\/b> in which stimulated emission takes place \\nbetween two energy levels of an ion; <b>...<\\/b> He was <b>co<\\/b>-discoverer of <b>lasers<\\/b> using \\nelectron impact <b>excitation<\\/b> in each of the noble <b>...<\\/b> <b>Semiconductor wafer inspection<\\/b>."},{"title":"NIS-Elements software | Nikon Metrology Blog","link":"http:\\/\\/blog.nikonmetrology.com\\/tag\\/nis-elements-software\\/","radio_15b":"least_likely","desc":"The Nikon LSI series of <b>inspection<\\/b> microscopes, Eclipse L200N and L200ND, \\nbuilds on the <b>...<\\/b> UV <b>excitation<\\/b> optimal for the <b>inspection<\\/b> of <b>semiconductor<\\/b> resist \\nresidues on 300mm <b>...<\\/b> This is highly beneficial in the <b>inspection<\\/b> of <b>semiconductor<\\/b> \\n<b>wafers<\\/b> and <b>...<\\/b> NIKON METROLOGY HELPS <b>COMPANIES<\\/b> INCREASE BOTTOM \\nLINE\\u00a0<b>...<\\/b>"}]', '', 'laser excitation for semiconductor wafer inspection', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(165, '2013-11-19 07:24:23', 2, 'Gut Microbiome', 'bio_organism', '', '', 'gansh3', 'gansh16', 'gansh16_3', '', '', 'test', 'b', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '55.5', 'Yes1', '0000-00-00 00:00:00', '', '2013-11-08 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'Gut microbiota insulin resistance', '', '{"1":{"radio_11a2":"No","title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"}}', -20, '', '>1m', 'Dont know', '', 0, '', 'No', 10, '[{"title":"Method for preventing and\\/or treating insulin resistance","link":"http:\\/\\/www.google.com\\/patents\\/WO2013032328A1?cl=en&dq=Gut+microbiota+insulin+resistance&source=uds;","filedate":"Thu, 30 Aug 2012 00:00:00 -0700","applicant":"Academisch Medisch Centrum, Wageningen Universiteit","desc":"The present inventors have found a causal role of the small <b>intestinal microbiota<\\/b>  in <b>insulin resistance<\\/b> and dyslipidemia. 18 male subjects with\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Nutritional composition for promoting gut microbiota balance and health","link":"http:\\/\\/www.google.com\\/patents\\/EP2498626A1?cl=en&dq=Gut+microbiota+insulin+resistance&source=uds;","filedate":"Thu, 11 Nov 2010 00:00:00 -0800","applicant":"Nestec S.A.","desc":"Also provided are methods of promoting <b>gut microbiota<\\/b> balance and <b>...<\\/b> to  decrease <b>insulin resistance<\\/b>, to decrease blood glucose excursions or\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Use of probiotics to ameliorate diet-induced insulin resistance","link":"http:\\/\\/www.google.com\\/patents\\/WO2010108865A1?cl=en&dq=Gut+microbiota+insulin+resistance&source=uds;","filedate":"Fri, 19 Mar 2010 00:00:00 -0700","applicant":"Chr. Hansen A\\/S","desc":"Diet-induced <b>insulin resistance<\\/b> In a person with normal metabolism, <b>....<\\/b> (2004)  describes that <b>gut microbiota<\\/b> is an environmental factor that\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Composition and use of a formulation to increase the ratio of ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2013032744A2?cl=en&dq=Gut+microbiota+insulin+resistance&source=uds;","filedate":"Fri, 17 Aug 2012 00:00:00 -0700","applicant":"Nume Health, Llc","desc":"Transfer of <b>Intestinal Microbiota<\\/b> from Lean Donors Increases <b>Insulin Sensitivity<\\/b> in  Subjects with Metabolic Syndrome. Gastroenterology (2012)\\u00a0<b>...<\\/b>","radio_11b":"most_relevant"},{"title":"Use of non-digestible carbohydrates for improving intestinal microbiota","link":"http:\\/\\/www.google.com\\/patents\\/WO2009082214A1?cl=en&dq=Gut+microbiota+insulin+resistance&source=uds;","filedate":"Fri, 19 Dec 2008 00:00:00 -0800","applicant":"Amor Kaouther Ben, Jan Knol, Willem Ferdinand Nieuwenhuizen, Nutricia Nv, Gelske Speelmans, Der Beek Eline Marleen Van","desc":"At birth infants are devoid of an <b>intestinal microbiota<\\/b>. <b>...<\\/b> optionally non-digestible  carbohydrates for use in prevention of obesity and\\/or <b>diabetes<\\/b>.","radio_11b":"somewhat_relevant"}]', '[{"title":"Reshaping the &lt;b&gt;gut&lt;\\/b&gt; &lt;b&gt;microbiota&lt;\\/b&gt; at an early age: functional impact on obesity risk?","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24217033","desc":"Luoto R, Collado MC, Salminen S, Isolauri E.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Annals of nutrition &amp; metabolism&quot;&gt;Ann Nutr Metab&lt;\\/span&gt;. 2013;63 Suppl 2:17-26. doi: 10.1159\\/000354896. Epub 2013 Nov 8.","radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Gut&lt;\\/b&gt; &lt;b&gt;microbiota&lt;\\/b&gt;-based translational biomarkers to prevent metabolic syndrome via nutritional modulation.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24219358","desc":"Xiao S, Zhao L.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;FEMS microbiology ecology&quot;&gt;FEMS Microbiol Ecol&lt;\\/span&gt;. 2013 Nov 12. doi: 10.1111\\/1574-6941.12250. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"The &lt;b&gt;gut&lt;\\/b&gt; microbiome as novel cardio-metabolic target: the time has come!","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24216389","desc":"Vinj&Atilde;&copy; S, Stroes E, Nieuwdorp M, Hazen SL.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;European heart journal&quot;&gt;Eur Heart J&lt;\\/span&gt;. 2013 Nov 11. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24187469","desc":"Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;World journal of gastroenterology : WJG&quot;&gt;World J Gastroenterol&lt;\\/span&gt;. 2013 Oct 28;19(40):6911-8. doi: 10.3748\\/wjg.v19.i40.6911.","radio_11b2":"least_relevant"},{"title":"The Role of &lt;b&gt;Gut&lt;\\/b&gt; &lt;b&gt;Microbiota&lt;\\/b&gt; on &lt;b&gt;Insulin Resistance&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3705322\\/","desc":"Andrea M. Caricilli, Mario J. A. Saad","details":"","radio_11b2":"somewhat_relevant"},{"title":"Structural Changes of &lt;b&gt;Gut&lt;\\/b&gt; &lt;b&gt;Microbiota&lt;\\/b&gt; during Berberine-Mediated Prevention of Obesity and &lt;b&gt;Insulin Resistance&lt;\\/b&gt; in High-Fat Diet-Fed Rats","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3411811\\/","desc":"Xu Zhang, Yufeng Zhao, Menghui Zhang, Xiaoyan Pang, Jia Xu, Chaoying Kang, Meng Li, Chenhong Zhang, Zhiguo Zhang, Yifei Zhang, Xiaoying Li, Guang Ning, Liping Zhao","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(8): e42529.  &lt;span class=&quot;&quot;&gt;Published online 2012 August 3. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0042529&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Gut&lt;\\/b&gt; &lt;b&gt;Microbiota&lt;\\/b&gt; Is a Key Modulator of &lt;b&gt;Insulin Resistance&lt;\\/b&gt; in TLR 2 Knockout Mice","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3232200\\/","desc":"","details":"PLoS Biol. &lt;span class=&quot;citation-publication-date&quot;&gt;2011 December; &lt;\\/span&gt;9(12): e1001212.  &lt;span class=&quot;&quot;&gt;Published online 2011 December 6. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pbio.1001212&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Influence of &lt;b&gt;Gut&lt;\\/b&gt; &lt;b&gt;Microbiota&lt;\\/b&gt; on Subclinical Inflammation and &lt;b&gt;Insulin Resistance&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3694527\\/","desc":"Bruno Melo Carvalho, Mario Jose Abdalla Saad","details":"Mediators Inflamm. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;2013: 986734.  &lt;span class=&quot;&quot;&gt;Published online 2013 June 12. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1155\\/2013\\/986734&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"null","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/undefined","desc":"null","details":"null","radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Insulin resistance&lt;\\/b&gt; and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24172304","desc":"Kong LC, Wuillemin PH, Bastard JP, Sokolovska N, Gougis S, Fellahi S, Darakhshan F, Bonnefont-Rousselot D, Bittar R, Dor&Atilde;&copy; J, Zucker JD, Cl&Atilde;&copy;ment K, Rizkalla S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;The American journal of clinical nutrition&quot;&gt;Am J Clin Nutr&lt;\\/span&gt;. 2013 Oct 30. [Epub ahead of print]","radio_11b2":"least_relevant"}]', 'a', 'a', 'a', '', '[{"title":"Metal-packing nanoparticles treat cancer, useful for MRI","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/metal-packin-nanoparticles-treat-cancer-useful-mri\\/2010-08-11","desc":" Inside each pore are magnetic <strong>zinc<\\/strong>-doped iron <strong>oxide<\\/strong> <strong>nanocrystals<\\/strong>. Then, little nanovalves hold the whole ...","radio_15":"least_likely"},{"title":"Multitasking nanomaterials- When nanotech meets biotech","link":"http:\\/\\/www.fiercedrugdelivery.com\\/special-reports\\/when-nanotech-meets-biotech\\/multitasking-nanomaterials-when-nanotech-meets-biotech","desc":" with diameters between two and 50 nanometers. Inside each pore are magnetic <strong>zinc<\\/strong>-doped iron <strong>oxide<\\/strong> <strong>nanocrystals<\\/strong> ...","radio_15":"least_likely"},{"title":"Elan''s NanoCrystal technology gets European OK","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/elans-nanocrystal-technology-gets-european-ok\\/2011-03-14","desc":" EDT''s <strong>NanoCrystal<\\/strong> technology. ","radio_15":"least_likely"},{"title":"Alzheimer''s treatment and earthquake on a wafer","link":"http:\\/\\/www.fiercedrugdelivery.com\\/also-noted\\/alzheimers-treatment-and-earthquake-wafer\\/2010-10-06","desc":" nanotubes for production and delivery of nitric <strong>oxide<\\/strong> and methods for production thereof. Patent application ...","radio_15":"least_likely"},{"title":"Industrial nano is toxic; drug-delivery nano, not so much","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/industrial-nano-toxic-drug-delivery-nano-not-so-much\\/2010-10-12","desc":" nanoparticles. They compared nanosized industrial byproducts such as <strong>zinc<\\/strong> <strong>oxide<\\/strong>, ferrous <strong>oxide<\\/strong> and fumed silica ...","radio_15":"least_likely"},{"title":"Nanocrystals- When nanotech meets biotech","link":"http:\\/\\/www.fiercedrugdelivery.com\\/special-reports\\/when-nanotech-meets-biotech\\/nanocrystals-when-nanotech-meets-biotech","desc":" announced that the first injectable product using its <strong>NanoCrystal<\\/strong> technology has been approved ...","radio_15":"least_likely"},{"title":"Big pharma inspection flunkies; packagers and repackagers unite;","link":"http:\\/\\/www.fiercepharmamanufacturing.com\\/story\\/big-pharma-inspection-flunkies-packagers-and-repackagers-unite\\/2011-03-03","desc":" professor is investigating the use of air as an environmentally benign <strong>oxidant<\\/strong> for pharmaceutical synthesis. Story > The FDA wants drugmakers to consider removing <strong>zinc<\\/strong> from denture cream due to a possible link between neurological problems and <strong>zinc<\\/strong> poisoning. Article > Merck''s expansion of a clinical ...","radio_15":"least_likely"},{"title":"NicOx gains new partner on glaucoma program","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/nicox-gains-new-partner-glaucoma-program\\/2010-03-03","desc":" credibility to nitric <strong>oxide<\\/strong> donating compounds after Pfizer''s halting of development,","radio_15":"least_likely"},{"title":"Elan''s drug delivery unit takes on innovation","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/what-elans-drug-delivery-unit-doing-thats-so-risky-innovating\\/2010-08-10","desc":" development companies, and markets are currently averse to risk.- read about Elan''s <strong>NanoCrystal<\\/strong> ...","radio_15":"least_likely"},{"title":"Alkermes, Elan deal forms well-positioned drug delivery company","link":"http:\\/\\/www.fiercedrugdelivery.com\\/story\\/new-supersized-alkermes-will-become-well-positioned-drug-delivery-company\\/2011-05-11","desc":" out the Elan release- read more about EDT''s <strong>NanoCrystal<\\/strong> technology- more on Alkermes'' ...","radio_15":"least_likely"}]', 'gut microbiome', '', '', '2', '2', '', 100);
INSERT INTO `inventions` VALUES(166, '2013-11-19 12:04:39', 17, 'test', 'patent', '', '', 'gansh3', 'gansh16', 'gansh16_2', '', 'no', 'test', 'c', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '115', 'Yes', '2013-11-18 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-11-21 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'the catalyst nanocrystal zinc oxide ', '{"1":{"radio_11a1":"May be","title":"Olefin catalyst for polymerization","id":"105","status":"field"}}', '', 23, '', '100k-1m', 'No', '', 0, '', 'Yes', 17.5, '[{"title":"Light emitting diode device having nanocrystal-metal oxide composite and ...","link":"http:\\/\\/www.google.com\\/patents\\/EP1990842A2?cl=en&dq=the+catalyst+nanocrystal+zinc+oxide&source=uds;","filedate":"Tue, 29 Apr 2008 00:00:00 -0700","applicant":"Samsung Electronics Co., Ltd.","desc":"The <b>nanocrystal<\\/b>-metal oxide composite may include TiO2, <b>ZnO<\\/b>, SiO2, <b>...<\\/b> a solvent  and a <b>catalyst<\\/b> to form a <b>nanocrystal<\\/b>-metal oxide precursor\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Synthesis of stable colloidal nanocrystals using organic dendrons","link":"http:\\/\\/www.google.com\\/patents\\/WO2003078699A2?cl=en&dq=the+catalyst+nanocrystal+zinc+oxide&source=uds;","filedate":"Tue, 14 May 2002 00:00:00 -0700","applicant":"Nanomaterials And Nanofabricat, Univ Arkansas","desc":"By coating <b>nanocrystals<\\/b> with a dense organic dendron coat and further <b>...<\\/b> <b>oxide<\\/b>,  cadmium selenide, cadmium sulfide, cadmium telluride, <b>zinc<\\/b> <b>.....<\\/b> the art will  appreciate that if a Grubbs <b>catalyst<\\/b> is combined DP <b>nanocrystals<\\/b> 60\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Synthetic control of metal oxide nanocrystal sizes and shapes","link":"http:\\/\\/www.google.com\\/patents\\/WO2006098756A2?cl=en&dq=the+catalyst+nanocrystal+zinc+oxide&source=uds;","filedate":"Tue, 16 Aug 2005 00:00:00 -0700","applicant":"Univ Arkansas","desc":"Synthesis of <b>ZnO nanocrystals<\\/b> and other types of nanostructures has <b>...<\\/b> emitting  materials, <b>catalysts<\\/b>, host materials for doped <b>nanocrystals<\\/b>, etc.","radio_11b":"relevant"},{"title":"Solvent-free synthesis of soluble nanocrystals","link":"http:\\/\\/www.google.com\\/patents\\/WO2009065010A2?cl=en&dq=the+catalyst+nanocrystal+zinc+oxide&source=uds;","filedate":"Fri, 14 Nov 2008 00:00:00 -0800","applicant":"Advanced Tech Materials, Guiquan Pan, Melissa A Petruska","desc":"Magnesium oxide <b>nanocrystals<\\/b> comprising substantially crystalline MgO, wherein  <b>...<\\/b> photoelectric devices, <b>catalysts<\\/b>, biolabels for bioimaging, sensors, <b>....<\\/b> made to \\" metal oxide\\" <b>nanocrystals<\\/b>, preferably MgO, <b>ZnO<\\/b>, In2O3, MnO,\\u00a0<b>...<\\/b>","radio_11b":"most_relevant"},{"title":"Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2004031732A2?cl=en&dq=the+catalyst+nanocrystal+zinc+oxide&source=uds;","filedate":"Fri, 03 Oct 2003 00:00:00 -0700","applicant":"Univ Arkansas, Xiaogang Peng, Haiyan Chen, Wenzhou Guo, Y Andrew Wang","desc":"This global cross-linking reaction sealed each <b>nanocrystal<\\/b> within a dendron box  to <b>...<\\/b> copper, indium, yttrium, <b>zinc<\\/b>, mixed <b>oxides<\\/b> thereof, or combinations thereof.  <b>...<\\/b> a <b>catalyst<\\/b>, an antibial, an organic dye, or a bio-active species.","radio_11b":"duplicate"},{"title":"Light emitting device including semiconductor nanocrystals","link":"http:\\/\\/www.google.com\\/patents\\/WO2010141800A1?cl=en&dq=the+catalyst+nanocrystal+zinc+oxide&source=uds;","filedate":"Fri, 04 Jun 2010 00:00:00 -0700","applicant":"Massachusetts Institute Of Technology","desc":"Light emitting device including semiconductor <b>nanocrystals<\\/b> <b>.....<\\/b> Other first  electrode materials can include gallium indium tin <b>oxide<\\/b>, <b>zinc<\\/b> indium tin <b>oxide<\\/b>, <b>...<\\/b>  (CVD) while simultaneously being exposed to an oxidative <b>catalyst<\\/b>.","radio_11b":"least_relevant"}]', '[{"title":"ZnO supported CoFe2O4 nanophotocatalysts for the mineralization of Direct Blue 71 in aqueous environments.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23523908","desc":"Sathishkumar P, Pugazhenthiran N, Mangalaraja RV, Asiri AM, Anandan S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of hazardous materials&quot;&gt;J Hazard Mater&lt;\\/span&gt;. 2013 May 15;252-253:171-9. doi: 10.1016\\/j.jhazmat.2013.02.030. Epub 2013 Feb 26.","radio_11b2":"least_relevant"},{"title":"Stainless steel wire mesh-supported ZnO for the catalytic photodegradation of methylene blue under ultraviolet irradiation.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23291337","desc":"Vu TT, del R&Atilde;&shy;o L, Vald&Atilde;&copy;s-Sol&Atilde;&shy;s T, Marb&Atilde;&iexcl;n G.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of hazardous materials&quot;&gt;J Hazard Mater&lt;\\/span&gt;. 2013 Feb 15;246-247:126-34. doi: 10.1016\\/j.jhazmat.2012.12.009. Epub 2012 Dec 13.","radio_11b2":"somewhat_relevant"},{"title":"Flame retardancy and UV protection of cotton based fabrics using nano ZnO and polycarboxylic acids.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23218312","desc":"El-Hady MM, Farouk A, Sharaf S.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Carbohydrate polymers&quot;&gt;Carbohydr Polym&lt;\\/span&gt;. 2013 Jan 30;92(1):400-6. doi: 10.1016\\/j.carbpol.2012.08.085. Epub 2012 Aug 30.","radio_11b2":"relevant"},{"title":"Photocatalytic removal of Escherichia coli from aquatic solutions using synthesized ZnO &lt;b&gt;nanoparticles&lt;\\/b&gt;: a kinetic study.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23202560","desc":"Alikhani MY, Lee SM, Yang JK, Shirzad-Siboni M, Peeri-Dogaheh H, Khorasani MS, Nooshak MA, Samarghandi MR.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Water science and technology : a journal of the International Association on Water Pollution Research&quot;&gt;Water Sci Technol&lt;\\/span&gt;. 2013;67(3):557-63. doi: 10.2166\\/wst.2012.593.","radio_11b2":"most_relevant"},{"title":"Pharmacokinetics, tissue distribution, and excretion of &lt;b&gt;zinc oxide&lt;\\/b&gt; &lt;b&gt;nanoparticles&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3394467\\/","desc":"Miri Baek, Hae-Eun Chung, Jin Yu, Jung-A Lee, Tae-Hyun Kim, Jae-Min Oh, Won-Jae Lee, Seung-Min Paek, Jong Kwon Lee, Jayoung Jeong, Jin-Ho Choy, Soo-Jin Choi","details":"","radio_11b2":"duplicate"},{"title":"Synthesis and characterization of a narrow size distribution of &lt;b&gt;zinc oxide&lt;\\/b&gt; &lt;b&gt;nanoparticles&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3141867\\/","desc":"A Khorsand Zak, R Razali, WH Abd Majid, Majid Darroudi","details":"","radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Zinc Oxide&lt;\\/b&gt; &lt;b&gt;Nanoparticles&lt;\\/b&gt; Catalyzed Condensation Reaction of Isocoumarins and 1,7-Heptadiamine in the Formation of Bis-Isoquinolinones","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3317590\\/","desc":"Varadhan Krishnakumar, Kesarla Mohan Kumar, Badal Kumar Mandal, Fazlur-Rahman Nawaz Khan","details":"ScientificWorldJournal. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;2012: 619080.  &lt;span class=&quot;&quot;&gt;Published online 2012 March 12. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1100\\/2012\\/619080&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"Protein Biosensors Based on Polymer Nanowires, Carbon Nanotubes and &lt;b&gt;Zinc Oxide&lt;\\/b&gt; Nanorods","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3231366\\/","desc":"Anish Kumar M., Soyoun Jung, Taeksoo Ji","details":"","radio_11b2":"duplicate"},{"title":"Synthesis, characterization and photocatalytic activity of magnetically separable hexagonal Ni\\/ZnO nanostructure.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22975724","desc":"Senapati S, Srivastava SK, Singh SB.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Nanoscale&quot;&gt;Nanoscale&lt;\\/span&gt;. 2012 Oct 21;4(20):6604-12.","radio_11b2":"duplicate"},{"title":"Preparation of C60(O)n-ZnO nanocomposite under electric furnace and photocatalytic degradation of organic dyes.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22966679","desc":"Cho BH, Oh YJ, Mun SM, Ko WB.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of nanoscience and nanotechnology&quot;&gt;J Nanosci Nanotechnol&lt;\\/span&gt;. 2012 Jul;12(7):5907-13.","radio_11b2":"duplicate"}]', 'a a a a a a', 'a a a a a a a', 'aa a a a a a', '', '[{"title":"Is <b>CELL<\\/b> a buy? - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/symbol\\/cell","desc":"Up to date analysis of Brightpoint, Inc. (<b>CELL<\\/b>) and its stock by hedge fund \\nmanagers and industry experts. Find out what Brightpoint, Inc. is saying about its\\n\\u00a0<b>...<\\/b>","radio_15":"somewhat_likely"},{"title":"Dustin Moore''s Instablog - Posts on <b>Cell<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/author\\/dustin-moore\\/instablog\\/tag\\/cell","desc":"Dustin Moore is a researcher and analyst focusing on overlooked and \\nundervalued investments. He enjoys analyzing under-the-radar companies with \\nmassive\\u00a0<b>...<\\/b>","radio_15":"least_likely"},{"title":"Exciting Stem <b>Cell<\\/b> Investment Candidates With Near-Term Catalysts <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1832992-exciting-stem-cell-investment-candidates-with-near-term-catalysts","desc":"Nov 12, 2013 <b>...<\\/b> Athersys, Inc. (NASDAQ:ATHX), Neuralstem, Inc. (NYSEMKT:CUR), NeoStem Inc \\n(NASDAQ:NBS): Exciting Stem <b>Cell<\\/b> Investment Candidates\\u00a0<b>...<\\/b>","radio_15":"least_likely"},{"title":"Advanced <b>Cell<\\/b> Technology''s CEO Discusses Q3 <b>...<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1834592-advanced-cell-technologys-ceo-discusses-q3-2013-results-earnings-call-transcript","desc":"Nov 12, 2013 <b>...<\\/b> Advanced <b>Cell<\\/b> Technology, Inc. (OTCMKTS:ACTC): Advanced <b>Cell<\\/b> Technology''s \\nCEO Discusses Q3 2013 Results - Earnings Call Transcript.","radio_15":"least_likely"},{"title":"NeoStem Inc (NBS): Stem <b>Cell<\\/b> Therapy: Coming Into Maturity And <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1753832-stem-cell-therapy-coming-into-maturity-and-becoming-medical-reality","desc":"Oct 18, 2013 <b>...<\\/b> NeoStem Inc (NASDAQ:NBS): Stem <b>Cell<\\/b> Therapy: Coming Into Maturity And \\nBecoming Medical Reality.","radio_15":"least_likely"},{"title":"Advanced <b>Cell<\\/b> Technology: Investors Should <b>...<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1643822-advanced-cell-technology-investors-should-consider-selling","desc":"Aug 19, 2013 <b>...<\\/b> Advanced <b>Cell<\\/b> Technology, Inc. (OTCMKTS:ACTC): Advanced <b>Cell<\\/b> Technology: \\nInvestors Should Consider Selling.","radio_15":"least_likely"},{"title":"<b>Cell<\\/b> Therapeutics Inc (CTIC): <b>Cell<\\/b> Therapeutics Management <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1791082-cell-therapeutics-management-discusses-q3-2013-results-earnings-call-transcript","desc":"Oct 30, 2013 <b>...<\\/b> <b>Cell<\\/b> Therapeutics Inc (NASDAQ:CTIC): <b>Cell<\\/b> Therapeutics Management \\nDiscusses Q3 2013 Results - Earnings Call Transcript.","radio_15":"least_likely"},{"title":"OncoMed''s Cancer Stem <b>Cell<\\/b> Therapies Could Provide Outsized <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1757592-oncomeds-cancer-stem-cell-therapies-could-provide-outsized-gains-for-investors","desc":"Oct 21, 2013 <b>...<\\/b> Oncomed Pharmaceuticals Inc (NASDAQ:OMED): OncoMed''s Cancer Stem <b>Cell<\\/b> \\nTherapies Could Provide Outsized Gains For Investors.","radio_15":"least_likely"}]', 'cell motility assay with microfluidic device', '', '', '2', '2', '', 100);
INSERT INTO `inventions` VALUES(167, '2013-11-20 14:03:33', 35, 'EcoPower Cycle', 'patent', '', '', 'gansh3', 'gansh15', 'gansh15_3', '', '', 'conversion of waste heat into electricity', 'd', '', '1.	A machine that converts thermal energy into electricity using an organic ranking application where the working fluid is pumped into a heat exchanger where hot liquid or exhaust gas is circulated acting as an evaporator converting the working fluid to vapor. Said vapor passes through a twin screw Expander creating shaft power to drive an electrical generator, the vapor is then re- directed to a second heat exchanger where cold water is circulated acting as a condenser where the vaporized working vapor is converted back to fluid which is then collected into an expansion tank where is pump', '', '', '', 'd', 'Private', 'Student', '', '', '', '', '', 'field', '70', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'Organic Rankine Cycle thermal energy to electricity', '', '{"2":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"}}', 29, '', '100k-1m', 'No', '', 0, '', 'Not Sure', 8.5, '{"0":{"title":"Organic rankine cycle power system","link":"http:\\/\\/www.google.com\\/patents\\/EP2532845A1?cl=en&dq=Organic+Rankine+Cycle+thermal+energy+to+electricity&source=uds;","desc":"A closed <b>Organic Rankine Cycle power<\\/b> system for producing <b>power<\\/b> from an  alternative <b>energy heat<\\/b> source such as solar <b>energy<\\/b> or <b>geothermal<\\/b>\\u00a0<b>...<\\/b>","filedate":"Tue, 28 Feb 2006 00:00:00 -0800","applicant":"Ormat Technologies Inc."},"1":{"title":"Combined geothermal and solar thermal organic rankine cycle system","link":"http:\\/\\/www.google.com\\/patents\\/WO2009134271A1?cl=en&dq=Organic+Rankine+Cycle+thermal+energy+to+electricity&source=uds;","desc":"Combined geothermal and solar thermal <b>organic rankine cycle<\\/b> system <b>....<\\/b>  applying available <b>geothermal energy<\\/b> to the generation of <b>electricity<\\/b>\\u00a0<b>...<\\/b>","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Utc Power Corporation"},"2":{"title":"Organic rankine cycle system with shared heat exchanger for use with a ...","link":"http:\\/\\/www.google.com\\/patents\\/EP1702141B1?cl=en&dq=Organic+Rankine+Cycle+thermal+energy+to+electricity&source=uds;","desc":"<b>Organic rankine cycle<\\/b> system with shared heat exchanger for use with a <b>...<\\/b> and  for transferring a <b>thermal energy<\\/b> to motive <b>power<\\/b>, with said fluid\\u00a0<b>...<\\/b>","filedate":"Wed, 17 Nov 2004 00:00:00 -0800","applicant":"Utc Power, Llc"},"4":{"title":"Low temperature rankine cycle solar power system with low critical ...","link":"http:\\/\\/www.google.com\\/patents\\/CA2741777A1?cl=en&dq=Organic+Rankine+Cycle+thermal+energy+to+electricity&source=uds;","desc":"This invention relates to a low temperature solar <b>thermal power<\\/b> system, which  combines the solar hot water collectors with the <b>organic Rankine<\\/b>\\u00a0<b>...<\\/b>","filedate":"Tue, 24 May 2011 00:00:00 -0700","applicant":"Ning Meng"},"5":{"title":"Cascaded organic rankine cycles for waste heat utilization","link":"http:\\/\\/www.google.com\\/patents\\/EP1869293B1?cl=en&dq=Organic+Rankine+Cycle+thermal+energy+to+electricity&source=uds;","desc":"Simple <b>ORC<\\/b> Systems using one fluid are efficient and cost effective when  transferring low temperature waste heat sources into <b>electrical power<\\/b>,\\u00a0<b>...<\\/b>","filedate":"Tue, 29 Mar 2005 00:00:00 -0800","applicant":"UTC Power Corporation"},"6":{"title":"Efficient low temperature thermal energy storage","link":"http:\\/\\/www.google.com\\/patents\\/WO2009064378A3?cl=en&dq=Organic+Rankine+Cycle+thermal+energy+to+electricity&source=uds;","desc":"The <b>organic Rankine cycle<\\/b> engine (106) may utilize an organic working <b>...<\\/b> Solar  <b>energy<\\/b> may be used to <b>power<\\/b> a <b>heat<\\/b> pump (120) or chiller that\\u00a0<b>...<\\/b>","filedate":"Mon, 10 Nov 2008 00:00:00 -0800","applicant":"Ausra, Inc."},"7":{"title":"Controlled organic rankine cycle system for recovery and conversion of ...","link":"http:\\/\\/www.google.com\\/patents\\/CA2679612A1?cl=en&dq=Organic+Rankine+Cycle+thermal+energy+to+electricity&source=uds;","desc":"A system for controlled recovery of <b>thermal energy<\\/b> and conversion to mechanical  energy. <b>...<\\/b> A tertiary, or back-up <b>power<\\/b> source may also be present. <b>...<\\/b> an <b>organic<\\/b>  <b>Rankine cycle<\\/b> in which <b>thermal energy<\\/b> is collected from the\\u00a0<b>...<\\/b>","filedate":"Mon, 03 Mar 2008 00:00:00 -0800","applicant":"Victor Juchymenko"}}', '[{"title":"Towards a Microbial Thermoelectric Cell","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3582603\\/","desc":"Ra&Atilde;&ordm;l Rodr&Atilde;&shy;guez-Barreiro, Christian Abendroth, Cristina Vilanova, Andr&Atilde;&copy;s Moya, Manuel Porcar","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(2): e56358.  &lt;span class=&quot;&quot;&gt;Published online 2013 February 26. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0056358&lt;\\/span&gt;"}]', 'Our machine is a device, not a method.', 'different working fluid', 'our machine can not be cascaded', '[{"title":"Fuel-Free, Emission Free <b>Power<\\/b> from Biomass | ElectraTherm","link":"http:\\/\\/electratherm.com\\/case_studies\\/st._helena_island_south_carolina\\/","desc":"<b>Thermal Heat<\\/b> Input: 200 - 500kWt <b>...<\\/b> American Capital Resources <b>Company<\\/b> (\\nACR) engaged the local utility early on to <b>...<\\/b> ACR purchased the hydronic boiler \\nand integrated the <b>ORC<\\/b> with it after seeing the <b>...<\\/b> The gas expands and turns a \\n<b>twin screw expander<\\/b>, the <b>power<\\/b> block, which drives a generator to produce \\n<b>electricity<\\/b>.","radio_15b":"least_likely"},{"title":"Geothermal <b>heat to power<\\/b> - ElectraTherm","link":"http:\\/\\/electratherm.com\\/docs\\/GeothermalBrochure.pdf","desc":"generate <b>power<\\/b> at temperatures and flows well below most <b>ORC<\\/b> <b>...<\\/b> grade <b>heat<\\/b> \\nsources to make <b>electricity<\\/b> with: \\u2022 No fuel <b>...<\\/b> Robust, <b>Twin Screw Expander power<\\/b> \\nblock <b>...<\\/b> that <b>co<\\/b>-produce hot water at optimal temperatures for the Green Machine.","radio_15b":"least_likely"},{"title":"What is a Green Machine? - ElectraTherm","link":"http:\\/\\/electratherm.com\\/orc_knowledge_center\\/what_is_a_green_machine\\/","desc":"The ElectraTherm Green Machine is an <b>ORC<\\/b> based <b>heat-to-power<\\/b> generating <b>...<\\/b> \\njacket water, biomass boilers, solar <b>thermal<\\/b> and <b>co<\\/b>-produced (or geothermal) \\nfluids. <b>...<\\/b> The Green Machine uses a <b>twin screw expander<\\/b> as its <b>power<\\/b> block; \\nwhich\\u00a0<b>...<\\/b>","radio_15b":"somewhat_likely"},{"title":"Frequently Asked Questions - ElectraTherm","link":"http:\\/\\/electratherm.com\\/orc_knowledge_center\\/frequently_asked_questions\\/","desc":"ElectraTherm <b>ORC<\\/b> Technology Frequently Asked Questions <b>...<\\/b> <b>heat to power<\\/b> \\ngenerator that uses <b>Organic Rankine Cycle<\\/b> (<b>ORC<\\/b>) technology to <b>...<\\/b> Process <b>Heat<\\/b> \\nRecovery; Solar <b>Thermal<\\/b> \\u00b7 Geothermal \\/<b>Co<\\/b>-Produced Fluids; Oil & Gas <b>Heat<\\/b> \\nRecovery <b>...<\\/b> Uses a proprietary <b>twin screw expander<\\/b> as a <b>power<\\/b> block which can \\naccept\\u00a0<b>...<\\/b>","radio_15b":"least_likely"},{"title":"Geothermal Technical - Helidyne LLC","link":"http:\\/\\/www.helidynepower.com\\/index.php?option=com_content&view=article&id=107&Itemid=115","desc":"Helidyne''s geothermal <b>expander<\\/b> design involves an unique arrangement of four \\n<b>...<\\/b> Dr. DiPippo, in his text Geothermal <b>Power<\\/b> Plants states: <b>...<\\/b> By the late 1980''s, \\nthe concept of using a <b>twin screw<\\/b> total-flow device was abandoned <b>...<\\/b> in replacing \\nrefrigeration pressure reduction valves and in waste <b>heat ORC<\\/b> applications.","radio_15b":"least_likely"},{"title":"ElectraTherm Green Machine Series 4000 - Turner EPS","link":"http:\\/\\/www.turnereps.com\\/green-power\\/electraterm-green-machine-series-4000.aspx","desc":"<b>...<\\/b> <b>power<\\/b> from low grade <b>heat<\\/b> using the <b>Organic Rankine Cycle<\\/b> (<b>ORC<\\/b>) and \\nproprietary <b>...<\\/b> The proven patented <b>twin screw expander<\\/b> enables its <b>heat-to-<\\/b>\\n<b>power<\\/b> <b>...<\\/b> Stationary Engines, Boilers, <b>Co<\\/b>-Produced Fluids from Geothermal\\/Oil & \\nGas, and\\u00a0<b>...<\\/b>","radio_15b":"somewhat_likely"},{"title":"ISSUU - ElectraTherm''s Master Brochure by ElectraTherm","link":"http:\\/\\/issuu.com\\/electratherm\\/docs\\/masterbrochure_web","desc":"WASTE <b>HEAT TO POWER<\\/b> Low temperature <b>Organic Rankine Cycle<\\/b> technology \\n<b>...<\\/b> Braised plate <b>heat<\\/b> exchangers \\u2022 Robust, <b>Twin Screw Expander power<\\/b> block <b>...<\\/b> \\nCombustion Engines \\u2022 Biomass Boilers \\u2022 <b>Co<\\/b>-Produced Fluids from Oil & Gas,\\u00a0<b>...<\\/b>","radio_15b":"somewhat_likely"},{"title":"Charcoal Gasification (energy forum at permies)","link":"http:\\/\\/www.permies.com\\/forums\\/posts\\/list\\/40\\/19954","desc":"If you use <b>power<\\/b> station temperatures in a screw <b>expander<\\/b> you will get <b>power<\\/b> <b>...<\\/b> \\nwith a lower temperature <b>ORC<\\/b> phase recovering the <b>heat<\\/b> below 350C. Its this \\nlower phase where <b>twin screw<\\/b> technology is being used very effectively. <b>....<\\/b> to \\npurchase but you will need to email the <b>companies<\\/b> to obtain prices.","radio_15b":"least_likely"}]', '[{"title":"Is <b>TWIN<\\/b> a buy? - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/symbol\\/twin","desc":"Up to date analysis of <b>Twin<\\/b> Disc, Incorporated (<b>TWIN<\\/b>) and its stock by hedge fund \\nmanagers and industry experts. Find out what <b>Twin<\\/b> Disc, Incorporated is\\u00a0<b>...<\\/b>","radio_15":"least_likely"},{"title":"Apple Inc. (AAPL): Refresh <b>Cycle<\\/b> Bodes Well For <b>...<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1828332-refresh-cycle-bodes-well-for-apple","desc":"Nov 11, 2013 <b>...<\\/b> Apple Inc. (NASDAQ:AAPL): Refresh <b>Cycle<\\/b> Bodes Well For Apple.","radio_15":"least_likely"},{"title":"<b>TWIN<\\/b>: <b>Twin<\\/b> Disc, Incorporated StockTalks - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/symbol\\/twin\\/stocktalks","desc":"Up to date analysis of <b>Twin<\\/b> Disc, Incorporated (<b>TWIN<\\/b>) and its stock by hedge fund \\nmanagers and industry experts. Find out what <b>Twin<\\/b> Disc, Incorporated is\\u00a0<b>...<\\/b>","radio_15":"least_likely"},{"title":"Late <b>Cycle<\\/b> Earnings Releases: Best Buy, Campbell Soup, Home <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1843052-late-cycle-earnings-releases-best-buy-campbell-soup-home-depot-and-tjx-companies","desc":"5 days ago <b>...<\\/b> Best Buy Co., Inc. (NYSE:BBY), Campbell Soup Company (NYSE:CPB), The \\nHome Depot, Inc. (NYSE:HD), The TJX Companies, Inc.","radio_15":"least_likely"},{"title":"<b>Twin<\\/b> Disc''s CEO Discusses F1Q 2014 Results - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1761812-twin-discs-ceo-discusses-f1q-2014-results-earnings-call-transcript","desc":"Oct 22, 2013 <b>...<\\/b> <b>Twin<\\/b> Disc, Incorporated (NASDAQ:<b>TWIN<\\/b>): <b>Twin<\\/b> Disc''s CEO Discusses F1Q 2014 \\nResults - Earnings Call Transcript.","radio_15":"least_likely"},{"title":"There''s Nothing ''Regular'' About The Business <b>Cycle<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1791522-theres-nothing-regular-about-the-business-cycle","desc":"Oct 31, 2013 <b>...<\\/b> Barclays ETN Schiller CAPE (NYSEARCA:CAPE), AdvisorShares Trust (\\nNYSEARCA:DBIZ), Huntington US Equity Rotation Strategy ETF\\u00a0<b>...<\\/b>","radio_15":"least_likely"},{"title":"Tesla May Be Out Of Gas And <b>Electricity<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1849841-tesla-may-be-out-of-gas-and-electricity?source=cc","desc":"1 day ago <b>...<\\/b> Tesla Motors Inc (NASDAQ:TSLA): Tesla May Be Out Of Gas And <b>Electricity<\\/b>.","radio_15":"least_likely"},{"title":"The Presidential Stock Market <b>Cycle<\\/b> Says Watch Out Below In 2014 <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1821552-the-presidential-stock-market-cycle-says-watch-out-below-in-2014","desc":"Nov 8, 2013 <b>...<\\/b> SPDR S&P 500 ETF Trust (NYSEARCA:SPY): The Presidential Stock Market \\n<b>Cycle<\\/b> Says Watch Out Below In 2014.","radio_15":"least_likely"}]', 'expandor Organic Rankine Cycle twin screw thermal to electricity', '', '', '1', '1', 'ab31242c1ed507e5a96a709770b728c7_photo.JPG', 100);
INSERT INTO `inventions` VALUES(168, '2013-11-21 08:26:15', 17, 'testing 15a, 15b and analytics', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'Silver and Gold nanoclusters for Photocatalysis', 'c', '', 'Silver and Gold nanoclusters for Photocatalysis', '', '', '', 'a', '', 'Gee Kaun', '', '', '', '', '', 'field', '90', 'Yes', '2013-10-15 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'Silver and Gold nanoclusters for Photocatalysis', '{"1":{"radio_11a1":"Yes","title":"silver and gold clusters in zinc oxide nanocrystals","id":"156","status":"field"}}', '{"1":{"radio_11a2":"No","title":"silver and gold clusters in zinc oxide nanocrystals","id":"156","status":"Disclosure Done & Under Review"}}', 75, '', '100k-1m', 'Yes', 'No', 4, '', 'Maybe', 15, '[{"title":"A photocatalytic body","link":"http:\\/\\/www.google.com\\/patents\\/WO2012035322A2?cl=en&dq=Silver+and+Gold+nanoclusters+for+Photocatalysis&source=uds;","filedate":"Fri, 09 Sep 2011 00:00:00 -0700","applicant":"Ucl Business Plc","desc":"The present invention provides a <b>photocatalytic<\\/b> body comprising: a <b>...<\\/b> Ti02 layer  doped with <b>silver and gold nanoparticles<\\/b> (\\"n-AuAg-Ti02\\" in the\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Interior photocatalytic coating, preparation method and application thereof","link":"http:\\/\\/www.google.com\\/patents\\/CN102220039B?cl=en&dq=Silver+and+Gold+nanoclusters+for+Photocatalysis&source=uds;","filedate":"Tue, 26 Apr 2011 00:00:00 -0700","applicant":"\\u798f\\u5dde\\u5927\\u5b66","desc":"The prepared <b>photocatalytic<\\/b> coating containing Au nanoparticles can <b>....<\\/b> the  aqueous solution of <b>silver<\\/b> nitrate, the poor stability of this solution, <b>...<\\/b> <b>gold<\\/b>  <b>nanoparticles<\\/b>, the <b>photocatalytic<\\/b> coating of <b>gold nanoparticles<\\/b> content of 0.","radio_11b":"somewhat_relevant"},{"title":"Photocatalysis intensifier","link":"http:\\/\\/www.google.com\\/patents\\/CN100425330C?cl=en&dq=Silver+and+Gold+nanoclusters+for+Photocatalysis&source=uds;","filedate":"Thu, 31 Mar 2005 00:00:00 -0800","applicant":"\\u9e3f\\u5bcc\\u9526\\u7cbe\\u5bc6\\u5de5\\u4e1a\\uff08\\u6df1\\u5733\\uff09\\u6709\\u9650\\u516c\\u53f8;\\u9e3f\\u6d77\\u7cbe\\u5bc6\\u5de5\\u4e1a\\u80a1\\u4efd\\u6709\\u9650\\u516c\\u53f8","desc":"The invention provides a <b>photocatalytic<\\/b> enhancing means, <b>...<\\/b> selected from  sodium Cambodia <b>silver<\\/b>, <b>gold nanoparticles<\\/b>, nano-molybdenum or\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Efficient hydrogen production by photocatalytic water splitting using ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2011011064A2?cl=en&dq=Silver+and+Gold+nanoclusters+for+Photocatalysis&source=uds;","filedate":"Wed, 21 Jul 2010 00:00:00 -0700","applicant":"Stc.Unm","desc":"<b>Photocatalytic<\\/b> water splitting is employed as a method to directly obtain clean <b>...<\\/b>  the hybrid <b>photocatalytic nanoparticles<\\/b> can be used for conversion of <b>...<\\/b> For  spherical <b>gold<\\/b> and <b>silver<\\/b> particles of 1 - 20 nm in diameters, only\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Air purification system comprising gold\\/titanium dioxide photocatalyst","link":"http:\\/\\/www.google.com\\/patents\\/CN1805789A?cl=en&dq=Silver+and+Gold+nanoclusters+for+Photocatalysis&source=uds;","filedate":"Mon, 14 Jun 2004 00:00:00 -0700","applicant":"\\u5f00\\u5229\\u516c\\u53f8","desc":"Gold \\/ titanium dioxide <b>photocatalytic<\\/b> \\/ hot catalytic coating, and the coating on <b>...<\\/b>  comprise a mixed metal gold <b>silver<\\/b>, rhodium, ruthenium, palladium, <b>.....<\\/b> is critical,  depending on the formation of very small <b>gold nanoparticles<\\/b>.","radio_11b":"relevant"},{"title":"Hybrid metal-semiconductor nanoparticles and methods for photo-inducing ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2129463A2?cl=en&dq=Silver+and+Gold+nanoclusters+for+Photocatalysis&source=uds;","filedate":"Wed, 20 Feb 2008 00:00:00 -0800","applicant":"Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.","desc":"The <b>photocatalysts<\\/b> (<b>nanoparticles<\\/b>) of the invention, or those <b>....<\\/b> <b>gold<\\/b> and  palladium; platinum and palladium; <b>silver and gold<\\/b>; <b>silver<\\/b> and platinum\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Titania photocatalytic compounds and methods of making the same","link":"http:\\/\\/www.google.com\\/patents\\/WO2013109507A1?cl=en&dq=Silver+and+Gold+nanoclusters+for+Photocatalysis&source=uds;","filedate":"Mon, 14 Jan 2013 00:00:00 -0800","applicant":"Nitto Denko Corporation","desc":"The <b>photocatalysts<\\/b> may, in some embodiments, provide superior <b>photocatalytic<\\/b> <b>...<\\/b>  with various noble metals and transition metals, such as <b>gold<\\/b>, <b>silver<\\/b>, <b>......<\\/b> For  example, the noble metal may form <b>nanoparticles<\\/b> (e.g., particles\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"}]', '[{"title":"null","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/undefined","desc":"null","details":"null","radio_11b2":"duplicate"},{"title":"Synthesis of &lt;b&gt;silver&lt;\\/b&gt;\\/montmorillonite nanocomposites using &Icirc;&sup3;-irradiation","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3000206\\/","desc":"Kamyar Shameli, Mansor Bin Ahmad, Wan Md Zin Wan Yunus, Nor Azowa Ibrahim, Yadollah Gharayebi, Sajjad Sedaghat","details":"","radio_11b2":"least_relevant"},{"title":"Porous Silicon Nanowires","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3236246\\/","desc":"Yongquan Qu, Hailong Zhou, Xiangfeng Duan","details":"","radio_11b2":"somewhat_relevant"},{"title":"Selective preparation of zero- and one-dimensional &lt;b&gt;gold&lt;\\/b&gt; nanostructures in a TiO&lt;sub&gt;2 &lt;\\/sub&gt;nanocrystal-containing photoactive mesoporous template","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3265400\\/","desc":"Go Kawamura, Teruhisa Okuno, Hiroyuki Muto, Atsunori Matsuda","details":"Nanoscale Res Lett. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(1): 27.  &lt;span class=&quot;&quot;&gt;Published online 2012 January 5. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1556-276X-7-27&lt;\\/span&gt;","radio_11b2":"relevant"},{"title":"Protein-protected luminescent noble metal quantum clusters: an emerging trend in atomic cluster nanoscience","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3272820\\/","desc":"Paulrajpillai Lourdu Xavier, Kamalesh Chaudhari, Ananya Baksi, Thalappil Pradeep","details":"Nano Rev. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;3: 10.3402\\/nano.v3i0.14767.  &lt;span class=&quot;&quot;&gt;Published online 2012 February 3. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3402\\/nano.v3i0.14767&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Reversing the size-dependence of surface plasmon resonances","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2930473\\/","desc":"Sheng Peng, Jeffrey M. McMahon, George C. Schatz, Stephen K. Gray, Yugang Sun","details":"","radio_11b2":"somewhat_relevant"},{"title":"Anisotropic nanomaterials: structure, growth, assembly, and functions","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3215190\\/","desc":"Panikkanvalappil R. Sajanlal, Theruvakkattil S. Sreeprasad, Akshaya K. Samal, Thalappil Pradeep","details":"Nano Rev. &lt;span class=&quot;citation-publication-date&quot;&gt;2011; &lt;\\/span&gt;2: 10.3402\\/nano.v2i0.5883.  &lt;span class=&quot;&quot;&gt;Published online 2011 February 16. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3402\\/nano.v2i0.5883&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Spontaneous synthesis of &lt;b&gt;gold&lt;\\/b&gt; nanoparticles on gum arabic-modified iron oxide nanoparticles as a magnetically recoverable nanocatalyst","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3432631\\/","desc":"Chien-Chen Wu, Dong-Hwang Chen","details":"Nanoscale Res Lett. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(1): 317.  &lt;span class=&quot;&quot;&gt;Published online 2012 June 19. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1556-276X-7-317&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Efficiency enhancements in Ag nanoparticles-SiO&lt;sub&gt;2&lt;\\/sub&gt;-TiO&lt;sub&gt;2&lt;\\/sub&gt; sandwiched structure via plasmonic effect-enhanced light capturing","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3599079\\/","desc":"Jinxia Xu, Xiangheng Xiao, Andrey L Stepanov, Fen Ren, Wei Wu, Guangxu Cai, Shaofeng Zhang, Zhigao Dai, Fei Mei, Changzhong Jiang","details":"Nanoscale Res Lett. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(1): 73.  &lt;span class=&quot;&quot;&gt;Published online 2013 February 12. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1556-276X-8-73&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Compressibility of porous TiO&lt;sub&gt;2&lt;\\/sub&gt; nanoparticle coating on paperboard","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3816206\\/","desc":"Milena Stepien, Jarkko J Saarinen, Hannu Teisala, Mikko Tuominen, Janne Haapanen, Jyrki M M&Atilde;&curren;kel&Atilde;&curren;, Jurkka Kuusipalo, Martti Toivakka","details":"Nanoscale Res Lett. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(1): 444.  &lt;span class=&quot;&quot;&gt;Published online 2013 October 25. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1556-276X-8-444&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"}]', 'test test test test test', 'test test test test test', 'test test est test test', '', '[{"title":"Mid-Atlantic BIO: The challenge of infectious disease","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/mid-atlantic-bio-the-challenge-of-infectious-disease\\/2006-10-12","desc":" of the NIH''s National Institute of Allergy and <strong>Infectious<\\/strong> <strong>Disease<\\/strong> (NIAID), delivered a fascinating speech on emerging and re-emerging <strong>infectious<\\/strong> <strong>diseases<\\/strong>. In 1963 a noted physician and anthropologist predicted the eventual eradication of <strong>infectious<\\/strong> <strong>disease<\\/strong> but as Fauci noted, this prediction couldn''t missed ...","radio_15":"somewhat_likely"},{"title":"WHO: Infectious disease a growing threat","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/who-infectious-disease-a-growing-threat\\/2007-08-24","desc":" systems,","radio_15":"least_likely"},{"title":"Dry antibiotic pipeline concerns infectious disease experts","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/dry-antibiotic-pipeline-concerns-infectious-disease-experts\\/2007-11-05","desc":" the report Related Articles: WHO: <strong>Infectious<\\/strong> <strong>disease<\\/strong> a growing threat. Report The challenges of <strong>infectious<\\/strong> ...","radio_15":"least_likely"},{"title":"SPOTLIGHT: Market expands for infectious diseases","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/spotlight-market-expands-for-infectious-diseases\\/2008-02-28","desc":" An increasing amount of global travel has caused several <strong>infectious<\\/strong> <strong>diseases<\\/strong>, such as Yellow Fever and West Nile Virus, to surface in developed countries after largely being restricted to underdeveloped areas. And that trend has opened up a channel for vaccine manufacturers to develop products for advanced ...","radio_15":"somewhat_likely"},{"title":"J&J spotlights infectious diseases as pipeline priority","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/j-j-spotlights-infectious-diseases-pipeline-priority\\/2010-10-20","desc":" 400 new vaccines and drugs for <strong>infectious<\\/strong> <strong>diseases<\\/strong> New bioterror lab will target <strong>infectious<\\/strong> <strong>disease<\\/strong> ...","radio_15":"least_likely"},{"title":"New bioterror lab will target infectious disease therapies ","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/new-bioterror-lab-will-target-infectious-disease-therapies\\/2010-06-22","desc":" and outbreaks of <strong>infectious<\\/strong> <strong>disease<\\/strong>.","radio_15":"somewhat_likely"},{"title":"2006 Mid-Atlantic Bio: The challenges of infectious disease","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/2006-mid-atlantic-bio-the-challenges-of-infectious-disease\\/2006-10-12","desc":" <strong>infectious<\\/strong> <strong>diseases<\\/strong> at a time not too far in the future. Indeed\\u00e2\\u20ac\\u00a6it seems reasonable to anticipate ...","radio_15":"least_likely"},{"title":"PhRMA: Roughly 400 new meds in pipeline for infectious diseases","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/phrma-roughly-400-new-meds-pipeline-infectious-diseases\\/2010-09-10","desc":" America''s biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight <strong>infectious<\\/strong> <strong>diseases<\\/strong>. Some of the <strong>diseases<\\/strong> targeted plague the developing world, while others threaten\\u00a0lives in every country. Six medicines and five vaccines for malaria are currently ...","radio_15":"somewhat_likely"},{"title":"Supramap helps researchers track, predict infectious disease","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/supramap-helps-researchers-track-predict-infectious-disease\\/2010-04-12","desc":" and transmission of a <strong>disease<\\/strong>. The tool''s users can obtain a pathogens'' phylogenetic tree\\u00a0by\\u00a0submitting ...","radio_15":"somewhat_likely"},{"title":"Soligenix, Infectious Disease Research Institute partner to combat anthrax","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/soligenix-infectious-disease-research-institute-partner-combat-anthrax\\/2012-07-02","desc":" and <strong>Infectious<\\/strong> <strong>Disease<\\/strong> grant supporting the development of advanced heat-stable vaccines against anthrax ...","radio_15":"somewhat_likely"}]', 'infectious diseases', '', '', '3', '4', '', 100);
INSERT INTO `inventions` VALUES(169, '2013-11-22 07:00:18', 17, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'HDAC inhibitor for pancreatic cancer', '', '{"2":{"title":"CDx without drug on market","id":"58","status":"field"},"3":{"title":"Cancer Target screening tools","id":"61","status":"field"},"4":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"5":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"6":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"7":{"title":"pancreatic cancer drug","id":"92","status":"field"},"8":{"title":"pancreatic diseases","id":"94","status":"field"},"9":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"10":{"title":"pancreatic cancer","id":"108","status":"field"},"11":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"}}', 0, '', '', '', '', 0, '', '', 0, '{"0":{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2547349A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum"},"1":{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the <b>...<\\/b> Use of  <b>hdac inhibitors for<\\/b> the treatment of gastrointestinal <b>cancers<\\/b>","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag"},"3":{"title":"Cancer therapy with a parvovirus combined with an HDAC inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2366398A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>HDAC inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","filedate":"Wed, 17 Mar 2010 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum"},"5":{"title":"Cancer therapy with combinations of fts with hdac inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2011056542A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"The method of any of claims 10-18, wherein the <b>HDAC inhibitor<\\/b> is <b>...<\\/b> of renal  carcinoma, skin cancer, <b>pancreatic cancer<\\/b>, colorectal cancer,\\u00a0<b>...<\\/b>","filedate":"Tue, 26 Oct 2010 00:00:00 -0700","applicant":"Ramot At Tel-Aviv University Ltd."},"6":{"title":"Combination therapy using HDAC inhibitors and melphalan for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2500063A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"The present invention pertains to a method for treating cancer, such as <b>...<\\/b>  Combination therapy using <b>HDAC inhibitors<\\/b> and melphalan for treating cancer <b>...<\\/b>  cancer, colon cancer, lung cancer, breast cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited"},"7":{"title":"A pharmaceutical composition comprising a hdac inhibitor and a steroid and ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2012128709A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"Said <b>HDAC inhibitor<\\/b> or steroid may alternatively be administrated <b>...<\\/b> renal cancer,  colon and colorectal cancer, <b>pancreatic cancer<\\/b>, head and\\u00a0<b>...<\\/b>","filedate":"Tue, 20 Mar 2012 00:00:00 -0700","applicant":"Valcuria Ab"}}', '[{"title":"Role of Hydroxamate-Based &lt;b&gt;Histone Deacetylase Inhibitors&lt;\\/b&gt; (Hb-HDACIs) in the Treatment of Solid Malignancies.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24202327","desc":"Grassadonia A, Cioffi P, Simiele F, Iezzi L, Zilli M, Natoli C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancers&quot;&gt;Cancers (Basel)&lt;\\/span&gt;. 2013 Jul 25;5(3):919-42. doi: 10.3390\\/cancers5030919."},{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Nov 8;441(1):102-7. doi: 10.1016\\/j.bbrc.2013.10.010. Epub 2013 Oct 14."},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17."},{"title":"The novel &lt;b&gt;HDAC inhibitor&lt;\\/b&gt; NDACI054 sensitizes human &lt;b&gt;cancer&lt;\\/b&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/span&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4.  10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]"},{"title":"Current evidence for &lt;b&gt;histone deacetylase inhibitors&lt;\\/b&gt; in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3574878\\/","desc":"Ioannis Koutsounas, Constantinos Giaginis, Efstratios Patsouris, Stamatios Theocharis","details":null},{"title":"Superior efficacy of co-treatment with dual PI3K\\/mTOR &lt;b&gt;inhibitor&lt;\\/b&gt; NVP-BEZ235 and pan-&lt;b&gt;histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt; &lt;b&gt;inhibitor&lt;\\/b&gt; against human &lt;b&gt;pancreatic cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3717802\\/","desc":"Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, Peter Atadja, Manuel Hidalgo, Anirban Maitra, Kapil N. Bhalla","details":null},{"title":"Experimental &lt;em&gt;in vivo&lt;\\/em&gt; and &lt;em&gt;in vitro&lt;\\/em&gt; treatment with a new &lt;b&gt;histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt; &lt;b&gt;inhibitor&lt;\\/b&gt; belinostat inhibits the growth of &lt;b&gt;pancreatic cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3407493\\/","desc":"Dmitriy I Dovzhanskiy, Stefanie M Arnold, Thilo Hackert, Ina Oehme, Olaf Witt, Klaus Felix, Nathalia Giese, Jens Werner","details":"BMC &lt;b&gt;Cancer&lt;\\/b&gt;. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;12: 226.  &lt;span class=&quot;&quot;&gt;Published online 2012 June 8. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1471-2407-12-226&lt;\\/span&gt;"},{"title":"Class I and Class II &lt;b&gt;Histone&lt;\\/b&gt; Deacetylases Are Potential Therapeutic Targets for Treating &lt;b&gt;Pancreatic Cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3522644\\/","desc":"Guan Wang, Jing He, Jianyun Zhao, Wenting Yun, Chengzhi Xie, Jeffrey W. Taub, Asfar Azmi, Ramzi M. Mohammad, Yan Dong, Wei Kong, Yingjie Guo, Yubin Ge","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(12): e52095.  &lt;span class=&quot;&quot;&gt;Published online 2012 December 14. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0052095&lt;\\/span&gt;"},{"title":"The anti-tumor effect of &lt;b&gt;HDAC&lt;\\/b&gt; inhibition in a human pancreas &lt;b&gt;cancer&lt;\\/b&gt; model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102."},{"title":"Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23994577","desc":"Farrelly LA, Savage NT, O''Callaghan C, Toulouse A, Yilmazer-Hanke DM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Regulatory peptides&quot;&gt;Regul Pept&lt;\\/span&gt;. 2013 Sep 10;186:123-30. doi: 10.1016\\/j.regpep.2013.08.005. Epub 2013 Aug 28."}]', '', '', '', '', '', 'cell', 'infectious diseases', '', '', '', '', 30);
INSERT INTO `inventions` VALUES(170, '2013-11-22 11:39:55', 17, 'test nov 22', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'HDAC inhibitor for KRAS mutant colon cancer', 'c', '', 'HDAC inhibitor', '', '', '', 'a', '', 'Gee Kaun', '', '', '', '', '', 'field', '97', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'HDAC inhibitor for pancreatic cancer', '{"1":{"radio_11a1":"Yes","title":"Mouse model for research use","id":"136","status":"field"}}', '{"2":{"title":"CDx without drug on market","id":"58","status":"field"},"3":{"title":"Cancer Target screening tools","id":"61","status":"field"},"4":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"5":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"6":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"7":{"title":"pancreatic cancer drug","id":"92","status":"field"},"8":{"title":"pancreatic diseases","id":"94","status":"field"},"9":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"10":{"title":"pancreatic cancer","id":"108","status":"field"},"11":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"}}', 142, '', '>1m', 'No', '', 0, '', 'Yes', 10, '{"0":{"title":"Cancer therapy with a parvovirus combined with an hdac inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2547349A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>hdac inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","filedate":"Thu, 17 Mar 2011 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","radio_11b":"least_relevant"},"1":{"title":"Use of hdac inhibitors for the treatment of gastrointestinal cancers","link":"http:\\/\\/www.google.com\\/patents\\/WO2008137630A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"The present invention relates to the use of an <b>HDAC inhibitor<\\/b> for the <b>...<\\/b> Use of  <b>hdac inhibitors for<\\/b> the treatment of gastrointestinal <b>cancers<\\/b>","filedate":"Fri, 02 May 2008 00:00:00 -0700","applicant":"Peter Wisdom Atadja, Novartis Ag","radio_11b":"least_relevant"},"3":{"title":"Cancer therapy with a parvovirus combined with an HDAC inhibitor","link":"http:\\/\\/www.google.com\\/patents\\/EP2366398A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"<b>Cancer<\\/b> therapy with a parvovirus combined with an <b>HDAC inhibitor<\\/b> <b>...<\\/b> <b>Pancreatic<\\/b>  ductal adenocarcinoma (PDAC) is one of the most lethal\\u00a0<b>...<\\/b>","filedate":"Wed, 17 Mar 2010 00:00:00 -0700","applicant":"Deutsches Krebsforschungszentrum","radio_11b":"least_relevant"},"5":{"title":"Cancer therapy with combinations of fts with hdac inhibitors","link":"http:\\/\\/www.google.com\\/patents\\/WO2011056542A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"The method of any of claims 10-18, wherein the <b>HDAC inhibitor<\\/b> is <b>...<\\/b> of renal  carcinoma, skin cancer, <b>pancreatic cancer<\\/b>, colorectal cancer,\\u00a0<b>...<\\/b>","filedate":"Tue, 26 Oct 2010 00:00:00 -0700","applicant":"Ramot At Tel-Aviv University Ltd.","radio_11b":"least_relevant"},"6":{"title":"Combination therapy using HDAC inhibitors and melphalan for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP2500063A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"The present invention pertains to a method for treating cancer, such as <b>...<\\/b>  Combination therapy using <b>HDAC inhibitors<\\/b> and melphalan for treating cancer <b>...<\\/b>  cancer, colon cancer, lung cancer, breast cancer, <b>pancreatic cancer<\\/b>,\\u00a0<b>...<\\/b>","filedate":"Fri, 03 Feb 2006 00:00:00 -0800","applicant":"TopoTarget UK Limited","radio_11b":"somewhat_relevant"},"7":{"title":"A pharmaceutical composition comprising a hdac inhibitor and a steroid and ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2012128709A1?cl=en&dq=HDAC+inhibitor+for+pancreatic+cancer&source=uds;","desc":"Said <b>HDAC inhibitor<\\/b> or steroid may alternatively be administrated <b>...<\\/b> renal cancer,  colon and colorectal cancer, <b>pancreatic cancer<\\/b>, head and\\u00a0<b>...<\\/b>","filedate":"Tue, 20 Mar 2012 00:00:00 -0700","applicant":"Valcuria Ab","radio_11b":"somewhat_relevant"}}', '[{"title":"Role of Hydroxamate-Based &lt;b&gt;Histone Deacetylase Inhibitors&lt;\\/b&gt; (Hb-HDACIs) in the Treatment of Solid Malignancies.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24202327","desc":"Grassadonia A, Cioffi P, Simiele F, Iezzi L, Zilli M, Natoli C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancers&quot;&gt;Cancers (Basel)&lt;\\/span&gt;. 2013 Jul 25;5(3):919-42. doi: 10.3390\\/cancers5030919.","radio_11b2":"least_relevant"},{"title":"Suppressed expression of NDRG2 correlates with poor prognosis in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24134849","desc":"Yamamura A, Miura K, Karasawa H, Morishita K, Abe K, Mizuguchi Y, Saiki Y, Fukushige S, Kaneko N, Sase T, Nagase H, Sunamura M, Motoi F, Egawa S, Shibata C, Unno M, Sasaki I, Horii A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biochemical and biophysical research communications&quot;&gt;Biochem Biophys Res Commun&lt;\\/span&gt;. 2013 Nov 8;441(1):102-7. doi: 10.1016\\/j.bbrc.2013.10.010. Epub 2013 Oct 14.","radio_11b2":"least_relevant"},{"title":"Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and &lt;b&gt;pancreatic&lt;\\/b&gt; carcinomas.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24092664","desc":"Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schn&Atilde;&para;lzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;EMBO molecular medicine&quot;&gt;EMBO Mol Med&lt;\\/span&gt;. 2013 Oct;5(10):1537-55. doi: 10.1002\\/emmm.201302796. Epub 2013 Sep 17.","radio_11b2":"least_relevant"},{"title":"The novel &lt;b&gt;HDAC inhibitor&lt;\\/b&gt; NDACI054 sensitizes human &lt;b&gt;cancer&lt;\\/b&gt; cells to radiotherapy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24060178","desc":"Hehlgans S, Storch K, Lange I, Cordes N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&quot;&gt;Radiother Oncol&lt;\\/span&gt;. 2013 Sep 20. doi:pii: S0167-8140(13)00423-4.  10.1016\\/j.radonc.2013.08.023. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Current evidence for &lt;b&gt;histone deacetylase inhibitors&lt;\\/b&gt; in &lt;b&gt;pancreatic cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3574878\\/","desc":"Ioannis Koutsounas, Constantinos Giaginis, Efstratios Patsouris, Stamatios Theocharis","details":null,"radio_11b2":"least_relevant"},{"title":"Superior efficacy of co-treatment with dual PI3K\\/mTOR &lt;b&gt;inhibitor&lt;\\/b&gt; NVP-BEZ235 and pan-&lt;b&gt;histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt; &lt;b&gt;inhibitor&lt;\\/b&gt; against human &lt;b&gt;pancreatic cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3717802\\/","desc":"Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, Peter Atadja, Manuel Hidalgo, Anirban Maitra, Kapil N. Bhalla","details":null,"radio_11b2":"somewhat_relevant"},{"title":"Experimental &lt;em&gt;in vivo&lt;\\/em&gt; and &lt;em&gt;in vitro&lt;\\/em&gt; treatment with a new &lt;b&gt;histone&lt;\\/b&gt; &lt;b&gt;deacetylase&lt;\\/b&gt; &lt;b&gt;inhibitor&lt;\\/b&gt; belinostat inhibits the growth of &lt;b&gt;pancreatic cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3407493\\/","desc":"Dmitriy I Dovzhanskiy, Stefanie M Arnold, Thilo Hackert, Ina Oehme, Olaf Witt, Klaus Felix, Nathalia Giese, Jens Werner","details":"BMC &lt;b&gt;Cancer&lt;\\/b&gt;. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;12: 226.  &lt;span class=&quot;&quot;&gt;Published online 2012 June 8. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1471-2407-12-226&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Class I and Class II &lt;b&gt;Histone&lt;\\/b&gt; Deacetylases Are Potential Therapeutic Targets for Treating &lt;b&gt;Pancreatic Cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3522644\\/","desc":"Guan Wang, Jing He, Jianyun Zhao, Wenting Yun, Chengzhi Xie, Jeffrey W. Taub, Asfar Azmi, Ramzi M. Mohammad, Yan Dong, Wei Kong, Yingjie Guo, Yubin Ge","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(12): e52095.  &lt;span class=&quot;&quot;&gt;Published online 2012 December 14. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0052095&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"The anti-tumor effect of &lt;b&gt;HDAC&lt;\\/b&gt; inhibition in a human pancreas &lt;b&gt;cancer&lt;\\/b&gt; model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24040391","desc":"Peulen O, Gonzalez A, Peixoto P, Turtoi A, Mottet D, Delvenne P, Castronovo V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Sep 11;8(9):e75102. doi: 10.1371\\/journal.pone.0075102.","radio_11b2":"least_relevant"},{"title":"Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23994577","desc":"Farrelly LA, Savage NT, O''Callaghan C, Toulouse A, Yilmazer-Hanke DM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Regulatory peptides&quot;&gt;Regul Pept&lt;\\/span&gt;. 2013 Sep 10;186:123-30. doi: 10.1016\\/j.regpep.2013.08.005. Epub 2013 Aug 28.","radio_11b2":"least_relevant"}]', 'test test test test test', 'test test test test test', 'test test est test test', '', '{"1":{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" of Gothenburg in Sweden believe that <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong>\\u00a0can also help prevent blood clots through stimulating ..."},"2":{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ..."},"3":{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" working on <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> include MEI Pharma ($MEIP) and 4SC, and gene therapy can flip the switch ..."},"4":{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ..."},"5":{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" azacitidine. Role of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> in cancer Genes that regulate cell growth are frequently silenced ..."},"6":{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ..."},"7":{"title":"Gloucester Pharmaceuticals- Top 20 VC deals of 2008","link":"http:\\/\\/www.fiercebiotech.com\\/special-reports\\/gloucester-pharmaceuticals-top-20-vc-deals-2008","desc":" deacetylase (<strong>HDAC<\\/strong>) <strong>inhibitor<\\/strong> in Phase III trials for T-cell lymphomas.  ..."},"8":{"title":"Acetylon raises $12.4M in new venture round ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-raises-124m-new-venture-round\\/2011-02-23","desc":" Boston upstart Acetylon Pharmaceuticals has raised $12.4 million in new venture funds, according to MassHighTech. Citing SEC documents the news service revealed that Acetylon is in the process of raising a $30 million round to back its work developing <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> for inflammatory and neurological diseases ..."},"9":{"title":"Celgene pays $15M for front-row seat on Acetylon myeloma program","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/celgene-pays-15m-front-row-seat-acetylon-myeloma-program\\/2012-02-08","desc":" strategy, Ogier tells FierceBiotech. A Phase Ib study that combines its <strong>HDAC<\\/strong>6 <strong>inhibitor<\\/strong> ..."},"10":{"title":"4SC surges on positive midstage data for advanced liver cancer","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-surges-positive-midstage-data-advanced-liver-cancer\\/2012-01-19","desc":" of <strong>HDAC<\\/strong> enzymes, is highly relevant for clinical practice, since the supplementary administration ..."}}', 'HDAC inhibitors', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(171, '2013-11-23 16:05:42', 1, 'Test by Karthik Team', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_2', '', '', 'Test', 'e', '', 'Test', '', '', '', 'b', '', 'q', 'giughiu', 'hiohjnoijh', 'hihih', '', '', 'field', '110', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'HDAC', '', '{"1":{"radio_11a2":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"May be","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"May be","title":"HDAC Inhibitor for colon cancer","id":"139","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"May be","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"May be","title":"test nov 22","id":"170","status":"Disclosure Done & Under Review"}}', 140, '', '100k-1m', 'Yes', 'No', 3, '', 'Yes', 15, '[{"title":"Hdac inhibitors to treat charcot-marie-tooth disease","link":"http:\\/\\/www.google.com\\/patents\\/WO2012045804A1?cl=en&dq=HDAC&source=uds;","filedate":"Thu, 06 Oct 2011 00:00:00 -0700","applicant":"Life Sciences Research Partners Vzw, Vib Vzw","desc":"The present application relates to diseases in the peripheral nervous system,  particularly hereditary neuropathies, most particularly,\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Fluorinated hdac inhibitors and uses thereof","link":"http:\\/\\/www.google.com\\/patents\\/WO2011084991A3?cl=en&dq=HDAC&source=uds;","filedate":"Wed, 05 Jan 2011 00:00:00 -0800","applicant":"President And Fellows Of Harvard College, Dana-Farber Cancer Institute, Inc.","desc":"Fluorinated deacetylase inhibitors of the general formulae (I), (II), and (III): and  pharmaceutically acceptable salts thereof, as described herein,\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Histone deacetylase (HDAC) inhibiting compounds and method of making same","link":"http:\\/\\/www.google.com\\/patents\\/EP2486923A1?cl=en&dq=HDAC&source=uds;","filedate":"Fri, 11 Feb 2011 00:00:00 -0800","applicant":"Dr. Felix J\\u00e4ger und Dr. Stefan Drinkuth Laborgemeinschaft OHG, Hochschule Darmstadt","desc":"The invention relates to novel <b>HDAC<\\/b> inhibitors and a method of making such  <b>HDAC<\\/b> inhibitors. The present invention provides novel <b>HDAC<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds","link":"http:\\/\\/www.google.com\\/patents\\/US8283357?dq=HDAC&source=uds;","filedate":"Mon, 07 Jun 2010 00:00:00 -0700","applicant":"Gilead Sciences, Inc.","desc":"The present invention provides a compound of general Formula (I) having  histone deacetylase (<b>HDAC<\\/b>) inhibitory activity, a pharmaceutical\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Hdac inhibitors and therapeutic methods using the same","link":"http:\\/\\/www.google.com\\/patents\\/EP2456757A2?cl=en&dq=HDAC&source=uds;","filedate":"Fri, 02 Jul 2010 00:00:00 -0700","applicant":"The Board of Trustees of the University of Illinois","desc":"Histone deacetylases inhibitors (HDACIs) and compositions containing the same  are disclosed. Methods of treating diseases and conditions\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Methods for the identification and characterization of hdac interacting ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2464967A1?cl=en&dq=HDAC&source=uds;","filedate":"Fri, 13 Aug 2010 00:00:00 -0700","applicant":"Cellzome Ag","desc":"The present invention relates to methods for the identification and  characterization (e.g. selectivity profiling) of <b>HDAC<\\/b> interacting compounds\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Adjuvant compositions and methods of potentiating hdac inhibitors used to ...","link":"http:\\/\\/www.google.com\\/patents\\/US20130243852?dq=HDAC&source=uds;","filedate":"Thu, 09 May 2013 00:00:00 -0700","applicant":"Robert Sabin","desc":"A composition and method for potentiating, sensitizing, and\\/or amplifying at least  one <b>HDAC<\\/b> inhibitor targeting at least one disease in a patient\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"}]', '[{"title":"Enhancement of lysine acetylation accelerates wound repair.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24265859","desc":"Spallotta F, Cencioni C, Straino S, Sbardella G, Castellano S, Capogrossi MC, Martelli F, Gaetano C.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Communicative &amp; integrative biology&quot;&gt;Commun Integr Biol&lt;\\/span&gt;. 2013 Sep 1;6(5):e25466. Epub 2013 Jul 2.","radio_11b2":"least_relevant"},{"title":"Profile of panobinostat and its potential for treatment in solid tumors: an update.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24265556","desc":"Anne M, Sammartino D, Barginear MF, Budman D.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;OncoTargets and therapy&quot;&gt;Onco Targets Ther&lt;\\/span&gt;. 2013 Nov 15;6:1613-1624. Review.","radio_11b2":"least_relevant"},{"title":"Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24264142","desc":"Li D, Sun X, Zhang L, Yan B, Xie S, Liu R, Liu M, Zhou J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Protein &amp; cell&quot;&gt;Protein Cell&lt;\\/span&gt;. 2013 Nov 21. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Histone deacetylase inhibitors in cancer therapy. A&Acirc;&nbsp;review.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24263215","desc":"Hrabeta J, Stiborova M, Adam V, Kizek R, Eckschlager T.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia&quot;&gt;Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub&lt;\\/span&gt;. 2013 Nov 21. doi: 10.5507\\/bp.2013.085. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Molecular dynamics simulation of complex Histones Deacetylase (&lt;b&gt;HDAC&lt;\\/b&gt;) Class II &lt;em&gt;Homo Sapiens&lt;\\/em&gt; with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3732443\\/","desc":"Usman Sumo Friend Tambunan, Ridla Bakri, Tirtana Prasetia, Arli Aditya Parikesit, Djati Kerami","details":"","radio_11b2":"least_relevant"},{"title":"Nuclear Smad7 Overexpressed in Mesenchymal Cells Acts as a Transcriptional Corepressor by Interacting with &lt;b&gt;HDAC&lt;\\/b&gt;-1 and E2F to Regulate Cell Cycle","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3507285\\/","desc":"Takashi Emori, Koki Kitamura, Kenji Okazaki","details":"","radio_11b2":"least_relevant"},{"title":"Imbalance between HAT and &lt;b&gt;HDAC&lt;\\/b&gt; Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of &lt;b&gt;HDAC&lt;\\/b&gt; Inhibitors on TNF Alpha Production","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3748901\\/","desc":"Eric Toussirot, Wasim Abbas, Kashif Aziz Khan, Marion Tissot, Alicia Jeudy, Lucile Baud, Ewa Bertolini, Daniel Wendling, Georges Herbein","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(8): e70939.  &lt;span class=&quot;&quot;&gt;Published online 2013 August 15. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0070939&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of &lt;b&gt;HDAC&lt;\\/b&gt; and Aurora inhibitors in BCR-ABL-expressing cells","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3635933\\/","desc":"Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Shinya Kimura, Taira Maekawa, Kazuma Ohyashiki","details":"Cancer Cell Int. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;13: 32.  &lt;span class=&quot;&quot;&gt;Published online 2013 April 4. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1475-2867-13-32&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Dermatology and the cancer patient : conditions of the skin, hair, and nails during cancer treatment and survivors","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101605168","desc":"Lacouture, Mario E.","details":"&lt;span class=&quot;src&quot;&gt;Hoboken, N.J. : Wiley-Blackwell, c2013.&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Natural products and cancer drug discovery","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101605094","desc":"Koehn, Frank E.","details":"&lt;span class=&quot;src&quot;&gt;New York : Humana Press, c2013.&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"least_relevant"}]', 'Test test test test test', 'test test test test test', 'test test test test test', '', '[{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" Swedish researchers believe that <strong>HDAC<\\/strong> inhibitors,\\u00a0substances common to some cancer and epilepsy drugs, may also be used to help prevent heart attacks. <strong>HDAC<\\/strong> inhibitors are used to treat cancer because <strong>HDAC<\\/strong> proteins regulate how DNA behaves, and cancer can make <strong>HDAC<\\/strong> proteins turn off genes that keep ...","radio_15":"somewhat_likely"},{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" at the 54th annual meeting of the American Society of Hematology (ASH). <strong>HDACs<\\/strong> are members of a group of enzymes that help regulate gene expression. Acetylon''s lead drug, the <strong>HDAC<\\/strong>6 inhibitor ACY-1215, ...","radio_15":"least_likely"},{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" and Stuart Schreiber at Harvard University. ","radio_15":"least_likely"},{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" additional selective <strong>HDAC<\\/strong> inhibitor drug candidates for non-cancer disease indications including autoimmune ...","radio_15":"somewhat_likely"},{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> inhibitors can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ...","radio_15":"least_likely"},{"title":"Gloucester Pharmaceuticals- Top 20 VC deals of 2008","link":"http:\\/\\/www.fiercebiotech.com\\/special-reports\\/gloucester-pharmaceuticals-top-20-vc-deals-2008","desc":" deacetylase (<strong>HDAC<\\/strong>) inhibitor in Phase III trials for T-cell lymphomas.  ...","radio_15":"least_likely"},{"title":"Acetylon raises $12.4M in new venture round ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-raises-124m-new-venture-round\\/2011-02-23","desc":" Boston upstart Acetylon Pharmaceuticals has raised $12.4 million in new venture funds, according to MassHighTech. Citing SEC documents the news service revealed that Acetylon is in the process of raising a $30 million round to back its work developing <strong>HDAC<\\/strong> inhibitors for inflammatory and neurological diseases ...","radio_15":"somewhat_likely"},{"title":"Celgene pays $15M for front-row seat on Acetylon myeloma program","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/celgene-pays-15m-front-row-seat-acetylon-myeloma-program\\/2012-02-08","desc":" strategy, Ogier tells FierceBiotech. A Phase Ib study that combines its <strong>HDAC<\\/strong>6 inhibitor ...","radio_15":"somewhat_likely"},{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" azacitidine. Role of <strong>HDAC<\\/strong> inhibitors in cancer Genes that regulate cell growth are frequently silenced ...","radio_15":"least_likely"},{"title":"4SC surges on positive midstage data for advanced liver cancer","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-surges-positive-midstage-data-advanced-liver-cancer\\/2012-01-19","desc":" autoimmune disease. A number of biotechs are working on <strong>HDAC<\\/strong> inhibitors, including Curis and Acetylon.- ...","radio_15":"least_likely"}]', 'HDAC', '', '', '2', '3', '', 100);
INSERT INTO `inventions` VALUES(172, '2013-11-25 01:40:02', 2, 'test', 'cr_sw', '', '', 'gansh2', 'gansh13', 'gansh13_2', '', '', 'test', 'c', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '85', 'Yes1', '0000-00-00 00:00:00', '', '2013-11-07 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'loreum', '', '', -14, '', '>1m', 'Not Sure', '', 0, '', 'Not Sure', 10, '[{"title":"Systems and methods for generating personalized dynamic presentations from ...","link":"http:\\/\\/www.google.com\\/patents\\/about?id=I_K-AAAAEBAJ&dq=loreum&num=8&client=internal-uds&source=uds;","filedate":"Mon, 17 Sep 2007 00:00:00 -0700","applicant":"MOET HENNESSY","desc":"11 TITLE SUBTITLE <b>Loreum<\\/b> ipsum dolor si amet, consectetuer Patent  Application Publication Mar. 19, 2009 Sheet 11 of 14 US 2009\\/0076834 Al.","radio_11b":"least_relevant"}]', '[{"title":"A taste of individualized medicine: physicians'' reactions to automated genetic interpretations.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24001515","desc":"L&Atilde;&brvbar;rum H, Bremer S, Bergan S, Gr&Atilde;&frac14;nfeld T.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of the American Medical Informatics Association : JAMIA&quot;&gt;J Am Med Inform Assoc&lt;\\/span&gt;. 2013 Sep 3. doi: 10.1136\\/amiajnl-2012-001587. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"Does age influence the symptom experience of lung cancer patients prior to surgery?","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23916857","desc":"Oksholm T, Miaskowski C, Kongerud JS, Cooper B, Paul SM, &lt;b&gt;Laerum&lt;\\/b&gt; L, Rustoen T.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Lung cancer (Amsterdam, Netherlands)&quot;&gt;Lung Cancer&lt;\\/span&gt;. 2013 Oct;82(1):156-61. doi: 10.1016\\/j.lungcan.2013.06.016. Epub 2013 Aug 3.","radio_11b2":"duplicate"},{"title":"B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23800860","desc":"Bax HI, Freeman AF, Anderson VL, Vesterhus P, &lt;b&gt;Laerum&lt;\\/b&gt; D, Pittaluga S, Wilson WH, Holland SM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of clinical immunology&quot;&gt;J Clin Immunol&lt;\\/span&gt;. 2013 Aug;33(6):1062-6. doi: 10.1007\\/s10875-013-9907-0. Epub 2013 Jun 26.","radio_11b2":"duplicate"},{"title":"Effect of comprehensive cardiac rehabilitation after heart valve surgery (CopenHeartVR): study protocol for a randomised clinical trial.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23782510","desc":"Sibilitz KL, Berg SK, Hansen TB, Risom SS, Rasmussen TB, Hassager C, K&Atilde;&cedil;ber L, Steinbr&Atilde;&frac14;chel D, Gluud C, Winkel P, Thygesen LC, Hansen JL, Schmid JP, Conraads V, Brocki BC, Zwisler AD.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Trials&quot;&gt;Trials&lt;\\/span&gt;. 2013 Apr 22;14:104. doi: 10.1186\\/1745-6215-14-104.","radio_11b2":"duplicate"},{"title":"On the cicada genus\\n&lt;em&gt;Nipponosemia&lt;\\/em&gt; Kato, with description of one new species from China (Hemiptera,&Acirc;&nbsp;Cicadidae)","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3677403\\/","desc":"Mingsheng Yang, Cong Wei","details":"","radio_11b2":"duplicate"},{"title":"A remarkable new genus of leafhoppers (Hemiptera, Cicadellidae, Iassinae) from Southeast Asia","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3497258\\/","desc":"Wu Dai, Chris H. Dietrich","details":"","radio_11b2":"duplicate"},{"title":"Tungurahualini, a new tribe of Neotropical leafhoppers, with notes on the subfamily Mileewinae (Hemiptera, Cicadellidae)","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3175117\\/","desc":"C. H. Dietrich","details":"","radio_11b2":"duplicate"},{"title":"The genus &lt;em&gt;Nelcyndana&lt;\\/em&gt; St&Atilde;&yen;l (Hemiptera, Cicadidae, Taphurini) with description of three new species from Borneo","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3088350\\/","desc":"Joannes Petrus Duffels","details":"","radio_11b2":"duplicate"},{"title":"&lt;b&gt;Forum&lt;\\/b&gt; implantologicum","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101592666","desc":"","details":"","radio_11b2":"duplicate"},{"title":"Art in science : selections from Emerging infectious diseases","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101613379","desc":"Potter, Polyxeni; Centers for Disease Control and Prevention (US).","details":"&lt;span class=&quot;src&quot;&gt;Oxford : Oxford University Press, [2014]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"}]', 'a a a a a a a a a a', 'a', 'a', '[{"title":"Fisher <b>Scientific<\\/b>: Welcome - CMStatic","link":"http:\\/\\/www.fishersci.com\\/","desc":"Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals\\n, supplies, and <b>...<\\/b> 2013 Thermo Fisher <b>Scientific Inc<\\/b>. - All rights reserved.","radio_15b":"duplicate"},{"title":"Boston <b>Scientific<\\/b> - Leading innovator of medical solutions","link":"http:\\/\\/www.bostonscientific.com\\/","desc":"Boston <b>Scientific<\\/b> to acquire C.R. Bard, <b>Inc<\\/b>.''s Electrophysiology <b>Business<\\/b>. \\"We \\nbelieve the innovation and global reach that Bard EP delivers will meaningfully\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"The <b>Science Company<\\/b>\\u00ae","link":"http:\\/\\/www.sciencecompany.com\\/","desc":"Sells a selection of weather instruments, microscopes, telescopes and laboratory \\nsupplies.","radio_15b":"duplicate"},{"title":"Thermo Fisher <b>Scientific<\\/b> - Welcome","link":"http:\\/\\/www.thermofisher.com\\/","desc":"At Thermo Fisher Scientific,. we enable <b>...<\\/b> and support. The world leader in \\nserving science <b>...<\\/b> Copyright 2013 Thermo Fisher <b>Scientific Inc<\\/b>. All rights \\nreserved.","radio_15b":"duplicate"},{"title":"Thermo <b>Scientific<\\/b>","link":"http:\\/\\/www.thermoscientific.com\\/","desc":"Thermo Scientific <b>....<\\/b> The Life Science Research Community features information \\nfor those <b>...<\\/b> Copyright 2013 Thermo Fisher <b>Scientific Inc<\\/b>. All Rights Reserved.","radio_15b":"duplicate"},{"title":"Campbell <b>Scientific<\\/b>: dataloggers, data acquisition systems, weather <b>...<\\/b>","link":"http:\\/\\/www.campbellsci.com\\/","desc":"for Long-term Monitoring. USA OTHER COUNTRIES \\u00b7 Login \\u00b7 Products; Support; \\nAbout \\u00b7 Home Site Map ISO 9001:2008 Certified \\u00a9 2013 Campbell <b>Scientific<\\/b>, <b>Inc<\\/b>\\n\\u00a0<b>...<\\/b>","radio_15b":"duplicate"},{"title":"Drummond <b>Scientific Company<\\/b>","link":"http:\\/\\/www.drummondsci.com\\/","desc":"Precision micro liquid transfer devices such as pipets, pipet-aids, capillary tubing, \\noocyte injectors.","radio_15b":"duplicate"},{"title":"Flinn <b>Scientific<\\/b>","link":"http:\\/\\/www.flinnsci.com\\/","desc":"Flinn <b>Scientific<\\/b> is a fun and informative <b>science<\\/b> education resource, providing \\n<b>science<\\/b> supplies and innovative ideas to help teachers and students succeed.","radio_15b":"duplicate"}]', '[{"title":"Star <b>Scientific<\\/b>, Inc. (STSI): Star <b>Scientific<\\/b>: Cash Strapped And Under <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1744142-star-scientific-cash-strapped-and-under-the-influence-of-death-spiral-financing","desc":"Oct 14, 2013 <b>...<\\/b> Star <b>Scientific<\\/b>, Inc. (NASDAQ:STSI): Star <b>Scientific<\\/b>: Cash Strapped And Under \\nThe Influence Of Death-Spiral Financing.","radio_15":"duplicate"},{"title":"Boston <b>Scientific<\\/b> Corporation (BSX): Boston <b>Scientific<\\/b> Management <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1769772-boston-scientific-management-discusses-q3-2013-results-earnings-call-transcript","desc":"Oct 24, 2013 <b>...<\\/b> Boston <b>Scientific<\\/b> Corporation (NYSE:BSX): Boston <b>Scientific<\\/b> Management \\nDiscusses Q3 2013 Results - Earnings Call Transcript.","radio_15":"duplicate"},{"title":"Is Boston <b>Scientific<\\/b> A Potential Acquisition Target For Johnson <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1625412-is-boston-scientific-a-potential-acquisition-target-for-johnson-johnson","desc":"Aug 9, 2013 <b>...<\\/b> Johnson & Johnson (NYSE:JNJ), Boston <b>Scientific<\\/b> Corporation (NYSE:BSX), \\nSunshine Heart Inc (NASDAQ:SSH), St. Jude Medical, Inc.","radio_15":"duplicate"},{"title":"Boston <b>Scientific<\\/b> Corporation (BSX): Job Cuts At Boston <b>Scientific<\\/b> <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1771192-job-cuts-at-boston-scientific-indicative-of-an-industry-in-flux","desc":"Oct 24, 2013 <b>...<\\/b> Boston <b>Scientific<\\/b> Corporation (NYSE:BSX): Job Cuts At Boston <b>Scientific<\\/b> \\nIndicative Of An Industry In Flux.","radio_15":"duplicate"},{"title":"Boston <b>Scientific<\\/b> Corporation Discusses Q3 2013 Results (Webcast <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1766662-boston-scientific-corporation-discusses-q3-2013-results-webcast","desc":"Oct 24, 2013 <b>...<\\/b> Boston <b>Scientific<\\/b> Corporation (NYSE:BSX): Boston <b>Scientific<\\/b> Corporation \\nDiscusses Q3 2013 Results (Webcast)","radio_15":"duplicate"},{"title":"<b>Scientific<\\/b> Games Corp (SGMS): <b>Scientific<\\/b> Games'' CEO Discusses <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1820842-scientific-games-ceo-discusses-q3-2013-results-earnings-call-transcript","desc":"Nov 7, 2013 <b>...<\\/b> <b>Scientific<\\/b> Games Corp (NASDAQ:SGMS): <b>Scientific<\\/b> Games'' CEO Discusses Q3 \\n2013 Results - Earnings Call Transcript.","radio_15":"duplicate"},{"title":"Thermo Fisher <b>Scientific<\\/b> Management Discusses <b>...<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1764302-thermo-fisher-scientific-management-discusses-q3-2013-results-earnings-call-transcript","desc":"Oct 23, 2013 <b>...<\\/b> Thermo Fisher <b>Scientific<\\/b> Inc. (NYSE:TMO): Thermo Fisher <b>Scientific<\\/b> Management \\nDiscusses Q3 2013 Results - Earnings Call Transcript.","radio_15":"duplicate"},{"title":"Emerging Markets: The Next Leg Up For Boston <b>Scientific<\\/b> Corporation","link":"http:\\/\\/seekingalpha.com\\/article\\/1666682-emerging-markets-the-next-leg-up-for-boston-scientific-corporation","desc":"Aug 30, 2013 <b>...<\\/b> Boston <b>Scientific<\\/b> Corporation (BSX) is continuing to expand its range of \\nelectrophysiology (EP) products, with U.S. Food and Drug Agency\\u00a0<b>...<\\/b>","radio_15":"duplicate"}]', 'scientific', '', '', '2', '2', '', 100);
INSERT INTO `inventions` VALUES(185, '2013-11-26 13:22:20', 33, 'test', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'test', 'c', '', 'test', '', '', '', 'b', '', 'test', '', '', '', '', '', 'field', '83', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'test', '', '', 0, '', '>1m', 'Not Sure', '', 0, '', 'Not Sure', 10, '', '', 'test test test test test', 'test test test test test', 'test test test test test', '', '[{"title":"The Stock Market''s November <b>Test<\\/b> [PowerShares QQQ Trust, Series <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1792842-the-stock-markets-november-test","desc":"Oct 31, 2013 <b>...<\\/b> FedEx Corporation (NYSE:FDX), ProShares UltraShort QQQ (ETF) (NYSEARCA:\\nQID), PowerShares QQQ Trust, Series 1 (ETF)\\u00a0<b>...<\\/b>"},{"title":"Another <b>Test<\\/b> Of NQ Mobile''s Credibility - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1818922-another-test-of-nq-mobiles-credibility","desc":"Nov 7, 2013 <b>...<\\/b> NQ Mobile Inc (ADR) (NYSE:NQ): Another <b>Test<\\/b> Of NQ Mobile''s Credibility."},{"title":"CardioDX IPO Might <b>Test<\\/b> Well For Aggressive Investors [Quest <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1839232-cardiodx-ipo-might-test-well-for-aggressive-investors","desc":"Nov 14, 2013 <b>...<\\/b> CardioDx, Inc. (), Quest Diagnostics Inc (NYSE:DGX): CardioDX IPO Might <b>Test<\\/b> \\nWell For Aggressive Investors."},{"title":"Is Your REIT RIPE? Introducing The RIPE-IQ <b>Test<\\/b> With Realty <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1764542-is-your-reit-ripe-introducing-the-ripe-iq-test-with-realty-income-corp","desc":"Oct 23, 2013 <b>...<\\/b> Introducing The BARS-IQ <b>Test<\\/b> With Realty Income Corp.,"},{"title":"Nokia Will <b>Test<\\/b> $8 Per Share This Year - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/article\\/1756312-nokia-will-test-8-per-share-this-year","desc":"Oct 21, 2013 <b>...<\\/b> Nokia Corporation (ADR) (NYSE:NOK), Microsoft Corporation (NASDAQ:MSFT): \\nNokia Will <b>Test<\\/b> $8 Per Share This Year."},{"title":"Quest Diagnostics launches lower priced BRCA <b>test<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/currents\\/post\\/1328742","desc":"Oct 15, 2013 <b>...<\\/b> It looks like the race to the bottom is on regarding pricing for BRCA <b>testing<\\/b>. Quest \\nDiagnostics (DGX +0.1%) today announced the launch of\\u00a0<b>...<\\/b>"},{"title":"Matthew Potter''s Instablog - Posts on <b>Test<\\/b> - Seeking Alpha","link":"http:\\/\\/seekingalpha.com\\/author\\/matthew-potter\\/instablog\\/tag\\/test","desc":"Jan 22, 2012 <b>...<\\/b> Matthew Potter is a contributor at DefenseProcurementNews.com (http:\\/\\/www.\\nDefenseprocurementnews.com\\/) as well as writing about life and\\u00a0<b>...<\\/b>"},{"title":"Aehr <b>Test<\\/b> Systems Discusses Q1 2014 Results (Webcast) - Seeking <b>...<\\/b>","link":"http:\\/\\/seekingalpha.com\\/article\\/1714122-aehr-test-systems-discusses-q1-2014-results-webcast","desc":"Sep 26, 2013 <b>...<\\/b> Aehr <b>Test<\\/b> Systems (NASDAQ:AEHR): Aehr <b>Test<\\/b> Systems Discusses Q1 2014 \\nResults (Webcast)"}]', 'test', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(186, '2013-11-26 13:30:49', 13, 'test', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'test', 'c', '', 'test', '', '', '', 'a', '', 'USK1', '', '', '', '', '', 'field', '85', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-11-06 00:00:00', '', '', '0000-00-00 00:00:00', 'test', '', '{"2":{"title":"testing happy head","id":"63","status":"field"},"3":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"4":{"title":"test","id":"81","status":"field"},"5":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"6":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"7":{"title":"laser excitation fluorescence","id":"107","status":"field"},"8":{"title":"test 10-29-13 ","id":"109","status":"field"},"9":{"title":"test","id":"117","status":"process"},"10":{"title":"test","id":"122","status":"field"},"11":{"title":"tst","id":"129","status":"field"}}', 131, '', '100k-1m', 'No', '', 0, '', 'Maybe', 9, '[{"title":"Test mode control circuit in semiconductor memory device and test mode ...","link":"http:\\/\\/www.google.com\\/patents\\/US8537628?dq=test&source=uds;","desc":"A <b>test<\\/b> mode control circuit is provided to strictly allow entry into a <b>test<\\/b> mode or  prevent a boot failure from occurring during a boot operation for a\\u00a0<b>...<\\/b>","filedate":"Wed, 22 Jun 2011 00:00:00 -0700","applicant":"Samsung Electronics Co., Ltd.","radio_11b":"relevant"},{"title":"Scalable scan-based test architecture with reduced test time and test power","link":"http:\\/\\/www.google.com\\/patents\\/US8510616?dq=test&source=uds;","desc":"A scalable scan-based architecture with reduced <b>test<\\/b> time, <b>test<\\/b> power and <b>test<\\/b> pin -count in scan based <b>testing<\\/b> of ICs. In an embodiment, a <b>test<\\/b>\\u00a0<b>...<\\/b>","filedate":"Thu, 14 Feb 2008 00:00:00 -0800","applicant":"Nvidia Corporation","radio_11b":"somewhat_relevant"},{"title":"Systems and methods for test development process automation for a test harness","link":"http:\\/\\/www.google.com\\/patents\\/US20130275946?dq=test&source=uds;","desc":"Systems and methods for automatic generation of one or more\\u00a0<b>...<\\/b>","filedate":"Mon, 16 Apr 2012 00:00:00 -0700","applicant":"Oracle International Corporation","radio_11b":"somewhat_relevant"},{"title":"Test apparatus, additional circuit and test board for calculating load ...","link":"http:\\/\\/www.google.com\\/patents\\/US8558559?dq=test&source=uds;","desc":"Provided is a <b>test<\\/b> apparatus that measures charge\\/discharge current of an  intermediate capacitor provided between a transmission path\\u00a0<b>...<\\/b>","filedate":"Fri, 03 Sep 2010 00:00:00 -0700","applicant":"Advantest Corporation","radio_11b":"least_relevant"},{"title":"Test body, test arrangement, method for manufacturing of a test body, and ...","link":"http:\\/\\/www.google.com\\/patents\\/US8525535?dq=test&source=uds;","desc":"A <b>test<\\/b> body for use in determining moisture content in a laminated insulation of a  power transformer by measuring a dielectric frequency\\u00a0<b>...<\\/b>","filedate":"Wed, 01 Dec 2010 00:00:00 -0800","applicant":"Abb Technology Ltd.","radio_11b":"least_relevant"},{"title":"Thermal resistor test apparatus","link":"http:\\/\\/www.google.com\\/patents\\/US8550708?dq=test&source=uds;","desc":"A <b>test<\\/b> apparatus for a thermal resistor includes a control device, a temperature  processing circuit, a voltage regulating circuit and a temperature\\u00a0<b>...<\\/b>","filedate":"Wed, 29 Jun 2011 00:00:00 -0700","applicant":"Hong Fu Jin Precision Industry (Shenzhen) Co., Ltd., Hon Hai Precision Industry Co., Ltd.","radio_11b":"least_relevant"},{"title":"Delayed replica radar test set target","link":"http:\\/\\/www.google.com\\/patents\\/EP0363478B1?cl=en&dq=test&source=uds;","desc":"A radar <b>test<\\/b> set target which is co-located with the radar and produces a faithful  replica of the radar signal substantially delayed in time. The radar signal\\u00a0<b>...<\\/b>","filedate":"Mon, 27 Feb 1989 00:00:00 -0800","applicant":"Hughes Aircraft Company","radio_11b":"least_relevant"},{"title":"Test program set obsolescence mitigation through software and automatic test ...","link":"http:\\/\\/www.google.com\\/patents\\/US8484618?dq=test&source=uds;","desc":"Electronic <b>test<\\/b> system including hardware and software components and method  of use which provide obsolescence mitigation. A <b>test<\\/b> program\\u00a0<b>...<\\/b>","filedate":"Wed, 23 Nov 2011 00:00:00 -0800","applicant":"Advanced Testing Technologies, Inc.","radio_11b":"least_relevant"}]', '[{"title":"Setting up a new evidence-based hospice-at-home service in England.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273813","desc":"Butler C, Holdsworth L.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of palliative nursing&quot;&gt;Int J Palliat Nurs&lt;\\/span&gt;. 2013 Jul;19(7):355-9.","radio_11b2":"relevant"},{"title":"Impact of an educational pain management programme on nurses pain knowledge and attitudes in Kenya.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273811","desc":"Machira G, Kariuki H, Martindale L.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of palliative nursing&quot;&gt;Int J Palliat Nurs&lt;\\/span&gt;. 2013 Jul;19(7):341-6.","radio_11b2":"somewhat_relevant"},{"title":"DRIVER REHABILITATION IN PARKINSON''S DISEASE USING A DRIVING SIMULATOR: A PILOT STUDY.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273757","desc":"Uc E, Rizzo M, Anderson S, Lawrence J, Dawson J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Proceedings of the ... International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design&quot;&gt;Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des&lt;\\/span&gt;. 2011 Dec 1;2011:248-254.","radio_11b2":"somewhat_relevant"},{"title":"LATERAL CONTROL IN A DRIVING SIMULATOR: CORRELATIONS WITH NEUROPSYCHOLOGICAL TESTS AND ON-ROAD SAFETY ERRORS.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273756","desc":"Johnson A, Dawson J, Rizzo M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Proceedings of the ... International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design&quot;&gt;Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des&lt;\\/span&gt;. 2011 Dec 1;2011:45-61.","radio_11b2":"least_relevant"},{"title":"Evaluation Metrics for Biostatistical and Epidemiological Collaborations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3139813\\/","desc":"Doris McGartland Rubio, Deborah J. del Junco, Rafia Bhore, Christopher J. Lindsell, Robert A. Oster, Knut M. Wittkowski, Leah J. Welty, Yi-Ju Li, Dave DeMets, the Biostatistics, Epidemiology, and &lt;b&gt;Research Design&lt;\\/b&gt; (BERD) Key Function Committee of the Clinical and Translational Science Awards (CTSA) Consortium","details":null,"radio_11b2":"somewhat_relevant"},{"title":"Study\\/Experimental\\/&lt;b&gt;Research Design&lt;\\/b&gt;: Much More Than Statistics","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2808761\\/","desc":"Kenneth L. Knight","details":null,"radio_11b2":"least_relevant"},{"title":"Analysis of Combined Data from Heterogeneous Study Designs: A Methodological Proposal from the Patient Navigation &lt;b&gt;Research&lt;\\/b&gt; program","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3679186\\/","desc":"Richard G. Roetzheim, Karen M. Freund, Don K. Corle, David M. Murray, Frederick R. Snyder, Andrea C. Kronman, Pascal Jean-Pierre, Peter C. Raich, Alan E. C. Holden, Julie S. Darnell, Victoria Warren-Mears, Steven Patierno, PNRP &lt;b&gt;Design&lt;\\/b&gt;, Analysis Committee","details":null,"radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Research design&lt;\\/b&gt; considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3617214\\/","desc":null,"details":null,"radio_11b2":"somewhat_relevant"},{"title":"Boh''s pharmacy practice manual : a guide to the clinical experience","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101616447","desc":"Stein, Susan M (Susan Marie), 1966-.","details":"&lt;span class=&quot;src&quot;&gt;Fourth edition. &lt;br&gt;Philadelphia : Wolters Kluwer Health\\/Lippincott Williams &amp; Wilkins, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Clinical epidemiology : principles, methods, and applications for clinical &lt;b&gt;research&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101613792","desc":"Grobbee, D E; Hoes, Arno W.","details":"&lt;span class=&quot;src&quot;&gt;Second edition. &lt;br&gt;Burlington, Massachusetts : Jones &amp; Bartlett Learning, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"}]', 'test test test test test', 'test test test test test', 'test test test test test', '', '{"1":{"title":"Exosome Diagnostics urine test for prostate cancer; 15-year-old develops fast and accurate biomarker test;","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/exosome-diagnostics-urine-test-prostate-cancer-15-year-old-develops-fast-an\\/2012-05-30","desc":" in the Intel International Science and Engineering Fair for his\\u00a0<strong>test<\\/strong> to detect mesothelin, a protein biomarker ...","radio_15":"likely"},"2":{"title":"Roche bids for broad use of HPV test to screen for cervical cancer","link":"http:\\/\\/www.fiercepharma.com\\/story\\/roche-bids-broad-use-hpv-test-screen-cervical-cancer\\/2013-07-08","desc":" Roche ($RHHBY) is aiming to make its human papillomavirus <strong>test<\\/strong> a first-line diagnostic for cervical cancer, with a new FDA application for the Cobas HPV as a substitute for Pap <strong>tests<\\/strong>. Currently the <strong>test<\\/strong> is approved for use along with Pap <strong>testing<\\/strong>. Report  ...","radio_15":"somewhat_likely"},"3":{"title":"Better modeling to reduce animal testing","link":"http:\\/\\/www.fiercebiotechit.com\\/story\\/better-modeling-reduce-animal-testing\\/2010-08-30","desc":" Drug <strong>testing<\\/strong> via computer modeling, virtual tissue, and human and animal cells are helping the pharma industry move away from the use of animals as primary <strong>test<\\/strong> subjects. Researchers recruit tens of millions of animals annually for drug <strong>testing<\\/strong>, reports The Baltimore Sun. Eighty to 800 are needed per ...","radio_15":"somewhat_likely"},"4":{"title":"LifeCodexx gets go ahead for Down syndrome test in Switzerland","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/lifecodexx-gets-go-ahead-down-syndrome-test-switzerland\\/2012-07-31","desc":" to prenatal <strong>testing<\\/strong> for the condition, claiming that <strong>testing<\\/strong> leads to almost universal abortions. Article  ...","radio_15":"least_likely"},"5":{"title":"Company develops blood tests for psychiatric diseases","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/company-develops-blood-tests-psychiatric-diseases\\/2011-03-30","desc":" Rules Based Medicine is developing what it says is the first blood <strong>test<\\/strong> for schizophrenia. The <strong>test<\\/strong>, called VeriPsych, was developed with Cambridge University and relies on 51 biomarkers. Since the company''s launch six months ago, psychiatrists have ordered the <strong>test<\\/strong> for about 500 patients. ...","radio_15":"least_likely"},"6":{"title":"FDA to regulate new generation of diagnostic tests","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/fda-to-regulate-new-generation-of-diagnostic-tests\\/2006-09-06","desc":" and discourage the development of new <strong>tests<\\/strong>. Diagnostic <strong>tests<\\/strong> sold to labs and doctors are already under ...","radio_15":"least_likely"},"7":{"title":"OraSure''s OTC HIV test obtains crucial FDA panel backing","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/orasures-otc-hiv-test-wins-crucial-fda-panel-backing\\/2012-05-16","desc":" and BBC News. Typically, patients seeking <strong>testing<\\/strong> must go to a health care facility. An FDA reviewer ...","radio_15":"least_likely"},"8":{"title":"Genetic diagnostic tests growing more sophisticated","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-diagnostic-tests-growing-more-sophisticated\\/2006-04-13","desc":" The New York Times takes a look at the growing number of sophisticated genetic diagnostic <strong>tests<\\/strong> that are now available. On the bright side, these <strong>tests<\\/strong> are seen as guideposts to a future for personalized medicine, where such <strong>tests<\\/strong> will match patients with the drugs best suited to treat their condition. ...","radio_15":"least_likely"},"9":{"title":"Genetic testing advances as insurers balk","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-testing-advances-as-insurers-balk\\/2007-01-03","desc":" Genetic <strong>testing<\\/strong> offers real insights into how patients should be treated, but insurers have been reluctant to cover the cost of the <strong>tests<\\/strong>. With a wave of new, more targeted biologics in the pipeline along with new <strong>tests<\\/strong> to identify the people most likely to benefit from them, look for the issue to heat up ...","radio_15":"least_likely"},"10":{"title":"Genetic tests don''t increase healthcare use, study finds","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/genetic-tests-dont-increase-healthcare-use-study-finds\\/2012-05-22","desc":" between 25 and 40 who took up the offer from their healthcare provider of a multiplex <strong>test<\\/strong> for 8 common ...","radio_15":"least_likely"}}', 'test', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(187, '2013-11-27 01:23:36', 2, 'test', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'test', 'a', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '170', 'Yes', '2014-01-11 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'test', '{"1":{"radio_11a1":"May be","title":"Oct 16 hemophilia testing","id":"77","status":"field"},"2":{"radio_11a1":"May be","title":"Oct 25 Dx testing","id":"104","status":"field"},"3":{"radio_11a1":"May be","title":"Olefin catalyst for polymerization","id":"105","status":"field"},"4":{"radio_11a1":"May be","title":"test","id":"117","status":"process"},"5":{"radio_11a1":"May be","title":"test","id":"122","status":"field"},"6":{"radio_11a1":"May be","title":"tst","id":"129","status":"field"},"7":{"radio_11a1":"May be","title":"aavishkar","id":"132","status":"field"},"8":{"radio_11a1":"May be","title":"test14nov","id":"149","status":"field"},"9":{"radio_11a1":"May be","title":"test","id":"152","status":"field"},"10":{"radio_11a1":"May be","title":"test","id":"163","status":"field"}}', '{"2":{"title":"testing happy head","id":"63","status":"field"},"3":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"4":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"5":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"6":{"title":"laser excitation fluorescence","id":"107","status":"field"},"7":{"title":"test 10-29-13 ","id":"109","status":"field"},"8":{"title":"test","id":"117","status":"process"},"9":{"title":"test","id":"122","status":"field"},"10":{"title":"tst","id":"129","status":"field"},"11":{"title":"aavishkar","id":"132","status":"field"}}', 58, '', '>1m', 'Yes', 'No', 2, '', 'Yes', 38, '[{"title":"Scalable scan-based test architecture with reduced test time and test power","link":"http:\\/\\/www.google.com\\/patents\\/US8510616?dq=test&source=uds;","desc":"A scalable scan-based architecture with reduced <b>test<\\/b> time, <b>test<\\/b> power and <b>test<\\/b> pin -count in scan based <b>testing<\\/b> of ICs. In an embodiment, a <b>test<\\/b>\\u00a0<b>...<\\/b>","filedate":"Thu, 14 Feb 2008 00:00:00 -0800","applicant":"Nvidia Corporation","radio_11b":"least_relevant"},{"title":"Test mode control circuit in semiconductor memory device and test mode ...","link":"http:\\/\\/www.google.com\\/patents\\/US8537628?dq=test&source=uds;","desc":"A <b>test<\\/b> mode control circuit is provided to strictly allow entry into a <b>test<\\/b> mode or  prevent a boot failure from occurring during a boot operation for a\\u00a0<b>...<\\/b>","filedate":"Wed, 22 Jun 2011 00:00:00 -0700","applicant":"Samsung Electronics Co., Ltd.","radio_11b":"somewhat_relevant"},{"title":"Method for isolating a sample well of a test card for analysis, and ...","link":"http:\\/\\/www.google.com\\/patents\\/US20130273592?dq=test&source=uds;","desc":"The invention relates to a method for isolating at least one fluid sample well laid  out in a <b>test<\\/b> card for analyses, said <b>test<\\/b> card including a plate\\u00a0<b>...<\\/b>","filedate":"Wed, 19 Oct 2011 00:00:00 -0700","applicant":"Biomerieux","radio_11b":"relevant"},{"title":"Adaptive regression test selection within testing environments","link":"http:\\/\\/www.google.com\\/patents\\/US8276123?dq=test&source=uds;","desc":"In general, techniques are described for intelligently selecting <b>test<\\/b> cases within  <b>testing<\\/b> environments. Specifically, a computing device may\\u00a0<b>...<\\/b>","filedate":"Fri, 09 Jan 2009 00:00:00 -0800","applicant":"Juniper Networks, Inc.","radio_11b":"most_relevant"},{"title":"Test coverage analysis","link":"http:\\/\\/www.google.com\\/patents\\/US20130275953?dq=test&source=uds;","desc":"A <b>test<\\/b> coverage analysis method and corresponding apparatus are disclosed,  wherein, by executing the program under <b>test<\\/b> using one or more\\u00a0<b>...<\\/b>","filedate":"Fri, 07 Jun 2013 00:00:00 -0700","applicant":"International Business Machines Corporation","radio_11b":"least_relevant"},{"title":"Thermal resistor test apparatus","link":"http:\\/\\/www.google.com\\/patents\\/US8550708?dq=test&source=uds;","desc":"A <b>test<\\/b> apparatus for a thermal resistor includes a control device, a temperature  processing circuit, a voltage regulating circuit and a temperature\\u00a0<b>...<\\/b>","filedate":"Wed, 29 Jun 2011 00:00:00 -0700","applicant":"Hong Fu Jin Precision Industry (Shenzhen) Co., Ltd., Hon Hai Precision Industry Co., Ltd.","radio_11b":"somewhat_relevant"},{"title":"Test apparatus, additional circuit and test board for calculating load ...","link":"http:\\/\\/www.google.com\\/patents\\/US8558559?dq=test&source=uds;","desc":"Provided is a <b>test<\\/b> apparatus that measures charge\\/discharge current of an  intermediate capacitor provided between a transmission path\\u00a0<b>...<\\/b>","filedate":"Fri, 03 Sep 2010 00:00:00 -0700","applicant":"Advantest Corporation","radio_11b":"relevant"},{"title":"Immune chromatographic test piece and chromatographic analysis method","link":"http:\\/\\/www.google.com\\/patents\\/WO2001031340A1?cl=en&dq=test&source=uds;","desc":"An immune chromatographic <b>test<\\/b> piece which enables accurate qualitative or  quantitative analysis of a sample containing color components (for example,\\u00a0<b>...<\\/b>","filedate":"Wed, 25 Oct 2000 00:00:00 -0700","applicant":"Kitawaki Fumihisa, Matsushita Electric Ind Co Ltd, Nadaoka Masataka, Nakayama Hiroshi, Shigeto Nobuyuki, Takahashi Mie, Tanaka Hirotaka","radio_11b":"most_relevant"}]', '[{"title":"Setting up a new evidence-based hospice-at-home service in England.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273813","desc":"Butler C, Holdsworth L.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of palliative nursing&quot;&gt;Int J Palliat Nurs&lt;\\/span&gt;. 2013 Jul;19(7):355-9.","radio_11b2":"least_relevant"},{"title":"Impact of an educational pain management programme on nurses pain knowledge and attitudes in Kenya.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273811","desc":"Machira G, Kariuki H, Martindale L.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;International journal of palliative nursing&quot;&gt;Int J Palliat Nurs&lt;\\/span&gt;. 2013 Jul;19(7):341-6.","radio_11b2":"somewhat_relevant"},{"title":"DRIVER REHABILITATION IN PARKINSON''S DISEASE USING A DRIVING SIMULATOR: A PILOT STUDY.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273757","desc":"Uc E, Rizzo M, Anderson S, Lawrence J, Dawson J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Proceedings of the ... International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design&quot;&gt;Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des&lt;\\/span&gt;. 2011 Dec 1;2011:248-254.","radio_11b2":"relevant"},{"title":"LATERAL CONTROL IN A DRIVING SIMULATOR: CORRELATIONS WITH NEUROPSYCHOLOGICAL TESTS AND ON-ROAD SAFETY ERRORS.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273756","desc":"Johnson A, Dawson J, Rizzo M.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Proceedings of the ... International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design&quot;&gt;Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des&lt;\\/span&gt;. 2011 Dec 1;2011:45-61.","radio_11b2":"most_relevant"},{"title":"Evaluation Metrics for Biostatistical and Epidemiological Collaborations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3139813\\/","desc":"Doris McGartland Rubio, Deborah J. del Junco, Rafia Bhore, Christopher J. Lindsell, Robert A. Oster, Knut M. Wittkowski, Leah J. Welty, Yi-Ju Li, Dave DeMets, the Biostatistics, Epidemiology, and &lt;b&gt;Research Design&lt;\\/b&gt; (BERD) Key Function Committee of the Clinical and Translational Science Awards (CTSA) Consortium","details":null,"radio_11b2":"least_relevant"},{"title":"Study\\/Experimental\\/&lt;b&gt;Research Design&lt;\\/b&gt;: Much More Than Statistics","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2808761\\/","desc":"Kenneth L. Knight","details":null,"radio_11b2":"least_relevant"},{"title":"Analysis of Combined Data from Heterogeneous Study Designs: A Methodological Proposal from the Patient Navigation &lt;b&gt;Research&lt;\\/b&gt; program","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3679186\\/","desc":"Richard G. Roetzheim, Karen M. Freund, Don K. Corle, David M. Murray, Frederick R. Snyder, Andrea C. Kronman, Pascal Jean-Pierre, Peter C. Raich, Alan E. C. Holden, Julie S. Darnell, Victoria Warren-Mears, Steven Patierno, PNRP &lt;b&gt;Design&lt;\\/b&gt;, Analysis Committee","details":null,"radio_11b2":"duplicate"},{"title":"&lt;b&gt;Research design&lt;\\/b&gt; considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3617214\\/","desc":null,"details":null,"radio_11b2":"duplicate"},{"title":"Boh''s pharmacy practice manual : a guide to the clinical experience","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101616447","desc":"Stein, Susan M (Susan Marie), 1966-.","details":"&lt;span class=&quot;src&quot;&gt;Fourth edition. &lt;br&gt;Philadelphia : Wolters Kluwer Health\\/Lippincott Williams &amp; Wilkins, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"Clinical epidemiology : principles, methods, and applications for clinical &lt;b&gt;research&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101613792","desc":"Grobbee, D E; Hoes, Arno W.","details":"&lt;span class=&quot;src&quot;&gt;Second edition. &lt;br&gt;Burlington, Massachusetts : Jones &amp; Bartlett Learning, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"}]', 'a a a a a a', 'a a a a a a a a a', 'a a a a a a a  a a', '[{"title":"<b>test company<\\/b> | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/company\\/test-company","radio_15b":"likely","desc":"Welcome to the company profile of <b>test company<\\/b> on LinkedIn. test description."},{"title":"DNA <b>test company<\\/b> told to stop selling kits - FT.com","link":"http:\\/\\/www.ft.com\\/cms\\/s\\/0\\/09894400-562a-11e3-b6e7-00144feabdc0.html","radio_15b":"likely","desc":"1 day ago <b>...<\\/b> 23andMe, a DNA <b>testing company<\\/b> that came to symbolise Silicon Valley''s \\nambition of grabbing a leading position in the emerging world of\\u00a0<b>...<\\/b>"},{"title":"Create <b>Tests<\\/b> for Organizational Training and Certification Programs <b>...<\\/b>","link":"http:\\/\\/www.test.com\\/","radio_15b":"likely","desc":"<b>Test<\\/b>.com provides a complete software solution for creating online <b>tests<\\/b> and \\nmanaging enterprise and specialist <b>...<\\/b> Online <b>testing<\\/b>, training and <b>company<\\/b> news\\n\\u00a0<b>...<\\/b>"},{"title":"FDA slams DNA <b>testing company<\\/b> over safety - Washington Post","link":"http:\\/\\/www.washingtonpost.com\\/blogs\\/the-switch\\/wp\\/2013\\/11\\/25\\/fda-this-dna-testing-company-could-kill-you\\/","radio_15b":"likely","desc":"1 day ago <b>...<\\/b> In a harshly written letter to 23andMe, the federal agency accuses the <b>company<\\/b> \\nof marketing its over-the-counter DNA <b>test<\\/b> in ways that mislead\\u00a0<b>...<\\/b>"},{"title":"FDA Orders Personal Genomics <b>Company<\\/b> 23andMe To Stop <b>...<\\/b>","link":"http:\\/\\/www.popsci.com\\/article\\/science\\/fda-orders-personal-genomics-company-23andme-stop-selling-dna-test","radio_15b":"likely","desc":"1 day ago <b>...<\\/b> \\"FDA is concerned about the public health consequences of inaccurate results.\\""},{"title":"Software <b>Testing<\\/b> | uTest | www.utest.com","link":"http:\\/\\/www.utest.com\\/","radio_15b":"likely","desc":"By using uTest''s in-the-wild <b>testing<\\/b> services, real estate <b>company<\\/b> Trulia has \\ndecreased their time to market, increased their app quality and reduced their \\n<b>testing<\\/b>\\u00a0<b>...<\\/b>"},{"title":"Software <b>Testing<\\/b> and Software Quality Assurance (QA) | TESTCO","link":"http:\\/\\/testco.com\\/","radio_15b":"likely","desc":"TESTCo Offers Offshore Software <b>Testing<\\/b>, Website Quality Assurance and On \\nDemand <b>Testing<\\/b>. Check out our software quality <b>testing<\\/b> services menu."},{"title":"FDA orders personal genetics <b>company<\\/b> 23andMe to stop selling <b>tests<\\/b>","link":"http:\\/\\/arstechnica.com\\/science\\/2013\\/11\\/fda-orders-personal-genetics-company-23andme-to-stop-selling-tests\\/","radio_15b":"likely","desc":"1 day ago <b>...<\\/b> Claims <b>company<\\/b> ignored repeated efforts to get safety data and approval."}]', '{"1":{"title":"Exosome Diagnostics urine test for prostate cancer; 15-year-old develops fast and accurate biomarker test;","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/exosome-diagnostics-urine-test-prostate-cancer-15-year-old-develops-fast-an\\/2012-05-30","desc":" in the Intel International Science and Engineering Fair for his\\u00a0<strong>test<\\/strong> to detect mesothelin, a protein biomarker ...","radio_15":"likely"},"2":{"title":"Roche bids for broad use of HPV test to screen for cervical cancer","link":"http:\\/\\/www.fiercepharma.com\\/story\\/roche-bids-broad-use-hpv-test-screen-cervical-cancer\\/2013-07-08","desc":" Roche ($RHHBY) is aiming to make its human papillomavirus <strong>test<\\/strong> a first-line diagnostic for cervical cancer, with a new FDA application for the Cobas HPV as a substitute for Pap <strong>tests<\\/strong>. Currently the <strong>test<\\/strong> is approved for use along with Pap <strong>testing<\\/strong>. Report  ...","radio_15":"likely"},"3":{"title":"Better modeling to reduce animal testing","link":"http:\\/\\/www.fiercebiotechit.com\\/story\\/better-modeling-reduce-animal-testing\\/2010-08-30","desc":" Drug <strong>testing<\\/strong> via computer modeling, virtual tissue, and human and animal cells are helping the pharma industry move away from the use of animals as primary <strong>test<\\/strong> subjects. Researchers recruit tens of millions of animals annually for drug <strong>testing<\\/strong>, reports The Baltimore Sun. Eighty to 800 are needed per ...","radio_15":"likely"},"4":{"title":"LifeCodexx gets go ahead for Down syndrome test in Switzerland","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/lifecodexx-gets-go-ahead-down-syndrome-test-switzerland\\/2012-07-31","desc":" to prenatal <strong>testing<\\/strong> for the condition, claiming that <strong>testing<\\/strong> leads to almost universal abortions. Article  ...","radio_15":"likely"},"5":{"title":"Company develops blood tests for psychiatric diseases","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/company-develops-blood-tests-psychiatric-diseases\\/2011-03-30","desc":" Rules Based Medicine is developing what it says is the first blood <strong>test<\\/strong> for schizophrenia. The <strong>test<\\/strong>, called VeriPsych, was developed with Cambridge University and relies on 51 biomarkers. Since the company''s launch six months ago, psychiatrists have ordered the <strong>test<\\/strong> for about 500 patients. ...","radio_15":"likely"},"6":{"title":"FDA to regulate new generation of diagnostic tests","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/fda-to-regulate-new-generation-of-diagnostic-tests\\/2006-09-06","desc":" and discourage the development of new <strong>tests<\\/strong>. Diagnostic <strong>tests<\\/strong> sold to labs and doctors are already under ...","radio_15":"likely"},"7":{"title":"OraSure''s OTC HIV test obtains crucial FDA panel backing","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/orasures-otc-hiv-test-wins-crucial-fda-panel-backing\\/2012-05-16","desc":" and BBC News. Typically, patients seeking <strong>testing<\\/strong> must go to a health care facility. An FDA reviewer ...","radio_15":"likely"},"8":{"title":"Genetic diagnostic tests growing more sophisticated","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-diagnostic-tests-growing-more-sophisticated\\/2006-04-13","desc":" The New York Times takes a look at the growing number of sophisticated genetic diagnostic <strong>tests<\\/strong> that are now available. On the bright side, these <strong>tests<\\/strong> are seen as guideposts to a future for personalized medicine, where such <strong>tests<\\/strong> will match patients with the drugs best suited to treat their condition. ...","radio_15":"likely"},"9":{"title":"Genetic testing advances as insurers balk","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-testing-advances-as-insurers-balk\\/2007-01-03","desc":" Genetic <strong>testing<\\/strong> offers real insights into how patients should be treated, but insurers have been reluctant to cover the cost of the <strong>tests<\\/strong>. With a wave of new, more targeted biologics in the pipeline along with new <strong>tests<\\/strong> to identify the people most likely to benefit from them, look for the issue to heat up ...","radio_15":"likely"},"10":{"title":"Genetic tests don''t increase healthcare use, study finds","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/genetic-tests-dont-increase-healthcare-use-study-finds\\/2012-05-22","desc":" between 25 and 40 who took up the offer from their healthcare provider of a multiplex <strong>test<\\/strong> for 8 common ...","radio_15":"likely"}}', 'test', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(188, '2013-12-02 08:18:49', 35, 'Fiber optic high pressure transducer', 'patent', '', '', 'gansh3', 'gansh15', 'gansh15_2', '', '', 'Explosion measurement, oil downhole pressure measurement', 'd', '', 'High pressure transducers have been long desired, especially in process control and explosion measurement applications. Traditional high pressure sensors were fabricated based on piezoelectric principle which requires electrical excitation and detection. The invention in this disclosure is a fiber optic pressure transducer that is able to measure high pressure up to 100,000 psi. The detection area of the transducer is very small (~ 125 micrometers in diameter), which makes it convenient to deploy in any constrained space. The structure and the fabrication of the transducer is simple enough for high volume production. ', '', '', '', 'a,b', '', 'Xingwei Wang', ',', '', '', '', '', 'field', '105', 'Yes', '2012-03-06 00:00:00', 'Meeting_Slides_ToSteve_03-06-2012_WN.pptx', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'high pressure transducer for explosive measurement', '', '', 55, '', '100k-1m', 'Yes', 'Yes', 5, 'PCB Piezotronics, GE, Olympus NDT', 'Yes', 17, '[{"title":"A fluid pressure transmitter for use in potentially explosive atmospheres","link":"http:\\/\\/www.google.com\\/patents\\/EP0209495A2?cl=en&dq=high+pressure+transducer+for+explosive+measurement&source=uds;","filedate":"Tue, 29 Apr 1986 00:00:00 -0700","applicant":"KENT-TIEGHI S.p.A.","desc":"A fluid <b>pressure transmitter<\\/b> suitable for use in potentially <b>explosive<\\/b> atmospheres  of the type comprising a <b>measuring<\\/b> transducer provided with inductive, <b>...<\\/b> disks  1A and 1B of a material having a <b>high<\\/b> magnetic permeability.","radio_11b":"least_relevant"},{"title":"Method to mitigate the consequences of an unconfined or partially confined ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2153872A1?cl=en&dq=high+pressure+transducer+for+explosive+measurement&source=uds;","filedate":"Wed, 23 Jul 2008 00:00:00 -0700","applicant":"Total Petrochemicals Research Feluy","desc":"It is not clear wether the fire or <b>explosion<\\/b> suppression agent is released before or  <b>...<\\/b> <b>high<\\/b> surface-area-to-volume ratio protective material in the area in sufficient <b>.....<\\/b>  The signals from the <b>pressure transducers<\\/b> were <b>measured<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Capillary rheometer plunger pressure transducer and measurement technique","link":"http:\\/\\/www.google.com\\/patents\\/EP0578785A1?cl=en&dq=high+pressure+transducer+for+explosive+measurement&source=uds;","filedate":"Thu, 02 Apr 1992 00:00:00 -0800","applicant":"Dynisco, Inc.","desc":"A capillary rheometer including a plunger <b>pressure transducer<\\/b> assembly (25)  which contains a liquid metal fill capillary <b>...<\\/b> Capillary rheometer plunger <b>pressure<\\/b>  <b>transducer<\\/b> and <b>measurement<\\/b> technique <b>.....<\\/b> <b>High<\\/b> pressures in the barrel 6, such  as <b>.....<\\/b> Apr 23, 1946, Nov 8, 1949, Melton William L, <b>Explosive<\\/b> proof test tube  heater.","radio_11b":"least_relevant"},{"title":"Pressure transducer and method for monitoring the state of a pressure ...","link":"http:\\/\\/www.google.com\\/patents\\/CA2642353C?cl=en&dq=high+pressure+transducer+for+explosive+measurement&source=uds;","filedate":"Thu, 30 Oct 2008 00:00:00 -0700","applicant":"Kg Transmitter Components Gmbh, Udo Galinski","desc":"A <b>pressure transducer<\\/b> for a <b>pressure sensor<\\/b> (2) for determining at least <b>...<\\/b> is a  transducer for absolute, reference or relative pressure <b>measurement<\\/b>; <b>...<\\/b> a  particularly <b>high<\\/b> risk of <b>explosion<\\/b>, can also be monitored with regard to\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Pressure transmitter for measuring differential, absolute and\\/or pressure","link":"http:\\/\\/www.google.com\\/patents\\/WO2001013083A1?cl=en&dq=high+pressure+transducer+for+explosive+measurement&source=uds;","filedate":"Mon, 07 Aug 2000 00:00:00 -0700","applicant":"Rosemount Inc","desc":"A third absolute <b>pressure sensor<\\/b> (140) coupled to the transmitter circuit (128)  receives <b>...<\\/b> transmitter is installed in error in a <b>high<\\/b> pressure installation. <b>...<\\/b> must  be kept low to provide intrinsic safety in <b>explosive<\\/b> atmospheres.","radio_11b":"least_relevant"},{"title":"Pressure transmitter with multiple reference pressure sensors","link":"http:\\/\\/www.google.com\\/patents\\/WO2008008110A1?cl=en&dq=high+pressure+transducer+for+explosive+measurement&source=uds;","filedate":"Wed, 02 May 2007 00:00:00 -0700","applicant":"Rosemount Inc, John Schulte, Mark Romo, Stanley E Rud Jr","desc":"Reliability and accuracy in a <b>pressure measurement transmitter<\\/b> are <b>...<\\/b> <b>Transmitter<\\/b> ) protocol connection, or a <b>high<\\/b> speed Ethernet (HSE) or a fiber optic <b>...<\\/b> to comply  with intrinsic safety requirements in <b>explosive<\\/b> environments .","radio_11b":"least_relevant"},{"title":"Pressure transmitter with stress isolation depression","link":"http:\\/\\/www.google.com\\/patents\\/WO1992010731A1?cl=en&dq=high+pressure+transducer+for+explosive+measurement&source=uds;","filedate":"Wed, 20 Nov 1991 00:00:00 -0800","applicant":"Rosemount Inc","desc":"A <b>pressure transmitter<\\/b> (10) has a <b>pressure transducer<\\/b> (12) in a transmitter  housing (14). <b>...<\\/b> A <b>pressure transmitter<\\/b> for <b>measuring<\\/b> a fluid pressure from a  pressure <b>....<\\/b> to an isolator diaphragm when coupling <b>high<\\/b> fluid pressures. <b>....<\\/b> from  a potentially <b>explosive<\\/b> environment and providing a pressure output\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"}]', '[{"title":"A Multiscale Approach to Blast Neurotrauma Modeling: Part II: Methodology for Inducing Blast Injury to &lt;em&gt;in vitro&lt;\\/em&gt; Models","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3285773\\/","desc":"Gwen B. Effgen, Christopher D. Hue, Edward Vogel, III, Matthew B. Panzer, David F. Meaney, Cameron R. Bass, Barclay Morrison, III","details":"Front Neurol. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;3: 23.  &lt;span class=&quot;&quot;&gt;Published online 2012 February 24. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3389\\/fneur.2012.00023&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Porcine Head Response to Blast","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3347090\\/","desc":"","details":"Front Neurol. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;3: 70.  &lt;span class=&quot;&quot;&gt;Published online 2012 May 8. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3389\\/fneur.2012.00070&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Anaesthesia and physiological monitoring during &lt;em&gt;in vivo&lt;\\/em&gt; imaging of laboratory rodents: considerations on experimental outcomes and animal welfare","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3467189\\/","desc":"Jordi L Tremoleda, Angela Kerton, Willy Gsell","details":"EJNMMI Res. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;2: 44.  &lt;span class=&quot;&quot;&gt;Published online 2012 August 9. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/2191-219X-2-44&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Controlled tissue emulsification produced by &lt;b&gt;high&lt;\\/b&gt; intensity focused ultrasound shock waves and millisecond boiling","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3259668\\/","desc":"Tatiana D. Khokhlova, Michael S. Canney, Vera A. Khokhlova, Oleg A. Sapozhnikov, Lawrence A. Crum, Michael R. Bailey","details":"","radio_11b2":"least_relevant"},{"title":"Mechanisms of Hearing Loss after Blast Injury to the Ear","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3698122\\/","desc":"Sung-Il Cho, Simon S. Gao, Anping Xia, Rosalie Wang, Felipe T. Salles, Patrick D. Raphael, Homer Abaya, Jacqueline Wachtel, Jongmin Baek, David Jacobs, Matthew N. Rasband, John S. Oghalai","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(7): e67618.  &lt;span class=&quot;&quot;&gt;Published online 2013 July 1. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0067618&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Relationship between changes in the cochlear blood flow and disorder of hearing function induced by blast injury in guinea pigs","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3563195\\/","desc":"Wei Chen, Jianmin Wang, Jing Chen, Jichuan Chen, Zhiqiang Chen","details":"","radio_11b2":"least_relevant"},{"title":"","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3314189\\/","desc":"Matthew B. Panzer, Kyle A. Matthews, Allen W. Yu, Barclay Morrison, III, David F. Meaney, Cameron R. Bass","details":"Front Neurol. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;3: 46.  &lt;span class=&quot;&quot;&gt;Published online 2012 March 28. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3389\\/fneur.2012.00046&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3739428\\/","desc":"Lee E. Goldstein, Andrew M. Fisher, Chad A. Tagge, Xiao-Lei Zhang, Libor Velisek, John A. Sullivan, Chirag Upreti, Jonathan M. Kracht, Maria Ericsson, Mark W. Wojnarowicz, Cezar J. Goletiani, Giorgi M. Maglakelidze, Noel Casey, Juliet A. Moncaster, Olga Minaeva, Robert D. Moir, Christopher J. Nowinski, Robert A. Stern, Robert C. Cantu, James Geiling, Jan K. Blusztajn, Benjamin L. Wolozin, Tsuneya Ikezu, Thor D. Stein, Andrew E. Budson, Neil W. Kowall, David Chargin, Andre Sharon, Sudad Saman, Garth F. Hall, William C. Moss, Robin O. Cleveland, Rudolph E. Tanzi, Patric K. Stanton, Ann C. McKee","details":"Sci Transl Med. &lt;span class=&quot;ms-submitted-date&quot;&gt;Author manuscript; available in PMC 2013 August 9.&lt;\\/span&gt;&lt;div&gt;Published in final edited form as: &lt;span class=&quot;citation-version&quot;&gt;&lt;\\/span&gt;&lt;span class=&quot;citation-abbreviation&quot;&gt;Sci Transl Med. &lt;\\/span&gt;&lt;span class=&quot;citation-publication-date&quot;&gt;2012 May 16; &lt;\\/span&gt;&lt;span class=&quot;citation-volume&quot;&gt;4&lt;\\/span&gt;&lt;span class=&quot;citation-issue&quot;&gt;(134)&lt;\\/span&gt;&lt;span class=&quot;citation-flpages&quot;&gt;: 134ra60. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1126\\/scitranslmed.3003716&lt;\\/span&gt;&lt;\\/div&gt;","radio_11b2":"least_relevant"},{"title":"Blast-Induced Color Change in Photonic Crystals Corresponds with Brain Pathology","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3218413\\/","desc":"D. Kacy Cullen, Kevin D. Browne, Yongan Xu, Saleena Adeeb, John A. Wolf, Richard M. McCarron, Shu Yang, Mikulas Chavko, Douglas H. Smith","details":"","radio_11b2":"least_relevant"},{"title":"Combined passive detection and ultrafast active imaging of cavitation events induced by short pulses of &lt;b&gt;high&lt;\\/b&gt;-intensity ultrasound","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3350371\\/","desc":"J&Atilde;&copy;r&Atilde;&acute;me Gateau, Jean-Fran&Atilde;&sect;ois Aubry, Mathieu Pernot, Mathias Fink, Micka&Atilde;&laquo;l Tanter","details":"","radio_11b2":"least_relevant"}]', 'The invention uses optical fiber to fabricate transducers', 'The invention can measure the pressure up to 100,000 psi.', 'The invention has a very simple structure.', '', '', 'test', '', '', '3', '4', '43d4285cd4bf51cc18211a0b9b207b60_sig.docx', 100);
INSERT INTO `inventions` VALUES(189, '2013-12-03 01:24:33', 13, 'test', 'patent', '', '', 'gansh3', 'gansh16', 'gansh16_2', '', '', 'test', 'c', '', 'test', '', '', '', 'a', '', 'John Smith', 'test', '', '', '', '', 'field', '115', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'adaptive control for renewable energy', '', '{"2":{"title":"EcoPower Cycle","id":"167","status":"field"},"3":{"title":"Fiber optic high pressure transducer","id":"188","status":"field"},"4":{"title":"Solar farm control under cloud","id":"208","status":"field"}}', 41, '', '>1m', 'Dont know', '', 0, '', 'Maybe', 13, '{"0":{"title":"Adaptive controlled outdoor lighting system and method of operation thereof","link":"http:\\/\\/www.google.com\\/patents\\/WO2012172470A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","desc":"The system of claim 1 , wherein the <b>controller<\\/b> (102) selects a power <b>.....<\\/b> system  may determine to rely upon <b>wind power<\\/b> generation to power\\u00a0<b>...<\\/b>","filedate":"Mon, 11 Jun 2012 00:00:00 -0700","applicant":"Koninklijke Philips Electronics N.V.","radio_11b":"least_relevant"},"1":{"title":"Intelligent power converter control for grid integration of renewable energies","link":"http:\\/\\/www.google.com\\/patents\\/WO2010114792A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","desc":"Intelligent power converter control for grid integration of <b>renewable energies<\\/b> <b>...<\\/b>  one or more of PID, fuzzy and <b>adaptive control<\\/b> technologies. 7.","filedate":"Mon, 29 Mar 2010 00:00:00 -0700","applicant":"The Board Of Trustees Of The University Of Alabama","radio_11b":"somewhat_relevant"},"2":{"title":"Adaptive pitch control for variable speed wind turbines","link":"http:\\/\\/www.google.com\\/patents\\/WO2007123552A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","desc":"Average <b>power<\\/b> coefficients are determined for first and second periods of <b>...<\\/b> An  <b>adaptive control<\\/b> method for use with <b>wind<\\/b> turbines to better\\u00a0<b>...<\\/b>","filedate":"Wed, 26 Apr 2006 00:00:00 -0700","applicant":"Lee Jay Fingersh, Kathryn E Johnson, Midwest Research Inst","radio_11b":"somewhat_relevant"},"4":{"title":"Systems and methods for sustainable economic development through integrated ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2470786A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","desc":"A method for providing an energy supply using a <b>renewable energy<\\/b> <b>.....<\\/b> sub- systems with <b>adaptive control<\\/b> of autogenous cascading energy\\u00a0<b>...<\\/b>","filedate":"Mon, 16 Aug 2010 00:00:00 -0700","applicant":"McAlister Technologies, LLC","radio_11b":"relevant"},"5":{"title":"Sustainable economic development through integrated production of renewable ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2470312A2?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","desc":"In some embodiments, the system utilizes energy from <b>renewable energy<\\/b> <b>...<\\/b> sub- systems with <b>adaptive control<\\/b> of autogenous cascading energy\\u00a0<b>...<\\/b>","filedate":"Mon, 16 Aug 2010 00:00:00 -0700","applicant":"McAlister Technologies, LLC","radio_11b":"somewhat_relevant"},"6":{"title":"Method for controlling an electric power generation system based on energy ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2010095159A2?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","desc":"The present invention concerns a method, and the related controller device, <b>...<\\/b>  based on at least one energy source, in particular a <b>renewable energy<\\/b> source, <b>...<\\/b>  This means that an <b>adaptive control<\\/b> system, assisting the lookup\\u00a0<b>...<\\/b>","filedate":"Mon, 22 Feb 2010 00:00:00 -0800","applicant":"Universita'' Degli Studi Di Salerno","radio_11b":"somewhat_relevant"}}', '[{"title":"An &lt;b&gt;adaptive&lt;\\/b&gt; recurrent neural-network controller using a stabilization matrix and predictive inputs to solve a tracking problem under disturbances.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24161455","desc":"Fairbank M, Li S, Fu X, Alonso E, Wunsch D.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Neural networks : the official journal of the International Neural Network Society&quot;&gt;Neural Netw&lt;\\/span&gt;. 2014 Jan;49:74-86. doi: 10.1016\\/j.neunet.2013.09.010. Epub 2013 Oct 9.","radio_11b2":"somewhat_relevant"},{"title":"Improved single neuron controller for multivariable stochastic systems with non-Gaussianities and unmodeled dynamics.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23910156","desc":"Zhang J, Jiang M, Ren M, Hou G, Xu J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;ISA transactions&quot;&gt;ISA Trans&lt;\\/span&gt;. 2013 Nov;52(6):752-8. doi: 10.1016\\/j.isatra.2013.07.002. Epub 2013 Jul 30.","radio_11b2":"least_relevant"},{"title":"Dam design can impede &lt;b&gt;adaptive&lt;\\/b&gt; management of environmental flows: a case study from the Opuha Dam, New Zealand.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23124551","desc":"Lessard J, Hicks DM, Snelder TH, Arscott DB, Larned ST, Booker D, Suren AM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Environmental management&quot;&gt;Environ Manage&lt;\\/span&gt;. 2013 Feb;51(2):459-73. doi: 10.1007\\/s00267-012-9971-x. Epub 2012 Nov 3.","radio_11b2":"least_relevant"},{"title":"A new approach for probing the mobility and lifetime of photogenerated charge carriers in organic solar cells under real operating conditions.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22760962","desc":"Baumann A, Lorrmann J, Rauh D, Deibel C, Dyakonov V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Advanced materials (Deerfield Beach, Fla.)&quot;&gt;Adv Mater&lt;\\/span&gt;. 2012 Aug 22;24(32):4381-6. doi: 10.1002\\/adma.201200874. Epub 2012 Jul 3.","radio_11b2":"least_relevant"},{"title":"An &lt;b&gt;Adaptive&lt;\\/b&gt; Framework for Selecting Environmental Monitoring Protocols to Support Ocean &lt;b&gt;Renewable Energy&lt;\\/b&gt; Development","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3540755\\/","desc":"Emily J. Shumchenia, Sarah L. Smith, Jennifer McCann, Michelle Carnevale, Grover Fugate, Robert D. Kenney, John W. King, Peter Paton, Malia Schwartz, Malcolm Spaulding, Kristopher J. Winiarski","details":"ScientificWorldJournal. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;2012: 450685.  &lt;span class=&quot;&quot;&gt;Published online 2012 December 23. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1100\\/2012\\/450685&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Turbine Sound May Influence the Metamorphosis Behaviour of Estuarine Crab Megalopae","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3519903\\/","desc":"Matthew K. Pine, Andrew G. Jeffs, Craig A. Radford","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(12): e51790.  &lt;span class=&quot;&quot;&gt;Published online 2012 December 11. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0051790&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"&lt;b&gt;Energy&lt;\\/b&gt; systems transformation","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3574957\\/","desc":"A. T. C. J&Atilde;&copy;r&Atilde;&acute;me Dangerman, Hans Joachim Schellnhuber","details":null,"radio_11b2":"least_relevant"},{"title":"Design and development of synthetic microbial platform cells for bioenergy","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3630320\\/","desc":"Sang Jun Lee, Sang-Jae Lee, Dong-Woo Lee","details":"Front Microbiol. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;4: 92.  &lt;span class=&quot;&quot;&gt;Published online 2013 April 19. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3389\\/fmicb.2013.00092&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"null","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/undefined","desc":"null","details":"null","radio_11b2":"least_relevant"},{"title":"Confronting deep uncertainties in risk analysis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22489541","desc":"Cox LA Jr.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Risk analysis : an official publication of the Society for Risk Analysis&quot;&gt;Risk Anal&lt;\\/span&gt;. 2012 Oct;32(10):1607-29. doi: 10.1111\\/j.1539-6924.2012.01792.x. Epub 2012 Apr 10. Review.","radio_11b2":"somewhat_relevant"}]', 'test test test test test', 'test test test test test', 'test', '', '[{"title":"Exosome Diagnostics urine test for prostate cancer; 15-year-old develops fast and accurate biomarker test;","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/exosome-diagnostics-urine-test-prostate-cancer-15-year-old-develops-fast-an\\/2012-05-30","desc":" in the Intel International Science and Engineering Fair for his\\u00a0<strong>test<\\/strong> to detect mesothelin, a protein biomarker ...","radio_15":"somewhat_likely"},{"title":"Roche bids for broad use of HPV test to screen for cervical cancer","link":"http:\\/\\/www.fiercepharma.com\\/story\\/roche-bids-broad-use-hpv-test-screen-cervical-cancer\\/2013-07-08","desc":" Roche ($RHHBY) is aiming to make its human papillomavirus <strong>test<\\/strong> a first-line diagnostic for cervical cancer, with a new FDA application for the Cobas HPV as a substitute for Pap <strong>tests<\\/strong>. Currently the <strong>test<\\/strong> is approved for use along with Pap <strong>testing<\\/strong>. Report  ...","radio_15":"somewhat_likely"},{"title":"Better modeling to reduce animal testing","link":"http:\\/\\/www.fiercebiotechit.com\\/story\\/better-modeling-reduce-animal-testing\\/2010-08-30","desc":" Drug <strong>testing<\\/strong> via computer modeling, virtual tissue, and human and animal cells are helping the pharma industry move away from the use of animals as primary <strong>test<\\/strong> subjects. Researchers recruit tens of millions of animals annually for drug <strong>testing<\\/strong>, reports The Baltimore Sun. Eighty to 800 are needed per ...","radio_15":"least_likely"},{"title":"LifeCodexx gets go ahead for Down syndrome test in Switzerland","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/lifecodexx-gets-go-ahead-down-syndrome-test-switzerland\\/2012-07-31","desc":" to prenatal <strong>testing<\\/strong> for the condition, claiming that <strong>testing<\\/strong> leads to almost universal abortions. Article  ...","radio_15":"least_likely"},{"title":"FDA to regulate new generation of diagnostic tests","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/fda-to-regulate-new-generation-of-diagnostic-tests\\/2006-09-06","desc":" and discourage the development of new <strong>tests<\\/strong>. Diagnostic <strong>tests<\\/strong> sold to labs and doctors are already under ...","radio_15":"somewhat_likely"},{"title":"Company develops blood tests for psychiatric diseases","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/company-develops-blood-tests-psychiatric-diseases\\/2011-03-30","desc":" Rules Based Medicine is developing what it says is the first blood <strong>test<\\/strong> for schizophrenia. The <strong>test<\\/strong>, called VeriPsych, was developed with Cambridge University and relies on 51 biomarkers. Since the company''s launch six months ago, psychiatrists have ordered the <strong>test<\\/strong> for about 500 patients. ...","radio_15":"least_likely"},{"title":"OraSure''s OTC HIV test obtains crucial FDA panel backing","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/orasures-otc-hiv-test-wins-crucial-fda-panel-backing\\/2012-05-16","desc":" and BBC News. Typically, patients seeking <strong>testing<\\/strong> must go to a health care facility. An FDA reviewer ...","radio_15":"somewhat_likely"},{"title":"Genetic diagnostic tests growing more sophisticated","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-diagnostic-tests-growing-more-sophisticated\\/2006-04-13","desc":" The New York Times takes a look at the growing number of sophisticated genetic diagnostic <strong>tests<\\/strong> that are now available. On the bright side, these <strong>tests<\\/strong> are seen as guideposts to a future for personalized medicine, where such <strong>tests<\\/strong> will match patients with the drugs best suited to treat their condition. ...","radio_15":"least_likely"},{"title":"Genetic testing advances as insurers balk","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-testing-advances-as-insurers-balk\\/2007-01-03","desc":" Genetic <strong>testing<\\/strong> offers real insights into how patients should be treated, but insurers have been reluctant to cover the cost of the <strong>tests<\\/strong>. With a wave of new, more targeted biologics in the pipeline along with new <strong>tests<\\/strong> to identify the people most likely to benefit from them, look for the issue to heat up ...","radio_15":"somewhat_likely"},{"title":"Genetic tests don''t increase healthcare use, study finds","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/genetic-tests-dont-increase-healthcare-use-study-finds\\/2012-05-22","desc":" between 25 and 40 who took up the offer from their healthcare provider of a multiplex <strong>test<\\/strong> for 8 common ...","radio_15":"somewhat_likely"}]', 'adaptive control for renewable energy', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(190, '2013-12-03 01:27:58', 13, 'test', 'patent', '', '', 'gansh2', 'gansh13', 'gansh13_4', '', '', 'tt', 'c', '', 'test', '', '', '', 'a', '', 'test', '', '', '', '', '', 'field', '105', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-12-02 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 29, '', '>1m', 'Not Sure', '', 0, '', 'Maybe', 10, '', '', 'test test test test test', 'test test test test test', 'test test test test test', '', '', '', '', '', '', '', '', 86);
INSERT INTO `inventions` VALUES(191, '2013-12-03 02:49:44', 13, 'test', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', 'no', 'test', 'e', '', 'test', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '170', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-12 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'test', '{"1":{"radio_11a1":"May be","title":"Oct 16 hemophilia testing","id":"77","status":"field"},"2":{"radio_11a1":"May be","title":"Oct 25 Dx testing","id":"104","status":"field"},"3":{"radio_11a1":"May be","title":"Olefin catalyst for polymerization","id":"105","status":"field"},"4":{"radio_11a1":"May be","title":"test","id":"117","status":"process"},"5":{"radio_11a1":"May be","title":"test","id":"122","status":"field"},"6":{"radio_11a1":"May be","title":"tst","id":"129","status":"field"},"7":{"radio_11a1":"May be","title":"aavishkar","id":"132","status":"field"},"8":{"radio_11a1":"May be","title":"test14nov","id":"149","status":"field"},"9":{"radio_11a1":"May be","title":"test","id":"152","status":"field"},"10":{"radio_11a1":"May be","title":"test","id":"163","status":"field"}}', '{"2":{"title":"testing happy head","id":"63","status":"field"},"3":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"4":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"5":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"6":{"title":"laser excitation fluorescence","id":"107","status":"field"},"7":{"title":"test 10-29-13 ","id":"109","status":"field"},"8":{"title":"test","id":"117","status":"process"},"9":{"title":"test","id":"122","status":"field"},"10":{"title":"tst","id":"129","status":"field"},"11":{"title":"aavishkar","id":"132","status":"field"}}', 79, '', '<100k', 'Yes', 'No', 2, '', 'Yes', 9, '[{"title":"Test mode control circuit in semiconductor memory device and test mode ...","link":"http:\\/\\/www.google.com\\/patents\\/US8537628?dq=test&source=uds;","desc":"A <b>test<\\/b> mode control circuit is provided to strictly allow entry into a <b>test<\\/b> mode or  prevent a boot failure from occurring during a boot operation for a\\u00a0<b>...<\\/b>","filedate":"Wed, 22 Jun 2011 00:00:00 -0700","applicant":"Samsung Electronics Co., Ltd.","radio_11b":"least_relevant"},{"title":"Scalable scan-based test architecture with reduced test time and test power","link":"http:\\/\\/www.google.com\\/patents\\/US8510616?dq=test&source=uds;","desc":"A scalable scan-based architecture with reduced <b>test<\\/b> time, <b>test<\\/b> power and <b>test<\\/b> pin -count in scan based <b>testing<\\/b> of ICs. In an embodiment, a <b>test<\\/b>\\u00a0<b>...<\\/b>","filedate":"Thu, 14 Feb 2008 00:00:00 -0800","applicant":"Nvidia Corporation","radio_11b":"somewhat_relevant"},{"title":"Method for isolating a sample well of a test card for analysis, and ...","link":"http:\\/\\/www.google.com\\/patents\\/US20130273592?dq=test&source=uds;","desc":"The invention relates to a method for isolating at least one fluid sample well laid  out in a <b>test<\\/b> card for analyses, said <b>test<\\/b> card including a plate\\u00a0<b>...<\\/b>","filedate":"Wed, 19 Oct 2011 00:00:00 -0700","applicant":"Biomerieux","radio_11b":"relevant"},{"title":"Thermal resistor test apparatus","link":"http:\\/\\/www.google.com\\/patents\\/US8550708?dq=test&source=uds;","desc":"A <b>test<\\/b> apparatus for a thermal resistor includes a control device, a temperature  processing circuit, a voltage regulating circuit and a temperature\\u00a0<b>...<\\/b>","filedate":"Wed, 29 Jun 2011 00:00:00 -0700","applicant":"Hong Fu Jin Precision Industry (Shenzhen) Co., Ltd., Hon Hai Precision Industry Co., Ltd.","radio_11b":"most_relevant"},{"title":"Test apparatus, additional circuit and test board for calculating load ...","link":"http:\\/\\/www.google.com\\/patents\\/US8558559?dq=test&source=uds;","desc":"Provided is a <b>test<\\/b> apparatus that measures charge\\/discharge current of an  intermediate capacitor provided between a transmission path\\u00a0<b>...<\\/b>","filedate":"Fri, 03 Sep 2010 00:00:00 -0700","applicant":"Advantest Corporation","radio_11b":"least_relevant"},{"title":"Adaptive regression test selection within testing environments","link":"http:\\/\\/www.google.com\\/patents\\/US8276123?dq=test&source=uds;","desc":"In general, techniques are described for intelligently selecting <b>test<\\/b> cases within  <b>testing<\\/b> environments. Specifically, a computing device may\\u00a0<b>...<\\/b>","filedate":"Fri, 09 Jan 2009 00:00:00 -0800","applicant":"Juniper Networks, Inc.","radio_11b":"somewhat_relevant"},{"title":"Immune chromatographic test piece and chromatographic analysis method","link":"http:\\/\\/www.google.com\\/patents\\/WO2001031340A1?cl=en&dq=test&source=uds;","desc":"An immune chromatographic <b>test<\\/b> piece which enables accurate qualitative or  quantitative analysis of a sample containing color components (for example,\\u00a0<b>...<\\/b>","filedate":"Wed, 25 Oct 2000 00:00:00 -0700","applicant":"Kitawaki Fumihisa, Matsushita Electric Ind Co Ltd, Nadaoka Masataka, Nakayama Hiroshi, Shigeto Nobuyuki, Takahashi Mie, Tanaka Hirotaka","radio_11b":"relevant"},{"title":"Delayed replica radar test set target","link":"http:\\/\\/www.google.com\\/patents\\/EP0363478B1?cl=en&dq=test&source=uds;","desc":"A radar <b>test<\\/b> set target which is co-located with the radar and produces a faithful  replica of the radar signal substantially delayed in time. The radar signal\\u00a0<b>...<\\/b>","filedate":"Mon, 27 Feb 1989 00:00:00 -0800","applicant":"Hughes Aircraft Company","radio_11b":"most_relevant"}]', '[{"title":"Barriers to Maori sole mothers'' primary health care access.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294620","desc":"Lee R, North N.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of primary health care&quot;&gt;J Prim Health Care&lt;\\/span&gt;. 2013 Dec 1;5(4):315-21.","radio_11b2":"least_relevant"},{"title":"Patients'' perceptions of their general practitioner''s health and weight influences their perceptions of nutrition and exercise advice received.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294618","desc":"Fraser SE, Leveritt MD, Ball LE.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of primary health care&quot;&gt;J Prim Health Care&lt;\\/span&gt;. 2013 Dec 1;5(4):301-7.","radio_11b2":"somewhat_relevant"},{"title":"Shaping the future medical workforce: take care with selection tools.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294614","desc":"Poole P, Shulruf B.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of primary health care&quot;&gt;J Prim Health Care&lt;\\/span&gt;. 2013 Dec 1;5(4):269-75.","radio_11b2":"relevant"},{"title":"Selecting medical students who will become general practitioners: is the aptitude &lt;b&gt;test&lt;\\/b&gt; suitable?","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24294613","desc":"Stephenson A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of primary health care&quot;&gt;J Prim Health Care&lt;\\/span&gt;. 2013 Dec 1;5(4):268. No abstract available. ","radio_11b2":"most_relevant"},{"title":"Evaluation Metrics for Biostatistical and Epidemiological Collaborations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3139813\\/","desc":"Doris McGartland Rubio, Deborah J. del Junco, Rafia Bhore, Christopher J. Lindsell, Robert A. Oster, Knut M. Wittkowski, Leah J. Welty, Yi-Ju Li, Dave DeMets, the Biostatistics, Epidemiology, and &lt;b&gt;Research Design&lt;\\/b&gt; (BERD) Key Function Committee of the Clinical and Translational Science Awards (CTSA) Consortium","details":null,"radio_11b2":"least_relevant"},{"title":"Study\\/Experimental\\/&lt;b&gt;Research Design&lt;\\/b&gt;: Much More Than Statistics","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2808761\\/","desc":"Kenneth L. Knight","details":null,"radio_11b2":"somewhat_relevant"},{"title":"Analysis of Combined Data from Heterogeneous Study Designs: A Methodological Proposal from the Patient Navigation &lt;b&gt;Research&lt;\\/b&gt; program","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3679186\\/","desc":"Richard G. Roetzheim, Karen M. Freund, Don K. Corle, David M. Murray, Frederick R. Snyder, Andrea C. Kronman, Pascal Jean-Pierre, Peter C. Raich, Alan E. C. Holden, Julie S. Darnell, Victoria Warren-Mears, Steven Patierno, PNRP &lt;b&gt;Design&lt;\\/b&gt;, Analysis Committee","details":null,"radio_11b2":"relevant"},{"title":"&lt;b&gt;Research design&lt;\\/b&gt; considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3617214\\/","desc":null,"details":null,"radio_11b2":"most_relevant"},{"title":"Boh''s pharmacy practice manual : a guide to the clinical experience","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101616447","desc":"Stein, Susan M (Susan Marie), 1966-.","details":"&lt;span class=&quot;src&quot;&gt;Fourth edition. &lt;br&gt;Philadelphia : Wolters Kluwer Health\\/Lippincott Williams &amp; Wilkins, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Clinical epidemiology : principles, methods, and applications for clinical &lt;b&gt;research&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101613792","desc":"Grobbee, D E; Hoes, Arno W.","details":"&lt;span class=&quot;src&quot;&gt;Second edition. &lt;br&gt;Burlington, Massachusetts : Jones &amp; Bartlett Learning, [2015]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"}]', 'a a a a a a a a a a', 'a a a a a a a a a', 'a a a a a a a  a a', '[{"title":"<b>test company<\\/b> | LinkedIn","link":"http:\\/\\/www.linkedin.com\\/company\\/test-company","radio_15b":"duplicate","desc":"Welcome to the company profile of <b>test company<\\/b> on LinkedIn. test description."},{"title":"DNA <b>test company<\\/b> told to stop selling kits - FT.com","link":"http:\\/\\/www.ft.com\\/cms\\/s\\/0\\/09894400-562a-11e3-b6e7-00144feabdc0.html","radio_15b":"duplicate","desc":"Nov 26, 2013 <b>...<\\/b> 23andMe, a DNA <b>testing company<\\/b> that came to symbolise Silicon Valley''s \\nambition of grabbing a leading position in the emerging world of\\u00a0<b>...<\\/b>"},{"title":"Create <b>Tests<\\/b> for Organizational Training and Certification Programs <b>...<\\/b>","link":"http:\\/\\/www.test.com\\/","radio_15b":"duplicate","desc":"<b>Test<\\/b>.com provides a complete software solution for creating online <b>tests<\\/b> and \\nmanaging enterprise and specialist <b>...<\\/b> Online <b>testing<\\/b>, training and <b>company<\\/b> news\\n\\u00a0<b>...<\\/b>"},{"title":"FDA Orders Personal Genomics <b>Company<\\/b> 23andMe To Stop <b>...<\\/b>","link":"http:\\/\\/www.popsci.com\\/article\\/science\\/fda-orders-personal-genomics-company-23andme-stop-selling-dna-test","radio_15b":"duplicate","desc":"Nov 25, 2013 <b>...<\\/b> Since 2007, 23andMe has been selling a personal genomics <b>test<\\/b>: using a kit, you \\nsubmit your saliva for genetic sequencing, and receive a\\u00a0<b>...<\\/b>"},{"title":"Software <b>Testing<\\/b> | uTest | www.utest.com","link":"http:\\/\\/www.utest.com\\/","radio_15b":"duplicate","desc":"By using uTest''s in-the-wild <b>testing<\\/b> services, real estate <b>company<\\/b> Trulia has \\ndecreased their time to market, increased their app quality and reduced their \\n<b>testing<\\/b>\\u00a0<b>...<\\/b>"},{"title":"Software <b>Testing<\\/b> and Software Quality Assurance (QA) | TESTCO","link":"http:\\/\\/testco.com\\/","radio_15b":"duplicate","desc":"TESTCo occupies a unique niche in the world-wide group of software <b>testing<\\/b> \\n<b>companies<\\/b>. TESTCo is specifically designed to provide as few as one high \\nquality\\u00a0<b>...<\\/b>"},{"title":"Example Domain","link":"http:\\/\\/example.com\\/","radio_15b":"duplicate","desc":"Example Domain. This domain is established to be used for illustrative examples \\nin documents. You may use this domain in examples without prior coordination\\u00a0<b>...<\\/b>"},{"title":"Advance <b>Testing Company<\\/b>, Inc.: Construction Materials Testing <b>...<\\/b>","link":"http:\\/\\/www.advancetesting.com\\/","radio_15b":"duplicate","desc":"...is a consulting construction materials testing laboratory that has been providing \\noutstanding service to its clients since 1984. Advance <b>Testing Company<\\/b>\\u00a0<b>...<\\/b>"}]', '{"1":{"title":"Exosome Diagnostics urine test for prostate cancer; 15-year-old develops fast and accurate biomarker test;","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/exosome-diagnostics-urine-test-prostate-cancer-15-year-old-develops-fast-an\\/2012-05-30","desc":" in the Intel International Science and Engineering Fair for his\\u00a0<strong>test<\\/strong> to detect mesothelin, a protein biomarker ...","radio_15":"duplicate"},"2":{"title":"Roche bids for broad use of HPV test to screen for cervical cancer","link":"http:\\/\\/www.fiercepharma.com\\/story\\/roche-bids-broad-use-hpv-test-screen-cervical-cancer\\/2013-07-08","desc":" Roche ($RHHBY) is aiming to make its human papillomavirus <strong>test<\\/strong> a first-line diagnostic for cervical cancer, with a new FDA application for the Cobas HPV as a substitute for Pap <strong>tests<\\/strong>. Currently the <strong>test<\\/strong> is approved for use along with Pap <strong>testing<\\/strong>. Report  ...","radio_15":"duplicate"},"3":{"title":"Better modeling to reduce animal testing","link":"http:\\/\\/www.fiercebiotechit.com\\/story\\/better-modeling-reduce-animal-testing\\/2010-08-30","desc":" Drug <strong>testing<\\/strong> via computer modeling, virtual tissue, and human and animal cells are helping the pharma industry move away from the use of animals as primary <strong>test<\\/strong> subjects. Researchers recruit tens of millions of animals annually for drug <strong>testing<\\/strong>, reports The Baltimore Sun. Eighty to 800 are needed per ...","radio_15":"duplicate"},"4":{"title":"LifeCodexx gets go ahead for Down syndrome test in Switzerland","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/lifecodexx-gets-go-ahead-down-syndrome-test-switzerland\\/2012-07-31","desc":" to prenatal <strong>testing<\\/strong> for the condition, claiming that <strong>testing<\\/strong> leads to almost universal abortions. Article  ...","radio_15":"duplicate"},"5":{"title":"Company develops blood tests for psychiatric diseases","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/company-develops-blood-tests-psychiatric-diseases\\/2011-03-30","desc":" Rules Based Medicine is developing what it says is the first blood <strong>test<\\/strong> for schizophrenia. The <strong>test<\\/strong>, called VeriPsych, was developed with Cambridge University and relies on 51 biomarkers. Since the company''s launch six months ago, psychiatrists have ordered the <strong>test<\\/strong> for about 500 patients. ...","radio_15":"duplicate"},"6":{"title":"FDA to regulate new generation of diagnostic tests","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/fda-to-regulate-new-generation-of-diagnostic-tests\\/2006-09-06","desc":" and discourage the development of new <strong>tests<\\/strong>. Diagnostic <strong>tests<\\/strong> sold to labs and doctors are already under ...","radio_15":"duplicate"},"7":{"title":"OraSure''s OTC HIV test obtains crucial FDA panel backing","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/orasures-otc-hiv-test-wins-crucial-fda-panel-backing\\/2012-05-16","desc":" and BBC News. Typically, patients seeking <strong>testing<\\/strong> must go to a health care facility. An FDA reviewer ...","radio_15":"duplicate"},"8":{"title":"Genetic diagnostic tests growing more sophisticated","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-diagnostic-tests-growing-more-sophisticated\\/2006-04-13","desc":" The New York Times takes a look at the growing number of sophisticated genetic diagnostic <strong>tests<\\/strong> that are now available. On the bright side, these <strong>tests<\\/strong> are seen as guideposts to a future for personalized medicine, where such <strong>tests<\\/strong> will match patients with the drugs best suited to treat their condition. ...","radio_15":"duplicate"},"9":{"title":"Genetic testing advances as insurers balk","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/genetic-testing-advances-as-insurers-balk\\/2007-01-03","desc":" Genetic <strong>testing<\\/strong> offers real insights into how patients should be treated, but insurers have been reluctant to cover the cost of the <strong>tests<\\/strong>. With a wave of new, more targeted biologics in the pipeline along with new <strong>tests<\\/strong> to identify the people most likely to benefit from them, look for the issue to heat up ...","radio_15":"duplicate"},"10":{"title":"Genetic tests don''t increase healthcare use, study finds","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/genetic-tests-dont-increase-healthcare-use-study-finds\\/2012-05-22","desc":" between 25 and 40 who took up the offer from their healthcare provider of a multiplex <strong>test<\\/strong> for 8 common ...","radio_15":"duplicate"}}', 'test', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(194, '2013-12-03 06:12:25', 2, 'testing 12-3', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'TKI inhibitors for lung cancer', 'e', 'b', 'TKI inhibitors for lung cancer', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '100', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'Tyrosine kinase inhibitors for cancer', '{"1":{"radio_11a1":"May be","title":"Cancer Target screening tools","id":"61","status":"field"},"2":{"radio_11a1":"No","title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"}}', '{"2":{"title":"CDx without drug on market","id":"58","status":"field"},"3":{"title":"Cancer Target screening tools","id":"61","status":"field"},"4":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"5":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"6":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"7":{"title":"pancreatic cancer drug","id":"92","status":"field"},"8":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"9":{"title":"pancreatic cancer","id":"108","status":"field"},"10":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"11":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"}}', 46, '', '100k-1m', 'Yes', 'No', 2, '', 'Yes', 19.5, '{"0":{"title":"Molecular biomarkers for predicting response to tyrosine kinase inhibitors ...","link":"http:\\/\\/www.google.com\\/patents\\/CA2780875A1?cl=en&dq=Tyrosine+kinase+inhibitors+for+cancer&source=uds;","desc":"A method for predicting the response of a patient suffering from non-small cell  lung <b>cancer<\\/b> to an EGFR <b>tyrosine kinase inhibitor<\\/b> wherein said\\u00a0<b>...<\\/b>","filedate":"Mon, 15 Nov 2010 00:00:00 -0800","applicant":"Pangaea Biotech, S.L., Costa Rafael Rosell, Roca Miguel Taron","radio_11b":"relevant"},"1":{"title":"Use of egfr tyrosine kinase inhibitor for preventing breast cancer","link":"http:\\/\\/www.google.com\\/patents\\/CA2389411C?cl=en&dq=Tyrosine+kinase+inhibitors+for+cancer&source=uds;","desc":"Use of an EGFR <b>tyrosine kinase inhibitor<\\/b> in the manufacture of a medicament for  use in chemoprevention of the onset of breast <b>cancer<\\/b> in an\\u00a0<b>...<\\/b>","filedate":"Wed, 01 Nov 2000 00:00:00 -0800","applicant":"The University Of Manchester, Nigel James Bundred","radio_11b":"relevant"},"2":{"title":"Use of egfr tyrosine kinase inhibitors for treating breast cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2001032155A2?cl=en&dq=Tyrosine+kinase+inhibitors+for+cancer&source=uds;","desc":"Thus, it was believed that such EGFR <b>tyrosine kinase inhibitors<\\/b> operate to inhibit  the downstream signalling for the EGFR in ER- <b>cancer<\\/b> cells\\u00a0<b>...<\\/b>","filedate":"Wed, 01 Nov 2000 00:00:00 -0800","applicant":"Bundred Nigel James, Univ Manchester","radio_11b":"somewhat_relevant"},"4":{"title":"Use of egfr tyrosine kinase inhibitors for treating brest cancer","link":"http:\\/\\/www.google.com\\/patents\\/EP1272188B1?cl=en&dq=Tyrosine+kinase+inhibitors+for+cancer&source=uds;","desc":"Use of an EGFR <b>tyrosine kinase inhibitor<\\/b> in the manufacture of a medicament for  use in chemoprevention of the onset of breast <b>cancer<\\/b> in an\\u00a0<b>...<\\/b>","filedate":"Wed, 01 Nov 2000 00:00:00 -0800","applicant":"The University of Manchester","radio_11b":"somewhat_relevant"},"5":{"title":"Biomarkers for response to tyrosine kinase pathway inhibitors in cancer","link":"http:\\/\\/www.google.com\\/patents\\/US20130230511?dq=Tyrosine+kinase+inhibitors+for+cancer&source=uds;","desc":"Biomarkers for response to <b>tyrosine kinase<\\/b> pathway <b>inhibitors<\\/b> in <b>cancer<\\/b>. US  20130230511 A1. Abstract. Copy number gains detected in tumors\\u00a0<b>...<\\/b>","filedate":"Mon, 04 Feb 2013 00:00:00 -0800","applicant":"Board Of Regents, The University Of Texas System","radio_11b":"least_relevant"},"6":{"title":"Autophagic compounds and tyrosine kinase inhibitors for treating cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2008036254A3?cl=en&dq=Tyrosine+kinase+inhibitors+for+cancer&source=uds;","desc":"Autophagic compounds and <b>tyrosine kinase inhibitors<\\/b> for treating <b>cancer<\\/b>. WO  2008036254 A3. Abstract. The invention provides combinations\\u00a0<b>...<\\/b>","filedate":"Tue, 18 Sep 2007 00:00:00 -0700","applicant":"Gen Hospital Corp, Ultan Mcdermott, Jeffrey Settleman, Sreenath V Sharma","radio_11b":"least_relevant"}}', '[{"title":"Role of Met Axis in Head and Neck &lt;b&gt;Cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24287743","desc":"Xu Y, Fisher GJ.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cancers&quot;&gt;Cancers (Basel)&lt;\\/span&gt;. 2013 Nov 26;5(4):1601-1618.","radio_11b2":"somewhat_relevant"},{"title":"miR-30b and miR-30c expression predicted response to &lt;b&gt;tyrosine kinase&lt;\\/b&gt; &lt;b&gt;inhibitors&lt;\\/b&gt; as first line treatment in non-small cell lung &lt;b&gt;cancer&lt;\\/b&gt;.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24286402","desc":"Gu YF, Zhang H, Su D, Mo ML, Song P, Zhang F, Zhang SC.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Chinese medical journal&quot;&gt;Chin Med J (Engl)&lt;\\/span&gt;. 2013 Dec;126(23):4435-9.","radio_11b2":"somewhat_relevant"},{"title":"Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung &lt;b&gt;cancer&lt;\\/b&gt; on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24285021","desc":"Beau-Faller M, Prim N, Ruppert AM, Nanni-Met&Atilde;&copy;llus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Cr&Atilde;&copy;moux P, Solassol J, de Fraipont F, Bi&Atilde;&uml;che I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Legrain M, Voegeli AC, Baudrin L, Morin F, Zalcman G, Quoix E, Blons H, Cadranel J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Annals of oncology : official journal of the European Society for Medical Oncology \\/ ESMO&quot;&gt;Ann Oncol&lt;\\/span&gt;. 2013 Nov 26. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Tyrosine kinase&lt;\\/b&gt; &lt;b&gt;inhibitors&lt;\\/b&gt; induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24282820","desc":"Ahmadieh H, Salti I.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;BioMed research international&quot;&gt;Biomed Res Int&lt;\\/span&gt;. 2013;2013:725410. doi: 10.1155\\/2013\\/725410. Epub 2013 Oct 27. Review.","radio_11b2":"least_relevant"},{"title":"Small-molecule &lt;b&gt;protein tyrosine kinase&lt;\\/b&gt; &lt;b&gt;inhibitors&lt;\\/b&gt; for the treatment of metastatic prostate &lt;b&gt;cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3285098\\/","desc":"Gary E Gallick, Paul G Corn, Amado J Zurita, Sue-Hwa Lin","details":null,"radio_11b2":"somewhat_relevant"},{"title":"Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor &Icirc;&plusmn; Protein in MCF-7 Cells Require the CSK c-Src &lt;b&gt;Tyrosine Kinase&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3617152\\/","desc":"Wei-Lan Yeh, Keiko Shioda, Kathryn R. Coser, Danielle Rivizzigno, Kristen R. McSweeney, Toshi Shioda","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(4): e60889.  &lt;span class=&quot;&quot;&gt;Published online 2013 April 4. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0060889&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Tyrosine kinase&lt;\\/b&gt; &lt;b&gt;inhibitors&lt;\\/b&gt; as modulators of ABC transporter-mediated drug resistance","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3348341\\/","desc":"Suneet Shukla, Zhe-Sheng Chen, Suresh V. Ambudkar","details":null,"radio_11b2":"relevant"},{"title":"Oncogenic &lt;em&gt;CSF3R&lt;\\/em&gt; Mutations in Chronic Neutrophilic Leukemia and Atypical CML","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3730275\\/","desc":"Julia E. Maxson, Jason Gotlib, Daniel A. Pollyea, Angela G. Fleischman, Anupriya Agarwal, Christopher A. Eide, Daniel Bottomly, Beth Wilmot, Shannon K. McWeeney, Cristina E. Tognon, J. Blake Pond, Robert H. Collins, Basem Goueli, Stephen T. Oh, Michael W. Deininger, Bill H. Chang, Marc M. Loriaux, Brian J. Druker, Jeffrey W. Tyner","details":null,"radio_11b2":"somewhat_relevant"},{"title":"Crizotinib for previously treated non-small-cell lung &lt;b&gt;cancer&lt;\\/b&gt; associated with an anaplastic lymphoma &lt;b&gt;kinase&lt;\\/b&gt; fusion gene","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101619366","desc":"National Institute for Health and Care Excellence (Great Britain).","details":"&lt;span class=&quot;src&quot;&gt;[London] : National Institute for Health and Care Excellence, [2013]&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung &lt;b&gt;cancer&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101595028","desc":"National Institute for Health and Clinical Excellence (Great Britain).","details":"&lt;span class=&quot;src&quot;&gt;London : National Institute for Health and Clinical Excellence, c2012.&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"least_relevant"}]', 'test test test test test', 'test test test test test', 'test test test test test', '', '[{"title":"Plant-based inhibitor could halt HIV infection","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/plant-based-inhibitor-could-halt-hiv-infection\\/2013-08-01","desc":" other viruses Stem cell tech could bolster <strong>cancer<\\/strong>, HIV immune response New gene <strong>therapy<\\/strong> approach ...","radio_15":"likely"},{"title":"Personalized lung cancer treatments are already out there, researchers conclude","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/personalized-lung-cancer-treatments-are-already-out-there-researchers-concl\\/2012-09-10","desc":" Squamous cell lung <strong>cancer<\\/strong>--among the most common forms of the disease--has no targeted <strong>therapies<\\/strong> ...","radio_15":"somewhat_likely"},{"title":"Pfizer nabs another targeted cancer drug OK from FDA","link":"http:\\/\\/www.fiercepharma.com\\/story\\/pfizer-nabs-another-targeted-cancer-drug-ok-fda\\/2012-09-05","desc":" Pazdur said in a statement. That ","radio_15":"least_likely"},{"title":"Ambit Biosciences finds $50M more from VCs as leukemia therapy advances","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/ambit-biosciences-finds-50m-more-vcs-leukemia-therapy-advances\\/2012-11-06","desc":" involved 333 patients whose <strong>cancer<\\/strong> relapsed after first-line chemotherapy or persisted despite treatment with second-line chemotherapy or hematopoietic stem cell transplants. The compound is an FMS-like <strong>tyrosine<\\/strong> <strong>kinase<\\/strong>-3 <strong>inhibitor<\\/strong> with activity against about a quarter of AML cases with mutations in the FLT3 genes. ","radio_15":"somewhat_likely"},{"title":"QIAGEN, Pfizer team up on companion diagnostic","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/qiagen-pfizer-team-companion-diagnostic\\/2011-08-16","desc":" found in human <strong>cancers<\\/strong>. Because EGFR <strong>inhibitors<\\/strong> are generally effective in patients without these KRAS ...","radio_15":"somewhat_likely"},{"title":"Cougar founder snags Pfizer cancer drug, raises $55M and launches new biotech","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cougar-founder-snags-pfizer-cancer-drug-raises-55m-and-launches-new-biotech\\/2011-10-06","desc":" inked a deal for the rights to a late-stage <strong>cancer<\\/strong> drug from Pfizer ($PFE) and scrapped two clinical ...","radio_15":"least_likely"},{"title":"Novartis CDK 4\\/6 cancer drug effective in preclinical tests, advances to PhI","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/novartis-cdk-46-cancer-drug-effective-preclincal-tests-advances-phi\\/2013-10-21","desc":" and drug-resistant breast <strong>cancer<\\/strong> when tested in combination with other targeted <strong>therapies<\\/strong>. Novartis ($NVS) is now launching Phase I studies to test the oral <strong>inhibitor<\\/strong>. Both Pfizer ($PFE) and Eli Lilly ($LLY) have CDK 4\\/6 ...","radio_15":"somewhat_likely"},{"title":"Glaxo inks $375M epigenetics deal with SuperGen","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/glaxo-inks-375m-epigenetics-deal-supergen\\/2009-10-26","desc":" <strong>cancer<\\/strong> <strong>therapies<\\/strong>, and investors spurred its shares up by 28 percent on the news. In a deal ...","radio_15":"somewhat_likely"},{"title":"Novartis buries a PhIII kidney cancer failure behind Q2 successes","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/novartis-buries-phiii-kidney-cancer-failure-behind-q2-successes\\/2013-07-19","desc":" <strong>cancer<\\/strong> drugs at the top of its oncology pipeline, including the mid-stage results for dovitinib (TKI258), a <strong>tyrosine<\\/strong> <strong>kinase<\\/strong> <strong>inhibitor<\\/strong> the pharma giant believed had a good shot at besting Nexavar in treating kidney <strong>cancer<\\/strong>. Yesterday, if you dug down past its PR on second-quarter successes and into a more detailed ...","radio_15":"duplicate"},{"title":"Pfizer''s new cancer drug for dogs wins approval","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/pfizers-new-cancer-drug-dogs-wins-approval\\/2009-06-04","desc":" Pfizer has won approval for a new <strong>cancer<\\/strong> drug for dogs with the kind of clinical data most ...","radio_15":"duplicate"}]', 'tyrosine kinase inhibitors in cancer therapy', 'hemophilia', '', '3', '2', '', 100);
INSERT INTO `inventions` VALUES(200, '2013-12-04 05:00:35', 2, 'test 12-4', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_3', '', '', 'early detection of Type 1 diabetes', 'c', '', 'early detection of childhood diabetes', '', '', '', 'a', '', 'Jane Doe', 'NIH', 'ee122', 'test', '', '', 'field', '87', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-12 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'type 1 diabetes biomarker', '{"1":{"title":"test 10-29-13 ","id":"109","status":"field"},"2":{"title":"testing 12-3","id":"194","status":"field"}}', '{"2":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"3":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"4":{"title":"Plastics 10-29-13","id":"103","status":"field"},"5":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"6":{"title":"test 10-29-13 ","id":"109","status":"field"},"7":{"title":"test14nov","id":"149","status":"field"},"8":{"title":"testing 11-19-13","id":"160","status":"field"},"9":{"title":"test nov 18th","id":"164","status":"field"},"10":{"title":"EcoPower Cycle","id":"167","status":"field"},"11":{"title":"testing 15a, 15b and analytics","id":"168","status":"field"}}', 0, '', '', '', '', 0, '', '', 0, '{"0":{"title":"Peptide and protein biomarkers for type 1 diabetes mellitus","link":"http:\\/\\/www.google.com\\/patents\\/US20130045887?dq=type+1+diabetes+biomarker&source=uds;","desc":"A method for identifying persons with increased risk of developing <b>type 1<\\/b>  <b>diabetes<\\/b> mellitus, or having <b>type I diabetes<\\/b> mellitus, utilizing selected\\u00a0<b>...<\\/b>","filedate":"Wed, 15 Aug 2012 00:00:00 -0700","applicant":"Battelle Memorial Institute"},"1":{"title":"Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes","link":"http:\\/\\/www.google.com\\/patents\\/WO2013106851A3?cl=en&dq=type+1+diabetes+biomarker&source=uds;","desc":"The present invention provides <b>biomarkers<\\/b> that are useful in determining whether  a subject has <b>type 1 diabetes<\\/b> or is at risk for developing type I\\u00a0<b>...<\\/b>","filedate":"Mon, 14 Jan 2013 00:00:00 -0800","applicant":"Eastern Virginia Medical School"},"2":{"title":"Biomarkers for differentiating between type 1 and type 2 diabetes","link":"http:\\/\\/www.google.com\\/patents\\/US8594949?dq=type+1+diabetes+biomarker&source=uds;","desc":"<b>Biomarkers<\\/b> that are diagnostic of <b>type 1 diabetes<\\/b>, type 2 diabetes and\\/or diabetic  disorder are identified. Detection of different <b>biomarkers<\\/b> of the\\u00a0<b>...<\\/b>","filedate":"Mon, 26 Sep 2011 00:00:00 -0700","applicant":"University Of Florida Research Foundation, Inc."},"4":{"title":"Gdf-15 as biomarker in type 1 diabetes","link":"http:\\/\\/www.google.com\\/patents\\/WO2009141357A1?cl=en&dq=type+1+diabetes+biomarker&source=uds;","desc":"The present invention relates to a method of predicting if a <b>diabetes type 1<\\/b> patient  will suffer from one or more complications selected from\\u00a0<b>...<\\/b>","filedate":"Tue, 19 May 2009 00:00:00 -0700","applicant":"Roche Diagnostics Gmbh, F. Hoffmann La-Roche Ag"},"6":{"title":"Biomarkers for differentiating between type 2 and type 2 diabetes","link":"http:\\/\\/www.google.com\\/patents\\/EP1718327A4?cl=en&dq=type+1+diabetes+biomarker&source=uds;","desc":"<b>Biomarkers<\\/b> that are diagnostic of <b>type 1 diabetes<\\/b>, type 2 diabetes and\\/or diabetic  disorder are identified. Detection of different <b>biomarkers<\\/b> of the\\u00a0<b>...<\\/b>","filedate":"Mon, 21 Jun 2004 00:00:00 -0700","applicant":"Univ Florida"}}', '[{"title":"The ratio of red cell distribution width to mean corpuscular volume in patients with diabetic ketoacidosis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273933","desc":"Liu DS, Jin Y, Ma SG, Bai F, Xu W.","details":"&lt;span title=&quot;Clinical laboratory&quot; class=&quot;jrnl&quot;&gt;Clin Lab&lt;\\/span&gt;. 2013;59(9-10):1099-104."},{"title":"Correlation between blood glucose fluctuations and activation of oxidative stress in type 1 diabetic children during the acute metabolic disturbance period.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24229667","desc":"Wu D, Gong CX, Meng X, Yang QL.","details":"&lt;span title=&quot;Chinese medical journal&quot; class=&quot;jrnl&quot;&gt;Chin Med J (Engl)&lt;\\/span&gt;. 2013 Nov;126(21):4019-22."},{"title":"Predictors of progression to &lt;b&gt;Type 1 diabetes&lt;\\/b&gt;: preparing for immune interventions in the preclinical disease phase.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24215407","desc":"Gorus FK, Keymeulen B, Veld PA, Pipeleers DG.","details":"&lt;span title=&quot;Expert review of clinical immunology&quot; class=&quot;jrnl&quot;&gt;Expert Rev Clin Immunol&lt;\\/span&gt;. 2013 Dec;9(12):1173-83. doi: 10.1586\\/1744666X.2013.856757."},{"title":"Label-Free Detection of Insulin and Glucagon within Human Islets of Langerhans Using Raman Spectroscopy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24167603","desc":"Hilderink J, Otto C, Slump C, Lenferink A, Engelse M, van Blitterswijk C, de Koning E, Karperien M, van Apeldoorn A.","details":"&lt;span title=&quot;PloS one&quot; class=&quot;jrnl&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Oct 22;8(10):e78148. doi: 10.1371\\/journal.pone.0078148."},{"title":"Serum Levels of TWEAK and Scavenger Receptor CD163 in &lt;b&gt;Type 1 Diabetes Mellitus&lt;\\/b&gt;: Relationship with Cardiovascular Risk Factors. A Case-Control Study","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3427173\\/","desc":"Gemma Llaurad&Atilde;&sup3;, Jos&Atilde;&copy;-Miguel Gonz&Atilde;&iexcl;lez-Clemente, Elsa Maym&Atilde;&sup3;-Masip, David Sub&Atilde;&shy;as, Joan Vendrell, Matilde R. Chac&Atilde;&sup3;n","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(8): e43919.  &lt;span&gt;Published online 2012 August 24. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0043919&lt;\\/span&gt;"},{"title":"Detecting early-warning signals of &lt;b&gt;type 1 diabetes&lt;\\/b&gt; and its leading biomolecular networks by dynamical network biomarkers","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3654886\\/","desc":"Xiaoping Liu, Rui Liu, Xing-Ming Zhao, Luonan Chen","details":"BMC Med Genomics. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;6(Suppl 2): S8.  &lt;span&gt;Published online 2013 May 7. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1755-8794-6-S2-S8&lt;\\/span&gt;"},{"title":"Early &lt;b&gt;Markers&lt;\\/b&gt; of Glycaemic Control in Children with &lt;b&gt;Type 1 Diabetes Mellitus&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3180292\\/","desc":"Samuel W. Cutfield, Jos&Atilde;&copy; G. B. Derraik, Peter W. Reed, Paul L. Hofman, Craig Jefferies, Wayne S. Cutfield","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2011; &lt;\\/span&gt;6(9): e25251.  &lt;span&gt;Published online 2011 September 26. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0025251&lt;\\/span&gt;"},{"title":"Serum proteomics reveals systemic dysregulation of innate immunity in &lt;b&gt;type 1 diabetes&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3549705\\/","desc":"Qibin Zhang, Thomas L. Fillmore, Athena A. Schepmoes, Therese R.W. Clauss, Marina A. Gritsenko, Patricia W. Mueller, Marian Rewers, Mark A. Atkinson, Richard D. Smith, Thomas O. Metz","details":null},{"title":"null","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/undefined","desc":"null","details":"null"},{"title":"On the use of [&lt;sup&gt;18&lt;\\/sup&gt;F]DOPA as an imaging &lt;b&gt;biomarker&lt;\\/b&gt; for transplanted islet mass.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24166476","desc":"Eriksson O, Mintz A, Liu C, Yu M, Naji A, Alavi A.","details":"&lt;span title=&quot;Annals of nuclear medicine&quot; class=&quot;jrnl&quot;&gt;Ann Nucl Med&lt;\\/span&gt;. 2013 Oct 29. [Epub ahead of print]"}]', '', '', '', '', '', '', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(206, '2013-12-04 08:41:27', 2, 'Diabetes biomarker', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_3', '', '', 'Type 1 diabetes biomarker', 'c', '', 'Diabetes biomarker', '', '', '', 'a,b', '', 'Jane Doe', 'NIH,Company', 'nn', 'nn', '', '', 'field', '87', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-19 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'Biomarker for type 1 diabetes', '{"1":{"radio_11a1":"Yes","title":"test 10-29-13 ","id":"109","status":"field"},"2":{"radio_11a1":"May be","title":"testing 12-3","id":"194","status":"field"},"3":{"radio_11a1":"No","title":"test 12-4","id":"200","status":"field"}}', '{"1":{"radio_11a2":"Yes","title":"Oct 16 hemophilia testing","id":"77","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"No","title":"Biomarker Dx for cancer","id":"100","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"May be","title":"Plastics 10-29-13","id":"103","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"No","title":"Oct 25 Dx testing","id":"104","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"No","title":"test 10-29-13 ","id":"109","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"No","title":"test14nov","id":"149","status":"Disclosure Done & Under Review"},"7":{"radio_11a2":"No","title":"testing 11-19-13","id":"160","status":"Disclosure Done & Under Review"},"8":{"radio_11a2":"No","title":"test nov 18th","id":"164","status":"Disclosure Done & Under Review"},"9":{"radio_11a2":"No","title":"EcoPower Cycle","id":"167","status":"Disclosure Done & Under Review"},"10":{"radio_11a2":"No","title":"testing 15a, 15b and analytics","id":"168","status":"Disclosure Done & Under Review"}}', 73, '', '100k-1m', 'Yes', 'No', 3, '', 'Maybe', 32.25, '[{"title":"Peptide and protein biomarkers for type 1 diabetes mellitus","link":"http:\\/\\/www.google.com\\/patents\\/US20130045887?dq=Biomarker+for+type+1+diabetes&source=uds;","filedate":"Wed, 15 Aug 2012 00:00:00 -0700","applicant":"Battelle Memorial Institute","desc":"A method for identifying persons with increased risk of developing <b>type 1<\\/b>  <b>diabetes<\\/b> mellitus, or having <b>type I diabetes<\\/b> mellitus, utilizing selected\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Gdf-15 as biomarker in type 1 diabetes","link":"http:\\/\\/www.google.com\\/patents\\/WO2009141357A1?cl=en&dq=Biomarker+for+type+1+diabetes&source=uds;","filedate":"Tue, 19 May 2009 00:00:00 -0700","applicant":"Roche Diagnostics Gmbh, F. Hoffmann La-Roche Ag","desc":"The present invention relates to a method of predicting if a <b>diabetes type 1<\\/b> patient  will suffer from one or more complications selected from\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes","link":"http:\\/\\/www.google.com\\/patents\\/WO2013106851A2?cl=en&dq=Biomarker+for+type+1+diabetes&source=uds;","filedate":"Mon, 14 Jan 2013 00:00:00 -0800","applicant":"Eastern Virginia Medical School","desc":"The present invention provides <b>biomarkers<\\/b> that are useful in determining whether  a subject has <b>type 1 diabetes<\\/b> or is at risk for developing type I\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Biomarkers for differentiating between type 1 and type 2 diabetes","link":"http:\\/\\/www.google.com\\/patents\\/US8594949?dq=Biomarker+for+type+1+diabetes&source=uds;","filedate":"Mon, 26 Sep 2011 00:00:00 -0700","applicant":"University Of Florida Research Foundation, Inc.","desc":"<b>Biomarkers<\\/b> that are diagnostic of <b>type 1 diabetes<\\/b>, type 2 diabetes and\\/or diabetic  disorder are identified. Detection of different <b>biomarkers<\\/b> of the\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Biomarkers for differentiating between type 2 and type 2 diabetes","link":"http:\\/\\/www.google.com\\/patents\\/CA2529759A1?cl=en&dq=Biomarker+for+type+1+diabetes&source=uds;","filedate":"Mon, 21 Jun 2004 00:00:00 -0700","applicant":"University Of Florida, Tamir M. Ellis, Alba Esther Morales, Mark A. Atkinson, Clive Henry Wasserfall, University Of Florida Research Foundation Inc.","desc":"<b>Biomarkers<\\/b> that are diagnostic of <b>type 1 diabetes<\\/b>, type 2 diabetes and\\/or diabetic  disorder are identified. Detection of different <b>biomarkers<\\/b> of the\\u00a0<b>...<\\/b>","radio_11b":"duplicate"}]', '[{"title":"The ratio of red cell distribution width to mean corpuscular volume in patients with diabetic ketoacidosis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24273933","desc":"Liu DS, Jin Y, Ma SG, Bai F, Xu W.","details":"&lt;span title=&quot;Clinical laboratory&quot; class=&quot;jrnl&quot;&gt;Clin Lab&lt;\\/span&gt;. 2013;59(9-10):1099-104.","radio_11b2":"least_relevant"},{"title":"Correlation between blood glucose fluctuations and activation of oxidative stress in type 1 diabetic children during the acute metabolic disturbance period.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24229667","desc":"Wu D, Gong CX, Meng X, Yang QL.","details":"&lt;span title=&quot;Chinese medical journal&quot; class=&quot;jrnl&quot;&gt;Chin Med J (Engl)&lt;\\/span&gt;. 2013 Nov;126(21):4019-22.","radio_11b2":"least_relevant"},{"title":"Predictors of progression to &lt;b&gt;Type 1 diabetes&lt;\\/b&gt;: preparing for immune interventions in the preclinical disease phase.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24215407","desc":"Gorus FK, Keymeulen B, Veld PA, Pipeleers DG.","details":"&lt;span title=&quot;Expert review of clinical immunology&quot; class=&quot;jrnl&quot;&gt;Expert Rev Clin Immunol&lt;\\/span&gt;. 2013 Dec;9(12):1173-83. doi: 10.1586\\/1744666X.2013.856757.","radio_11b2":"somewhat_relevant"},{"title":"Label-Free Detection of Insulin and Glucagon within Human Islets of Langerhans Using Raman Spectroscopy.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24167603","desc":"Hilderink J, Otto C, Slump C, Lenferink A, Engelse M, van Blitterswijk C, de Koning E, Karperien M, van Apeldoorn A.","details":"&lt;span title=&quot;PloS one&quot; class=&quot;jrnl&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Oct 22;8(10):e78148. doi: 10.1371\\/journal.pone.0078148.","radio_11b2":"relevant"},{"title":"Serum Levels of TWEAK and Scavenger Receptor CD163 in &lt;b&gt;Type 1 Diabetes Mellitus&lt;\\/b&gt;: Relationship with Cardiovascular Risk Factors. A Case-Control Study","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3427173\\/","desc":"Gemma Llaurad&Atilde;&sup3;, Jos&Atilde;&copy;-Miguel Gonz&Atilde;&iexcl;lez-Clemente, Elsa Maym&Atilde;&sup3;-Masip, David Sub&Atilde;&shy;as, Joan Vendrell, Matilde R. Chac&Atilde;&sup3;n","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(8): e43919.  &lt;span&gt;Published online 2012 August 24. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0043919&lt;\\/span&gt;","radio_11b2":"relevant"},{"title":"Detecting early-warning signals of &lt;b&gt;type 1 diabetes&lt;\\/b&gt; and its leading biomolecular networks by dynamical network biomarkers","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3654886\\/","desc":"Xiaoping Liu, Rui Liu, Xing-Ming Zhao, Luonan Chen","details":"BMC Med Genomics. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;6(Suppl 2): S8.  &lt;span&gt;Published online 2013 May 7. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1755-8794-6-S2-S8&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Early &lt;b&gt;Markers&lt;\\/b&gt; of Glycaemic Control in Children with &lt;b&gt;Type 1 Diabetes Mellitus&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3180292\\/","desc":"Samuel W. Cutfield, Jos&Atilde;&copy; G. B. Derraik, Peter W. Reed, Paul L. Hofman, Craig Jefferies, Wayne S. Cutfield","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2011; &lt;\\/span&gt;6(9): e25251.  &lt;span&gt;Published online 2011 September 26. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0025251&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Serum proteomics reveals systemic dysregulation of innate immunity in &lt;b&gt;type 1 diabetes&lt;\\/b&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3549705\\/","desc":"Qibin Zhang, Thomas L. Fillmore, Athena A. Schepmoes, Therese R.W. Clauss, Marina A. Gritsenko, Patricia W. Mueller, Marian Rewers, Mark A. Atkinson, Richard D. Smith, Thomas O. Metz","details":"","radio_11b2":"somewhat_relevant"},{"title":"null","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/undefined","desc":"null","details":"null","radio_11b2":"somewhat_relevant"},{"title":"On the use of [&lt;sup&gt;18&lt;\\/sup&gt;F]DOPA as an imaging &lt;b&gt;biomarker&lt;\\/b&gt; for transplanted islet mass.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24166476","desc":"Eriksson O, Mintz A, Liu C, Yu M, Naji A, Alavi A.","details":"&lt;span title=&quot;Annals of nuclear medicine&quot; class=&quot;jrnl&quot;&gt;Ann Nucl Med&lt;\\/span&gt;. 2013 Oct 29. [Epub ahead of print]","radio_11b2":"least_relevant"}]', 'early detection biomarker test test', 'test test test test test', 'test test test test test', '', '[{"title":"Biomarker panel spots the risk of Type 2 diabetes","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/biomarker-panel-spots-risk-type-2-diabetes\\/2012-10-08","desc":" be linked with <strong>Type<\\/strong> 2 <strong>diabetes<\\/strong> and found 14 contenders. At the beginning of the study, none of the people ...","radio_15":"somewhat_likely"},{"title":"Protein biomarker predicts Type 2 diabetes years in advance","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/protein-biomarker-predicts-type-2-diabetes-years-advance\\/2012-11-14","desc":" Researchers have found a blood protein that could predict <strong>Type<\\/strong> 2 <strong>diabetes<\\/strong> years in advance, according to a study published in the journal Cell Metabolism. <strong>Type<\\/strong> 2 <strong>diabetes<\\/strong> is a complex disorder, linked ...","radio_15":"least_likely"},{"title":"Epigenetic markers could point to type 1 diabetes risk; Gene discovery indicates osteoporosis risk;","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/epigenetic-markers-could-point-type-1-diabetes-risk-gene-discovery-indicate\\/2011-10-05","desc":" > New <strong>biomarker<\\/strong> tests could provide an alternative to biopsies to track disease in patients with lupus. Release > Fecal <strong>biomarkers<\\/strong> of inflammation could beat a path to new diagnostics and ways ...","radio_15":"likely"},{"title":"Apolipoproteins mark diabetic visual loss","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/apolipoproteins-mark-diabetic-visual-loss\\/2012-07-02","desc":" be stronger <strong>biomarkers<\\/strong> than lipids in <strong>diabetic<\\/strong> eye disease, and they may also be useful in other <strong>diabetic<\\/strong> ...","radio_15":"least_likely"},{"title":"Myriad, Sanofi to team on diabetes biomarker Dx discovery work","link":"http:\\/\\/www.fiercemedicaldevices.com\\/story\\/myriad-sanofi-team-diabetes-biomarker-dx-discovery-work\\/2012-12-12","desc":" A Myriad Genetics ($MYGN) subsidiary will team up with Sanofi ($SNY) and others to conduct protein <strong>biomarker<\\/strong> discovery work on more than 8,000 serum samples from prediabetes or <strong>Type<\\/strong> 2 <strong>diabetes<\\/strong> patients. The goal of the project: Identify <strong>biomarkers<\\/strong> that could help improve patient care and treatment. Myriad ...","radio_15":"likely"},{"title":"Biomarkers predict risk of diabetes-related kidney trouble ","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/biomarkers-predict-risk-diabetes-related-kidney-trouble\\/2013-04-01","desc":" in <strong>Type<\\/strong> 1 <strong>diabetes<\\/strong> patients can heighten their chance of getting macroalbuminuria, a condition where ...","radio_15":"somewhat_likely"},{"title":"Scientists piecing together genetic puzzle in type 1 diabetes ","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/scientists-piecing-together-genetic-puzzle-type-1-diabetes\\/2011-10-05","desc":" but it would not have occurred to anyone that it may be active in <strong>type<\\/strong> 1 <strong>diabetes<\\/strong>. GWAS continues to turn up ...","radio_15":"least_likely"},{"title":"Scientists ID molecule that could predict Type 2 diabetes","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/scientists-id-molecule-could-predict-type-2-diabetes\\/2010-09-22","desc":" Scientists from King''s College London have identified a molecule that could help predict <strong>Type<\\/strong> 2 <strong>diabetes<\\/strong> and identify <strong>diabetics<\\/strong> that are most vulnerable to heart and circulatory disease. The study, led ...","radio_15":"least_likely"},{"title":"12-year study flags new biomarker for high risk of diabetes","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/12-year-study-flags-new-biomarker-high-risk-diabetes\\/2013-09-18","desc":" could shape drug design Scientists create more accurate animal model of <strong>Type<\\/strong> 2 <strong>diabetes<\\/strong>  ...","radio_15":"somewhat_likely"},{"title":"Excitable nerves mark symptomless diabetic neuropathy","link":"http:\\/\\/www.fiercebiomarkers.com\\/story\\/excitable-nerves-mark-symptomless-diabetic-neuropathy\\/2012-06-20","desc":" The levels of <strong>diabetes<\\/strong> are climbing worldwide, both <strong>Type<\\/strong> 1 and <strong>Type<\\/strong> 2, and this means ...","radio_15":"least_likely"}]', 'type 1 diabetes biomarker', 'type 1 diabetes', '', '3', '2', '', 100);
INSERT INTO `inventions` VALUES(207, '2013-12-04 15:13:44', 13, 'test 12-4', 'bio_organism', '', '', 'gansh1', 'gansh11', 'gansh11_3', '', '', 'Pancreatic cancer research', 'c', '', 'test', '', '', '', 'a', '', 'Gee kaun', '', '', '', '', '', 'field', '44.5', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'patent on basmati rice', '', '', 0, '', '', '', '', 0, '', '', 0, '{"0":{"title":"Freeze-drying of basmati rice","link":"http:\\/\\/www.google.com\\/patents\\/WO1999013736A1?cl=en&dq=patent+on+basmati+rice&source=uds;","desc":"Authentic aromatic one minute <b>Basmati rice<\\/b> has all the best cooling qualities of  <b>Basmati rice<\\/b> retaining maximum aroma and after reconstitution\\u00a0<b>...<\\/b>","filedate":"Thu, 18 Sep 1997 00:00:00 -0700","applicant":"Kumar Rajesh, Menezes Alain Vinod, Menezes Alexander"},"1":{"title":"Single tube multiplex assay for detection and quantification of adulterants ...","link":"http:\\/\\/www.google.com\\/patents\\/US20120295816?dq=patent+on+basmati+rice&source=uds;","desc":"<b>...<\\/b> for distinguishing basmati from non-<b>basmati rice<\\/b> varieties, and thereby <b>...<\\/b> 23,  2010, which is a divisional of co-pending U.S. <b>patent<\\/b> application\\u00a0<b>...<\\/b>","filedate":"Fri, 22 Jun 2012 00:00:00 -0700","applicant":"Centre For Dna Fingerprinting And Diagnostics (Cdfd)"},"2":{"title":"Single tube multiplex assay for detection of adulterants in basmati rice samples","link":"http:\\/\\/www.google.com\\/patents\\/EP2013359A1?cl=en&dq=patent+on+basmati+rice&source=uds;","desc":"The present invention relates to a single tube multiplex assay for distinguishing  basmati from non-<b>basmati rice<\\/b> varieties and thereby the\\u00a0<b>...<\\/b>","filedate":"Mon, 17 Jul 2006 00:00:00 -0700","applicant":"Centre For Dna Fingerprinting And Diagnostics Ministry of Science and Technology Goverment of India"},"4":{"title":"\\u5305\\u88c5\\u888b(502\\u7eaf\\u9999\\u7c73) Bags (502 Pure Basmati Rice)","link":"http:\\/\\/www.google.com\\/patents\\/CN301152345S?cl=en&dq=patent+on+basmati+rice&source=uds;","desc":"<b>Patents<\\/b>. \\u5176\\u4ed6\\u89c6\\u56fe\\u65e0\\u8bbe\\u8ba1 <b>...<\\/b> \\u5305\\u88c5\\u888b(502\\u7eaf\\u9999\\u7c73) Bags (502 Pure <b>Basmati Rice<\\/b>)  translated from\\u00a0<b>...<\\/b>","filedate":"Sat, 18 Jul 2009 00:00:00 -0700","applicant":"\\u540e\\u8fdb\\u840d"},"5":{"title":"\\u7c73\\u888b(\\u5929\\u9f99\\u6ee1\\u5802\\u9999\\u7c73) Sack (Denon full house basmati rice)","link":"http:\\/\\/www.google.com\\/patents\\/CN300858159S?cl=en&dq=patent+on+basmati+rice&source=uds;","desc":"<b>Patents<\\/b>. 1.\\u7701\\u7565\\u5176\\u4ed6 <b>...<\\/b> (\\u5929\\u9f99\\u6ee1\\u5802\\u9999\\u7c73) Sack (Denon full house <b>basmati rice<\\/b>)  <b>Patent<\\/b> CN300858159S - \\u7c73\\u888b( <b>...<\\/b> house <b>basmati rice<\\/b>) translated from\\u00a0<b>...<\\/b>","filedate":"Sun, 02 Dec 2007 00:00:00 -0800","applicant":"\\u6e56\\u5357\\u7701\\u5929\\u9f99\\u7c73\\u4e1a\\u6709\\u9650\\u516c\\u53f8"},"6":{"title":"\\u5305\\u88c5\\u888b(\\u5cb1\\u5c71\\u6e56-\\u4e1d\\u82d7\\u9999\\u7c73) Bags (Daishan Lake - Steamed basmati rice)","link":"http:\\/\\/www.google.com\\/patents\\/CN301232109S?cl=en&dq=patent+on+basmati+rice&source=uds;","desc":"www.google.comhttp:\\/\\/www.google.com\\/<b>patents<\\/b>\\/CN301232109S?cl= <b>...<\\/b> Steamed  <b>basmati rice<\\/b>) <b>Patent<\\/b> CN301232109S - \\u5305\\u88c5\\u888b(\\u5cb1\\u5c71\\u6e56-\\u4e1d\\u82d7\\u9999\\u00a0<b>...<\\/b>","filedate":"Fri, 18 Sep 2009 00:00:00 -0700","applicant":"\\u5408\\u80a5\\u5e02\\u65b0\\u79be\\u7c73\\u4e1a\\u6709\\u9650\\u516c\\u53f8"},"7":{"title":"An improved process for the stabilization of 2-acetyl-1-pyrroline, the ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2004056202A1?cl=en&dq=patent+on+basmati+rice&source=uds;","desc":"The main uses of the present invention are (i) making the <b>basmati rice<\\/b> flavouring  in easily dispersible powder form and (ii) imparting stability to\\u00a0<b>...<\\/b>","filedate":"Fri, 20 Dec 2002 00:00:00 -0800","applicant":"Council Scient Ind Res, Gurudutt Kambadoor Nagarajarao, Raghavan Bashyam, Srinivas Pullabhatla, Sulochanamma Guruguntla"}}', '[{"title":"How Large Is the Metabolome? A Critical Analysis of Data Exchange Practices in Chemistry","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2673031\\/","desc":"Tobias Kind, Martin Scholz, Oliver Fiehn","details":"PLoS ONE. &lt;span class=&quot;citation-publication-date&quot;&gt;2009; &lt;\\/span&gt;4(5): e5440.  &lt;span class=&quot;&quot;&gt;Published online 2009 May 5. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0005440&lt;\\/span&gt;"},{"title":"Intellectual property rights and patents in perspective of Ayurveda","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3456857\\/","desc":"Anand Chaudhary, Neetu Singh","details":null},{"title":"Application of Genomic Tools in Plant Breeding","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3382273\\/","desc":"A.M. P&Atilde;&copy;rez-de-Castro, S. Vilanova, J. Ca&Atilde;&plusmn;izares, L. Pascual, J.M. Blanca, M.J. D&Atilde;&shy;ez, J. Prohens, B. Pic&Atilde;&sup3;","details":null},{"title":"Ethnobotany as a Pharmacological Research Tool and Recent Developments in CNS-active Natural Products from Ethnobotanical Sources","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC2700180\\/","desc":"Will C. McClatchey, Gail B. Mahady, Bradley C. Bennett, Laura Shiels, Valentina Savo","details":null},{"title":"American household botany : a history of useful plants, 1620-1900","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101508974","desc":"Sumner, Judith.","details":"&lt;span class=&quot;src&quot;&gt;Portland : Timber Press, 2004.&lt;br&gt;&lt;\\/span&gt;"},{"title":"Redesigning life? : the worldwide challenge to genetic engineering","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101119988","desc":"Tokar, Brian.","details":"&lt;span class=&quot;src&quot;&gt;London ; New York : New York : Zed Books ; Distributed by Palgrave, 2001.&lt;br&gt;&lt;\\/span&gt;"},{"title":"Who Owns Biodiversity, and How Should the Owners Be Compensated?","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC419806\\/","desc":"Paul Gepts","details":null},{"title":"A Detailed Study of &lt;b&gt;Patent&lt;\\/b&gt; System for Protection of Inventions","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3038276\\/","desc":"G. Krishna Tulasi, B. Subba Rao","details":null},{"title":"Management of intellectual property rights in India: An updated review","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3312695\\/","desc":"R. Tiwari, G. Tiwari, A. K. Rai, Birendra Srivastawa","details":null},{"title":"Purification and characterization of thermostable monomeric chloroplastic Cu\\/Zn superoxide dismutase from &lt;em&gt;Chenopodium murale&lt;\\/em&gt;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3550362\\/","desc":"Sabarinath Sundaram, Sunil Khanna, Renu Khanna-Chopra","details":null}]', '', '', '', '', '', '', '', '', '', '', '', 65);
INSERT INTO `inventions` VALUES(208, '2013-12-06 07:21:59', 1, 'Solar farm control under cloud', 'patent', '', '', 'gansh3', 'gansh17', 'gansh17_2', '', '', 'solar power generation', 'c', '', 'solar farm control under cloud', '', '', '', 'b', '', 'jane doe', 'company 1', 'ww', 'www', '', '', 'field', '79', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '2013-12-05 00:00:00', '', '', '0000-00-00 00:00:00', 'adaptive control for renewable energy', '', '{"1":{"radio_11a2":"Yes","title":"EcoPower Cycle","id":"167","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"May be","title":"Fiber optic high pressure transducer","id":"188","status":"Disclosure Done & Under Review"}}', 61, '', '>1m', 'Yes', 'No', 4, '', 'Maybe', 18, '[{"title":"Adaptive controlled outdoor lighting system and method of operation thereof","link":"http:\\/\\/www.google.com\\/patents\\/WO2012172470A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","filedate":"Mon, 11 Jun 2012 00:00:00 -0700","applicant":"Koninklijke Philips Electronics N.V.","desc":"The system of claim 1 , wherein the <b>controller<\\/b> (102) selects a power <b>.....<\\/b> system  may determine to rely upon <b>wind power<\\/b> generation to power\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Intelligent power converter control for grid integration of renewable energies","link":"http:\\/\\/www.google.com\\/patents\\/WO2010114792A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","filedate":"Mon, 29 Mar 2010 00:00:00 -0700","applicant":"The Board Of Trustees Of The University Of Alabama","desc":"Intelligent power converter control for grid integration of <b>renewable energies<\\/b> <b>...<\\/b>  one or more of PID, fuzzy and <b>adaptive control<\\/b> technologies. 7.","radio_11b":"relevant"},{"title":"Adaptive pitch control for variable speed wind turbines","link":"http:\\/\\/www.google.com\\/patents\\/WO2007123552A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","filedate":"Wed, 26 Apr 2006 00:00:00 -0700","applicant":"Lee Jay Fingersh, Kathryn E Johnson, Midwest Research Inst","desc":"Average <b>power<\\/b> coefficients are determined for first and second periods of <b>...<\\/b> An  <b>adaptive control<\\/b> method for use with <b>wind<\\/b> turbines to better\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Systems and methods for sustainable economic development through integrated ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2470786A1?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","filedate":"Mon, 16 Aug 2010 00:00:00 -0700","applicant":"McAlister Technologies, LLC","desc":"A method for providing an energy supply using a <b>renewable energy<\\/b> <b>.....<\\/b> sub- systems with <b>adaptive control<\\/b> of autogenous cascading energy\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Sustainable economic development through integrated production of renewable ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2470312A2?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","filedate":"Mon, 16 Aug 2010 00:00:00 -0700","applicant":"McAlister Technologies, LLC","desc":"In some embodiments, the system utilizes energy from <b>renewable energy<\\/b> <b>...<\\/b> sub- systems with <b>adaptive control<\\/b> of autogenous cascading energy\\u00a0<b>...<\\/b>","radio_11b":"duplicate"},{"title":"Method for controlling an electric power generation system based on energy ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2010095159A2?cl=en&dq=adaptive+control+for+renewable+energy&source=uds;","filedate":"Mon, 22 Feb 2010 00:00:00 -0800","applicant":"Universita'' Degli Studi Di Salerno","desc":"The present invention concerns a method, and the related controller device, <b>...<\\/b>  based on at least one energy source, in particular a <b>renewable energy<\\/b> source, <b>...<\\/b>  This means that an <b>adaptive control<\\/b> system, assisting the lookup\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"}]', '[{"title":"An &lt;b&gt;adaptive&lt;\\/b&gt; recurrent neural-network controller using a stabilization matrix and predictive inputs to solve a tracking problem under disturbances.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24161455","desc":"Fairbank M, Li S, Fu X, Alonso E, Wunsch D.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Neural networks : the official journal of the International Neural Network Society&quot;&gt;Neural Netw&lt;\\/span&gt;. 2013 Oct 9;49C:74-86. doi: 10.1016\\/j.neunet.2013.09.010. [Epub ahead of print]","radio_11b2":"relevant"},{"title":"Improved single neuron controller for multivariable stochastic systems with non-Gaussianities and unmodeled dynamics.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23910156","desc":"Zhang J, Jiang M, Ren M, Hou G, Xu J.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;ISA transactions&quot;&gt;ISA Trans&lt;\\/span&gt;. 2013 Nov;52(6):752-8. doi: 10.1016\\/j.isatra.2013.07.002. Epub 2013 Jul 30.","radio_11b2":"somewhat_relevant"},{"title":"Dam design can impede &lt;b&gt;adaptive&lt;\\/b&gt; management of environmental flows: a case study from the Opuha Dam, New Zealand.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/23124551","desc":"Lessard J, Hicks DM, Snelder TH, Arscott DB, Larned ST, Booker D, Suren AM.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Environmental management&quot;&gt;Environ Manage&lt;\\/span&gt;. 2013 Feb;51(2):459-73. doi: 10.1007\\/s00267-012-9971-x. Epub 2012 Nov 3.","radio_11b2":"somewhat_relevant"},{"title":"A new approach for probing the mobility and lifetime of photogenerated charge carriers in organic solar cells under real operating conditions.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22760962","desc":"Baumann A, Lorrmann J, Rauh D, Deibel C, Dyakonov V.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Advanced materials (Deerfield Beach, Fla.)&quot;&gt;Adv Mater&lt;\\/span&gt;. 2012 Aug 22;24(32):4381-6. doi: 10.1002\\/adma.201200874. Epub 2012 Jul 3.","radio_11b2":"least_relevant"},{"title":"An &lt;b&gt;Adaptive&lt;\\/b&gt; Framework for Selecting Environmental Monitoring Protocols to Support Ocean &lt;b&gt;Renewable Energy&lt;\\/b&gt; Development","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3540755\\/","desc":"Emily J. Shumchenia, Sarah L. Smith, Jennifer McCann, Michelle Carnevale, Grover Fugate, Robert D. Kenney, John W. King, Peter Paton, Malia Schwartz, Malcolm Spaulding, Kristopher J. Winiarski","details":"ScientificWorldJournal. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;2012: 450685.  &lt;span class=&quot;&quot;&gt;Published online 2012 December 23. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1100\\/2012\\/450685&lt;\\/span&gt;","radio_11b2":"somewhat_relevant"},{"title":"Turbine Sound May Influence the Metamorphosis Behaviour of Estuarine Crab Megalopae","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3519903\\/","desc":"Matthew K. Pine, Andrew G. Jeffs, Craig A. Radford","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2012; &lt;\\/span&gt;7(12): e51790.  &lt;span class=&quot;&quot;&gt;Published online 2012 December 11. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0051790&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"&lt;b&gt;Energy&lt;\\/b&gt; systems transformation","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3574957\\/","desc":"A. T. C. J&Atilde;&copy;r&Atilde;&acute;me Dangerman, Hans Joachim Schellnhuber","details":"","radio_11b2":"duplicate"},{"title":"Design and development of synthetic microbial platform cells for bioenergy","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3630320\\/","desc":"Sang Jun Lee, Sang-Jae Lee, Dong-Woo Lee","details":"Front Microbiol. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;4: 92.  &lt;span class=&quot;&quot;&gt;Published online 2013 April 19. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.3389\\/fmicb.2013.00092&lt;\\/span&gt;","radio_11b2":"relevant"},{"title":"null","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/undefined","desc":"null","details":"null","radio_11b2":"least_relevant"},{"title":"Confronting deep uncertainties in risk analysis.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/22489541","desc":"Cox LA Jr.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Risk analysis : an official publication of the Society for Risk Analysis&quot;&gt;Risk Anal&lt;\\/span&gt;. 2012 Oct;32(10):1607-29. doi: 10.1111\\/j.1539-6924.2012.01792.x. Epub 2012 Apr 10. Review.","radio_11b2":"somewhat_relevant"}]', 'test test test test test', 'test test test test test', 'test test test test test', '', '', 'test', 'solar power', '', '3', '2', '', 100);
INSERT INTO `inventions` VALUES(209, '2013-12-07 06:05:24', 17, 'test', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_3', '', '', 'HDAC inhibitor for KRAS mutant colon cancer', 'e', 'b', 'kras mutant colon cancer drug', '', '', '', 'a', '', 'Gee Kaun', 'NIH', '11', 'xx', '', '', 'field', '107', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-18 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'HDAC inhibitor for pancreatic cancer', '{"1":{"radio_11a1":"No","title":"test nov 22","id":"170","status":"field"}}', '{"1":{"radio_11a2":"Yes","title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"2":{"radio_11a2":"Yes","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"},"3":{"radio_11a2":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"Disclosure Done & Under Review"},"4":{"radio_11a2":"No","title":"HDAC Inhibitor for colon cancer","id":"139","status":"Disclosure Done & Under Review"},"5":{"radio_11a2":"May be","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"Disclosure Done & Under Review"},"6":{"radio_11a2":"May be","title":"test nov 22","id":"170","status":"Disclosure Done & Under Review"}}', 87, '', '>1m', 'Yes', 'No', 3, '', 'No', 29, '[{"title":"Hdac inhibitors to treat charcot-marie-tooth disease","link":"http:\\/\\/www.google.com\\/patents\\/WO2012045804A1?cl=en&dq=HDAC&source=uds;","filedate":"Thu, 06 Oct 2011 00:00:00 -0700","applicant":"Life Sciences Research Partners Vzw, Vib Vzw","desc":"The present application relates to diseases in the peripheral nervous system,  particularly hereditary neuropathies, most particularly,\\u00a0<b>...<\\/b>","radio_11b":"relevant"},{"title":"Fluorinated hdac inhibitors and uses thereof","link":"http:\\/\\/www.google.com\\/patents\\/WO2011084991A3?cl=en&dq=HDAC&source=uds;","filedate":"Wed, 05 Jan 2011 00:00:00 -0800","applicant":"President And Fellows Of Harvard College, Dana-Farber Cancer Institute, Inc.","desc":"Fluorinated deacetylase inhibitors of the general formulae (I), (II), and (III): and  pharmaceutically acceptable salts thereof, as described herein,\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Histone deacetylase (HDAC) inhibiting compounds and method of making same","link":"http:\\/\\/www.google.com\\/patents\\/EP2486923A1?cl=en&dq=HDAC&source=uds;","filedate":"Fri, 11 Feb 2011 00:00:00 -0800","applicant":"Dr. Felix J\\u00e4ger und Dr. Stefan Drinkuth Laborgemeinschaft OHG, Hochschule Darmstadt","desc":"The invention relates to novel <b>HDAC<\\/b> inhibitors and a method of making such  <b>HDAC<\\/b> inhibitors. The present invention provides novel <b>HDAC<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds","link":"http:\\/\\/www.google.com\\/patents\\/US8283357?dq=HDAC&source=uds;","filedate":"Mon, 07 Jun 2010 00:00:00 -0700","applicant":"Gilead Sciences, Inc.","desc":"The present invention provides a compound of general Formula (I) having  histone deacetylase (<b>HDAC<\\/b>) inhibitory activity, a pharmaceutical\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Hdac inhibitors and therapeutic methods using the same","link":"http:\\/\\/www.google.com\\/patents\\/EP2456757A2?cl=en&dq=HDAC&source=uds;","filedate":"Fri, 02 Jul 2010 00:00:00 -0700","applicant":"The Board of Trustees of the University of Illinois","desc":"Histone deacetylases inhibitors (HDACIs) and compositions containing the same  are disclosed. Methods of treating diseases and conditions\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Methods for the identification and characterization of hdac interacting ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2464967A1?cl=en&dq=HDAC&source=uds;","filedate":"Fri, 13 Aug 2010 00:00:00 -0700","applicant":"Cellzome Ag","desc":"The present invention relates to methods for the identification and  characterization (e.g. selectivity profiling) of <b>HDAC<\\/b> interacting compounds\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"HDAC inhibitors and therapeutic methods of using same","link":"http:\\/\\/www.google.com\\/patents\\/US8431538?dq=HDAC&source=uds;","filedate":"Fri, 02 Jul 2010 00:00:00 -0700","applicant":"The Board Of Trustees Of The University Of Illinois","desc":"Histone deacetylases inhibitors (HDACIs) and compositions containing the same  are disclosed. Methods of treating diseases and conditions\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"}]', '[{"title":"Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24312501","desc":"Liu D, Liu C, Li J, Azadzoi K, Yang Y, Fei Z, Dou K, Kowall NW, Choi HP, Vieira F, Yang JH.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;PloS one&quot;&gt;PLoS One&lt;\\/span&gt;. 2013 Dec 2;8(12):e80779. doi: 10.1371\\/journal.pone.0080779.","radio_11b2":"somewhat_relevant"},{"title":"Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24309938","desc":"Riley JS, Hutchinson R, McArt DG, Crawford N, Holohan C, Paul I, Van Schaeybroeck S, Salto-Tellez M, Johnston PG, Fennell DA, Gately K, O''Byrne K, Cummins R, Kay E, Hamilton P, Stasik I, Longley DB.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Cell death &amp; disease&quot;&gt;Cell Death Dis&lt;\\/span&gt;. 2013 Dec 5;4:e951. doi: 10.1038\\/cddis.2013.481.","radio_11b2":"somewhat_relevant"},{"title":"The Response of Secondary Genes to Lipopolysaccharides in Macrophages Depends on Histone Deacetylase and Phosphorylation of C\\/EBP&Icirc;&sup2;","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24307736","desc":"Serrat N, Sebastian C, Pereira-Lopes S, Valverde-Estrella L, Lloberas J, Celada A.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Journal of immunology (Baltimore, Md. : 1950)&quot;&gt;J Immunol&lt;\\/span&gt;. 2013 Dec 4. [Epub ahead of print]","radio_11b2":"least_relevant"},{"title":"187 increased efficiency of deriving bovine stem cell-like colonies using valproic Acid and small-molecule cocktails.","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pubmed\\/24305370","desc":"Grace A, McMillan M, Schmoelzl S, Hinch G.","details":"&lt;span class=&quot;jrnl&quot; title=&quot;Reproduction, fertility, and development&quot;&gt;Reprod Fertil Dev&lt;\\/span&gt;. 2013 Dec;26(1):208. doi: 10.1071\\/RDv26n1Ab187.","radio_11b2":"least_relevant"},{"title":"Molecular dynamics simulation of complex Histones Deacetylase (&lt;b&gt;HDAC&lt;\\/b&gt;) Class II &lt;em&gt;Homo Sapiens&lt;\\/em&gt; with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3732443\\/","desc":"Usman Sumo Friend Tambunan, Ridla Bakri, Tirtana Prasetia, Arli Aditya Parikesit, Djati Kerami","details":"","radio_11b2":"somewhat_relevant"},{"title":"Nuclear Smad7 Overexpressed in Mesenchymal Cells Acts as a Transcriptional Corepressor by Interacting with &lt;b&gt;HDAC&lt;\\/b&gt;-1 and E2F to Regulate Cell Cycle","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3507285\\/","desc":"Takashi Emori, Koki Kitamura, Kenji Okazaki","details":"","radio_11b2":"somewhat_relevant"},{"title":"Imbalance between HAT and &lt;b&gt;HDAC&lt;\\/b&gt; Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of &lt;b&gt;HDAC&lt;\\/b&gt; Inhibitors on TNF Alpha Production","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3748901\\/","desc":"Eric Toussirot, Wasim Abbas, Kashif Aziz Khan, Marion Tissot, Alicia Jeudy, Lucile Baud, Ewa Bertolini, Daniel Wendling, Georges Herbein","details":"PLoS One. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;8(8): e70939.  &lt;span class=&quot;&quot;&gt;Published online 2013 August 15. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1371\\/journal.pone.0070939&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of &lt;b&gt;HDAC&lt;\\/b&gt; and Aurora inhibitors in BCR-ABL-expressing cells","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/pmc\\/articles\\/PMC3635933\\/","desc":"Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Shinya Kimura, Taira Maekawa, Kazuma Ohyashiki","details":"Cancer Cell Int. &lt;span class=&quot;citation-publication-date&quot;&gt;2013; &lt;\\/span&gt;13: 32.  &lt;span class=&quot;&quot;&gt;Published online 2013 April 4. &lt;\\/span&gt;&lt;span class=&quot;doi&quot;&gt;doi:&Acirc;&nbsp;10.1186\\/1475-2867-13-32&lt;\\/span&gt;","radio_11b2":"least_relevant"},{"title":"Dermatology and the cancer patient : conditions of the skin, hair, and nails during cancer treatment and survivors","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101605168","desc":"Lacouture, Mario E.","details":"&lt;span class=&quot;src&quot;&gt;Hoboken, N.J. : Wiley-Blackwell, c2013.&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"},{"title":"Natural products and cancer drug discovery","link":"http:\\/\\/www.ncbi.nlm.nih.gov\\/\\/nlmcatalog\\/101605094","desc":"Koehn, Frank E.","details":"&lt;span class=&quot;src&quot;&gt;New York : Humana Press, c2013.&lt;br&gt;&lt;\\/span&gt;","radio_11b2":"duplicate"}]', 'test test test test test', 'test test test test test', 'test test test test test', '', '{"1":{"title":"Swedish researchers hope HDAC inhibitors can wipe out blood clots","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/swedish-hope-hdac-inhibitors-can-wipe-out-blood-clots\\/2011-11-23","desc":" cash for next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong> Florida Keys home to potential colon <strong>cancer<\\/strong> fighter Bracing for FDA ...","radio_15":"likely"},"2":{"title":"Acetylon grabs $27M in venture cash for next-gen HDAC inhibitor","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-grabs-27m-venture-cash-next-gen-hdac-inhibitor\\/2011-06-29","desc":" Pharmaceuticals has gone back to its investors for $27 million to fund continued work on a next-gen <strong>HDAC<\\/strong> <strong>inhibitor<\\/strong>. But don''t look for a crew of big-name venture groups in its release. Most of the money came ...","radio_15":"somewhat_likely"},"3":{"title":"Enzyme inhibitor spurs breakthrough on pancreatic cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/enzyme-inhibitor-spurs-breakthrough-pancreatic-cancer\\/2009-09-25","desc":" was useless in stopping <strong>pancreatic<\\/strong> <strong>cancer<\\/strong>, but the researchers said that in combination with the TAK-1 ...","radio_15":"least_likely"},"4":{"title":"Cambridge startup launches HDAC platform with Series A","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/cambridge-startup-launches-hdac-platform-series\\/2009-08-07","desc":" as it moves toward an IND. They''ll be engaged in development programs aimed at inhibiting the <strong>HDAC<\\/strong> ...","radio_15":"least_likely"},"5":{"title":"Press Release: Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275","link":"http:\\/\\/www.fiercebiotech.com\\/node\\/6460","desc":" that the ability of <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> to biochemically restore drug targets is a powerful strategy to improve ...","radio_15":"somewhat_likely"},"6":{"title":"UPDATED: Incyte shares soar on positive pancreatic cancer trial data for Jakafi","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/incyte-shares-surge-positive-pancreatic-cancer-trial-data-jakafi\\/2013-08-21","desc":" group of patients with refractory metastatic <strong>pancreatic<\\/strong> <strong>cancer<\\/strong> who can be identified without ...","radio_15":"somewhat_likely"},"7":{"title":"4SC spotlights partnership talks after liver cancer combo extends survival ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/4sc-spotlights-partnership-talks-after-liver-cancer-combo-extends-survival\\/2012-09-13","desc":" researchers hope <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> can wipe out blood clots Germany''s 4SC misses mark in key RA drug trial, ...","radio_15":"least_likely"},"8":{"title":"Kancera credits new drug with slowing pancreatic cancer tumor growth","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/kancera-credits-new-drug-slowing-pancratic-cancer-tumor-growth\\/2012-11-09","desc":" that the drug generated a 20% reduction in <strong>pancreatic<\\/strong> <strong>cancer<\\/strong> tumor growth versus placebo treatment. That may ...","radio_15":"least_likely"},"9":{"title":"Acetylon raises $12.4M in new venture round ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/acetylon-raises-124m-new-venture-round\\/2011-02-23","desc":" million round to back its work developing <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> for inflammatory and neurological diseases as well as <strong>cancer<\\/strong>. Its technology builds on the work of four top scientists at Dana-Farber <strong>Cancer<\\/strong> ...","radio_15":"somewhat_likely"},"10":{"title":"Acetylon''s HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/acetylons-hdac-drug-fights-sickle-cell-disease-beta-thalassemia-blood-cell\\/2012-12-18","desc":" working on <strong>HDAC<\\/strong> <strong>inhibitors<\\/strong> include MEI Pharma ($MEIP) and 4SC, and gene therapy can flip the switch ...","radio_15":"likely"}}', 'hdac inhibitor pancreatic cancer', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(210, '2013-12-09 11:16:09', 13, 'test Q15 with science', 'patent', '', '', 'gansh2', 'gansh13', 'gansh13_2', '', '', 'test', 'c', '', 'test', '', '', '', 'a', '', 'Jane Doe', '', '', '', '', '', 'field', '102', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '>1m', 'No', '', 0, '', 'Not Sure', 20, '', '', '', '', '', '', '', '', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(211, '2013-12-11 15:42:14', 39, 'HDAC inhibitor for alzheimers', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'treatment of alzheimers patients', 'a', '', 'treatment of alzheimers patients', '', '', '', 'b', '', 'John Smith', 'DST', '15', '3 million 8/12-7/15', '', '', 'field', '120', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'treatment of alzheimers patients', '{"1":{"radio_11a1":"No","title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"radio_11a1":"No","title":"Bhasma nanoparticles","id":"87","status":"field"}}', '{"1":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"2":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"Disclosure Done & Under Review"},"3":{"title":"Bhasma nanoparticles","id":"87","status":"Disclosure Done & Under Review"}}', 27, '', '>1m', 'Dont know', '', 0, '', 'Maybe', 10, '[{"title":"Prevention and treatment of alzheimer''s disease","link":"http:\\/\\/www.google.com\\/patents\\/WO1995006470A1?cl=en&dq=treatment+of+alzheimers+patients&source=uds;","filedate":"Tue, 05 Jul 1994 00:00:00 -0700","applicant":"Merck & Co Inc, Edward M Scolnick","desc":"The method for preventing, treating, or ameliorating the <b>symptoms of Alzheimer''s<\\/b>  <b>disease<\\/b> in a human patient of Claim 1 comprising administration to the patient\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Metal chelators for use in the treatment of alzheimer''s disease","link":"http:\\/\\/www.google.com\\/patents\\/WO1999045907A2?cl=en&dq=treatment+of+alzheimers+patients&source=uds;","filedate":"Thu, 11 Mar 1999 00:00:00 -0800","applicant":"Gen Hospital Corp","desc":"The invention relates to the identification of pharmacological agents to be used in  the <b>treatment of Alzheimer''s disease<\\/b> and related pathological conditions and\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Radiation therapy for treating alzheimer''s disease","link":"http:\\/\\/www.google.com\\/patents\\/EP2613849A1?cl=en&dq=treatment+of+alzheimers+patients&source=uds;","filedate":"Fri, 09 Sep 2011 00:00:00 -0700","applicant":"Alvaro Martinez, Brian Marples, George Wilson, James Fontanesi","desc":"A method <b>treating dementia<\\/b> of the <b>Alzheimer''s<\\/b> type in a <b>patient<\\/b> by administering  ionizing radiation to the brain of the <b>patient<\\/b>.","radio_11b":"least_relevant"},{"title":"Treatment for Alzheimer''s disease","link":"http:\\/\\/www.google.com\\/patents\\/EP2075007B9?cl=en&dq=treatment+of+alzheimers+patients&source=uds;","filedate":"Mon, 03 May 2004 00:00:00 -0700","applicant":"Aracl\\u00f3n Biotech, S. L.","desc":"Treatment for Alzheimer''s <b>disease<\\/b>. EP 2075007 B9. Claims(8). Use of a peptide  conjugated to a protein, that acts as an immunogen for the\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Diagnosis and treatment of alzheimer''s disease","link":"http:\\/\\/www.google.com\\/patents\\/EP1325338A2?cl=en&dq=treatment+of+alzheimers+patients&source=uds;","filedate":"Tue, 03 Apr 2001 00:00:00 -0700","applicant":"Oxford GlycoSciences (UK) Limited, Pfizer Inc.","desc":"The present invention provides methods and compositions for screening,  diagnosis and prognosis of Alzheimer''s <b>disease<\\/b>, for monitoring the effectiveness  of\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"Alzheimer''s disease-specific alterations of protein kinase c epsilon (pkc ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2539709A1?cl=en&dq=treatment+of+alzheimers+patients&source=uds;","filedate":"Tue, 22 Feb 2011 00:00:00 -0800","applicant":"Blanchette Rockefeller Neurosciences Institute","desc":"The present invention relates to methods of diagnosing Alzheimer''s <b>Disease<\\/b> in a  human patient by detecting alterations in the ratio of PKC\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"},{"title":"4-phenylbutyric acid for the treatment of alzheimer''s disease","link":"http:\\/\\/www.google.com\\/patents\\/EP2599479A1?cl=en&dq=treatment+of+alzheimers+patients&source=uds;","filedate":"Wed, 30 Nov 2011 00:00:00 -0800","applicant":"Lunamed AG","desc":"The present invention relates to the therapeutic use of 4-phenylbutyric acid (4-PB ) in the <b>treatment of Alzheimer''s disease<\\/b>. Particularly, the\\u00a0<b>...<\\/b>","radio_11b":"least_relevant"}]', '', 'better in sensitivity and accuracy', 'happier and blah blah blah blah', 'test', '', '[{"title":"New studies raise hopes for Pfizer, J&J Alzheimer''s treatment","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/new-studies-raise-hopes-pfizer-jj-alzheimers-treatment\\/2011-07-20","desc":" New studies are raising hopes that bapineuzumab, an experimental <strong>Alzheimer<\\/strong>''s drug, may ...","radio_15":"least_likely"},{"title":"UPDATED: Elan chases a holy grail of Alzheimer''s treatment: Prevention ","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/elan-chases-holy-grail-alzheimers-treatment-prevention\\/2012-04-19","desc":" <strong>treatment<\\/strong> for the memory-stealing disease and other illnesses involving misfolding proteins in the brain.\\u00a0 ...","radio_15":"least_likely"},{"title":"Mouse study triggers demands for a possible Alzheimer''s treatment","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/mouse-study-triggers-demands-possible-alzheimers-treatment\\/2012-02-10","desc":" as Targretin--lowered levels of beta amyloid, a long-suspected culprit behind <strong>Alzheimer<\\/strong>''s, and improved ...","radio_15":"least_likely"},{"title":"Investigators push for switch in Alzheimer''s patient profiles; Ironwood preps PhIII linaclotide study in China;","link":"http:\\/\\/www.fiercebiotech.com\\/story\\/investigators-push-switch-alzheimers-patient-profiles-ironwood-preps-phiii\\/2012-07-18","desc":" from late-stage cases to an early-stage group. Laurie Ryan, director of the <strong>Alzheimer<\\/strong>''s Disease ...","radio_15":"least_likely"},{"title":"NICE opens up early Alzheimer''s treatment","link":"http:\\/\\/www.fiercepharma.com\\/story\\/nice-opens-early-alzheimers-treatment\\/2010-10-07","desc":" prescribe the drugs for <strong>patients<\\/strong> with milder forms of the disease. <strong>Alzheimer<\\/strong>''s Society expert Clive ...","radio_15":"least_likely"},{"title":"Novartis sees first patient death following Gilenya treatment; Baxter to buy Synovis Life Technologies;","link":"http:\\/\\/www.fiercepharma.com\\/story\\/novartis-sees-first-patient-death-following-gilenya-treatment-baxter-buy-sy\\/2011-12-13","desc":" novel solution to fight <strong>Alzheimer<\\/strong>''s disease. Article | Follow @FierceBiotech @JohnCFierce: ...","radio_15":"least_likely"},{"title":"EU signs off on Lilly''s Amyvid, its diagnostic test for Alzheimer''s","link":"http:\\/\\/www.fiercepharma.com\\/story\\/eu-signs-lillys-amyvid-its-diagnostic-test-alzheimers\\/2013-01-16","desc":" of the <strong>treatment<\\/strong> this summer came up short on measures of cognitive and functional status in <strong>patients<\\/strong> with mild-to-moderate <strong>Alzheimer<\\/strong>''s disease. Data from <strong>patients<\\/strong> with mild disease, however, showed a 34% reduction ...","radio_15":"least_likely"},{"title":"Health officials call for adult vaccine campaign; Could tomatos hold Alzheimer''s vaccine key?;","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/health-officials-call-high-profile-adult-vaccine-campaign-could-tomato-hold-key-alzheimers-vac","desc":" pandemic versions. Report Among <strong>patients<\\/strong> with castration-resistant prostate cancer, the addition of hormone therapy following vaccine <strong>treatment<\\/strong> improved overall survival compared with either <strong>treatment<\\/strong> alone or when the vaccine followed hormone <strong>treatment<\\/strong>, according to recent data published in the July 15 Clinical Cancer ...","radio_15":"least_likely"},{"title":"Novartis, Cytos Alzheimer''s vax shows immune response","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/novartis-cytos-alzheimers-vax-shows-immune-response\\/2012-06-14","desc":" in a clinical trial in people with <strong>Alzheimer<\\/strong>''s disease. This vaccine could have potential to slow ...","radio_15":"least_likely"},{"title":"CA whooping cough outbreak continues; Researcher explore plaque-preventing Alzheimer''s vaccine;","link":"http:\\/\\/www.fiercevaccines.com\\/story\\/ca-whooping-cough-outbreak-continues-researcher-explore-plaque-preventing-alzheimers-vaccine\\/2","desc":" Therapeutics\\u00a0says it''s\\u00a0developed an new way\\u00a0to manufacture the dendritic cell-based vaccine for the <strong>treatment<\\/strong> ...","radio_15":"least_likely"}]', 'treatment of alzheimers patients', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(212, '2013-12-11 15:56:56', 39, 'CDx without drug on market', 'patent', '', '', 'gansh1', 'gansh11', 'gansh11_1', '', '', 'CDx for kras mutant colon cancer therapy', 'a', '', 'CDx for kras mutant colon cancer therapy', '', '', '', 'b', '', 'John Smith', 'DST', '15', '3 million 8/12-7/15', '', '', 'field', '65', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'CDx for kras mutant colon cancer therapy', '{"1":{"radio_11a1":"No","title":"Bhasma nanoparticles","id":"87","status":"field"},"2":{"radio_11a1":"No","title":"pancreatic cancer drug","id":"92","status":"field"},"3":{"radio_11a1":"No","title":"Biomarker Dx for cancer","id":"100","status":"field"},"4":{"radio_11a1":"No","title":"pancreatic cancer","id":"108","status":"field"},"5":{"radio_11a1":"No","title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"6":{"radio_11a1":"No","title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"7":{"radio_11a1":"No","title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"8":{"radio_11a1":"No","title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"},"9":{"radio_11a1":"No","title":"Cancer drug","id":"146","status":"field"},"10":{"radio_11a1":"No","title":"KRAS mutant colon cancer therapy","id":"148","status":"field"}}', '{"1":{"title":"CDx without drug on market","id":"58","status":"Disclosure Done & Under Review"},"2":{"title":"Cancer Target screening tools","id":"61","status":"Disclosure Done & Under Review"},"3":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"Disclosure Done & Under Review"},"4":{"title":"Bhasma nanoparticles","id":"87","status":"Disclosure Done & Under Review"},"5":{"title":"pancreatic cancer drug","id":"92","status":"Disclosure Done & Under Review"},"6":{"title":"Biomarker Dx for cancer","id":"100","status":"Disclosure Done & Under Review"},"7":{"title":"pancreatic cancer","id":"108","status":"Disclosure Done & Under Review"},"8":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"Disclosure Done & Under Review"},"9":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"Disclosure Done & Under Review"},"10":{"title":"Mouse model for research use","id":"136","status":"Disclosure Done & Under Review"}}', 20, '', '<100k', 'Not Sure', '', 0, '', 'No', 5, '[{"title":"DNA methylation markers associated with the CpG island methylator phenotyp ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2345743A1?cl=en&dq=CDx+for+kras+mutant+colon+cancer+therapy&source=uds;","filedate":"Tue, 02 May 2006 00:00:00 -0700","applicant":"University of Southern California","desc":"<b>...<\\/b> phenotype (CIMP) in <b>colorectal cancer<\\/b>, and provide novel validated <b>...<\\/b> of the  cancers (e.g., BRAF mutation, <b>KRAS mutation<\\/b> and MSI status); <b>...<\\/b> 115 and 101,  wherein the <b>treatment<\\/b> is suitable to convert at least <b>......<\\/b> <b>CDX<\\/b> 1, <b>CDX<\\/b> 1-M1B, HB- 19 5, Caudal type homeo box transcripti on factor 1, N, N, 5q31-q33.","radio_11b":"somewhat_relevant"},{"title":"DNA methylation markers associated with the CpG island methylator phenotype ...","link":"http:\\/\\/www.google.com\\/patents\\/EP2395101A1?cl=en&dq=CDx+for+kras+mutant+colon+cancer+therapy&source=uds;","filedate":"Tue, 02 May 2006 00:00:00 -0700","applicant":"University of Southern California","desc":"<b>...<\\/b> phenotype (CIMP) in <b>colorectal cancer<\\/b>, and provide novel validated <b>...<\\/b> of the  cancers (e.g., BRAF mutation, <b>KRAS mutation<\\/b> and MSI status); <b>...<\\/b> 124, and 110,  wherein the <b>treatment<\\/b> is suitable to convert at least <b>......<\\/b> <b>CDX<\\/b> 1, <b>CDX<\\/b> 1-M1B, HB  195, Caudal type homeobox transcription factor 1, N, N, 5q31-q33.","radio_11b":"somewhat_relevant"},{"title":"Molecular profiling for cancer","link":"http:\\/\\/www.google.com\\/patents\\/WO2012092336A2?cl=en&dq=CDx+for+kras+mutant+colon+cancer+therapy&source=uds;","filedate":"Wed, 28 Dec 2011 00:00:00 -0800","applicant":"Caris Mpi, Inc.","desc":"A method of identifying a candidate <b>treatment<\\/b> for an ovarian cancer in a subject <b>...<\\/b>  overexpress, underexpress, and\\/ or have <b>mutations<\\/b> in one or more members of  <b>....<\\/b> chronic myeloproliferative disorders; <b>colon cancer<\\/b>; <b>colorectal cancer<\\/b>; <b>.....<\\/b> on 1,  2, 3, 4, 5 or 6 of: BRAF, c- kit, EGFR, <b>KRAS<\\/b>, RAS, and PIK3CA.","radio_11b":"somewhat_relevant"},{"title":"5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound ...","link":"http:\\/\\/www.google.com\\/patents\\/CN103159742A?cl=en&dq=CDx+for+kras+mutant+colon+cancer+therapy&source=uds;","filedate":"Fri, 16 Dec 2011 00:00:00 -0800","applicant":"\\u5317\\u4eac\\u97e9\\u7f8e\\u836f\\u54c1\\u6709\\u9650\\u516c\\u53f8","desc":"<b>...<\\/b> pharmaceutical composition for the <b>treatment<\\/b>, including the formula (I)  compound <b>...<\\/b> In addition, the study found, NSCLC containing <b>KRAS mutations<\\/b> <b>......<\\/b>  prostate cancer, bladder cancer, <b>colorectal cancer<\\/b>, ovarian cancer, cancer, <b>...<\\/b>  Zaru Humira, pertuzumab, MDX-214, <b>CDX<\\/b>-110, IMC- 11F8, Zemab, Her2\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Antibodies, analogs and uses thereof","link":"http:\\/\\/www.google.com\\/patents\\/WO2010033913A1?cl=en&dq=CDx+for+kras+mutant+colon+cancer+therapy&source=uds;","filedate":"Mon, 21 Sep 2009 00:00:00 -0700","applicant":"Icb International, Inc.","desc":"<b>...<\\/b> prognostics, <b>therapy<\\/b>, and simultaneous diagnosis and <b>therapy<\\/b>. <b>...<\\/b> [0037] In  some embodiments, the biomarkers for <b>Colorectal Cancer<\\/b> may be SMAD4, EGFR , <b>KRAS<\\/b>, <b>......<\\/b> Examples of such alterations include <b>mutations<\\/b>, partial or total <b>......<\\/b>  <b>therapy<\\/b>. PMID: 10850455. <b>CDX<\\/b>-2. \\u2022 A reliable marker of colorectal\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Gene amplifications and deletions","link":"http:\\/\\/www.google.com\\/patents\\/WO2007150071A1?cl=en&dq=CDx+for+kras+mutant+colon+cancer+therapy&source=uds;","filedate":"Mon, 25 Jun 2007 00:00:00 -0700","applicant":"Victor Abkevich, Alexander Gutin, Srikanth Jammulapati, Jerry Lanchbury, Myriad Genetics Inc, Kirsten Timms","desc":"The invention relates to gene amplifications and deletions in <b>cancer<\\/b> and <b>...<\\/b> [0005]  <b>Mutations<\\/b> in certain genes can induce or contribute to oncogenesis. <b>....<\\/b> PTEN, pl6 , c20orfl33, TGF-\\u03b22, ctnnal , ctnnbl , <b>KRAS<\\/b>, BRAF, and pik3ca. <b>......<\\/b> for the  <b>treatment<\\/b> of tumors and <b>cancers<\\/b>, for example, breast <b>cancer<\\/b>, <b>colon<\\/b>\\u00a0<b>...<\\/b>","radio_11b":"somewhat_relevant"},{"title":"Genetic polymorphisms associated with short stature, methods of detection ...","link":"http:\\/\\/www.google.com\\/patents\\/WO2012151305A2?cl=en&dq=CDx+for+kras+mutant+colon+cancer+therapy&source=uds;","filedate":"Wed, 02 May 2012 00:00:00 -0700","applicant":"Celera Corporation, Ipsen Pharma S.A.S.","desc":"Patients with ALS <b>mutations<\\/b> have shown short stature in childhood and <b>......<\\/b> 2003) ; Stephens et al , \\"Antisense oligonucleotide <b>therapy<\\/b> in cancer,\\" Curr <b>......<\\/b>  PRKAR1B (OR=17.64, the largest effect size in the study), <b>KRAS<\\/b> <b>......<\\/b> OMIM  Information: <b>Colorectal cancer<\\/b>, 114500 (3) <b>.....<\\/b> SNP Source: <b>CDX<\\/b>;dbSNP.","radio_11b":"somewhat_relevant"}]', '', 'better in sensitivity and accuracy', 'our inhibitors are more specific (100 fold) and higher affinity', 'test', '', '{"1":{"title":"Therapeutic vaccine targets colon cancer proteins","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/therapeutic-vaccine-targets-colon-cancer-proteins\\/2009-07-27","desc":" are at risk of <strong>colon<\\/strong> <strong>cancer<\\/strong>. "},"2":{"title":"ALSO NOTED: New chip technology replaces animal studies;ESCs developed from flawed embryos; Research points to new therapies fo","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/also-noted-new-chip-technology-replaces-animal-studiesescs-developed-from-f\\/2008-01-29","desc":" <strong>therapies<\\/strong> for stroke victims. Report Korea''s RNL Bio will advance its stem cell research at a new hub ..."},"3":{"title":"Florida Keys home to potential colon cancer fighter","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/florida-keys-home-potential-colon-cancer-fighter\\/2010-10-05","desc":" Related Article: Blueberry pigment linked to lower rate of <strong>colon<\\/strong> <strong>cancer<\\/strong>  ..."},"4":{"title":"New class of Merck drugs targets therapy-resistant cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/new-class-merck-drugs-targets-therapy-resistant-cancer\\/2013-04-08","desc":" options for patients with certain <strong>cancers<\\/strong> driven by genetic mutations. When mutations happen in critical genes such as BRAF or <strong>KRAS<\\/strong>\\/NRAS, they alter the normal processes of cell proliferation, differentiation and death and can cause patients to become resistant to <strong>therapies<\\/strong> that target BRAF directly. The research ..."},"5":{"title":"Agios compounds could be alternative treatment to chemo for leukemia, brain cancer","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/agios-compounds-could-be-alternative-treatment-chemo-leukemia-brain-cancer\\/2013-04-09","desc":" <strong>cancer<\\/strong>. In a variety of blood and solid tumors, these IDHI and IDH2 genes are altered and produce ..."},"6":{"title":"ALSO NOTED: Human tests near for stem cell bone therapy; Gene therapy targets adult leukemia; Vitamin C controversy brews in ca","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/also-noted-human-tests-near-for-stem-cell-bone-therapy-gene-therapy-targets\\/2008-02-19","desc":" China''s Beike Biotech offers stem cell <strong>therapies<\\/strong> to desperate Americans who can''t get these treatments at home. Article Genetics A group of scientists at UCSD believes that a gene <strong>therapy<\\/strong> could be used ..."},"7":{"title":"Mutant proteins could treat blocked arteries","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/mutant-proteins-could-treat-blocked-arteries\\/2008-03-25","desc":" that offer the kind of stability needed for a new <strong>therapy<\\/strong>. Blaber says that private outfits have demonstrated an interest in the commercial development of his work. A <strong>therapy<\\/strong> of this nature would likely be tested first ..."},"8":{"title":"New target that stops metastasis could lead to safer cancer therapies","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/new-target-stops-metastasis-could-lead-safer-cancer-treatments\\/2013-02-01","desc":" cause metastasis and other diseases when errors occur. <strong>Cancer<\\/strong> at its originating site is not typically ..."},"9":{"title":"Researchers test cardiac stem cell therapy; genetic code deciphered for the common cold;","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/researchers-test-cardiac-stem-cell-therapy-genetic-code-deciphered-common-cold-molecular-decoy","desc":" or heart attack. Release <strong>Cancer<\\/strong> Research A team led by Marie Dutreix of the Curie Institute in Paris has ..."},"10":{"title":"Takeda, Hopkins developing new pancreatic cancer drugs","link":"http:\\/\\/www.fiercebiotechresearch.com\\/story\\/takeda-hopkins-developing-new-pancreatic-cancer-drugs\\/2013-10-22","desc":" on their surfaces. The FDA has approved two such antibody-drug conjugates as <strong>cancer<\\/strong> <strong>therapies<\\/strong>. In preclinical ..."}}', 'CDx for kras mutant colon cancer therapy', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(213, '2013-12-13 12:24:11', 13, 'test Q 1 12-13-13', 'patent', '', '', 'gansh2', 'gansh13', 'gansh13_2', '', '', 'test', 'c', '', 'test', '', '', '', 'a', '', 'test', '', '', '', '', '', 'field', '90', 'Yes', '2012-03-06 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'Yes', '1969-12-31 17:00:00', 'fiber optic high pressure transducer', '', '{"2":{"title":"Fiber optic high pressure transducer","id":"188","status":"field"}}', 3, '', '100k-1m', 'Yes', 'No', 5, '', 'Yes', 17, '{"0":{"title":"High sensitivity fiber optic pressure sensor for use in harsh environments","link":"http:\\/\\/www.google.com\\/patents\\/EP1012553B1?cl=en&dq=fiber+optic+high+pressure+transducer&source=uds;","desc":"A <b>pressure sensor<\\/b> capable of measuring pressure in a harsh environment  includes at least one intrinsic <b>fiber optic<\\/b> sensor element formed\\u00a0<b>...<\\/b>","filedate":"Tue, 01 Sep 1998 00:00:00 -0700","applicant":"Weatherford\\/Lamb, Inc.","radio_11b":"relevant"},"2":{"title":"Fiber optic combustion pressure sensors for engine knock and misfire detection","link":"http:\\/\\/www.google.com\\/patents\\/WO1997031251A1?cl=en&dq=fiber+optic+high+pressure+transducer&source=uds;","desc":"Spark plug (20) integrated <b>fiber optic<\\/b> combustion <b>pressure sensors<\\/b> (30, 36) are <b>...<\\/b>  The unified part formed from an optical fiber in-line connector and a <b>high<\\/b>\\u00a0<b>...<\\/b>","filedate":"Wed, 03 Apr 1996 00:00:00 -0800","applicant":"Optrand Inc, F L T Iskra S A, Marek T Wlodarczyk, Jerzy Adam Kabala, Andrzej Mendak","radio_11b":"relevant"},"4":{"title":"High pressure fiber optic sensor system","link":"http:\\/\\/www.google.com\\/patents\\/US8590385?dq=fiber+optic+high+pressure+transducer&source=uds;","desc":"The present application provides a <b>fiber optic sensor<\\/b> system. The <b>fiber optic<\\/b>  <b>sensor<\\/b> system may include a small diameter bellows, a large\\u00a0<b>...<\\/b>","filedate":"Mon, 12 Dec 2011 00:00:00 -0800","applicant":"General Electric Company","radio_11b":"relevant"},"5":{"title":"Fiber optic pressure transducers and pressure sensing system incorporating same","link":"http:\\/\\/www.google.com\\/patents\\/WO1999002953A1?cl=en&dq=fiber+optic+high+pressure+transducer&source=uds;","desc":"A <b>fiber optic pressure transducer<\\/b> having enhanced resolution and <b>...<\\/b> Dabkiewicz  in an article entitled \\"<b>High<\\/b> Pressure <b>Fiber Optic<\\/b> Sensor with\\u00a0<b>...<\\/b>","filedate":"Thu, 02 Jul 1998 00:00:00 -0700","applicant":"Petroleum Res & Dev Nv, Schlumberger Ca Ltd, Schlumberger Holdings, Schlumberger Ltd, Schlumberger Overseas, Schlumberger Services Petrol, Schlumberger Surenco Sa, Schlumberger Technology Bv","radio_11b":"somewhat_relevant"},"7":{"title":"Temperature compensated fiber-optic pressure sensor","link":"http:\\/\\/www.google.com\\/patents\\/WO2001004592A2?cl=en&dq=fiber+optic+high+pressure+transducer&source=uds;","desc":"Compensation techniques for <b>high<\\/b> temperature <b>fiber<\\/b>-<b>optic pressure sensors<\\/b> are  aimed at correcting for the sensor sensitivity and offset\\u00a0<b>...<\\/b>","filedate":"Fri, 07 Jul 2000 00:00:00 -0700","applicant":"Poorman Thomas J, Wlodarczyk Marek T","radio_11b":"least_relevant"}}', '', 'test test test test test', 'test test test test test', 'test test test test test', '', '', 'test', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(214, '2013-12-16 05:54:27', 39, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(215, '2013-12-16 13:02:04', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(216, '2013-12-16 13:05:42', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(217, '2013-12-16 13:06:31', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(218, '2013-12-16 13:06:47', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(219, '2013-12-16 13:07:01', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(220, '2013-12-16 13:07:39', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(221, '2013-12-16 13:10:39', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(222, '2013-12-16 13:59:10', 44, 'test', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'test', 'a', '', 'test', '', '', '', 'b', '', 'test', 'test', 'test', 'test', '', '', 'field', '170', 'Yes', '2013-12-10 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-16 00:00:00', '', 'Yes', '2013-12-10 00:00:00', '', '', '0000-00-00 00:00:00', 'nanotech', '', '', 0, '', '', '', '', 0, '', '', 0, '', '[{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""}]', '', '', '', '', '', '', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(223, '2013-12-16 14:46:41', 46, 'Bhasma nanoparticles', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_2', '', '', 'immunology and cancer', 'a', '', 'ff', '', '', '', 'b', '', 'John Smith', 'NIH', '213', '3 million 8/12-7/15', '', '', 'field', '112', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'ayurvedic bhasma nanoparticles cancer therapy', '', '', 9, '', '<100k', 'Not Sure', '', 0, '', 'Not Sure', 15, '', '', 'more sensitive than any of the other methods (100 fold)', 'novel contrast agent chemistry - this ligand has not been identified before', 'novel vector for stability and no loss of copy number', '', '', 'hemocoagulase', '', '', '', '', '', 100);
INSERT INTO `inventions` VALUES(224, '2013-12-16 14:49:56', 46, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(225, '2013-12-16 14:50:34', 46, 'rr', 'patent', '', '', 'gansh1', 'gansh9', '', '', '', 'ttt', 'a', '', 'tttt', '', '', '', 'a', '', 'tt', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 51);
INSERT INTO `inventions` VALUES(226, '2013-12-16 17:03:35', 51, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(227, '2013-12-16 17:06:05', 51, 'HDAC inhibitors', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_1', '', '', 'cancer medicine', 'a', '', 'help to heal cancer', '', '', '', 'a', '', 'Karthik Avishkar', 'Test', '', '', '', '', 'field', '85', 'Yes', '2013-12-12 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'HDAC active inhibitors ', '', '{"2":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"3":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"4":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"5":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"6":{"title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"7":{"title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"},"8":{"title":"test nov 22","id":"170","status":"field"},"9":{"title":"testing 12-3","id":"194","status":"field"},"10":{"title":"HDAC inhibitor for alzheimers","id":"211","status":"field"}}', 0, '', '', '', '', 0, '', '', 0, '', '[{"radio_11b2":"relevant","desc":"","title":"","details":""},{"radio_11b2":"relevant","desc":"","title":"","details":""},{"radio_11b2":"relevant","desc":"","title":"","details":""},{"radio_11b2":"relevant","desc":"","title":"","details":""},{"radio_11b2":"somewhat_relevant","desc":"","title":"","details":""}]', '', '', '', '', '', '', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(228, '2013-12-16 17:50:33', 52, 'hdac inhibitors', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'hdac inhibitors', 'a', '', 'hdac inhibitors', '', '', '', 'a', '', 'Ramesh Pateel', 'aaa', 'aaa', 'aaa', '', '', 'field', '120', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'hdac inhibitors', '', '{"2":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"3":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"},"4":{"title":"Nov 6 hdac inhibitor for colon cancer","id":"131","status":"field"},"5":{"title":"HDAC Inhibitor for colon cancer","id":"139","status":"field"},"6":{"title":"HDAC inhibitor for pancreatic cancer","id":"140","status":"field"},"7":{"title":"test nov 22","id":"170","status":"field"},"8":{"title":"testing 12-3","id":"194","status":"field"},"9":{"title":"HDAC inhibitor for alzheimers","id":"211","status":"field"},"10":{"title":"HDAC inhibitors","id":"227","status":"field"}}', 15, '', '', '', '', 0, '', '', 0, '', '[{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"},{"title":"","link":"","desc":"","details":"","radio_11b2":"least_relevant"}]', 'test', 'test', 'test', '', '', '', '', '', '', '', '', 79);
INSERT INTO `inventions` VALUES(229, '2013-12-16 18:05:26', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(230, '2013-12-16 18:06:05', 1, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(231, '2013-12-16 18:07:27', 17, 'Test', 'patent', '', '', 'gansh2', 'gansh12', 'gansh12_2', '', '', 'weapons explosion', 'c', '', 'test', '', '', '', 'a', '', 'test', '', '', '', '', '', 'field', '95', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'fiber optic ', '', '{"2":{"title":"Fiber optic high pressure transducer","id":"188","status":"field"}}', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 65);
INSERT INTO `inventions` VALUES(232, '2013-12-16 18:45:06', 52, 'hdac inhibitors', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_1', '', '', 'hdac inhibitors', 'b', '', 'HDAC inhibitors for pancreatic cancer', '', '', '', 'a', '', 'Ramesh Pateel', 'aaa', 'aaa', 'aaa', '', '', 'field', '82', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'HDAC inhibitors for pancreatic cancer', '{"1":{"title":"hdac inhibitors","id":"228","status":"field"}}', '{"2":{"title":"CDx without drug on market","id":"58","status":"field"},"3":{"title":"Cancer Target screening tools","id":"61","status":"field"},"4":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"5":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"6":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"7":{"title":"pancreatic cancer drug","id":"92","status":"field"},"8":{"title":"pancreatic diseases","id":"94","status":"field"},"9":{"title":"Biomarker Dx for cancer","id":"100","status":"field"},"10":{"title":"pancreatic cancer","id":"108","status":"field"},"11":{"title":"HDAC inhibitors for pancreatic cancer","id":"112","status":"field"}}', 15, '', '', '', '', 0, '', '', 0, '', '', 'test', 'test', 'test', '', '', '', '', '', '', '', '', 79);
INSERT INTO `inventions` VALUES(233, '2013-12-16 21:11:45', 44, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 16);
INSERT INTO `inventions` VALUES(234, '2013-12-16 21:15:50', 53, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(235, '2013-12-16 21:19:49', 53, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(236, '2013-12-16 21:39:43', 54, 'HDAC inhibitor for alzheimers', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_1', '', '', 'treatment of alzheimers patients', 'a', '', 'treatment of alzheimers patients', '', '', '', 'a', '', 'John Smith', 'DST', '11', '3 million 8/12-7/15', '', '', 'field', '65', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'treatment of alzheimers patients', '{"1":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"2":{"title":"Bhasma nanoparticles","id":"87","status":"field"}}', '{"2":{"title":"Kras mutant pancreatic cancer drug","id":"62","status":"field"},"3":{"title":"HDAC inhibitor for alzheimers","id":"85","status":"field"},"4":{"title":"Bhasma nanoparticles","id":"87","status":"field"},"5":{"title":"HDAC inhibitor for alzheimers","id":"211","status":"field"}}', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(237, '2013-12-16 23:36:45', 44, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(238, '2013-12-17 00:41:12', 55, 'Bhasma nanoparticles', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_2', '', '', 'immunology and cancer', 'g', '', 'ddd', '', '', '', 'a', '', 'ttt', '', '', '', '', '', 'field', '140', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'hemocoagulase', '', '', 24, '', '', '', '', 0, '', '', 0, '', '[{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""}]', 'more sensitive than any of the other methods (100 fold)', 'novel contrast agent chemistry - this ligand has not been identified before', 'can pick out even transformed cells that are pre-cancerous.', '', '', '', '', '', '', '', '', 79);
INSERT INTO `inventions` VALUES(239, '2013-12-17 01:50:18', 55, 'Bhasma nanoparticles', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'Hemocoagulase enzyme with applications in wound healing, hemophilia, plastic surgery etc', 'b', '', 'ffff', '', '', '', 'a', '', 'John Smith', 'NIH', '', '', '', '', 'field', '155', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'java', '', '', 24, '', '', '', '', 0, '', '', 0, '', '[{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""}]', '', '', '', '', '', '', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(240, '2013-12-17 01:59:17', 55, 'Bhasma nanoparticles', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_2', '', '', 'immunology and cancer', 'a', '', 'hh', '', '', '', 'a', '', 'John Smith', '', '', '', '', '', 'field', '72', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'java', '', '', 24, '', '', '', '', 0, '', '', 0, '', '[{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"somewhat_relevant","desc":"","title":"","details":""}]', 'more sensitive than any of the other methods (100 fold)', 'novel contrast agent chemistry - this ligand has not been identified before', 'can pick out even transformed cells that are pre-cancerous.', '', '', '', '', '', '', '', '', 79);
INSERT INTO `inventions` VALUES(241, '2013-12-17 02:42:46', 55, 'CDx without drug on market', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'CDx for kras mutant colon cancer therapy', 'b', '', 'ddd', '', '', '', 'a', '', 'Michael Scott', 'NIH', '', '', '', '', 'field', '157', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'companion diagnostic for kras mutant colon cancer therapy', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 72);
INSERT INTO `inventions` VALUES(242, '2013-12-17 03:03:13', 55, 'ttitle', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_2', '', '', 'dddd', 'a', '', 'ddd', '', '', '', 'a', '', 'dddd', 'ee', '', '', '', '', 'field', '102', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'biotech', '', '', 15, '', '', '', '', 0, '', '', 0, '', '[{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""},{"radio_11b2":"least_relevant","desc":"","title":"","details":""}]', 'ss', 'ee', 'dd', '', '', '', '', '', '', '', '', 79);
INSERT INTO `inventions` VALUES(243, '2013-12-17 03:14:08', 55, 'ttitle', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'dddd', 'a', '', 'rrrr', '', '', '', 'a', '', 'dddd', '', '', '', '', '', 'field', '155', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'biotech', '', '', 21, '', '>1m', '', '', 0, '', '', 10, '{"1":{"radio_11b":"least_relevant"},"2":{"radio_11b":"least_relevant"},"3":{"radio_11b":"least_relevant"},"4":{"radio_11b":"least_relevant"},"5":{"radio_11b":"least_relevant"},"6":{"radio_11b":"least_relevant"},"7":{"radio_11b":"least_relevant"}}', '', 'ss', 'ee', 'dd', '', '', 'Biotech', '', '', '', '', '', 93);
INSERT INTO `inventions` VALUES(244, '2013-12-17 05:18:32', 55, 'ttitle', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_2', '', '', 'dddd', 'b', '', 'ddd', '', '', '', 'a', '', 'dddd', '', '', '', '', '', 'field', '110', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'nanotec', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 65);
INSERT INTO `inventions` VALUES(245, '2013-12-17 05:27:33', 55, 'ttitle', 'patent', '', '', 'gansh1', 'gansh9', 'gansh9_1', '', '', 'dddd', 'd', '', 'ddd', '', '', '', 'a', '', 'dddd', '', '', '', '', '', 'field', '170', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', 'biotech', '', '', 33, '', '', '', '', 0, '', '', 0, '{"1":{"radio_11b":"least_relevant"},"2":{"radio_11b":"least_relevant"},"3":{"radio_11b":"least_relevant"},"4":{"radio_11b":"least_relevant"},"5":{"radio_11b":"least_relevant"},"6":{"radio_11b":"least_relevant"},"7":{"radio_11b":"least_relevant"},"8":{"radio_11b":"least_relevant"},"9":{"radio_11b":"least_relevant"},"10":{"radio_11b":"least_relevant"},"11":{"radio_11b":"least_relevant"}}', '', 'ss', 'ee', 'dd', '', '', 'biotech', '', '', '', '', '', 86);
INSERT INTO `inventions` VALUES(246, '2013-12-17 07:04:17', 17, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', 'No', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', '', 'No', '0000-00-00 00:00:00', 'fiber optic', '', '{"2":{"title":"Fiber optic high pressure transducer","id":"188","status":"field"}}', 0, '', '>1m', 'Yes', 'No', 4, '', 'Yes', 18, '', '', 't', 't', 't', '', '', 'test', '', '', '', '', '', 58);
INSERT INTO `inventions` VALUES(247, '2013-12-17 17:04:45', 56, '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'process', '', '', '0000-00-00 00:00:00', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '0000-00-00 00:00:00', '', '', '', 0, '', '', '', '', 0, '', '', 0, '', '', '', '', '', '', '', '', '', '', '', '', '', 0);
INSERT INTO `inventions` VALUES(248, '2013-12-17 17:06:03', 56, 'HDAC inhibitors', 'patent', '', '', 'gansh1', 'gansh10', 'gansh10_1', '', '', 'cancer', 'a', '', 'to cure cancer', '', '', '', 'b', '', 'Uma', '', '', '', '', '', 'field', '85', 'Yes', '2013-12-04 00:00:00', '', '0000-00-00 00:00:00', '', 'Yes', '2013-12-18 00:00:00', '', 'Yes', '2013-12-17 00:00:00', '', '', '0000-00-00 00:00:00', 'TEST', '', '{"2":{"title":"testing happy head","id":"63","status":"field"},"3":{"title":"Oct 16 hemophilia testing","id":"77","status":"field"},"4":{"title":"Oct 25 Dx testing","id":"104","status":"field"},"5":{"title":"Olefin catalyst for polymerization","id":"105","status":"field"},"6":{"title":"laser excitation fluorescence","id":"107","status":"field"},"7":{"title":"test 10-29-13 ","id":"109","status":"field"},"8":{"title":"test","id":"117","status":"process"},"9":{"title":"aavishkar","id":"132","status":"field"},"10":{"title":"Better plastics","id":"141","status":"field"},"11":{"title":"test14nov","id":"149","status":"field"}}', -2, '', '', '', '', 0, '', '', 0, '{"1":{"radio_11b":"relevant"},"2":{"radio_11b":"relevant"},"3":{"radio_11b":"relevant"},"4":{"radio_11b":"relevant"},"5":{"radio_11b":"relevant"},"6":{"radio_11b":"relevant"},"7":{"radio_11b":"relevant"},"8":{"radio_11b":"relevant"},"9":{"radio_11b":"relevant"},"10":{"radio_11b":"relevant"},"11":{"radio_11b":"relevant"}}', '', 'cures', 'tests', 'fixes problem', '', '', 'TEST', '', '', '', '', '', 86);

-- --------------------------------------------------------

--
-- Table structure for table `invention_inventor`
--

CREATE TABLE `invention_inventor` (
  `id` int(11) NOT NULL auto_increment,
  `invention_id` int(11) NOT NULL,
  `inventor_id` int(11) NOT NULL,
  `institutional` varchar(255) NOT NULL,
  `count_inventor` int(11) NOT NULL,
  `created` datetime NOT NULL,
  PRIMARY KEY  (`id`)
) ENGINE=InnoDB  DEFAULT CHARSET=latin1 AUTO_INCREMENT=1428 ;

--
-- Dumping data for table `invention_inventor`
--

INSERT INTO `invention_inventor` VALUES(484, 92, 1, 'Gansh2', 22, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(661, 124, 1, 'Gansh2', 20, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(716, 117, 1, 'Gansh6', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(738, 108, 1, 'Gansh2', 13, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(740, 131, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(741, 131, 75, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(748, 132, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(757, 133, 1, 'Gansh2', 15, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(758, 133, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(768, 88, 1, 'Gansh2', 21, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(790, 135, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(818, 138, 80, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(819, 137, 80, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(825, 118, 74, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(828, 139, 1, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(830, 61, 2, 'Gansh2', 2, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(837, 141, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(869, 146, 1, 'Gansh2', 18, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(870, 146, 81, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(875, 147, 85, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(892, 63, 2, 'Gansh2', 4, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(915, 134, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(918, 100, 1, 'Gansh2', 9, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(945, 148, 1, 'Gansh2', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(961, 164, 86, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(965, 136, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(978, 158, 79, 'Gansh2', 7, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(979, 160, 79, 'Gansh2', 5, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(988, 142, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1008, 105, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1009, 106, 66, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1010, 106, 2, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1011, 107, 66, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1012, 107, 2, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1013, 109, 2, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1016, 89, 2, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1035, 168, 79, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1037, 165, 1, 'Gansh2', 63, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1038, 166, 1, 'Gansh2', 64, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1050, 169, 79, 'Visiting Scientist', 9, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1086, 149, 1, 'Gansh2', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1095, 170, 79, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1104, 150, 6, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1109, 140, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1112, 187, 1, 'Gansh1', 36, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1113, 185, 97, 'Gansh2', 1, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1180, 172, 1, 'Gansh2', 66, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1181, 172, 1, 'Gansh2', 36, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1182, 186, 99, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1190, 191, 1, 'Gansh1', 38, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1201, 44, 2, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1207, 194, 2, 'Gansh2', 9, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1212, 156, 79, 'Gansh2', 6, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1220, 200, 2, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1233, 171, 1, 'Gansh7', 65, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1242, 162, 1, 'Gansh2', 61, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1246, 190, 1, 'Gansh1', 37, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1260, 208, 2, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1261, 208, 5, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1273, 104, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1279, 209, 79, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1280, 103, 1, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1282, 58, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1288, 189, 1, 'Gansh2', 32, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1292, 210, 2, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1294, 167, 88, 'Gansh7', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1299, 207, 79, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1300, 62, 2, 'Gansh2', 3, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1301, 206, 2, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1302, 152, 1, 'Gansh2', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1312, 211, 145, 'Gansh6', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1314, 212, 145, 'Gansh2', 1, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1317, 188, 129, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1318, 188, 114, 'Gansh5', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1320, 213, 74, 'Gansh2', 1, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1330, 216, 1, 'Gansh1', 33, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1332, 217, 2, 'Gansh2', 13, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1334, 218, 2, 'Gansh1', 14, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1336, 220, 149, 'Gansh1', 15, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1339, 221, 86, 'Gansh1', 1, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1340, 87, 1, 'Gansh2', 20, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1342, 222, 1, 'Gansh1', 34, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1344, 223, 151, 'Gansh1', 15, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1348, 225, 155, 'Gansh1', 15, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1353, 226, 157, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1362, 227, 161, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1368, 228, 158, 'Gansh6', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1372, 229, 1, 'Gansh2', 35, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1375, 230, 1, 'Gansh2', 36, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1378, 112, 1, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1381, 232, 158, 'Gansh6', 2, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1382, 233, 1, 'Gansh1', 37, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1391, 236, 162, 'Gansh6', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1393, 238, 163, 'Gansh1', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1395, 239, 163, 'Gansh1', 1, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1400, 240, 163, 'Gansh2', 2, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1402, 241, 163, 'Gansh1', 3, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1404, 242, 163, 'Gansh1', 4, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1406, 243, 163, 'Gansh1', 5, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1408, 244, 163, 'Gansh1', 6, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1410, 245, 163, 'Gansh1', 7, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1411, 231, 79, 'Gansh2', 13, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1413, 246, 79, 'Gansh2', 14, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1414, 94, 1, 'Gansh2', 24, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1419, 85, 1, 'Gansh2', 18, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1420, 77, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1425, 247, 64, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor` VALUES(1427, 248, 164, 'Gansh2', 0, '0000-00-00 00:00:00');

-- --------------------------------------------------------

--
-- Table structure for table `invention_inventor_bkp_17nov`
--

CREATE TABLE `invention_inventor_bkp_17nov` (
  `id` int(11) NOT NULL auto_increment,
  `invention_id` int(11) NOT NULL,
  `inventor_id` int(11) NOT NULL,
  `institutional` varchar(255) NOT NULL,
  `count_inventor` int(11) NOT NULL,
  `created` datetime NOT NULL,
  PRIMARY KEY  (`id`)
) ENGINE=InnoDB  DEFAULT CHARSET=latin1 AUTO_INCREMENT=1109 ;

--
-- Dumping data for table `invention_inventor_bkp_17nov`
--

INSERT INTO `invention_inventor_bkp_17nov` VALUES(13, 2, 14, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(14, 3, 15, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(28, 5, 16, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(29, 6, 17, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(40, 7, 18, '', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(51, 8, 1, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(80, 9, 39, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(81, 9, 50, 'Gansh5', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(100, 14, 57, 'Gansh5', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(109, 15, 58, 'Gansh1', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(110, 12, 29, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(111, 1, 13, 'Gansh1', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(113, 13, 56, 'Gansh6', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(115, 16, 2, 'Gansh1', 5, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(118, 19, 8, 'Gansh1', 2, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(122, 31, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(125, 11, 2, 'Gansh2', 3, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(127, 34, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(130, 36, 2, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(133, 37, 2, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(134, 18, 60, 'Gansh1', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(136, 38, 2, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(138, 39, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(139, 40, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(143, 41, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(146, 42, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(150, 43, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(154, 45, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(155, 46, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(158, 47, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(164, 51, 63, 'Gansh6', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(170, 52, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(171, 55, 8, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(180, 57, 2, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(212, 66, 1, 'Gansh2', 4, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(219, 67, 1, '', 5, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(220, 69, 1, '', 7, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(239, 70, 1, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(240, 70, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(244, 71, 2, 'Gansh2', 5, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(250, 72, 1, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(251, 72, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(257, 64, 2, 'Gansh2', 5, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(287, 75, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(288, 74, 1, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(289, 74, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(292, 73, 1, 'Gansh1', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(309, 4, 1, 'Gansh1', 4, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(312, 78, 1, 'Gansh2', 13, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(317, 79, 1, 'Gansh2', 14, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(321, 65, 1, 'Gansh1', 4, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(330, 83, 1, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(334, 84, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(350, 86, 1, 'Gansh2', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(363, 91, 1, 'Gansh3', 21, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(368, 93, 1, 'Gansh2', 23, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(382, 95, 1, 'Gansh2', 24, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(387, 96, 1, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(390, 82, 1, 'Gansh2', 15, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(396, 90, 1, 'Gansh2', 21, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(418, 97, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(434, 99, 1, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(479, 80, 2, 'Gansh2', 6, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(480, 80, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(484, 92, 1, 'Gansh2', 22, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(513, 101, 1, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(517, 104, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(520, 98, 1, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(531, 102, 1, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(611, 110, 1, 'Gansh1', 14, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(619, 113, 64, 'Gansh6', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(621, 114, 73, 'Gansh1', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(623, 115, 67, 'Gansh1', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(632, 112, 1, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(635, 116, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(657, 126, 1, 'Gansh7', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(659, 127, 1, 'Gansh3', 20, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(661, 124, 1, 'Gansh2', 20, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(687, 111, 1, 'Gansh2', 15, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(688, 128, 1, 'Gansh1', 21, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(691, 123, 1, 'Gansh2', 18, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(693, 103, 1, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(716, 117, 1, 'Gansh6', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(738, 108, 1, 'Gansh2', 13, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(740, 131, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(741, 131, 75, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(748, 132, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(757, 133, 1, 'Gansh2', 15, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(758, 133, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(759, 94, 1, 'Gansh2', 24, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(768, 88, 1, 'Gansh2', 21, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(790, 135, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(817, 130, 1, 'Gansh1', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(818, 138, 80, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(819, 137, 80, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(825, 118, 74, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(828, 139, 1, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(830, 61, 2, 'Gansh2', 2, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(833, 140, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(837, 141, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(869, 146, 1, 'Gansh2', 18, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(870, 146, 81, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(875, 147, 85, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(892, 63, 2, 'Gansh2', 4, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(910, 62, 2, 'Gansh2', 3, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(915, 134, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(918, 100, 1, 'Gansh2', 9, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(925, 87, 1, 'Gansh2', 20, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(926, 152, 1, 'Gansh2', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(945, 148, 1, 'Gansh2', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(953, 162, 1, 'Gansh2', 61, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(961, 164, 86, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(965, 136, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(968, 163, 1, 'Gansh2', 62, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(978, 158, 79, 'Gansh2', 7, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(979, 160, 79, 'Gansh2', 5, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(988, 142, 79, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1008, 105, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1009, 106, 66, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1010, 106, 2, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1011, 107, 66, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1012, 107, 2, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1013, 109, 2, 'Gansh2', 11, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1016, 89, 2, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1033, 167, 88, 'Gansh7', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1034, 129, 1, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1035, 168, 79, 'Gansh2', 8, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1037, 165, 1, 'Gansh2', 63, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1038, 166, 1, 'Gansh2', 64, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1041, 156, 79, 'Gansh2', 6, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1050, 169, 79, 'Visiting Scientist', 9, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1060, 171, 1, 'Gansh7', 65, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1064, 175, 1, 'Gansh1', 67, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1066, 176, 89, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1068, 177, 91, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1071, 178, 1, 'Gansh7', 68, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1072, 44, 2, 'Gansh2', 16, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1075, 180, 1, 'Gansh2', 69, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1077, 181, 94, '', 1, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1078, 58, 66, 'Gansh3', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1079, 182, 96, 'Gansh2', 70, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1081, 183, 2, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1083, 172, 1, 'Gansh2', 66, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1086, 149, 1, 'Gansh2', 19, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1088, 122, 1, 'Gansh2', 17, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1089, 77, 1, 'Gansh2', 12, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1091, 184, 1, 'Gansh2', 70, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1092, 85, 1, 'Gansh2', 18, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1095, 170, 79, 'Gansh2', 10, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1102, 186, 99, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1104, 150, 6, 'Gansh2', 0, '0000-00-00 00:00:00');
INSERT INTO `invention_inventor_bkp_17nov` VALUES(1108, 185, 97, 'Gansh2', 1, '0000-00-00 00:00:00');

-- --------------------------------------------------------

--
-- Table structure for table `invention_project`
--

CREATE TABLE `invention_project` (
  `id` int(11) NOT NULL auto_increment,
  `invention_id` int(11) NOT NULL,
  `have_worked` varchar(255) NOT NULL,
  `company_name` varchar(255) NOT NULL,
  `mta` varchar(100) NOT NULL,
  `sra` varchar(100) NOT NULL,
  `scientific` varchar(100) NOT NULL,
  `clinical_trial` varchar(100) NOT NULL,
  `consulting` varchar(100) NOT NULL,
  `other` varchar(100) NOT NULL,
  `textother` varchar(255) NOT NULL,
  PRIMARY KEY  (`id`)
) ENGINE=InnoDB  DEFAULT CHARSET=latin1 AUTO_INCREMENT=3589 ;

--
-- Dumping data for table `invention_project`
--

INSERT INTO `invention_project` VALUES(90, 70, 'Yes', 'company 1', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(91, 70, 'In-disk', 'company 2', '', '', '', '', 'Consulting', '', '');
INSERT INTO `invention_project` VALUES(93, 71, 'Yes', '', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(127, 74, 'Yes', 'Company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(339, 84, 'Yes', 'company 1', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(405, 86, 'Yes', 'novartis', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(444, 90, 'Yes', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(529, 95, 'Yes', '', 'MTA', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(548, 96, 'Yes', '', 'MTA', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(591, 97, 'In-disk', 'Affymetrix', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(741, 99, 'Yes', '', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(811, 80, 'Yes', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(813, 92, 'Yes', '', '', '', '', '', 'Consulting', '', '');
INSERT INTO `invention_project` VALUES(819, 101, 'Yes', 'company 1', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(820, 98, 'Yes', 'company', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(902, 107, 'Yes', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(949, 110, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1049, 108, 'Yes', '', '', '', '', '', '', 'Other', '');
INSERT INTO `invention_project` VALUES(1214, 116, 'Yes', 'company 1', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1231, 81, 'Yes', '', '', '', '', 'Clinical Trial', '', '', '');
INSERT INTO `invention_project` VALUES(1247, 109, 'Yes', '', '', '', '', '', '', 'Other', '');
INSERT INTO `invention_project` VALUES(1269, 122, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1332, 128, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1337, 123, 'Yes', 'company 1', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1339, 111, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1355, 100, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1553, 131, 'In-disk', 'company 1', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1554, 131, 'Yes', 'company 2', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(1562, 132, 'Yes', '', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1628, 133, 'Yes', ' company', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1629, 133, 'In-disk', 'company 2', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(1699, 88, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1719, 106, 'In-disk', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(1738, 61, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1786, 135, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1863, 137, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(1895, 130, 'In-disk', '', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(1928, 118, 'Yes', 'company 1', 'MTA', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(1998, 139, 'Yes', 'merck', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(1999, 139, 'In-disk', 'company 2', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2066, 105, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2085, 141, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2127, 142, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2171, 146, 'Yes', 'company 1', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2208, 148, 'In-disk', 'company 1', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2230, 63, 'Yes', '', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2300, 136, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2314, 134, 'In-disk', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(2326, 62, 'Yes', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(2374, 162, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2424, 164, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2450, 163, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2535, 158, 'In-disk', 'COMPANY 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(2538, 160, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2719, 89, 'Yes', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(2750, 167, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2752, 168, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2766, 129, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2780, 165, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2783, 166, 'Yes', '', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2787, 156, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2842, 172, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2861, 171, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2947, 170, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(2965, 186, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3002, 150, 'Yes', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(3060, 140, 'Yes', 'novartis', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3061, 140, 'In-disk', 'company 2', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(3090, 187, 'In-disk', '', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3091, 185, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3184, 191, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3229, 44, 'Yes', '', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3248, 194, 'Yes', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(3256, 203, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3261, 205, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3313, 206, 'Yes', 'company 1', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3314, 206, 'In-disk', 'company 2', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(3336, 190, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3337, 190, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3378, 208, 'In-disk', 'company1 ', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(3400, 103, 'Yes', 'company 1', '', '', 'Scientific', '', '', '', '');
INSERT INTO `invention_project` VALUES(3420, 209, 'Yes', 'company 1', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3421, 58, 'Yes', '', '', '', '', '', 'Consulting', '', '');
INSERT INTO `invention_project` VALUES(3445, 189, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3456, 210, 'Yes', 't', '', '', '', '', 'Consulting', '', '');
INSERT INTO `invention_project` VALUES(3460, 152, 'Yes', '', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3499, 211, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3513, 212, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3519, 188, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3526, 213, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3530, 87, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3537, 223, 'Yes', 'company 1', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3546, 112, 'Yes', 'company 1', 'MTA', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3547, 112, 'In-disk', 'company 2', '', 'SRA', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3550, 243, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3560, 246, 'No', '', '', '', '', '', '', '', '');
INSERT INTO `invention_project` VALUES(3562, 85, 'In-disk', 'pfizer', '', '', 'Scientific', '', 'Consulting', '', '');
INSERT INTO `invention_project` VALUES(3587, 77, 'Yes', 'company 1', '', '', '', 'Clinical Trial', '', '', '');
INSERT INTO `invention_project` VALUES(3588, 77, 'Yes', 'company 2', '', 'SRA', '', '', '', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `inventors`
--

CREATE TABLE `inventors` (
  `id` int(11) NOT NULL auto_increment,
  `invention_number` int(11) NOT NULL,
  `investigator_name` varchar(255) NOT NULL,
  `institutional_title` varchar(255) NOT NULL,
  `citizen_ship` varchar(255) NOT NULL,
  `home_address` varchar(255) NOT NULL,
  `email` varchar(255) NOT NULL,
  `password` varchar(255) NOT NULL,
  `phone_number` varchar(255) NOT NULL,
  `isactive` enum('Y','N') NOT NULL default 'N',
  `created` datetime NOT NULL,
  `modified` datetime NOT NULL,
  `investigator_lname` varchar(255) NOT NULL,
  `user_type` int(11) NOT NULL,
  `is_admin` int(11) NOT NULL,
  PRIMARY KEY  (`id`)
) ENGINE=InnoDB  DEFAULT CHARSET=latin1 AUTO_INCREMENT=166 ;

--
-- Dumping data for table `inventors`
--

INSERT INTO `inventors` VALUES(1, 20001, 'John Smith', 'Professor', 'Test citi', 'Address 123', 'test@test.com', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '123456789', 'Y', '2013-08-27 15:42:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(2, 20002, 'Jane Doe', 'Associate Professor', 'Australian asd', 'Doe Drive, MA', 'jdoe@hospital.com', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '781-555-5555', 'Y', '2013-08-29 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(3, 20003, 'Jack Smith2', 'Assistant Professor', 'United Kingdom', 'Jack Street, MA', 'jack@university.edu', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '978-555-5555', 'Y', '2013-08-29 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(5, 20004, 'Mike Smith', 'Post-Doc', 'United States', 'Mike Road, MA', 'mike@univ.edu', '', '508-555-5555', 'Y', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(6, 20005, 'Jean Paul ', 'Professor', 'American', 'Paul Road, MA', 'paul@hospital.org', '', '617-777-7777', 'Y', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(20, 0, 'Adam Smith3', 'Student', 'Russian', 'adam drive, MA', 'adam@college.edu', '', '111-111-1111', 'Y', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(21, 0, 'Beth Inventor1', 'Visiting Scientist', 'Indian', 'Beth road, CA', 'beth@univ.edu', '', '222-222-2222', 'Y', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(22, 0, 'Cole Disclosure1', 'Chief', 'American', 'cole street, VA', 'cole@institution.org', '', '333-333-3333', 'Y', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(23, 0, 'Dolly Inventor2', 'Head of the Department', 'Ireland', 'dolly drive, IL', 'dolly@hospital.org', '', '444-444-4444', 'Y', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(24, 0, 'El Inventor3', 'Assistant Professor', 'United Kingdom', 'El road, FL', 'el@univ.edu', '', '555-555-5555', 'Y', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(64, 0, '', '', 'American', '8090', 'umaskaun@gmail.com', '', '09808089', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(65, 0, 'smith john', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(66, 0, 'Michael Scott', '', 'Scotland', 'Scott Dr', 'scott@test.org', '', '777-777-7777', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(67, 0, 'test', '', '', 'test', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(68, 0, 'John Smith', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(69, 0, 'Jane Doe', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(70, 0, 'Jane Doe', '', 'Scotland', 'Scott Dr', 'scott@test.org', '', '777-777-7777', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(71, 0, 'test survey', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(72, 0, 'valtease', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(73, 0, 'valtest', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(74, 0, 'USK1', '', 'United Kingdom', 'USK1 st', 'usk1@institution.org', '', '555-333-2222', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(75, 0, 'Michael Scott', '', 'American', 'Mike Road, MA', 'mike@univ.edu', '', '508-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(76, 0, 'Michael Scott', '', 'Scotland', 'Scott Dr', 'scott@test.org', '', '777-777-7777', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(77, 0, 'Michael Scott', '', 'American', 'Mike Road, MA', 'mike@univ.edu', '', '508-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(78, 0, 'Michael Scott', '', 'American', 'Mike Road, MA', 'mike@univ.edu', '', '508-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(79, 0, 'Gee Kaun', '', 'geeland', 'gee streetHH', 'gee@company.com', '', '888-999-1234', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(80, 0, 'Shyam Mah', '', 'smland', 'sm street', 'sm01@hospital.org', '', '777-444-2222', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(81, 0, 'Michael Scott', '', 'American', 'Mike Road, MA', 'mike@univ.edu', '', '508-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(82, 0, 'Michael Scott', '', 'Scotland', 'Scott Dr', 'scott@test.org', '', '777-777-7777', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(83, 0, 'Michael Scott', '', 'American', 'Mike Road, MA', 'mike@univ.edu', '', '508-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(84, 0, 'Michael Scott', '', 'American', 'Mike Road, MA', 'mike@univ.edu', '', '508-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(85, 0, 'VNS1', '', 'VNSland', 'VNS1', 'VNS1@email.com', '', '777-777-7777', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(86, 0, 'Jill Murthi', '', 'jill land', 'test st', 'jill@institution.edu', '', '222-222-1111', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(87, 0, 'test nov 18', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(88, 0, 'Alexander S. Martinez-Forte', '', 'USA', '1820 Skyline Drive Unit 14 Lowell, MA 01854', 'alexmartinez09@live.com', '', '401-585-2557', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(89, 0, 'Jack Smith2', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(90, 0, 'Jack Smith2', '', 'United Kingdom', 'Jack Street, MA', 'jack@university.edu', '', '978-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(91, 0, 'Jack Smith2', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(92, 0, 'Jack Smith2', '', 'United Kingdom', 'Jack Street, MA', 'jack@university.edu', '', '978-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(93, 0, 'Jane Doe', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(94, 0, 'Jill Murthi', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(95, 0, 'Jill Murthi', '', 'jill land', 'test st', 'jill@institution.edu', '', '222-222-1111', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(96, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(97, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(98, 0, 'Jean Paul ', '', 'American', 'Paul Road, MA', 'paul@hospital.org', '', '617-777-7777', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(99, 0, 'nov 26', '', 'United Kingdom', 'USK1 st', 'usk1@university.edu', '', '888-999-1234', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(100, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(101, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(102, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(103, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(104, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(105, 0, 'Jean Paul ', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(106, 0, 'Xingwei Wang', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(107, 0, 'Xingwei Wang', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(108, 0, 'Xingwei Wang', '', '', '17 Keyes House Rd., Shrewsbury, MA 01545', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(109, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(110, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(111, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', '', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(112, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(113, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(114, 0, 'Nan Wu', '', 'China', '1510 Skyline Dr. Unit 11, Lowell, MA 01854', 'nan_wu@uml.edu', '', '(978) 729-5047', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(115, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(116, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(117, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(118, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(119, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(120, 0, 'Yang Zhang', '', 'US', '', 'yang_zhang@student.uml.edu', '', '9367183108', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(121, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(122, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(123, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(124, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(125, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(126, 0, 'Tyler Schmitt', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(127, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(128, 0, 'Tyler Schmitt', '', 'US', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(129, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(130, 0, 'Tyler Schmitt', '', 'US', '', 'Tyler_Schmitt@student.uml.edu', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(131, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(132, 0, 'Tyler Schmitt', '', 'US', '', 'Tyler_Schmitt@student.uml.edu', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(133, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(134, 0, 'Tyler Schmitt', '', 'US', '', 'Tyler_Schmitt@student.uml.edu', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(135, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(136, 0, 'Tyler Schmitt', '', 'US', '', 'Tyler_Schmitt@student.uml.edu', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(137, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(138, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(139, 0, 'test nov 18', '', '', 'test', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(140, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(141, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(142, 0, 'John Smith', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(143, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(144, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(145, 0, 'Karthik Ramu', '', 'American', 'Bedford, MA', 'karthik1407@gmail.com', '', '9964053368', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(146, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(147, 0, 'Xingwei Wang', '', 'China', '17 Keyes House Rd., Shrewsbury, MA 01545', 'xingwei_wang@uml.edu', '', '(617) 530-0355', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(148, 0, 'Jane Doe', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(149, 0, 'Jane Doe', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(150, 0, 'Jane Doe', '', 'Australian asd', 'Doe Drive, MA', 'jdoe@hospital.com', '', '781-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(151, 0, 'Jane Doe', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(152, 0, 'Jane Doe', '', 'Australian asd', 'Doe Drive, MA', 'jdoe@hospital.com', '', '781-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(153, 0, 'Jane Doe', '', 'Test citi', 'Address 123', 'test@test.com', '', '123456789', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(154, 0, 'Jane Doe', '', 'Australian asd', 'Doe Drive, MA', 'jdoe@hospital.com', '', '781-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(155, 0, 'Jane Doe', '', 'Australian asd', 'Doe Drive, MA', 'jdoe@hospital.com', '', '781-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(156, 0, 'Jane Doe', '', 'Australian asd', 'Doe Drive, MA', 'jdoe@hospital.com', '', '781-555-5555', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(157, 0, 'Karthik ', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(158, 0, 'Ramesh Pateel ', '', 'Indian', 'Bedford MA', 'ramesh.pateel@gmail.com', '', '9964053368', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(159, 0, 'Ramesh Pateel ', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(160, 0, 'jon smith ', '', '', '', '', '', '', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(161, 0, 'Karthik avishkar', '', 'indian', '45 sweetwater ave', 'ar_karthi@yahoo.com', '', '707052870582', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(162, 0, 'Ramesh Kumar', '', 'American', 'Billerica, MA', 'ramesh.pateel@yahoo.com', '', '9784281884', 'N', '0000-00-00 00:00:00', '0000-00-00 00:00:00', '', 0, 0);
INSERT INTO `inventors` VALUES(163, 0, 'sachin', 'source', 'indian', 'dddd', 'shamith@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '123', 'N', '2013-12-17 00:12:26', '0000-00-00 00:00:00', 'tendulkar', 0, 0);
INSERT INTO `inventors` VALUES(164, 0, 'Uma', 'Proffesor', 'American', '8098, concord st', 'umaskaun@gmail.com', '63f62b3c4b4a19c67716560ee211d42b48775829', '70870700808', 'N', '2013-12-17 17:03:21', '0000-00-00 00:00:00', 'Kaundinya', 0, 0);
INSERT INTO `inventors` VALUES(165, 0, 'Lochan', 'Head of the Dept', 'India', '123, boston rd', 'lochan.karthikeyan@gmail.com', '96789db2d8efbca61c7dd9eccbcd5476cbea4b70', '1112223333', 'N', '2013-12-17 18:20:39', '0000-00-00 00:00:00', 'Karthikeyan', 0, 0);

-- --------------------------------------------------------

--
-- Table structure for table `users`
--

CREATE TABLE `users` (
  `id` int(11) NOT NULL auto_increment,
  `invention_number` int(11) NOT NULL,
  `investigator_name` varchar(255) NOT NULL,
  `institutional_title` varchar(255) NOT NULL,
  `citizen_ship` varchar(255) NOT NULL,
  `home_address` varchar(255) NOT NULL,
  `email` varchar(255) NOT NULL,
  `password` varchar(255) NOT NULL,
  `phone_number` varchar(255) NOT NULL,
  `confirm_code` varchar(255) NOT NULL,
  `isactive` enum('Y','N') NOT NULL default 'N',
  `user_type` int(11) NOT NULL,
  `is_admin` int(11) NOT NULL,
  `created` datetime NOT NULL,
  `modified` datetime NOT NULL,
  `investigator_lname` varchar(255) NOT NULL,
  PRIMARY KEY  (`id`)
) ENGINE=InnoDB  DEFAULT CHARSET=latin1 AUTO_INCREMENT=58 ;

--
-- Dumping data for table `users`
--

INSERT INTO `users` VALUES(1, 20001, 'John Smith', 'Professor', 'American', 'Smith Drive, MA', 'jsmith@institution.org', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '617-555-5555', '', 'Y', 0, 0, '2013-08-27 15:42:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(2, 20002, 'Jane Doe', 'Associate Professor', 'Australian', 'Doe Drive, MA', 'jdoe@hospital.com', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '781-555-5555', '', 'Y', 0, 0, '2013-08-29 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(3, 20003, 'Jack Smith2', 'Assistant Professor', 'United Kingdom', 'Jack Street, MA', 'jack@university.edu', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '978-555-5555', '', 'N', 0, 0, '2013-08-29 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(4, 20004, 'John Smith', 'Professor', 'American', 'Smith Drive, MA', 'jsmith@institution.org', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '617-555-5555', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(5, 20004, 'Mike Smith', 'Post-Doc', 'American', 'Mike Road, MA', 'mike@univ.edu', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '508-555-5555', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(6, 20005, 'Jean Paul ', 'Professor', 'American', 'Paul Road, MA', 'paul@hospital.org', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '617-777-7777', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(7, 0, 'Adam Smith3', 'Student', 'Russian', 'adam drive, MA', 'adam@college.edu', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '111-111-1111', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(8, 0, 'Beth Inventor1', 'Visiting Scientist', 'Indian', 'Beth road, CA', 'beth@univ.edu', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '222-222-2222', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(9, 0, 'Cole Disclosure1', 'Chief', 'American', 'cole street, VA', 'cole@institution.org', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '333-333-3333', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(10, 0, 'Dolly Inventor2', 'Head of the Department', 'Ireland', 'dolly drive, IL', 'dolly@hospital.org', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '444-444-4444', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(11, 0, 'El Inventor3', 'Assistant Professor', 'United Kingdom', 'El road, FL', 'el@univ.edu', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '555-555-5555', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(12, 20006, 'User22', 'Professor', 'American', 'Smith Drive, MA', 'user22@institution.org', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '617-555-5555', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(13, 0, 'USK1', '', '', '', 'USK1@university.edu', 'c9993a97b6e9b2f590fb72195fd381b38970c75a', '', '', 'Y', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(14, 0, 'TDPS', '', '', '', 'TDPS@university.edu', '0dcde0f999f8dc6e3709922373b6611c03853e50', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(15, 0, 'SM01', '', '', '', 'SM01@hospital.org', '508d64ed2b93ec072f99a573d840c8439e35531c', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(16, 0, 'DAH1', '', '', '', 'DAH1@hospital.org', '9e33485b0723617870d03e78d3452b2c2a092875', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(17, 0, 'GVK1', '', '', '', 'GVK1@company.com', 'ef9d8cfe4cb9b650ca772275ab5d99a716078364', '', '', 'Y', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(18, 0, 'JRMV1', '', '', '', 'JRMV1@university.edu', '3f71378fb3232c5c2d81a21a67c1cf592dab02dd', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(19, 0, 'VNS1', '', '', '', 'VNS1@company.com', '680b5ea89a4dfdc93d32f0041aa1b21d777f565c', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(20, 0, 'VJ01', '', '', '', 'VJ01@company.com', '3302e657fc0f78bf76027c8b2cbcfc94801ed85e', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(21, 0, 'Dave1', '', '', '', 'Dave1@hospital.org', 'b2b6f9b8ded62baa5db73117a2b9a7f9f0c01400', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(22, 0, 'TQdo', '', '', '', 'TQdo@hospital.org', 'be3979885006d541646ce041cbaccfd44f8ce579', '', '', 'N', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(23, 0, 'USK2', '', '', '', 'USK2@institution.org', '581910ceca6fa725e39d2af869778aaeb56bc1c8', '', '', 'Y', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(24, 0, 'GVK2', '', '', '', 'GVK2@institution.com', 'b26717343b7844b686fc59069da238ecf49bbd56', '', '', 'Y', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(25, 0, 'JYL1', '', '', '', 'JYL1@institution.org', '9fbc9cd3c7bf25d3e7541581bb631d8c99f03db5', '', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(26, 0, 'RKP1', '', '', '', 'RKP1@institution.org', 'ba746cff4f8b09919f22ce909627bbbedf796361', '', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(27, 0, 'TQDo2 ', '', '', '', 'TQDo2@institution.org', '63438778787cc8fadf56c2038ac70512f0197ad2', '', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(28, 0, 'colm', '', '', '', 'colm@institution.org', '2741a059d5b5106e268261e953e8141ca46672b5', '', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(29, 0, 'VNS1', '', '', '', 'VNS1@institution.org', '680b5ea89a4dfdc93d32f0041aa1b21d777f565c', '', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(30, 0, 'JRMV', '', '', '', 'JRMV@institution.org', 'a5102208781a58cbefe7ba53a47dde09fcb0046b', '', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(31, 0, 'USK22', '', '', '', 'USK22@institution.org', 'efab687f6a86b80d1d8f6da0015a415be0053b3f', '', '', 'Y', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(32, 0, 'Dave2', '', '', '', 'Dave2@institution.org', 'fb04d50b29022a765faced026abf68c000b905a5', '', '', 'N', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(33, 0, 'Rkaushik1', '', '', '', 'Rkaushik1@uml.edu', 'b20cb2c7aabbcb732658a9e7e2c927bc0131e0df', '', '', 'Y', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(34, 0, 'Rkaushik2', '', '', '', 'Rkaushik2@uml.edu', 'a949d9550b6f19e2c6d8868085a9bf85d04950d8', '', '', 'Y', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(35, 0, 'Jill1', '', '', '', 'Jill1@uml.edu', '48ea9b9db7694b5907e092b316f90ecd3f87030f', '', '', 'Y', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(36, 0, 'Jill2', '', '', '', 'Jill2@uml.edu', 'ffa8385f0b37388d4f0aa3ba1ec9471c958d3ab8', '', '', 'Y', 2, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(37, 1, 'Swami Narayan', 'Student', 'American', 'bedford,MA', 'swami@gmail.com', '16a41bb00bfde6c1e9c93f2a129099d7aa474ee4', '9785532216', '123', 'Y', 1, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '');
INSERT INTO `users` VALUES(38, 1, 'Swami Narayan', 'Student', 'American', 'Bedford, MA', 'snarayan@gmail.com', '16a41bb00bfde6c1e9c93f2a129099d7aa474ee4', '9785532216', '123', 'Y', 1, 0, '2013-12-11 15:35:36', '2013-12-11 15:35:36', '');
INSERT INTO `users` VALUES(39, 1, 'Karthik Ramu', 'Student', 'American', 'Bedford, MA', 'karthik1407@gmail.com', '8aa2d594b8b6cbd435e577c19ad9a4a889284483', '9964053368', '123', 'Y', 1, 0, '2013-12-11 15:40:49', '2013-12-11 15:40:49', '');
INSERT INTO `users` VALUES(40, 1, 'Ganesh Kaundinya', 'CSO', 'USA', 'Ganesh Test Address', 'geekaun@gmail.com', '9edb2cf02a587c267cfc303a94df20f7328815f0', '617-699-4499', '123', 'Y', 1, 0, '2013-12-13 12:51:34', '2013-12-13 12:51:34', '');
INSERT INTO `users` VALUES(43, 0, 'ramesh', 'test', '12', 'sss', 'ramesh_pateel@gmail.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'N', 0, 1, '2013-12-16 13:21:32', '0000-00-00 00:00:00', 'pateel');
INSERT INTO `users` VALUES(44, 0, 'test', 'source', 'ddd', 'dddd', 'prakash@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'Y', 0, 0, '2013-12-16 13:23:51', '0000-00-00 00:00:00', 'khan');
INSERT INTO `users` VALUES(45, 0, 'test', 'source', 'test', 'ddd', 'vkerford@gmail.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'N', 0, 0, '2013-12-16 14:24:08', '0000-00-00 00:00:00', 'khan');
INSERT INTO `users` VALUES(46, 0, 'test', 'source', 'test', 'ddd', 'varun@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'Y', 0, 0, '2013-12-16 14:24:29', '0000-00-00 00:00:00', 'khan');
INSERT INTO `users` VALUES(47, 0, 'test', 'test', 'test', 'ddd', 'vkdderford@gmail.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'N', 0, 0, '2013-12-16 14:26:28', '0000-00-00 00:00:00', 'khan');
INSERT INTO `users` VALUES(48, 0, 'test', 'source', 'test', 'ttt', 'varunii@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'N', 0, 0, '2013-12-16 14:37:18', '0000-00-00 00:00:00', 'khan');
INSERT INTO `users` VALUES(49, 0, 'test', 'test', 'test', 'fff', 'varffun@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'N', 0, 0, '2013-12-16 14:39:02', '0000-00-00 00:00:00', 'khan');
INSERT INTO `users` VALUES(50, 0, 'test', 'source', '12', 'vvv', 'varufffn@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '', 'N', 0, 0, '2013-12-16 14:45:44', '0000-00-00 00:00:00', 'khan');
INSERT INTO `users` VALUES(51, 0, 'Karthik', 'avishkar', 'indian', '34 sweet water ave', 'ar_karthi@yahoo.com', '3c75e533f133c47fe63c62330f5e2e6ee39635de', '78034379980', '', 'Y', 0, 0, '2013-12-16 16:56:33', '0000-00-00 00:00:00', 'Bedford');
INSERT INTO `users` VALUES(52, 0, 'Ramesh', 'Student', 'American', 'Billerica, MA', 'ramesh.pateel@gmail.com', '01eb06556381cb1f8bef952fe28288373f54a9ba', '9964053368', '', 'Y', 0, 0, '2013-12-16 17:46:27', '0000-00-00 00:00:00', 'Pateel');
INSERT INTO `users` VALUES(53, 0, 'vijeth', 'test', 'test', 'cccc', 'source@source.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '123', '', 'Y', 0, 0, '2013-12-16 21:15:08', '0000-00-00 00:00:00', 'k');
INSERT INTO `users` VALUES(54, 0, 'Ramesh', 'Student', 'American', 'Billerica, MA', 'ramesh.pateel@yahoo.com', '01eb06556381cb1f8bef952fe28288373f54a9ba', '9978281884', '', 'Y', 0, 0, '2013-12-16 21:38:53', '0000-00-00 00:00:00', 'Kumar');
INSERT INTO `users` VALUES(55, 0, 'sachin', 'source', 'indian', 'dddd', 'shamith@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '123', '', 'Y', 0, 0, '2013-12-17 00:12:26', '0000-00-00 00:00:00', 'tendulkar');
INSERT INTO `users` VALUES(56, 0, 'Uma', 'Proffesor', 'American', '8098, concord st', 'umaskaun@gmail.com', '63f62b3c4b4a19c67716560ee211d42b48775829', '70870700808', '', 'Y', 0, 0, '2013-12-17 17:03:21', '0000-00-00 00:00:00', 'Kaundinya');
INSERT INTO `users` VALUES(57, 0, 'Lochan', 'Head of the Dept', 'India', '123, boston rd', 'lochan.karthikeyan@gmail.com', '96789db2d8efbca61c7dd9eccbcd5476cbea4b70', '1112223333', '', 'Y', 0, 0, '2013-12-17 18:20:39', '0000-00-00 00:00:00', 'Karthikeyan');

-- --------------------------------------------------------

--
-- Table structure for table `users1`
--

CREATE TABLE `users1` (
  `id` int(11) unsigned NOT NULL auto_increment,
  `investigator_name` varchar(255) NOT NULL,
  `investigator_lname` varchar(255) NOT NULL,
  `institutional_title` varchar(255) NOT NULL,
  `citizen_ship` varchar(255) NOT NULL,
  `home_address` varchar(255) NOT NULL,
  `email` varchar(255) NOT NULL,
  `password` varchar(255) NOT NULL,
  `phone_number` varchar(255) NOT NULL,
  `created` datetime NOT NULL,
  `isactive` enum('Y','N') NOT NULL default 'N',
  `is_admin` int(11) NOT NULL,
  PRIMARY KEY  (`id`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=23 ;

--
-- Dumping data for table `users1`
--

INSERT INTO `users1` VALUES(1, 'test', 'khan', 'source', 'test', 'tttt', 'vkerford1@gmail.com', '0fdee856a24dabe8d046aa88d4088505916ba282', '919632006527', '2013-12-13 13:47:29', 'N', 0);
INSERT INTO `users1` VALUES(4, 'test', 'khan', 'source', 'test', 'test', 'vkerford@gmail.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '2013-12-13 16:11:20', 'Y', 0);
INSERT INTO `users1` VALUES(5, 'test', 'khan', 'source', 'test', 'fff', 'vkerford@gmail.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '2013-12-13 16:13:51', 'N', 0);
INSERT INTO `users1` VALUES(6, 'test', 'khan', 'source', 'test', 'fffff', 'varun@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '2013-12-13 16:16:41', 'N', 0);
INSERT INTO `users1` VALUES(7, 'test', 'k', 'test', 'eeee', 'eeee', 'jsmithe@institution.org', '65eb6224a4199622f72bf622e3244480f4b3ee84', '123456', '2013-12-14 10:32:56', 'N', 0);
INSERT INTO `users1` VALUES(8, 'test', 'k', 'test', 'eeee', 'eeee', 'jsmithea@institution.org', '65eb6224a4199622f72bf622e3244480f4b3ee84', '123456', '2013-12-14 10:42:28', 'N', 0);
INSERT INTO `users1` VALUES(9, 'test', 'k', 'test', 'eeee', 'eeee', 'jsmithea@institution.org', '65eb6224a4199622f72bf622e3244480f4b3ee84', '123456', '2013-12-14 10:55:05', 'N', 0);
INSERT INTO `users1` VALUES(12, 'varun', 'khan', 'source', 'test', 'kkk', 'vijeth@sourcepagetech.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '2013-12-14 14:20:49', 'Y', 1);
INSERT INTO `users1` VALUES(13, 'vvvvv', 'vvv', 'test', 'ddd', 'ddd', 'jsmith111@institution.org', '718a798aed0cbfea4f6ad24e21f60efc9ca95611', '123456', '2013-12-14 15:08:51', 'N', 0);
INSERT INTO `users1` VALUES(14, 'test', 'khan', 'source', 'test', 'ff', 'vkerford11@gmail.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '2013-12-15 05:37:08', 'N', 0);
INSERT INTO `users1` VALUES(15, 'test', 'khan', 'source', 'test', 'dddd', 'vkerford11111@gmail.com', '65eb6224a4199622f72bf622e3244480f4b3ee84', '919632006527', '2013-12-15 05:37:49', 'N', 0);
INSERT INTO `users1` VALUES(16, 'test', 'khan', 'source', 'test', 'eee', 'jsmith@institution.org', '927ceeea13af1f7e65a6a545cf2781dd93f8371b', '919632006527', '2013-12-15 06:00:32', 'N', 0);
